proprietary_name,ndc_package_code,strength,dosage_form,route,appl_no,labeler_name,product_ndc,nonproprietary_name,substance_name,product_type_name,start_marketing_date,end_marketing_date,market_category,package_description,pharm_class,dea,sample_package,listing_record_certified_through,ndc,drug_name,bup_strength_clean
Alfentanil Hydrochloride,17478-067-02,500 ug/mL,INJECTION,INTRAVENOUS,NDA019353,Akorn,17478-067,Alfentanil Hydrochloride,ALFENTANIL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/01/2010,N/A,NDA,10 AMPULE in 1 CARTON (17478-067-02)  / 2 mL in 1 AMPULE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17478006702,Alfentanil,500
Alfentanil Hydrochloride,17478-067-05,500 ug/mL,INJECTION,INTRAVENOUS,NDA019353,Akorn,17478-067,Alfentanil Hydrochloride,ALFENTANIL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/01/2010,N/A,NDA,10 AMPULE in 1 CARTON (17478-067-05)  / 5 mL in 1 AMPULE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17478006705,Alfentanil,500
BELBUCA,59385-021-60,75 ug/1,"FILM, SOLUBLE",BUCCAL,NDA207932,BioDelivery Sciences International Inc,59385-021,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/01/2017,N/A,NDA,"60 POUCH in 1 CARTON (59385-021-60)  / 1 FILM, SOLUBLE in 1 POUCH (59385-021-01)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,59385002160,Buprenorphine,75
BELBUCA,59385-022-60,150 ug/1,"FILM, SOLUBLE",BUCCAL,NDA207932,BioDelivery Sciences International Inc,59385-022,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/01/2017,N/A,NDA,"60 POUCH in 1 CARTON (59385-022-60)  / 1 FILM, SOLUBLE in 1 POUCH (59385-022-01)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,59385002260,Buprenorphine,150
BELBUCA,59385-023-60,300 ug/1,"FILM, SOLUBLE",BUCCAL,NDA207932,BioDelivery Sciences International Inc,59385-023,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/01/2017,N/A,NDA,"60 POUCH in 1 CARTON (59385-023-60)  / 1 FILM, SOLUBLE in 1 POUCH (59385-023-01)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,59385002360,Buprenorphine,300
BELBUCA,59385-024-60,450 ug/1,"FILM, SOLUBLE",BUCCAL,NDA207932,BioDelivery Sciences International Inc,59385-024,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/21/2017,N/A,NDA,"60 POUCH in 1 CARTON (59385-024-60)  / 1 FILM, SOLUBLE in 1 POUCH (59385-024-01)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,59385002460,Buprenorphine,450
BELBUCA,59385-025-60,600 ug/1,"FILM, SOLUBLE",BUCCAL,NDA207932,BioDelivery Sciences International Inc,59385-025,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/24/2017,N/A,NDA,"60 POUCH in 1 CARTON (59385-025-60)  / 1 FILM, SOLUBLE in 1 POUCH (59385-025-01)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,59385002560,Buprenorphine,600
BELBUCA,59385-026-60,750 ug/1,"FILM, SOLUBLE",BUCCAL,NDA207932,BioDelivery Sciences International Inc,59385-026,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/01/2017,N/A,NDA,"60 POUCH in 1 CARTON (59385-026-60)  / 1 FILM, SOLUBLE in 1 POUCH (59385-026-01)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,59385002660,Buprenorphine,750
BELBUCA,59385-027-60,900 ug/1,"FILM, SOLUBLE",BUCCAL,NDA207932,BioDelivery Sciences International Inc,59385-027,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/11/2017,N/A,NDA,"60 POUCH in 1 CARTON (59385-027-60)  / 1 FILM, SOLUBLE in 1 POUCH (59385-027-01)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,59385002760,Buprenorphine,900
Buprenex,12496-0757-5,.3 mg/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA018401,Indivior Inc.,12496-0757,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/30/1985,N/A,NDA,5 AMPULE in 1 CARTON (12496-0757-5)  / 1 mL in 1 AMPULE (12496-0757-1),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,12496075705,Buprenorphine,0.3
BUPRENORPHINE,71335-0950-2,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/13/2018,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0950-2),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335095002,Buprenorphine,2
Buprenorphine,42858-586-40,15 ug/h,PATCH,TRANSDERMAL,NDA021306,Rhodes Pharmaceuticals L.P.,42858-586,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,07/05/2017,N/A,NDA AUTHORIZED GENERIC,4 POUCH in 1 CARTON (42858-586-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,42858058640,Buprenorphine,15
BUPRENORPHINE,71335-0950-4,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2022,N/A,ANDA,7 TABLET in 1 BOTTLE (71335-0950-4),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335095004,Buprenorphine,2
Buprenorphine,62756-459-83,2 mg/1,TABLET,SUBLINGUAL,ANDA201760,"Sun Pharmaceutical Industries, Inc.",62756-459,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (62756-459-83),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,62756045983,Buprenorphine,2
Buprenorphine,62756-460-83,8 mg/1,TABLET,SUBLINGUAL,ANDA201760,"Sun Pharmaceutical Industries, Inc.",62756-460,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (62756-460-83),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,62756046083,Buprenorphine,8
BUPRENORPHINE,71335-0950-8,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0950-8),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335095008,Buprenorphine,2
Buprenorphine,0093-3657-40,10 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA204937,"Teva Pharmaceuticals USA, Inc.",0093-3657,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,11/26/2018,N/A,ANDA,4 POUCH in 1 CARTON (0093-3657-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00093365740,Buprenorphine,10
Buprenorphine,0228-3153-03,8 mg/1,TABLET,SUBLINGUAL,ANDA090819,"Actavis Pharma, Inc.",0228-3153,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/10/2015,N/A,ANDA,30 TABLET in 1 BOTTLE (0228-3153-03),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00228315303,Buprenorphine,8
Buprenorphine,0228-3156-03,2 mg/1,TABLET,SUBLINGUAL,ANDA090819,"Actavis Pharma, Inc.",0228-3156,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/10/2015,N/A,ANDA,30 TABLET in 1 BOTTLE (0228-3156-03),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00228315603,Buprenorphine,2
BUPRENORPHINE,42858-501-03,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Rhodes Pharmaceuticals L.P.,42858-501,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/25/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (42858-501-03),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,42858050103,Buprenorphine,2
Buprenorphine,62756-459-64,2 mg/1,TABLET,SUBLINGUAL,ANDA201760,"Sun Pharmaceutical Industries, Inc.",62756-459,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2016,N/A,ANDA,3 BLISTER PACK in 1 CARTON (62756-459-64)  / 10 TABLET in 1 BLISTER PACK,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,62756045964,Buprenorphine,2
BUPRENORPHINE,71335-0950-5,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-0950-5),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335095005,Buprenorphine,2
BUPRENORPHINE,71335-0950-7,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2022,N/A,ANDA,12 TABLET in 1 BOTTLE (71335-0950-7),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335095007,Buprenorphine,2
BUPRENORPHINE,71335-1154-0,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1154-0),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335115400,Buprenorphine,8
BUPRENORPHINE,71335-1154-1,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1154-1),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335115401,Buprenorphine,8
BUPRENORPHINE,71335-1154-2,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1154-2),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335115402,Buprenorphine,8
BUPRENORPHINE,71335-1154-3,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/22/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1154-3),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335115403,Buprenorphine,8
BUPRENORPHINE,71335-1154-4,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1154-4),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335115404,Buprenorphine,8
BUPRENORPHINE,71335-1154-5,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/16/2020,N/A,ANDA,7 TABLET in 1 BOTTLE (71335-1154-5),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335115405,Buprenorphine,8
BUPRENORPHINE,71335-1154-6,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/28/2021,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1154-6),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335115406,Buprenorphine,8
BUPRENORPHINE,71335-1154-7,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,1 TABLET in 1 BOTTLE (71335-1154-7),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335115407,Buprenorphine,8
BUPRENORPHINE,71335-1154-8,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,12 TABLET in 1 BOTTLE (71335-1154-8),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335115408,Buprenorphine,8
BUPRENORPHINE,71335-1154-9,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-1154,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,14 TABLET in 1 BOTTLE (71335-1154-9),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335115409,Buprenorphine,8
Buprenorphine,62756-460-64,8 mg/1,TABLET,SUBLINGUAL,ANDA201760,"Sun Pharmaceutical Industries, Inc.",62756-460,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2016,N/A,ANDA,3 BLISTER PACK in 1 CARTON (62756-460-64)  / 10 TABLET in 1 BLISTER PACK,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,62756046064,Buprenorphine,8
BUPRENORPHINE,58118-0501-8,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,"Clinical Solutions Wholesale, LLC",58118-0501,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/25/2017,N/A,ANDA,30 TABLET in 1 BLISTER PACK (58118-0501-8),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,58118050108,Buprenorphine,2
BUPRENORPHINE,71335-0950-6,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2022,N/A,ANDA,1 TABLET in 1 BOTTLE (71335-0950-6),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335095006,Buprenorphine,2
BUPRENORPHINE,58118-0502-8,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,"Clinical Solutions Wholesale, LLC",58118-0502,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/07/2022,N/A,ANDA,30 TABLET in 1 BLISTER PACK (58118-0502-8),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,58118050208,Buprenorphine,8
Buprenorphine,60687-481-21,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,American Health Packaging,60687-481,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/06/2020,N/A,ANDA,"30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-481-21)  / 1 TABLET in 1 BLISTER PACK (60687-481-11)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,60687048121,Buprenorphine,2
Buprenorphine,60687-492-21,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,American Health Packaging,60687-492,Buprenorphine,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/06/2020,N/A,ANDA,"30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-492-21)  / 1 TABLET in 1 BLISTER PACK (60687-492-11)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,60687049221,Buprenorphine,8
Buprenorphine,42858-353-40,7.5 ug/h,PATCH,TRANSDERMAL,NDA021306,Rhodes Pharmaceuticals L.P.,42858-353,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,07/05/2017,N/A,NDA AUTHORIZED GENERIC,4 POUCH in 1 CARTON (42858-353-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,42858035340,Buprenorphine,7.5
Buprenorphine,42858-493-40,10 ug/h,PATCH,TRANSDERMAL,NDA021306,Rhodes Pharmaceuticals L.P.,42858-493,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,07/05/2017,N/A,NDA AUTHORIZED GENERIC,4 POUCH in 1 CARTON (42858-493-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,42858049340,Buprenorphine,10
BUPRENORPHINE,42858-502-03,8 mg/1,TABLET,SUBLINGUAL,ANDA207276,Rhodes Pharmaceuticals L.P.,42858-502,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/25/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (42858-502-03),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,42858050203,Buprenorphine,8
Buprenorphine,42858-839-40,20 ug/h,PATCH,TRANSDERMAL,NDA021306,Rhodes Pharmaceuticals L.P.,42858-839,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,07/05/2017,N/A,NDA AUTHORIZED GENERIC,4 POUCH in 1 CARTON (42858-839-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,42858083940,Buprenorphine,20
Buprenorphine,42858-750-40,5 ug/h,PATCH,TRANSDERMAL,NDA021306,Rhodes Pharmaceuticals L.P.,42858-750,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,07/05/2017,N/A,NDA AUTHORIZED GENERIC,4 POUCH in 1 CARTON (42858-750-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,42858075040,Buprenorphine,5
Buprenorphine,0093-3659-40,20 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA204937,"Teva Pharmaceuticals USA, Inc.",0093-3659,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,11/26/2018,N/A,ANDA,4 POUCH in 1 CARTON (0093-3659-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00093365940,Buprenorphine,20
Buprenorphine,0093-3239-40,7.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA204937,"Teva Pharmaceuticals USA, Inc.",0093-3239,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,4 POUCH in 1 CARTON (0093-3239-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00093323940,Buprenorphine,7.5
BUPRENORPHINE,63629-9475-1,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,63629-9475,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/28/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (63629-9475-1),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,63629947501,Buprenorphine,2
BUPRENORPHINE,71335-0950-1,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/13/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0950-1),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335095001,Buprenorphine,2
Buprenorphine,69238-1202-2,5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA211586,Amneal Pharmaceuticals NY LLC,69238-1202,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,04/20/2020,N/A,ANDA,4 POUCH in 1 CARTON (69238-1202-2)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,69238120202,Buprenorphine,5
Buprenorphine,69238-1203-2,10 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA211586,Amneal Pharmaceuticals NY LLC,69238-1203,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,04/20/2020,N/A,ANDA,4 POUCH in 1 CARTON (69238-1203-2)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,69238120302,Buprenorphine,10
Buprenorphine,69238-1204-2,15 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA211586,Amneal Pharmaceuticals NY LLC,69238-1204,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,04/20/2020,N/A,ANDA,4 POUCH in 1 CARTON (69238-1204-2)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,69238120402,Buprenorphine,15
Buprenorphine,69238-1205-2,20 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA211586,Amneal Pharmaceuticals NY LLC,69238-1205,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,04/20/2020,N/A,ANDA,4 POUCH in 1 CARTON (69238-1205-2)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,69238120502,Buprenorphine,20
Buprenorphine,69238-1505-2,7.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA211586,Amneal Pharmaceuticals NY LLC,69238-1505,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,04/20/2020,N/A,ANDA,4 POUCH in 1 CARTON (69238-1505-2)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,69238150502,Buprenorphine,7.5
BUPRENORPHINE,71335-0950-3,2 mg/1,TABLET,SUBLINGUAL,ANDA207276,Bryant Ranch Prepack,71335-0950,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0950-3),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335095003,Buprenorphine,2
Buprenorphine,0093-3656-40,5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA204937,"Teva Pharmaceuticals USA, Inc.",0093-3656,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,11/26/2018,N/A,ANDA,4 POUCH in 1 CARTON (0093-3656-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00093365640,Buprenorphine,5
Buprenorphine,0093-3658-40,15 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA204937,"Teva Pharmaceuticals USA, Inc.",0093-3658,Buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,11/26/2018,N/A,ANDA,4 POUCH in 1 CARTON (0093-3658-40)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00093365840,Buprenorphine,15
Buprenorphine and Naloxone,43598-580-30,"4 mg/1,                         1  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,ANDA205806,Dr.Reddys Laboratories Inc,43598-580,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/14/2018,N/A,ANDA,"30 POUCH in 1 CARTON (43598-580-30)  / 1 FILM, SOLUBLE in 1 POUCH (43598-580-01)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,43598058030,Buprenorphine,4
Buprenorphine and Naloxone,0378-8765-93,"2 mg/1,                         .5  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA211785,Mylan Pharmaceuticals Inc.,0378-8765,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,04/17/2020,N/A,ANDA,30 POUCH in 1 CARTON (0378-8765-93)  / 1 FILM in 1 POUCH (0378-8765-16),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00378876593,Buprenorphine,2
Buprenorphine and Naloxone,0378-8766-93,"4 mg/1,                         1  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA211785,Mylan Pharmaceuticals Inc.,0378-8766,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,04/17/2020,N/A,ANDA,30 POUCH in 1 CARTON (0378-8766-93)  / 1 FILM in 1 POUCH (0378-8766-16),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00378876693,Buprenorphine,4
Buprenorphine and Naloxone,43598-579-30,"2 mg/1,                         .5  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,ANDA205299,Dr.Reddys Laboratories Inc,43598-579,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/14/2018,N/A,ANDA,"30 POUCH in 1 CARTON (43598-579-30)  / 1 FILM, SOLUBLE in 1 POUCH (43598-579-01)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,43598057930,Buprenorphine,2
Buprenorphine and Naloxone,0378-8768-93,"12 mg/1,                         3  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA207607,Mylan Pharmaceuticals Inc.,0378-8768,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/20/2019,N/A,ANDA,30 POUCH in 1 CARTON (0378-8768-93)  / 1 FILM in 1 POUCH (0378-8768-16),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00378876893,Buprenorphine,12
Buprenorphine and Naloxone,47781-355-03,"2 mg/1,                         .5  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA205954,Alvogen Inc.,47781-355,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/11/2019,N/A,ANDA,30 POUCH in 1 CARTON (47781-355-03)  / 1 FILM in 1 POUCH (47781-355-11),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,47781035503,Buprenorphine,2
Buprenorphine and Naloxone,47781-356-03,"4 mg/1,                         1  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA205954,Alvogen Inc.,47781-356,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/11/2019,N/A,ANDA,30 POUCH in 1 CARTON (47781-356-03)  / 1 FILM in 1 POUCH (47781-356-11),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,47781035603,Buprenorphine,4
Buprenorphine and Naloxone,47781-357-03,"8 mg/1,                         2  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA205954,Alvogen Inc.,47781-357,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/11/2019,N/A,ANDA,30 POUCH in 1 CARTON (47781-357-03)  / 1 FILM in 1 POUCH (47781-357-11),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,47781035703,Buprenorphine,8
Buprenorphine and Naloxone,47781-358-03,"12 mg/1,                         3  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA205954,Alvogen Inc.,47781-358,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/11/2019,N/A,ANDA,30 POUCH in 1 CARTON (47781-358-03)  / 1 FILM in 1 POUCH (47781-358-11),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,47781035803,Buprenorphine,12
Buprenorphine and Naloxone,0378-8767-93,"8 mg/1,                         2  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA207607,Mylan Pharmaceuticals Inc.,0378-8767,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE DIHYDRATE,HUMAN PRESCRIPTION DRUG,02/20/2019,N/A,ANDA,30 POUCH in 1 CARTON (0378-8767-93)  / 1 FILM in 1 POUCH (0378-8767-16),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00378876793,Buprenorphine,8
Buprenorphine and Naloxone,60505-7053-5,"8 mg/1,                         2  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA212756,Apotex Corp.,60505-7053,buprenorphine and naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2022,N/A,ANDA,30 POUCH in 1 CARTON (60505-7053-5)  / 1 FILM in 1 POUCH (60505-7053-0),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,60505705305,Buprenorphine,8
Buprenorphine and Naloxone,60505-7054-5,"12 mg/1,                         3  mg/1",FILM,BUCCAL; SUBLINGUAL,ANDA212756,Apotex Corp.,60505-7054,buprenorphine and naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2022,N/A,ANDA,30 POUCH in 1 CARTON (60505-7054-5)  / 1 FILM in 1 POUCH (60505-7054-0),"Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,60505705405,Buprenorphine,12
Buprenorphine and Naloxone,43598-581-30,"12 mg/1,                         3  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,ANDA205806,Dr.Reddys Laboratories Inc,43598-581,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/14/2018,N/A,ANDA,"30 POUCH in 1 CARTON (43598-581-30)  / 1 FILM, SOLUBLE in 1 POUCH (43598-581-01)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,43598058130,Buprenorphine,12
Buprenorphine and Naloxone,43598-582-30,"8 mg/1,                         2  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,ANDA205299,Dr.Reddys Laboratories Inc,43598-582,Buprenorphine and Naloxone,BUPRENORPHINE HYDROCHLORIDE;  NALOXONE,HUMAN PRESCRIPTION DRUG,06/14/2018,N/A,ANDA,"30 POUCH in 1 CARTON (43598-582-30)  / 1 FILM, SOLUBLE in 1 POUCH (43598-582-01)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,43598058230,Buprenorphine,8
Buprenorphine HCl,70518-2014-0,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,REMEDYREPACK INC.,70518-2014,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/12/2019,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-2014-0),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,70518201400,Buprenorphine,8
Buprenorphine HCl,70518-2014-1,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,REMEDYREPACK INC.,70518-2014,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/01/2021,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (70518-2014-1)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,70518201401,Buprenorphine,8
Buprenorphine HCl,68071-2915-3,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,"NuCare Pharmaceuticals,Inc.",68071-2915,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/17/2023,N/A,ANDA,30 TABLET in 1 BOTTLE (68071-2915-3),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,68071291503,Buprenorphine,8
Buprenorphine HCl,0054-0176-13,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,Hikma Pharmaceuticals USA Inc.,0054-0176,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2009,N/A,ANDA,30 TABLET in 1 BOTTLE (0054-0176-13),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00054017613,Buprenorphine,2
Buprenorphine HCl,0054-0177-13,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Hikma Pharmaceuticals USA Inc.,0054-0177,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2009,N/A,ANDA,30 TABLET in 1 BOTTLE (0054-0177-13),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00054017713,Buprenorphine,8
Buprenorphine HCl,70518-2226-0,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,REMEDYREPACK INC.,70518-2226,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/19/2019,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-2226-0),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,70518222600,Buprenorphine,2
Buprenorphine HCl,70518-2226-1,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,REMEDYREPACK INC.,70518-2226,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/12/2020,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (70518-2226-1)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,70518222601,Buprenorphine,2
Buprenorphine HCl,70518-2226-2,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,REMEDYREPACK INC.,70518-2226,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/04/2021,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (70518-2226-2)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,70518222602,Buprenorphine,2
Buprenorphine HCl,70518-2226-3,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,REMEDYREPACK INC.,70518-2226,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/04/2021,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (70518-2226-3)","Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,70518222603,Buprenorphine,2
Buprenorphine HCl,71335-1163-0,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1163-0),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335116300,Buprenorphine,8
Buprenorphine HCl,0904-7154-04,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,Major Pharmaceuticals,0904-7154,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2009,N/A,ANDA,30 BLISTER PACK in 1 CARTON (0904-7154-04)  / 1 TABLET in 1 BLISTER PACK,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00904715404,Buprenorphine,2
Buprenorphine HCl,0904-7155-04,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Major Pharmaceuticals,0904-7155,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2009,N/A,ANDA,30 BLISTER PACK in 1 CARTON (0904-7155-04)  / 1 TABLET in 1 BLISTER PACK,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00904715504,Buprenorphine,8
Buprenorphine HCl,58118-0176-8,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,"Clinical Solutions Wholesale, LLC",58118-0176,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/15/2018,N/A,ANDA,30 TABLET in 1 BLISTER PACK (58118-0176-8),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,58118017608,Buprenorphine,2
Buprenorphine HCl,58118-0177-8,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,"Clinical Solutions Wholesale, LLC",58118-0177,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/15/2018,N/A,ANDA,30 TABLET in 1 BLISTER PACK (58118-0177-8),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,58118017708,Buprenorphine,8
Buprenorphine HCl,71335-1163-1,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/21/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1163-1),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335116301,Buprenorphine,8
Buprenorphine HCl,71335-1163-2,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/24/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1163-2),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335116302,Buprenorphine,8
Buprenorphine HCl,71335-1163-3,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/01/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1163-3),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335116303,Buprenorphine,8
Buprenorphine HCl,71335-1163-4,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1163-4),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335116304,Buprenorphine,8
Buprenorphine HCl,71335-1163-5,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,7 TABLET in 1 BOTTLE (71335-1163-5),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335116305,Buprenorphine,8
Buprenorphine HCl,71335-1163-6,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1163-6),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335116306,Buprenorphine,8
Buprenorphine HCl,71335-1163-7,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,1 TABLET in 1 BOTTLE (71335-1163-7),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335116307,Buprenorphine,8
Buprenorphine HCl,71335-1163-8,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,12 TABLET in 1 BOTTLE (71335-1163-8),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335116308,Buprenorphine,8
Buprenorphine HCl,71335-1163-9,8 mg/1,TABLET,SUBLINGUAL,ANDA078633,Bryant Ranch Prepack,71335-1163,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2022,N/A,ANDA,14 TABLET in 1 BOTTLE (71335-1163-9),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,71335116309,Buprenorphine,8
Buprenorphine HCl,55700-302-30,2 mg/1,TABLET,SUBLINGUAL,ANDA078633,Lake Erie Medical DBA Quality Care Products LLC,55700-302,Buprenorphine HCl,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2015,N/A,ANDA,30 TABLET in 1 BOTTLE (55700-302-30),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,55700030230,Buprenorphine,2
Buprenorphine Hydrochloride,0143-9246-05,.324 mg/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,ANDA076931,Hikma Pharmaceuticals USA Inc.,0143-9246,Buprenorphine Hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/12/2019,N/A,ANDA,5 VIAL in 1 CARTON (0143-9246-05)  / 1 mL in 1 VIAL (0143-9246-01),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00143924605,Buprenorphine,0.324
Buprenorphine Hydrochloride,42023-179-05,.324 mg/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,ANDA206586,"Par Pharmaceutical, Inc.",42023-179,Buprenorphine Hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/30/2015,N/A,ANDA,5 VIAL in 1 CARTON (42023-179-05)  / 1 mL in 1 VIAL,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,42023017905,Buprenorphine,0.324
buprenorphine hydrochloride,50090-1571-0,8 mg/1,TABLET,SUBLINGUAL,ANDA090622,A-S Medication Solutions,50090-1571,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/23/2014,N/A,ANDA,30 TABLET in 1 BOTTLE (50090-1571-0),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,50090157100,Buprenorphine,8
buprenorphine hydrochloride,50383-924-93,2 mg/1,TABLET,SUBLINGUAL,ANDA090622,Akorn Operating Company LLC (dba Akorn),50383-924,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2010,N/A,ANDA,30 TABLET in 1 BOTTLE (50383-924-93),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,50383092493,Buprenorphine,2
Buprenorphine Hydrochloride,0409-2012-32,.3 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA074137,"Hospira, Inc.",0409-2012,Buprenorphine Hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/14/2005,N/A,ANDA,10 CARTRIDGE in 1 CARTON (0409-2012-32)  / 1 mL in 1 CARTRIDGE (0409-2012-03),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,00409201232,Buprenorphine,0.3
buprenorphine hydrochloride,50383-930-93,8 mg/1,TABLET,SUBLINGUAL,ANDA090622,Akorn Operating Company LLC (dba Akorn),50383-930,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2010,N/A,ANDA,30 TABLET in 1 BOTTLE (50383-930-93),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,50383093093,Buprenorphine,8
buprenorphine hydrochloride,70518-2216-0,2 mg/1,TABLET,SUBLINGUAL,ANDA090622,REMEDYREPACK INC.,70518-2216,buprenorphine hydrochloride,BUPRENORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/15/2019,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-2216-0),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,70518221600,Buprenorphine,2
buprenorphine transdermal system,47781-406-04,5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA207490,Alvogen Inc.,47781-406,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,08/29/2022,N/A,ANDA,4 POUCH in 1 CARTON (47781-406-04)  / 1 PATCH in 1 POUCH (47781-406-11)  / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,47781040604,Buprenorphine,5
buprenorphine transdermal system,47781-407-04,10 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA207490,Alvogen Inc.,47781-407,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,08/29/2022,N/A,ANDA,4 POUCH in 1 CARTON (47781-407-04)  / 1 PATCH in 1 POUCH (47781-407-11)  / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,47781040704,Buprenorphine,10
buprenorphine transdermal system,47781-408-04,20 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA207490,Alvogen Inc.,47781-408,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,08/29/2022,N/A,ANDA,4 POUCH in 1 CARTON (47781-408-04)  / 1 PATCH in 1 POUCH (47781-408-11)  / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,47781040804,Buprenorphine,20
buprenorphine transdermal system,47781-419-04,15 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA207490,Alvogen Inc.,47781-419,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,08/29/2022,N/A,ANDA,4 POUCH in 1 CARTON (47781-419-04)  / 1 PATCH in 1 POUCH (47781-419-11)  / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,47781041904,Buprenorphine,15
buprenorphine transdermal system,58064-408-04,20 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA207490,"LTS Therapy Systems, LLC",58064-408,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,08/29/2022,N/A,ANDA,4 POUCH in 1 CARTON (58064-408-04)  / 1 PATCH in 1 POUCH (58064-408-11)  / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,58064040804,Buprenorphine,20
Butrans,59011-750-04,5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA021306,Purdue Pharma LP,59011-750,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,02/14/2011,N/A,NDA,4 POUCH in 1 CARTON (59011-750-04)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,59011075004,Buprenorphine,5
Butrans,59011-757-04,7.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA021306,Purdue Pharma LP,59011-757,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,02/14/2011,N/A,NDA,4 POUCH in 1 CARTON (59011-757-04)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,59011075704,Buprenorphine,7.5
Butrans,59011-752-04,20 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA021306,Purdue Pharma LP,59011-752,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,02/14/2011,N/A,NDA,4 POUCH in 1 CARTON (59011-752-04)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,59011075204,Buprenorphine,20
Butrans,59011-758-04,15 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA021306,Purdue Pharma LP,59011-758,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,02/14/2011,N/A,NDA,4 POUCH in 1 CARTON (59011-758-04)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,59011075804,Buprenorphine,15
Butrans,59011-751-04,10 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA021306,Purdue Pharma LP,59011-751,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,02/14/2011,N/A,NDA,4 POUCH in 1 CARTON (59011-751-04)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH,"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2023,59011075104,Buprenorphine,10
SUBLOCADE,12496-0100-1,100 mg/1,SOLUTION,SUBCUTANEOUS,NDA209819,Indivior Inc.,12496-0100,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,02/26/2018,N/A,NDA,1 POUCH in 1 CARTON (12496-0100-1)  / 1 SYRINGE in 1 POUCH (12496-0100-2)  / 1 SOLUTION in 1 SYRINGE (12496-0100-5),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,12496010001,Buprenorphine,100
SUBLOCADE,12496-0300-1,300 mg/1,SOLUTION,SUBCUTANEOUS,NDA209819,Indivior Inc.,12496-0300,buprenorphine,BUPRENORPHINE,HUMAN PRESCRIPTION DRUG,02/26/2018,N/A,NDA,1 POUCH in 1 CARTON (12496-0300-1)  / 1 SYRINGE in 1 POUCH (12496-0300-2)  / 1 SOLUTION in 1 SYRINGE (12496-0300-5),"Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,12496030001,Buprenorphine,300
Suboxone,12496-1202-3,"2 mg/1,                         .5  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,NDA022410,INDIVIOR INC.,12496-1202,"buprenorphine hydrochloride, naloxone hydrochloride",BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/13/2010,N/A,NDA,"30 POUCH in 1 CARTON (12496-1202-3)  / 1 FILM, SOLUBLE in 1 POUCH (12496-1202-1)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,12496120203,Buprenorphine,2
Suboxone,12496-1204-3,"4 mg/1,                         1  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,NDA022410,INDIVIOR INC.,12496-1204,"buprenorphine hydrochloride, naloxone hydrochloride",BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/24/2012,N/A,NDA,"30 POUCH in 1 CARTON (12496-1204-3)  / 1 FILM, SOLUBLE in 1 POUCH (12496-1204-1)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,12496120403,Buprenorphine,4
Suboxone,12496-1208-3,"8 mg/1,                         2  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,NDA022410,INDIVIOR INC.,12496-1208,"buprenorphine hydrochloride, naloxone hydrochloride",BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/13/2010,N/A,NDA,"30 POUCH in 1 CARTON (12496-1208-3)  / 1 FILM, SOLUBLE in 1 POUCH (12496-1208-1)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,12496120803,Buprenorphine,8
Suboxone,12496-1212-3,"12 mg/1,                         3  mg/1","FILM, SOLUBLE",BUCCAL; SUBLINGUAL,NDA022410,INDIVIOR INC.,12496-1212,"buprenorphine hydrochloride, naloxone hydrochloride",BUPRENORPHINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/24/2012,N/A,NDA,"30 POUCH in 1 CARTON (12496-1212-3)  / 1 FILM, SOLUBLE in 1 POUCH (12496-1212-1)","Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist [EPC],  Partial Opioid Agonists [MoA]",CIII,No,12/31/2024,12496121203,Buprenorphine,12
Butorphanol Tartrate,0143-9864-10,1 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA078400,Hikma Pharmaceuticals USA Inc.,0143-9864,Butorphanol Tartrate,BUTORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,05/01/2009,N/A,ANDA,"1 mL in 1 VIAL, SINGLE-DOSE (0143-9864-10)","Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",CIV,No,12/31/2023,00143986410,butorphanol,1
Butorphanol Tartrate,0143-9867-10,2 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA078400,Hikma Pharmaceuticals USA Inc.,0143-9867,Butorphanol Tartrate,BUTORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,05/01/2009,N/A,ANDA,"1 mL in 1 VIAL, SINGLE-DOSE (0143-9867-10)","Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",CIV,No,12/31/2023,00143986710,butorphanol,2
Butorphanol Tartrate,0409-1623-01,1 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA074626,"Hospira, Inc.",0409-1623,Butorphanol Tartrate,BUTORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,09/23/2005,N/A,ANDA,"10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1623-01)  / 1 mL in 1 VIAL, SINGLE-DOSE (0409-1623-21)","Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",CIV,No,12/31/2024,00409162301,butorphanol,1
Butorphanol Tartrate,0409-1626-01,2 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA074626,"Hospira, Inc.",0409-1626,Butorphanol Tartrate,BUTORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,03/17/2006,N/A,ANDA,"10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1626-01)  / 1 mL in 1 VIAL, SINGLE-DOSE (0409-1626-21)","Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",CIV,No,12/31/2024,00409162601,butorphanol,2
Butorphanol Tartrate,0409-1626-02,2 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA074626,"Hospira, Inc.",0409-1626,Butorphanol Tartrate,BUTORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,12/20/2005,N/A,ANDA,"10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1626-02)  / 2 mL in 1 VIAL, SINGLE-DOSE (0409-1626-42)","Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",CIV,No,12/31/2024,00409162602,butorphanol,2
Butorphanol Tartrate,60505-0813-1,10 mg/mL,SPRAY,"NASAL",ANDA075499,Apotex Corp.,60505-0813,Butorphanol Tartrate,BUTORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,12/04/2002,N/A,ANDA,"1 BOTTLE, SPRAY in 1 CONTAINER (60505-0813-1)  / 2.5 mL in 1 BOTTLE, SPRAY","Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",CIV,No,12/31/2023,60505081301,butorphanol,10
Butorphanol Tartrate,0054-3090-36,10 mg/mL,"SPRAY, METERED","NASAL",ANDA075824,Hikma Pharmaceuticals USA Inc.,0054-3090,Butorphanol Tartrate,BUTORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,03/12/2002,N/A,ANDA,"1 BOTTLE, SPRAY in 1 CONTAINER (0054-3090-36)  / 15 mL in 1 BOTTLE, SPRAY","Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",CIV,No,12/31/2023,00054309036,butorphanol,10
ACETAMINOPHEN AND CODEINE,61919-484-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Direct_Rx,61919-484,ACETAMINOPHEN AND CODEINE,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/12/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (61919-484-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,61919048430,Codeine,300
ACETAMINOPHEN AND CODEINE,61919-484-18,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Direct_Rx,61919-484,ACETAMINOPHEN AND CODEINE,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/12/2019,N/A,ANDA,18 TABLET in 1 BOTTLE (61919-484-18),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,61919048418,Codeine,300
Acetaminophen and Codeine,65162-033-10,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Amneal Pharmaceuticals LLC,65162-033,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/29/2008,N/A,ANDA,100 TABLET in 1 BOTTLE (65162-033-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,65162003310,Codeine,300
Acetaminophen and Codeine,65162-033-11,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Amneal Pharmaceuticals LLC,65162-033,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/29/2008,N/A,ANDA,1000 TABLET in 1 BOTTLE (65162-033-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,65162003311,Codeine,300
Acetaminophen and Codeine,65162-033-50,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Amneal Pharmaceuticals LLC,65162-033,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/29/2008,N/A,ANDA,500 TABLET in 1 BOTTLE (65162-033-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,65162003350,Codeine,300
Acetaminophen And Codeine,63187-470-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA089805,Proficient Rx LP,63187-470,acetaminophen and codeine phosphate,CODEINE PHOSPHATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/02/2015,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (63187-470-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187047030,Codeine,300
Acetaminophen and Codeine,63187-491-60,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Proficient Rx LP,63187-491,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/02/2015,N/A,ANDA,60 TABLET in 1 BOTTLE (63187-491-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187049160,Codeine,300
Acetaminophen And Codeine,63187-470-90,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA089805,Proficient Rx LP,63187-470,acetaminophen and codeine phosphate,CODEINE PHOSPHATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/02/2015,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (63187-470-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187047090,Codeine,300
Acetaminophen And Codeine,63187-470-60,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA089805,Proficient Rx LP,63187-470,acetaminophen and codeine phosphate,CODEINE PHOSPHATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/02/2015,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (63187-470-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187047060,Codeine,300
Acetaminophen and Codeine,63187-491-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Proficient Rx LP,63187-491,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/02/2015,N/A,ANDA,30 TABLET in 1 BOTTLE (63187-491-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187049130,Codeine,300
Acetaminophen and Codeine,63187-491-20,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Proficient Rx LP,63187-491,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/02/2015,N/A,ANDA,20 TABLET in 1 BOTTLE (63187-491-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187049120,Codeine,300
Acetaminophen and Codeine,63187-491-90,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Proficient Rx LP,63187-491,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/02/2015,N/A,ANDA,90 TABLET in 1 BOTTLE (63187-491-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187049190,Codeine,300
Acetaminophen and Codeine,76420-103-03,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,"Asclemed USA, Inc.",76420-103,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,10/30/2020,N/A,ANDA,3 TABLET in 1 BOTTLE (76420-103-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,76420010303,Codeine,300
Acetaminophen and Codeine,76420-103-10,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,"Asclemed USA, Inc.",76420-103,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,10/30/2020,N/A,ANDA,10 TABLET in 1 BOTTLE (76420-103-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,76420010310,Codeine,300
Acetaminophen and Codeine,76420-103-20,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,"Asclemed USA, Inc.",76420-103,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,10/30/2020,N/A,ANDA,20 TABLET in 1 BOTTLE (76420-103-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,76420010320,Codeine,300
Acetaminophen and Codeine,76420-103-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,"Asclemed USA, Inc.",76420-103,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,10/30/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (76420-103-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,76420010330,Codeine,300
ACETAMINOPHEN AND CODEINE,61919-484-71,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Direct_Rx,61919-484,ACETAMINOPHEN AND CODEINE,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/12/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (61919-484-71),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,61919048471,Codeine,300
ACETAMINOPHEN AND CODEINE,61919-023-60,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,DIRECT RX,61919-023,ACETAMINOPHEN AND CODEINE,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,09/01/2015,N/A,ANDA,60 TABLET in 1 BOTTLE (61919-023-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,61919002360,Codeine,300
ACETAMINOPHEN AND CODEINE,61919-023-90,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,DIRECT RX,61919-023,ACETAMINOPHEN AND CODEINE,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,90 TABLET in 1 BOTTLE (61919-023-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,61919002390,Codeine,300
Acetaminophen and Codeine,67296-1772-6,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,"RedPharm Drug, Inc.",67296-1772,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/01/2020,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-1772-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67296177206,Codeine,300
Acetaminophen and Codeine,71335-0545-0,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Bryant Ranch Prepack,71335-0545,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-0545-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335054500,Codeine,300
Acetaminophen and Codeine,71335-0545-5,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Bryant Ranch Prepack,71335-0545,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/23/2018,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-0545-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335054505,Codeine,300
Acetaminophen and Codeine,71335-0545-7,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Bryant Ranch Prepack,71335-0545,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/15/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-0545-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335054507,Codeine,300
Acetaminophen and Codeine,71335-0545-9,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Bryant Ranch Prepack,71335-0545,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/01/2018,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0545-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335054509,Codeine,300
Acetaminophen and Codeine,71335-0545-3,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Bryant Ranch Prepack,71335-0545,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/11/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0545-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335054503,Codeine,300
Acetaminophen and Codeine,71335-0545-8,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Bryant Ranch Prepack,71335-0545,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/10/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0545-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335054508,Codeine,300
ACETAMINOPHEN AND CODEINE,61919-905-60,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,Direct_Rx,61919-905,ACETAMINOPHEN AND CODEINE,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/03/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (61919-905-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,61919090560,Codeine,300
Acetaminophen and Codeine,71335-0545-1,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Bryant Ranch Prepack,71335-0545,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,6 TABLET in 1 BOTTLE (71335-0545-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335054501,Codeine,300
Acetaminophen and Codeine,71335-0545-6,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Bryant Ranch Prepack,71335-0545,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0545-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335054506,Codeine,300
Acetaminophen and Codeine,71335-0545-2,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Bryant Ranch Prepack,71335-0545,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/01/2018,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-0545-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335054502,Codeine,300
Acetaminophen and Codeine,71335-0545-4,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040779,Bryant Ranch Prepack,71335-0545,Acetaminophen and Codeine,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-0545-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335054504,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71610-111-72,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",71610-111,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/06/2018,N/A,ANDA,112 TABLET in 1 BOTTLE (71610-111-72),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71610011172,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,55154-7553-0,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Cardinal Health 107, LLC",55154-7553,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,06/29/2009,N/A,ANDA,10 BLISTER PACK in 1 BAG (55154-7553-0)  / 1 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,55154755300,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63629-3031-3,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,63629-3031,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/18/2006,N/A,ANDA,60 TABLET in 1 BOTTLE (63629-3031-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63629303103,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63629-3031-4,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,63629-3031,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/03/2007,N/A,ANDA,90 TABLET in 1 BOTTLE (63629-3031-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63629303104,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63629-3031-5,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,63629-3031,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/29/2009,N/A,ANDA,40 TABLET in 1 BOTTLE (63629-3031-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63629303105,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63629-3031-6,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,63629-3031,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/01/2011,N/A,ANDA,20 TABLET in 1 BOTTLE (63629-3031-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63629303106,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,70518-3705-0,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,REMEDYREPACK INC.,70518-3705,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/10/2023,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-3705-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,70518370500,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71610-111-46,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",71610-111,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/06/2018,N/A,ANDA,56 TABLET in 1 BOTTLE (71610-111-46),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71610011146,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71610-111-53,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",71610-111,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/09/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (71610-111-53),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71610011153,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71610-111-70,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",71610-111,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/09/2018,N/A,ANDA,120 TABLET in 1 BOTTLE (71610-111-70),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71610011170,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71610-111-80,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",71610-111,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/09/2018,N/A,ANDA,180 TABLET in 1 BOTTLE (71610-111-80),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71610011180,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,50090-5201-1,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,A-S Medication Solutions,50090-5201,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,10/02/2020,N/A,ANDA,16 TABLET in 1 BOTTLE (50090-5201-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,50090520101,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0701-1,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA088629,Bryant Ranch Prepack,71335-0701,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/14/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0701-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335070101,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0701-6,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA088629,Bryant Ranch Prepack,71335-0701,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/21/2018,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-0701-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335070106,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0701-5,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA088629,Bryant Ranch Prepack,71335-0701,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-0701-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335070105,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0701-4,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA088629,Bryant Ranch Prepack,71335-0701,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0701-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335070104,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63629-1185-1,"300 mg/1,                         15  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,63629-1185,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/02/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-1185-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63629118501,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1818-0,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1818,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/21/2021,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-1818-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335181800,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1818-1,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1818,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/21/2021,N/A,ANDA,6 TABLET in 1 BOTTLE (71335-1818-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335181801,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1818-2,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1818,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/21/2021,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1818-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335181802,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1818-3,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1818,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/21/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1818-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335181803,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1818-4,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1818,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/21/2021,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-1818-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335181804,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1818-5,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1818,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/21/2021,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-1818-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335181805,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1818-6,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1818,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/21/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1818-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335181806,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1818-7,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1818,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/21/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1818-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335181807,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71610-111-75,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",71610-111,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/06/2018,N/A,ANDA,150 TABLET in 1 BOTTLE (71610-111-75),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71610011175,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63629-3031-7,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,63629-3031,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/15/2012,N/A,ANDA,112 TABLET in 1 BOTTLE (63629-3031-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63629303107,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63629-3031-8,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,63629-3031,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/15/2012,N/A,ANDA,84 TABLET in 1 BOTTLE (63629-3031-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63629303108,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63629-3031-9,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,63629-3031,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,15 TABLET in 1 BOTTLE (63629-3031-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63629303109,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,50090-5200-0,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,A-S Medication Solutions,50090-5200,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,10/02/2020,N/A,ANDA,10 TABLET in 1 BOTTLE (50090-5200-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,50090520000,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,50090-5200-1,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,A-S Medication Solutions,50090-5200,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,10/02/2020,N/A,ANDA,12 TABLET in 1 BOTTLE (50090-5200-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,50090520001,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,50090-5200-2,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,A-S Medication Solutions,50090-5200,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,10/02/2020,N/A,ANDA,15 TABLET in 1 BOTTLE (50090-5200-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,50090520002,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,50090-5200-3,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,A-S Medication Solutions,50090-5200,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,10/02/2020,N/A,ANDA,20 TABLET in 1 BOTTLE (50090-5200-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,50090520003,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,50090-5200-4,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,A-S Medication Solutions,50090-5200,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,10/02/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (50090-5200-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,50090520004,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,50090-5200-7,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,A-S Medication Solutions,50090-5200,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,10/02/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (50090-5200-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,50090520007,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71610-111-60,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",71610-111,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/09/2018,N/A,ANDA,90 TABLET in 1 BOTTLE (71610-111-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71610011160,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,70518-3575-1,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,REMEDYREPACK INC.,70518-3575,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/31/2023,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-3575-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,70518357501,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71930-054-12,"300 mg/1,                         15  mg/1",TABLET,ORAL,ANDA211610,Eywa Pharma Inc,71930-054,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/02/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (71930-054-12),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71930005412,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71930-054-52,"300 mg/1,                         15  mg/1",TABLET,ORAL,ANDA211610,Eywa Pharma Inc,71930-054,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/02/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (71930-054-52),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71930005452,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63629-3031-1,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,63629-3031,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/18/2006,N/A,ANDA,30 TABLET in 1 BOTTLE (63629-3031-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63629303101,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63629-3031-2,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,63629-3031,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/02/2006,N/A,ANDA,120 TABLET in 1 BOTTLE (63629-3031-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63629303102,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63629-3031-0,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,63629-3031,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/25/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-3031-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63629303100,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,50090-5201-0,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,A-S Medication Solutions,50090-5201,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,10/02/2020,N/A,ANDA,40 TABLET in 1 BOTTLE (50090-5201-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,50090520100,Codeine,300
Acetaminophen and Codeine Phosphate,50090-0215-0,"120 mg/5mL,                         12  mg/5mL",SOLUTION,ORAL,ANDA087508,A-S Medication Solutions,50090-0215,ACETAMINOPHEN and CODEINE PHOSPHATE,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,11/28/2014,N/A,ANDA,118 mL in 1 BOTTLE (50090-0215-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CV,No,12/31/2024,50090021500,Codeine,120
ACETAMINOPHEN AND CODEINE PHOSPHATE,63629-1190-1,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,63629-1190,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/02/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (63629-1190-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63629119001,Codeine,300
Acetaminophen and Codeine Phosphate,50383-079-16,"120 mg/5mL,                         12  mg/5mL",SOLUTION,ORAL,ANDA040119,Akorn,50383-079,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/26/1996,N/A,ANDA,473 mL in 1 BOTTLE (50383-079-16),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CV,No,12/31/2023,50383007916,Codeine,120
Acetaminophen and Codeine Phosphate,70934-799-15,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"Denton Pharma, Inc. DBA Northwind Pharmaceuticals",70934-799,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,11/02/2020,12/31/2023,ANDA,"15 TABLET in 1 BOTTLE, PLASTIC (70934-799-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,N/A,70934079915,Codeine,300
Acetaminophen and Codeine Phosphate,70934-799-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"Denton Pharma, Inc. DBA Northwind Pharmaceuticals",70934-799,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,11/02/2020,12/31/2023,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (70934-799-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,N/A,70934079930,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71930-055-12,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,Eywa Pharma Inc,71930-055,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/02/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (71930-055-12),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71930005512,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71930-055-52,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,Eywa Pharma Inc,71930-055,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/02/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (71930-055-52),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71930005552,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68071-2800-6,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,"NuCare Pharmaceuticals,Inc.",68071-2800,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/19/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (68071-2800-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071280006,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,70518-3575-0,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,REMEDYREPACK INC.,70518-3575,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,11/10/2022,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-3575-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,70518357500,Codeine,300
Acetaminophen and Codeine Phosphate,63187-815-20,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Proficient Rx LP,63187-815,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/01/2017,N/A,ANDA,20 TABLET in 1 BOTTLE (63187-815-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187081520,Codeine,300
Acetaminophen and Codeine Phosphate,63187-815-60,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Proficient Rx LP,63187-815,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/01/2017,N/A,ANDA,60 TABLET in 1 BOTTLE (63187-815-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187081560,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68071-2681-6,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,"NuCare Pharmaceuticals,Inc.",68071-2681,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/28/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (68071-2681-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071268106,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,49999-026-30,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Quality Care Products LLC,49999-026,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,30 TABLET in 1 BOTTLE (49999-026-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,49999002630,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,49999-026-60,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Quality Care Products LLC,49999-026,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,60 TABLET in 1 BOTTLE (49999-026-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,49999002660,Codeine,300
Acetaminophen and Codeine Phosphate,45865-439-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Medsource Pharmaceuticals,45865-439,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/01/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (45865-439-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,45865043930,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,49999-060-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Lake Erie Medical DBA Quality Care Products LLC,49999-060,ACETAMINOPHEN AND CODEINE PHOSPHATE,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,09/14/2011,N/A,ANDA,30 TABLET in 1 BOTTLE (49999-060-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,49999006030,Codeine,300
Acetaminophen and Codeine Phosphate,70518-2989-0,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,REMEDYREPACK INC.,70518-2989,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/14/2021,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-2989-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,70518298900,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68788-7859-1,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Preferred Pharmaceuticals Inc.,68788-7859,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/05/2021,N/A,ANDA,15 TABLET in 1 BOTTLE (68788-7859-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,68788785901,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68788-7859-2,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Preferred Pharmaceuticals Inc.,68788-7859,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/05/2021,N/A,ANDA,20 TABLET in 1 BOTTLE (68788-7859-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,68788785902,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68788-7859-3,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Preferred Pharmaceuticals Inc.,68788-7859,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/05/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (68788-7859-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,68788785903,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68788-7859-6,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Preferred Pharmaceuticals Inc.,68788-7859,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/05/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (68788-7859-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,68788785906,Codeine,300
Acetaminophen and Codeine Phosphate,50383-339-13,"300 mg/12.5mL,                         30  mg/12.5mL",SOLUTION,ORAL,ANDA040119,Akorn,50383-339,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/01/2020,N/A,ANDA,"4 TRAY in 1 CASE (50383-339-13)  / 10 CUP, UNIT-DOSE in 1 TRAY / 12.5 mL in 1 CUP, UNIT-DOSE (50383-339-12)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CV,No,12/31/2023,50383033913,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,49999-060-90,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Lake Erie Medical DBA Quality Care Products LLC,49999-060,ACETAMINOPHEN AND CODEINE PHOSPHATE,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,09/14/2011,N/A,ANDA,90 TABLET in 1 BOTTLE (49999-060-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,49999006090,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0336-0,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0336,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-0336-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335033600,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0336-1,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0336,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0336-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335033601,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0336-2,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0336,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0336-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335033602,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0336-3,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0336,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0336-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335033603,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0336-4,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0336,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0336-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335033604,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0336-5,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0336,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-0336-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335033605,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,0406-0485-01,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,SpecGx LLC,0406-0485,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/31/2001,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-0485-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,00406048501,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,0406-0485-05,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,SpecGx LLC,0406-0485,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/31/2001,N/A,ANDA,500 TABLET in 1 BOTTLE (0406-0485-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,00406048505,Codeine,300
Acetaminophen and Codeine Phosphate,50090-1935-0,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,A-S Medication Solutions,50090-1935,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/16/2015,N/A,ANDA,15 TABLET in 1 BOTTLE (50090-1935-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,50090193500,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63629-1188-1,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,63629-1188,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/02/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (63629-1188-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63629118801,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,50090-3871-0,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,A-S Medication Solutions,50090-3871,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,11/27/2018,N/A,ANDA,15 TABLET in 1 BOTTLE (50090-3871-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,50090387100,Codeine,300
Acetaminophen and Codeine Phosphate,63304-562-10,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA085868,"Sun Pharmaceutical Industries, Inc.",63304-562,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,11/16/1978,N/A,ANDA,1000 TABLET in 1 BOTTLE (63304-562-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63304056210,Codeine,300
Acetaminophen and Codeine Phosphate,63304-562-05,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA085868,"Sun Pharmaceutical Industries, Inc.",63304-562,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,11/16/1978,N/A,ANDA,500 TABLET in 1 BOTTLE (63304-562-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63304056205,Codeine,300
Acetaminophen and Codeine Phosphate,67296-0525-1,"120 mg/5mL,                         12  mg/5mL",SOLUTION,ORAL,ANDA087508,"Redpharm Drug, Inc",67296-0525,ACETAMINOPHEN and CODEINE PHOSPHATE,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/21/1981,N/A,ANDA,118 mL in 1 BOTTLE (67296-0525-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CV,No,12/31/2024,67296052501,Codeine,120
Acetaminophen and Codeine Phosphate,60687-615-01,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,American Health Packaging,60687-615,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/13/2021,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-615-01)  / 1 TABLET in 1 BLISTER PACK (60687-615-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,60687061501,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,50090-5198-0,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,A-S Medication Solutions,50090-5198,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,10/02/2020,N/A,ANDA,15 TABLET in 1 BOTTLE (50090-5198-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,50090519800,Codeine,300
Acetaminophen and Codeine Phosphate,13107-058-01,"300 mg/1,                         15  mg/1",TABLET,ORAL,ANDA202800,"Aurolife Pharma, LLC",13107-058,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/15/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-058-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,13107005801,Codeine,300
Acetaminophen and Codeine Phosphate,13107-058-05,"300 mg/1,                         15  mg/1",TABLET,ORAL,ANDA202800,"Aurolife Pharma, LLC",13107-058,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/15/2013,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-058-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,13107005805,Codeine,300
Acetaminophen and Codeine Phosphate,13107-058-30,"300 mg/1,                         15  mg/1",TABLET,ORAL,ANDA202800,"Aurolife Pharma, LLC",13107-058,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/15/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-058-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,13107005830,Codeine,300
Acetaminophen and Codeine Phosphate,13107-058-99,"300 mg/1,                         15  mg/1",TABLET,ORAL,ANDA202800,"Aurolife Pharma, LLC",13107-058,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/15/2013,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-058-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,13107005899,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,0406-0484-01,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,SpecGx LLC,0406-0484,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/31/2001,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-0484-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,00406048401,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0256-7,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0256,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-0256-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335025607,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0256-8,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0256,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/01/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0256-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335025608,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71930-056-12,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,Eywa Pharma Inc,71930-056,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/02/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (71930-056-12),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71930005612,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71930-056-52,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,Eywa Pharma Inc,71930-056,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/02/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (71930-056-52),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71930005652,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0256-3,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0256,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/20/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0256-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335025603,Codeine,300
Acetaminophen and Codeine Phosphate,50090-1934-0,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,A-S Medication Solutions,50090-1934,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/16/2015,N/A,ANDA,40 TABLET in 1 BOTTLE (50090-1934-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,50090193400,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0336-6,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0336,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-0336-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335033606,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0336-7,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0336,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,112 TABLET in 1 BOTTLE (71335-0336-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335033607,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0336-8,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0336,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-0336-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335033608,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0336-9,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0336,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-0336-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335033609,Codeine,300
Acetaminophen and Codeine Phosphate,50090-1934-1,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,A-S Medication Solutions,50090-1934,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/16/2015,N/A,ANDA,16 TABLET in 1 BOTTLE (50090-1934-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,50090193401,Codeine,300
Acetaminophen and Codeine Phosphate,50090-1934-6,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,A-S Medication Solutions,50090-1934,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/16/2015,N/A,ANDA,60 TABLET in 1 BOTTLE (50090-1934-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,50090193406,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0256-6,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0256,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/06/2018,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0256-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335025606,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0256-9,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0256,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/28/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0256-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335025609,Codeine,300
Acetaminophen and Codeine Phosphate,71205-001-20,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA088628,Proficient Rx LP,71205-001,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,06/01/2018,N/A,ANDA,20 TABLET in 1 BOTTLE (71205-001-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71205000120,Codeine,300
Acetaminophen and Codeine Phosphate,71205-001-90,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA088628,Proficient Rx LP,71205-001,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,06/01/2018,N/A,ANDA,90 TABLET in 1 BOTTLE (71205-001-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71205000190,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,0406-0484-03,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,SpecGx LLC,0406-0484,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/31/2001,N/A,ANDA,30 TABLET in 1 BOTTLE (0406-0484-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,00406048403,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,0406-0484-10,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,SpecGx LLC,0406-0484,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/31/2001,N/A,ANDA,1000 TABLET in 1 BOTTLE (0406-0484-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,00406048410,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,0406-0484-20,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,SpecGx LLC,0406-0484,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/31/2001,N/A,ANDA,20 TABLET in 1 BOTTLE (0406-0484-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,00406048420,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,0406-0484-23,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,SpecGx LLC,0406-0484,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/31/2001,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-0484-23),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,00406048423,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,0406-0484-50,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,SpecGx LLC,0406-0484,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/31/2001,N/A,ANDA,50 TABLET in 1 BOTTLE (0406-0484-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,00406048450,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,0406-0484-62,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,SpecGx LLC,0406-0484,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/31/2001,N/A,ANDA,100 TABLET in 1 BLISTER PACK (0406-0484-62),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,00406048462,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0256-2,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0256,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/06/2018,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-0256-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335025602,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0256-4,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0256,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-0256-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335025604,Codeine,300
Acetaminophen and Codeine Phosphate,63187-291-04,"120 mg/5mL,                         12  mg/5mL",SOLUTION,ORAL,ANDA087508,Proficient Rx LP,63187-291,ACETAMINOPHEN and CODEINE PHOSPHATE,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/01/2019,N/A,ANDA,118 mL in 1 BOTTLE (63187-291-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CV,No,12/31/2023,63187029104,Codeine,120
ACETAMINOPHEN AND CODEINE PHOSPHATE,58118-4484-8,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Clinical Solutions Wholesale, LLC",58118-4484,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/27/2019,N/A,ANDA,30 TABLET in 1 BLISTER PACK (58118-4484-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,58118448408,Codeine,300
Acetaminophen and Codeine Phosphate,45865-439-60,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Medsource Pharmaceuticals,45865-439,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/01/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (45865-439-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,45865043960,Codeine,300
Acetaminophen and Codeine Phosphate,63304-562-01,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA085868,"Sun Pharmaceutical Industries, Inc.",63304-562,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,11/16/1978,N/A,ANDA,100 TABLET in 1 BOTTLE (63304-562-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63304056201,Codeine,300
Acetaminophen and Codeine Phosphate,67296-1516-1,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"RedPharm Drug, Inc.",67296-1516,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/05/2017,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-1516-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67296151601,Codeine,300
Acetaminophen and Codeine Phosphate,67296-1516-2,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"RedPharm Drug, Inc.",67296-1516,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/05/2017,N/A,ANDA,20 TABLET in 1 BOTTLE (67296-1516-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67296151602,Codeine,300
Acetaminophen and Codeine Phosphate,67296-1516-6,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"RedPharm Drug, Inc.",67296-1516,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/05/2017,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-1516-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67296151606,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,70518-2764-0,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,REMEDYREPACK INC.,70518-2764,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,06/05/2020,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-2764-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,70518276400,Codeine,300
Acetaminophen and Codeine Phosphate,13107-059-01,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"Aurolife Pharma, LLC",13107-059,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/15/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-059-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,13107005901,Codeine,300
Acetaminophen and Codeine Phosphate,13107-059-05,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"Aurolife Pharma, LLC",13107-059,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/15/2013,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-059-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,13107005905,Codeine,300
Acetaminophen and Codeine Phosphate,13107-059-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"Aurolife Pharma, LLC",13107-059,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/15/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-059-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,13107005930,Codeine,300
Acetaminophen and Codeine Phosphate,13107-059-99,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"Aurolife Pharma, LLC",13107-059,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/15/2013,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-059-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,13107005999,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68071-4533-2,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"NuCare Pharmaceuticals,Inc.",68071-4533,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/20/2018,N/A,ANDA,20 TABLET in 1 BOTTLE (68071-4533-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071453302,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68071-4533-3,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"NuCare Pharmaceuticals,Inc.",68071-4533,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/20/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (68071-4533-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071453303,Codeine,300
Acetaminophen and Codeine Phosphate,63304-561-05,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA087083,"Sun Pharmaceutical Industries, Inc.",63304-561,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/23/1980,N/A,ANDA,500 TABLET in 1 BOTTLE (63304-561-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63304056105,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0256-0,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0256,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-0256-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335025600,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67046-886-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,coupler enterprises inc.,67046-886,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/31/2001,N/A,ANDA,30 TABLET in 1 BLISTER PACK (67046-886-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67046088630,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,49999-060-60,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Lake Erie Medical DBA Quality Care Products LLC,49999-060,ACETAMINOPHEN AND CODEINE PHOSPHATE,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,09/14/2011,N/A,ANDA,60 TABLET in 1 BOTTLE (49999-060-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,49999006060,Codeine,300
Acetaminophen and Codeine Phosphate,45865-466-30,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,Medsource Pharmaceuticals,45865-466,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/01/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (45865-466-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,45865046630,Codeine,300
Acetaminophen and Codeine Phosphate,63187-815-15,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Proficient Rx LP,63187-815,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/28/2020,N/A,ANDA,15 TABLET in 1 BOTTLE (63187-815-15),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187081515,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0256-1,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0256,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/31/2019,N/A,ANDA,6 TABLET in 1 BOTTLE (71335-0256-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335025601,Codeine,300
Acetaminophen and Codeine Phosphate,63304-561-01,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA087083,"Sun Pharmaceutical Industries, Inc.",63304-561,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/23/1980,N/A,ANDA,100 TABLET in 1 BOTTLE (63304-561-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63304056101,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0256-5,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Bryant Ranch Prepack,71335-0256,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/23/2018,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-0256-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335025605,Codeine,300
Acetaminophen and Codeine Phosphate,71205-001-15,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA088628,Proficient Rx LP,71205-001,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,06/01/2018,N/A,ANDA,15 TABLET in 1 BOTTLE (71205-001-15),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71205000115,Codeine,300
Acetaminophen and Codeine Phosphate,71205-001-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA088628,Proficient Rx LP,71205-001,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,06/01/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (71205-001-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71205000130,Codeine,300
Acetaminophen and Codeine Phosphate,72189-376-60,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,Direct_Rx,72189-376,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/31/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-376-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,72189037660,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,70518-2628-0,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,REMEDYREPACK INC.,70518-2628,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/12/2020,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-2628-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,70518262800,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71610-111-54,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",71610-111,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/06/2018,N/A,ANDA,84 TABLET in 1 BOTTLE (71610-111-54),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71610011154,Codeine,300
Acetaminophen and Codeine Phosphate,0615-8102-39,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"NCS HealthCare of KY, LLC dba Vangard Labs",0615-8102,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/05/2017,11/30/2023,ANDA,30 TABLET in 1 BLISTER PACK (0615-8102-39),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,N/A,00615810239,Codeine,300
Acetaminophen and Codeine Phosphate,68071-3100-2,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"NuCare Pharmaceuticals, Inc.",68071-3100,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/10/2017,N/A,ANDA,20 TABLET in 1 BOTTLE (68071-3100-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071310002,Codeine,300
Acetaminophen and Codeine Phosphate,68071-3100-3,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"NuCare Pharmaceuticals, Inc.",68071-3100,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/10/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (68071-3100-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071310003,Codeine,300
Acetaminophen and Codeine Phosphate,68071-3100-4,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"NuCare Pharmaceuticals, Inc.",68071-3100,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/10/2017,N/A,ANDA,24 TABLET in 1 BOTTLE (68071-3100-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071310004,Codeine,300
Acetaminophen and Codeine Phosphate,68071-3100-5,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"NuCare Pharmaceuticals, Inc.",68071-3100,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/10/2017,N/A,ANDA,15 TABLET in 1 BOTTLE (68071-3100-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071310005,Codeine,300
Acetaminophen and Codeine Phosphate,68071-3100-6,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"NuCare Pharmaceuticals, Inc.",68071-3100,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/10/2017,N/A,ANDA,60 TABLET in 1 BOTTLE (68071-3100-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071310006,Codeine,300
Acetaminophen and Codeine Phosphate,68071-3100-8,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"NuCare Pharmaceuticals, Inc.",68071-3100,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/10/2017,N/A,ANDA,84 TABLET in 1 BOTTLE (68071-3100-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071310008,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68071-4533-4,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"NuCare Pharmaceuticals,Inc.",68071-4533,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/20/2018,N/A,ANDA,24 TABLET in 1 BOTTLE (68071-4533-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071453304,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68071-4533-5,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"NuCare Pharmaceuticals,Inc.",68071-4533,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/20/2018,N/A,ANDA,15 TABLET in 1 BOTTLE (68071-4533-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071453305,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68071-4533-6,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"NuCare Pharmaceuticals,Inc.",68071-4533,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/20/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (68071-4533-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071453306,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68071-4533-8,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"NuCare Pharmaceuticals,Inc.",68071-4533,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/20/2018,N/A,ANDA,84 TABLET in 1 BOTTLE (68071-4533-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071453308,Codeine,300
Acetaminophen and Codeine Phosphate,0121-0504-00,"120 mg/5mL,                         12  mg/5mL",SOLUTION,ORAL,ANDA087508,"PAI Holdings, LLC",0121-0504,ACETAMINOPHEN and CODEINE PHOSPHATE,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/21/1981,N/A,ANDA,"10 TRAY in 1 CASE (0121-0504-00)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-0504-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CV,No,12/31/2024,00121050400,Codeine,120
Acetaminophen and Codeine Phosphate,0121-0504-04,"120 mg/5mL,                         12  mg/5mL",SOLUTION,ORAL,ANDA087508,"PAI Holdings, LLC",0121-0504,ACETAMINOPHEN and CODEINE PHOSPHATE,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/21/1981,N/A,ANDA,118 mL in 1 BOTTLE (0121-0504-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CV,No,12/31/2024,00121050404,Codeine,120
Acetaminophen and Codeine Phosphate,0121-0504-16,"120 mg/5mL,                         12  mg/5mL",SOLUTION,ORAL,ANDA087508,"PAI Holdings, LLC",0121-0504,ACETAMINOPHEN and CODEINE PHOSPHATE,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/21/1981,N/A,ANDA,473 mL in 1 BOTTLE (0121-0504-16),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CV,No,12/31/2024,00121050416,Codeine,120
Acetaminophen and Codeine Phosphate,60687-604-01,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,American Health Packaging,60687-604,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/31/2021,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-604-01)  / 1 TABLET in 1 BLISTER PACK (60687-604-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,60687060401,Codeine,300
Acetaminophen and Codeine Phosphate,45865-466-60,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,Medsource Pharmaceuticals,45865-466,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/01/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (45865-466-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,45865046660,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,60760-581-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,ST. MARY'S MEDICAL PARK PHARMACY,60760-581,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,09/30/2022,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (60760-581-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,60760058130,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71610-111-90,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",71610-111,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/09/2018,N/A,ANDA,240 TABLET in 1 BOTTLE (71610-111-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71610011190,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71610-111-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",71610-111,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/09/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (71610-111-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71610011130,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71610-111-45,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",71610-111,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/09/2018,N/A,ANDA,45 TABLET in 1 BOTTLE (71610-111-45),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71610011145,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,70518-2764-1,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,REMEDYREPACK INC.,70518-2764,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/23/2022,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-2764-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,70518276401,Codeine,300
Acetaminophen and Codeine Phosphate,60760-466-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,St. Mary's Medical Park Pharmacy,60760-466,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/08/2018,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (60760-466-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,60760046630,Codeine,300
Acetaminophen and Codeine Phosphate,64850-641-12,"300 mg/1,                         15  mg/1",TABLET,ORAL,ANDA212418,"Elite Laboratories, Inc.",64850-641,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,09/10/2019,N/A,ANDA,120 TABLET in 1 BOTTLE (64850-641-12),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,64850064112,Codeine,300
Acetaminophen and Codeine Phosphate,67296-1516-5,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"RedPharm Drug, Inc.",67296-1516,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/05/2017,N/A,ANDA,15 TABLET in 1 BOTTLE (67296-1516-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67296151605,Codeine,300
Acetaminophen and Codeine Phosphate,64850-643-12,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA212418,"Elite Laboratories, Inc.",64850-643,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,09/10/2019,N/A,ANDA,120 TABLET in 1 BOTTLE (64850-643-12),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,64850064312,Codeine,300
Acetaminophen and Codeine Phosphate,71205-001-60,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA088628,Proficient Rx LP,71205-001,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,06/01/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (71205-001-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71205000160,Codeine,300
Acetaminophen and Codeine Phosphate,63187-815-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,Proficient Rx LP,63187-815,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/01/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (63187-815-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187081530,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1522-0,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,71335-1522,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/17/2020,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-1522-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335152200,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1522-1,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,71335-1522,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/13/2020,N/A,ANDA,6 TABLET in 1 BOTTLE (71335-1522-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335152201,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1522-2,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,71335-1522,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/30/2020,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1522-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335152202,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1522-3,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,71335-1522,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/05/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1522-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335152203,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1522-4,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,71335-1522,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-1522-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335152204,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1522-5,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,71335-1522,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/06/2020,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-1522-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335152205,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1522-6,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,71335-1522,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/03/2020,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1522-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335152206,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1522-7,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,71335-1522,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1522-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335152207,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1522-8,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,71335-1522,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/24/2020,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1522-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335152208,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1522-9,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Bryant Ranch Prepack,71335-1522,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/06/2020,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1522-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335152209,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,58118-0485-8,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,"Clinical Solutions Wholesale, LLC",58118-0485,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,11/12/2021,N/A,ANDA,30 TABLET in 1 BLISTER PACK (58118-0485-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,58118048508,Codeine,300
Acetaminophen and Codeine Phosphate,13107-060-01,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,"Aurolife Pharma, LLC",13107-060,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/15/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-060-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,13107006001,Codeine,300
Acetaminophen and Codeine Phosphate,13107-060-05,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,"Aurolife Pharma, LLC",13107-060,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/15/2013,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-060-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,13107006005,Codeine,300
Acetaminophen and Codeine Phosphate,13107-060-30,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,"Aurolife Pharma, LLC",13107-060,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/15/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-060-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,13107006030,Codeine,300
Acetaminophen and Codeine Phosphate,13107-060-99,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,"Aurolife Pharma, LLC",13107-060,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/15/2013,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-060-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,13107006099,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68071-4475-2,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"NuCare Pharmaceuticals,Inc.",68071-4475,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,06/21/2018,N/A,ANDA,12 TABLET in 1 BOTTLE (68071-4475-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071447502,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-46,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/28/2021,N/A,ANDA,"56 TABLET in 1 BOTTLE, PLASTIC (67544-002-46)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000246,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-54,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/04/2021,N/A,ANDA,"84 TABLET in 1 BOTTLE, PLASTIC (67544-002-54)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000254,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-72,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/10/2021,N/A,ANDA,"112 TABLET in 1 BOTTLE, PLASTIC (67544-002-72)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000272,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-09,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"9 TABLET in 1 BOTTLE, PLASTIC (67544-002-09)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000209,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-45,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"45 TABLET in 1 BOTTLE, PLASTIC (67544-002-45)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000245,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-80,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"180 TABLET in 1 BOTTLE, PLASTIC (67544-002-80)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000280,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-003-60,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-003,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (67544-003-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000360,Codeine,300
Acetaminophen and Codeine Phosphate,50383-337-06,"120 mg/5mL,                         12  mg/5mL",SOLUTION,ORAL,ANDA040119,Akorn,50383-337,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/01/2020,N/A,ANDA,"4 TRAY in 1 CASE (50383-337-06)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (50383-337-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CV,No,12/31/2023,50383033706,Codeine,120
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-15,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"15 TABLET in 1 BOTTLE, PLASTIC (67544-002-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000215,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-55,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"75 TABLET in 1 BOTTLE, PLASTIC (67544-002-55)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000255,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68071-4475-4,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"NuCare Pharmaceuticals,Inc.",68071-4475,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,06/21/2018,N/A,ANDA,4 TABLET in 1 BOTTLE (68071-4475-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071447504,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68071-4475-6,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"NuCare Pharmaceuticals,Inc.",68071-4475,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,06/21/2018,N/A,ANDA,6 TABLET in 1 BOTTLE (68071-4475-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071447506,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-90,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"240 TABLET in 1 BOTTLE, PLASTIC (67544-002-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000290,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (67544-002-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000230,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-003-53,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-003,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (67544-003-53)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000353,Codeine,300
Acetaminophen and Codeine Phosphate,68071-5010-4,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"NuCare Pharmaceuticals,Inc.",68071-5010,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/01/2019,N/A,ANDA,4 TABLET in 1 BOTTLE (68071-5010-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071501004,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-85,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"200 TABLET in 1 BOTTLE, PLASTIC (67544-002-85)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000285,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-003-80,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-003,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"180 TABLET in 1 BOTTLE, PLASTIC (67544-003-80)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000380,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1846-0,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1846,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/29/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1846-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335184600,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1846-1,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1846,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/29/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1846-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335184601,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1846-2,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1846,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/29/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1846-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335184602,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1846-3,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1846,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/29/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1846-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335184603,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1846-4,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1846,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/29/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1846-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335184604,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63187-106-20,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Proficient Rx LP,63187-106,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/01/2019,N/A,ANDA,20 TABLET in 1 BOTTLE (63187-106-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187010620,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-40,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"40 TABLET in 1 BOTTLE, PLASTIC (67544-002-40)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000240,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-50,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"50 TABLET in 1 BOTTLE, PLASTIC (67544-002-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000250,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-70,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"120 TABLET in 1 BOTTLE, PLASTIC (67544-002-70)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000270,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-93,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"300 TABLET in 1 BOTTLE, PLASTIC (67544-002-93)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000293,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63187-106-15,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Proficient Rx LP,63187-106,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/03/2021,N/A,ANDA,15 TABLET in 1 BOTTLE (63187-106-15),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187010615,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63187-106-60,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Proficient Rx LP,63187-106,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,11/23/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (63187-106-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187010660,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63187-106-90,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Proficient Rx LP,63187-106,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,11/23/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (63187-106-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187010690,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-53,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (67544-002-53)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000253,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-003-90,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-003,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"240 TABLET in 1 BOTTLE, PLASTIC (67544-003-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000390,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,63187-106-30,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Proficient Rx LP,63187-106,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/01/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (63187-106-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,63187010630,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-60,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (67544-002-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000260,Codeine,300
Acetaminophen and Codeine Phosphate,68071-5010-6,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,"NuCare Pharmaceuticals,Inc.",68071-5010,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/01/2019,N/A,ANDA,6 TABLET in 1 BOTTLE (68071-5010-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,68071501006,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-75,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"150 TABLET in 1 BOTTLE, PLASTIC (67544-002-75)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000275,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-003-70,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-003,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"120 TABLET in 1 BOTTLE, PLASTIC (67544-003-70)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000370,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,0406-0483-01,"300 mg/1,                         15  mg/1",TABLET,ORAL,ANDA040419,SpecGx LLC,0406-0483,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/31/2001,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-0483-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,00406048301,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,67544-002-20,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,"Aphena Pharma Solutions - Tennessee, LLC",67544-002,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/06/2011,N/A,ANDA,"20 TABLET in 1 BOTTLE, PLASTIC (67544-002-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,67544000220,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1846-5,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1846,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/29/2021,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-1846-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335184605,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1846-6,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1846,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/29/2021,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1846-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335184606,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1846-7,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1846,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/29/2021,N/A,ANDA,112 TABLET in 1 BOTTLE (71335-1846-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335184607,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1846-8,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1846,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/29/2021,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-1846-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335184608,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1846-9,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1846,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/29/2021,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-1846-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335184609,Codeine,300
Acetaminophen and Codeine Phosphate,50090-1933-0,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,A-S Medication Solutions,50090-1933,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/16/2015,N/A,ANDA,10 TABLET in 1 BOTTLE (50090-1933-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,50090193300,Codeine,300
Acetaminophen and Codeine Phosphate,50090-1933-1,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,A-S Medication Solutions,50090-1933,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/16/2015,N/A,ANDA,12 TABLET in 1 BOTTLE (50090-1933-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,50090193301,Codeine,300
Acetaminophen and Codeine Phosphate,50090-1933-2,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,A-S Medication Solutions,50090-1933,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/16/2015,N/A,ANDA,15 TABLET in 1 BOTTLE (50090-1933-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,50090193302,Codeine,300
Acetaminophen and Codeine Phosphate,50090-1933-3,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,A-S Medication Solutions,50090-1933,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/16/2015,N/A,ANDA,20 TABLET in 1 BOTTLE (50090-1933-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,50090193303,Codeine,300
Acetaminophen and Codeine Phosphate,50090-1933-4,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,A-S Medication Solutions,50090-1933,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/16/2015,N/A,ANDA,30 TABLET in 1 BOTTLE (50090-1933-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,50090193304,Codeine,300
Acetaminophen and Codeine Phosphate,50090-1933-7,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,A-S Medication Solutions,50090-1933,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/16/2015,N/A,ANDA,100 TABLET in 1 BOTTLE (50090-1933-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,50090193307,Codeine,300
Acetaminophen and Codeine Phosphate,50090-1933-9,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA202800,A-S Medication Solutions,50090-1933,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/16/2015,N/A,ANDA,24 TABLET in 1 BOTTLE (50090-1933-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,50090193309,Codeine,300
Acetaminophen and Codeine Phosphate,64850-642-12,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA212418,"Elite Laboratories, Inc.",64850-642,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,09/10/2019,N/A,ANDA,120 TABLET in 1 BOTTLE (64850-642-12),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,64850064212,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1818-8,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1818,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/21/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1818-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335181808,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,71335-1818-9,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA211610,Bryant Ranch Prepack,71335-1818,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/21/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1818-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335181809,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0701-3,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA088629,Bryant Ranch Prepack,71335-0701,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/27/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0701-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335070103,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0701-0,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA088629,Bryant Ranch Prepack,71335-0701,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-0701-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335070100,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0701-7,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA088629,Bryant Ranch Prepack,71335-0701,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,112 TABLET in 1 BOTTLE (71335-0701-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335070107,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0701-9,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA088629,Bryant Ranch Prepack,71335-0701,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-0701-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335070109,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68788-7835-1,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Preferred Pharmaceuticals Inc.,68788-7835,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/18/2021,N/A,ANDA,15 TABLET in 1 BOTTLE (68788-7835-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,68788783501,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68788-7835-2,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Preferred Pharmaceuticals Inc.,68788-7835,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/18/2021,N/A,ANDA,20 TABLET in 1 BOTTLE (68788-7835-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,68788783502,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68788-7835-3,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Preferred Pharmaceuticals Inc.,68788-7835,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/18/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (68788-7835-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,68788783503,Codeine,300
ACETAMINOPHEN AND CODEINE PHOSPHATE,68788-7835-6,"300 mg/1,                         30  mg/1",TABLET,ORAL,ANDA040419,Preferred Pharmaceuticals Inc.,68788-7835,acetaminophen and codeine phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/18/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (68788-7835-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,68788783506,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0701-8,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA088629,Bryant Ranch Prepack,71335-0701,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-0701-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335070108,Codeine,300
Acetaminophen and Codeine Phosphate,70518-3051-0,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA202800,REMEDYREPACK INC.,70518-3051,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/18/2021,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-3051-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2024,70518305100,Codeine,300
Acetaminophen and Codeine Phosphate,71335-0701-2,"300 mg/1,                         60  mg/1",TABLET,ORAL,ANDA088629,Bryant Ranch Prepack,71335-0701,Acetaminophen and Codeine Phosphate,ACETAMINOPHEN;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0701-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIII,No,12/31/2023,71335070102,Codeine,300
"Acetaminophen, Caffeine, Dihydrocodeine Bitartrate",42195-840-10,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,"Xspire Pharma, Llc",42195-840,"Acetaminophen, Caffeine, Dihydrocodeine Bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/05/2015,N/A,ANDA,100 CAPSULE in 1 BOTTLE (42195-840-10),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,42195084010,Codeine,320.5
Ascomp with Codeine,79739-6094-1,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075231,"LGM PHARMA SOLUTIONS, LLC",79739-6094,"Butalbital, Aspirin, Cafeine, and Codeine Phosphate",ASPIRIN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/24/2020,N/A,ANDA,100 CAPSULE in 1 BOTTLE (79739-6094-1),"Anti-Inflammatory Agents,  Non-Steroidal [CS],  Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Platelet Aggregation Inhibitor [EPC],  Xanthines [CS]",CIII,No,12/31/2023,79739609401,Codeine,325
Ascomp with Codeine,51991-074-01,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075231,"Breckenridge Pharmaceutical, Inc.",51991-074,"Butalbital, Aspirin, Caffeine and Codeine Phosphate",ASPIRIN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/01/2009,N/A,ANDA,"100 CAPSULE in 1 BOTTLE, PLASTIC (51991-074-01)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Platelet Aggregation Inhibitor [EPC],  Xanthines [CS]",CIII,No,12/31/2023,51991007401,Codeine,325
Ascomp with Codeine,51991-074-05,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075231,"Breckenridge Pharmaceutical, Inc.",51991-074,"Butalbital, Aspirin, Caffeine and Codeine Phosphate",ASPIRIN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/01/2009,N/A,ANDA,"500 CAPSULE in 1 BOTTLE, PLASTIC (51991-074-05)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Platelet Aggregation Inhibitor [EPC],  Xanthines [CS]",CIII,No,12/31/2023,51991007405,Codeine,325
"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",71335-0194-7,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA076560,Bryant Ranch Prepack,71335-0194,"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",ACETAMINOPHEN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,18 CAPSULE in 1 BOTTLE (71335-0194-7),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,71335019407,Codeine,325
"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",71335-0194-4,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA076560,Bryant Ranch Prepack,71335-0194,"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",ACETAMINOPHEN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/13/2021,N/A,ANDA,60 CAPSULE in 1 BOTTLE (71335-0194-4),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,71335019404,Codeine,325
"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",71335-0194-6,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA076560,Bryant Ranch Prepack,71335-0194,"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",ACETAMINOPHEN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,15 CAPSULE in 1 BOTTLE (71335-0194-6),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,71335019406,Codeine,325
"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",71335-0194-1,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA076560,Bryant Ranch Prepack,71335-0194,"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",ACETAMINOPHEN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,20 CAPSULE in 1 BOTTLE (71335-0194-1),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,71335019401,Codeine,325
"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",0054-0650-25,"300 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA215138,Hikma Pharmaceuticals USA Inc.,0054-0650,"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",ACETAMINOPHEN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/09/2022,N/A,ANDA,100 CAPSULE in 1 BOTTLE (0054-0650-25),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,00054065025,Codeine,300
"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",0054-3000-01,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA215138,Hikma Pharmaceuticals USA Inc.,0054-3000,"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",ACETAMINOPHEN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,05/09/2022,N/A,ANDA,100 CAPSULE in 1 BOTTLE (0054-3000-01),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,00054300001,Codeine,325
"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",71335-0194-2,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA076560,Bryant Ranch Prepack,71335-0194,"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",ACETAMINOPHEN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/30/2019,N/A,ANDA,90 CAPSULE in 1 BOTTLE (71335-0194-2),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,71335019402,Codeine,325
"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",71335-0194-3,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA076560,Bryant Ranch Prepack,71335-0194,"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",ACETAMINOPHEN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,30 CAPSULE in 1 BOTTLE (71335-0194-3),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,71335019403,Codeine,325
"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",71335-0194-5,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA076560,Bryant Ranch Prepack,71335-0194,"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",ACETAMINOPHEN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,100 CAPSULE in 1 BOTTLE (71335-0194-5),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,71335019405,Codeine,325
"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",51991-073-01,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA076560,"Breckenridge Pharmaceutical, Inc.",51991-073,"Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",BUTALBITAL;  ACETAMINOPHEN;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/01/2004,N/A,ANDA,"100 CAPSULE in 1 BOTTLE, PLASTIC (51991-073-01)","Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,51991007301,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",79739-7028-1,"300 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA076560,"LGM Pharma Solutions, LLC",79739-7028,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",BUTALBITAL;  ACETAMINOPHEN;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,06/10/2004,N/A,ANDA,"100 CAPSULE in 1 BOTTLE, PLASTIC (79739-7028-1)","Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,79739702801,Codeine,300
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",79739-7028-5,"300 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA076560,"LGM Pharma Solutions, LLC",79739-7028,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",BUTALBITAL;  ACETAMINOPHEN;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,06/10/2004,N/A,ANDA,"500 CAPSULE in 1 BOTTLE, PLASTIC (79739-7028-5)","Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,79739702805,Codeine,300
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",71335-0653-1,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075929,Bryant Ranch Prepack,71335-0653,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",BUTALBITAL;  ACETAMINOPHEN;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/25/2018,N/A,ANDA,20 CAPSULE in 1 BOTTLE (71335-0653-1),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,71335065301,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",71335-0653-2,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075929,Bryant Ranch Prepack,71335-0653,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",BUTALBITAL;  ACETAMINOPHEN;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/25/2018,N/A,ANDA,90 CAPSULE in 1 BOTTLE (71335-0653-2),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,71335065302,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",71335-0653-3,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075929,Bryant Ranch Prepack,71335-0653,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",BUTALBITAL;  ACETAMINOPHEN;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/25/2018,N/A,ANDA,30 CAPSULE in 1 BOTTLE (71335-0653-3),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,71335065303,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",71335-0653-4,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075929,Bryant Ranch Prepack,71335-0653,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",BUTALBITAL;  ACETAMINOPHEN;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/25/2018,N/A,ANDA,60 CAPSULE in 1 BOTTLE (71335-0653-4),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,71335065304,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",71335-0653-5,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075929,Bryant Ranch Prepack,71335-0653,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",BUTALBITAL;  ACETAMINOPHEN;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/25/2018,N/A,ANDA,100 CAPSULE in 1 BOTTLE (71335-0653-5),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,71335065305,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",71335-0653-6,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075929,Bryant Ranch Prepack,71335-0653,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",BUTALBITAL;  ACETAMINOPHEN;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/25/2018,N/A,ANDA,15 CAPSULE in 1 BOTTLE (71335-0653-6),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,71335065306,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",71335-0653-7,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075929,Bryant Ranch Prepack,71335-0653,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",BUTALBITAL;  ACETAMINOPHEN;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,01/25/2018,N/A,ANDA,18 CAPSULE in 1 BOTTLE (71335-0653-7),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,71335065307,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",0591-3220-01,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,NDA020232,"Actavis Pharma, Inc.",0591-3220,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",ACETAMINOPHEN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,09/18/2003,N/A,NDA AUTHORIZED GENERIC,100 CAPSULE in 1 BOTTLE (0591-3220-01),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,00591322001,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",63629-3152-1,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,NDA020232,Bryant Ranch Prepack,63629-3152,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",CODEINE PHOSPHATE;  BUTALBITAL;  CAFFEINE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/11/2006,N/A,NDA AUTHORIZED GENERIC,20 CAPSULE in 1 BOTTLE (63629-3152-1),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629315201,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",63629-3152-2,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,NDA020232,Bryant Ranch Prepack,63629-3152,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",CODEINE PHOSPHATE;  BUTALBITAL;  CAFFEINE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/19/2006,N/A,NDA AUTHORIZED GENERIC,90 CAPSULE in 1 BOTTLE (63629-3152-2),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629315202,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",63629-3152-3,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,NDA020232,Bryant Ranch Prepack,63629-3152,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",CODEINE PHOSPHATE;  BUTALBITAL;  CAFFEINE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/07/2010,N/A,NDA AUTHORIZED GENERIC,30 CAPSULE in 1 BOTTLE (63629-3152-3),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629315203,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",63629-3152-4,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,NDA020232,Bryant Ranch Prepack,63629-3152,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",CODEINE PHOSPHATE;  BUTALBITAL;  CAFFEINE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/22/2010,N/A,NDA AUTHORIZED GENERIC,60 CAPSULE in 1 BOTTLE (63629-3152-4),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629315204,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",63629-3152-5,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,NDA020232,Bryant Ranch Prepack,63629-3152,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",CODEINE PHOSPHATE;  BUTALBITAL;  CAFFEINE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/14/2016,N/A,NDA AUTHORIZED GENERIC,100 CAPSULE in 1 BOTTLE (63629-3152-5),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629315205,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",0591-2641-01,"300 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA076560,"Actavis Pharma, Inc.",0591-2641,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",BUTALBITAL;  ACETAMINOPHEN;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/29/2013,N/A,ANDA,"100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2641-01)","Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,00591264101,Codeine,300
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",63629-3152-6,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,NDA020232,Bryant Ranch Prepack,63629-3152,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",CODEINE PHOSPHATE;  BUTALBITAL;  CAFFEINE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,NDA AUTHORIZED GENERIC,15 CAPSULE in 1 BOTTLE (63629-3152-6),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629315206,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",63629-3152-7,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,NDA020232,Bryant Ranch Prepack,63629-3152,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",CODEINE PHOSPHATE;  BUTALBITAL;  CAFFEINE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,NDA AUTHORIZED GENERIC,18 CAPSULE in 1 BOTTLE (63629-3152-7),"Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629315207,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",79739-6670-1,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA076560,"LGM Pharma Solutions, LLC",79739-6670,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",BUTALBITAL;  ACETAMINOPHEN;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,06/10/2004,N/A,ANDA,"100 CAPSULE in 1 BOTTLE, PLASTIC (79739-6670-1)","Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,79739667001,Codeine,325
"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",79739-6670-5,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA076560,"LGM Pharma Solutions, LLC",79739-6670,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",BUTALBITAL;  ACETAMINOPHEN;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,06/10/2004,N/A,ANDA,"500 CAPSULE in 1 BOTTLE, PLASTIC (79739-6670-5)","Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,79739667005,Codeine,325
"Butalbital, Aspirin, Caffeine and Codeine Phosphate",69238-1993-1,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA074951,Amneal Pharmaceuticals NY LLC,69238-1993,"Butalbital, Aspirin, Caffeine and Codeine Phosphate",ASPIRIN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,04/01/2019,N/A,ANDA,100 CAPSULE in 1 BOTTLE (69238-1993-1),"Anti-Inflammatory Agents,  Non-Steroidal [CS],  Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Platelet Aggregation Inhibitor [EPC],  Xanthines [CS]",CIII,No,12/31/2024,69238199301,Codeine,325
"Butalbital, Aspirin, Caffeine and Codeine Phosphate",0527-1312-01,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA074951,"Lannett Company, Inc.",0527-1312,"Butalbital, Aspirin, Caffeine and Codeine Phosphate",BUTALBITAL;  ASPIRIN;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,08/31/1998,N/A,ANDA,100 CAPSULE in 1 BOTTLE (0527-1312-01),"Anti-Inflammatory Agents,  Non-Steroidal [CS],  Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Platelet Aggregation Inhibitor [EPC],  Xanthines [CS]",CIII,No,12/31/2023,00527131201,Codeine,325
"BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE",63629-2952-1,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075231,Bryant Ranch Prepack,63629-2952,"Butalbital, Aspirin, Caffeine and Codeine Phosphate",ASPIRIN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,30 CAPSULE in 1 BOTTLE (63629-2952-1),"Anti-Inflammatory Agents,  Non-Steroidal [CS],  Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Platelet Aggregation Inhibitor [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629295201,Codeine,325
"BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE",63629-2952-2,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075231,Bryant Ranch Prepack,63629-2952,"Butalbital, Aspirin, Caffeine and Codeine Phosphate",ASPIRIN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,20 CAPSULE in 1 BOTTLE (63629-2952-2),"Anti-Inflammatory Agents,  Non-Steroidal [CS],  Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Platelet Aggregation Inhibitor [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629295202,Codeine,325
"BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE",63629-2952-3,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075231,Bryant Ranch Prepack,63629-2952,"Butalbital, Aspirin, Caffeine and Codeine Phosphate",ASPIRIN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/30/2010,N/A,ANDA,90 CAPSULE in 1 BOTTLE (63629-2952-3),"Anti-Inflammatory Agents,  Non-Steroidal [CS],  Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Platelet Aggregation Inhibitor [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629295203,Codeine,325
"BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE",63629-2952-4,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075231,Bryant Ranch Prepack,63629-2952,"Butalbital, Aspirin, Caffeine and Codeine Phosphate",ASPIRIN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/30/2010,N/A,ANDA,60 CAPSULE in 1 BOTTLE (63629-2952-4),"Anti-Inflammatory Agents,  Non-Steroidal [CS],  Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Platelet Aggregation Inhibitor [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629295204,Codeine,325
"BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE",63629-2952-5,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075231,Bryant Ranch Prepack,63629-2952,"Butalbital, Aspirin, Caffeine and Codeine Phosphate",ASPIRIN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,09/26/2014,N/A,ANDA,40 CAPSULE in 1 BOTTLE (63629-2952-5),"Anti-Inflammatory Agents,  Non-Steroidal [CS],  Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Platelet Aggregation Inhibitor [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629295205,Codeine,325
"BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE",63629-2952-6,"325 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA075231,Bryant Ranch Prepack,63629-2952,"Butalbital, Aspirin, Caffeine and Codeine Phosphate",ASPIRIN;  BUTALBITAL;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,18 CAPSULE in 1 BOTTLE (63629-2952-6),"Anti-Inflammatory Agents,  Non-Steroidal [CS],  Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Platelet Aggregation Inhibitor [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629295206,Codeine,325
CapCof,29978-420-16,"2 mg/5mL,                         10  mg/5mL,                         5  mg/5mL",LIQUID,ORAL,part341,"Capital Pharmaceutical, LLC",29978-420,"Codeine Phosphate, Phenylephrine Hydrochloride, Chlorpheniramine Maleate",CHLORPHENIRAMINE MALEATE;  CODEINE PHOSPHATE;  PHENYLEPHRINE HYDROCHLORIDE,HUMAN OTC DRUG,10/08/2010,N/A,OTC MONOGRAPH FINAL,473 mL in 1 BOTTLE (29978-420-16),"Adrenergic alpha1-Agonists [MoA],  Full Opioid Agonists [MoA],  Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  Opioid Agonist [EPC],  alpha-1 Adrenergic Agonist [EPC]",CV,No,12/31/2024,29978042016,Codeine,2
CODEINE GUAIFENESIN,68788-7921-1,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,Preferred Pharmaceuticals Inc.,68788-7921,"CODEINE PHOSPHATE, GUAIFENESIN",CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,06/14/2021,N/A,OTC MONOGRAPH FINAL,120 mL in 1 BOTTLE (68788-7921-1),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,68788792101,Codeine,10
Codeine sulfate,0054-0244-25,30 mg/1,TABLET,ORAL,NDA022402,West-Ward Pharmaceuticals Corp.,0054-0244,codeine sulfate,CODEINE SULFATE,HUMAN PRESCRIPTION DRUG,07/16/2009,N/A,NDA,100 TABLET in 1 BOTTLE (0054-0244-25),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054024425,Codeine,30
Codeine Sulfate,0527-1699-01,60 mg/1,TABLET,ORAL,ANDA203046,"Lannett Company, Inc.",0527-1699,Codeine Sulfate,CODEINE SULFATE,HUMAN PRESCRIPTION DRUG,06/13/2014,N/A,ANDA,100 TABLET in 1 BOTTLE (0527-1699-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527169901,Codeine,60
Codeine Sulfate,0527-1698-01,30 mg/1,TABLET,ORAL,ANDA203046,"Lannett Company, Inc.",0527-1698,Codeine Sulfate,CODEINE SULFATE,HUMAN PRESCRIPTION DRUG,06/13/2014,N/A,ANDA,100 TABLET in 1 BOTTLE (0527-1698-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527169801,Codeine,30
Codeine Sulfate,0527-1698-91,30 mg/1,TABLET,ORAL,ANDA203046,"Lannett Company, Inc.",0527-1698,Codeine Sulfate,CODEINE SULFATE,HUMAN PRESCRIPTION DRUG,06/13/2014,N/A,ANDA,4 BLISTER PACK in 1 CARTON (0527-1698-91)  / 25 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527169891,Codeine,30
Codeine sulfate,0054-0243-24,15 mg/1,TABLET,ORAL,NDA022402,West-Ward Pharmaceuticals Corp.,0054-0243,codeine sulfate,CODEINE SULFATE,HUMAN PRESCRIPTION DRUG,07/16/2009,N/A,NDA,10 BLISTER PACK in 1 BOX (0054-0243-24)  / 10 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054024324,Codeine,15
Codeine sulfate,0054-0244-24,30 mg/1,TABLET,ORAL,NDA022402,West-Ward Pharmaceuticals Corp.,0054-0244,codeine sulfate,CODEINE SULFATE,HUMAN PRESCRIPTION DRUG,07/16/2009,N/A,NDA,10 BLISTER PACK in 1 BOX (0054-0244-24)  / 10 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054024424,Codeine,30
Codeine sulfate,0054-0245-25,60 mg/1,TABLET,ORAL,NDA022402,West-Ward Pharmaceuticals Corp.,0054-0245,codeine sulfate,CODEINE SULFATE,HUMAN PRESCRIPTION DRUG,07/16/2009,N/A,NDA,100 TABLET in 1 BOTTLE (0054-0245-25),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054024525,Codeine,60
Codeine-Guaifenesin,17856-0273-1,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,ATLANTIC BIOLOGICALS CORP.,17856-0273,Codeine Phosphate and Guaifenesin,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,11/22/2022,N/A,OTC MONOGRAPH FINAL,"72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0273-1)  / 5 mL in 1 CUP, UNIT-DOSE (17856-0273-2)","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,17856027301,Codeine,10
Codeine-Guaifenesin,68788-7235-1,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,Preferred Pharmaceuticals Inc.,68788-7235,Codeine Phosphate and Guaifenesin,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,08/07/2018,N/A,OTC MONOGRAPH FINAL,120 mL in 1 BOTTLE (68788-7235-1),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,68788723501,Codeine,10
CODEINE-GUAIFENESIN,72189-337-04,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,Direct Rx,72189-337,codeine phosphate and guaifenesin solution,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,03/07/2022,N/A,OTC MONOGRAPH FINAL,118 mL in 1 BOTTLE (72189-337-04),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,72189033704,Codeine,10
Codeine-Guaifenesin,71205-624-04,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,Proficient Rx LP,71205-624,Codeine Phosphate and Guaifenesin,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,12/03/2021,N/A,OTC MONOGRAPH FINAL,118 mL in 1 BOTTLE (71205-624-04),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,71205062404,Codeine,10
Codeine-Guaifenesin,58657-500-04,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,"Method Pharmaceuticals, LLC",58657-500,Codeine Phosphate and Guaifenesin,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,04/01/2014,N/A,OTC MONOGRAPH FINAL,120 mL in 1 BOTTLE (58657-500-04),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,58657050004,Codeine,10
Codeine-Guaifenesin,58657-500-16,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,"Method Pharmaceuticals, LLC",58657-500,Codeine Phosphate and Guaifenesin,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,04/01/2014,N/A,OTC MONOGRAPH FINAL,473 mL in 1 BOTTLE (58657-500-16),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,58657050016,Codeine,10
Codeine-Guaifenesin,69367-272-04,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,"Westminster Pharmaceuticals, LLC",69367-272,Codeine Phosphate and Guaifenesin,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,07/15/2020,N/A,OTC MONOGRAPH FINAL,118 mL in 1 BOTTLE (69367-272-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CV,No,12/31/2023,69367027204,Codeine,10
Codeine-Guaifenesin,69367-272-16,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,"Westminster Pharmaceuticals, LLC",69367-272,Codeine Phosphate and Guaifenesin,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,07/15/2020,N/A,OTC MONOGRAPH FINAL,473 mL in 1 BOTTLE (69367-272-16),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CV,No,12/31/2023,69367027216,Codeine,10
Fioricet with Codeine,52544-082-01,"300 mg/1,                         50  mg/1,                         40  mg/1,                         30  mg/1",CAPSULE,ORAL,ANDA076560,"Actavis Pharma, Inc.",52544-082,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate",BUTALBITAL;  ACETAMINOPHEN;  CAFFEINE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,07/29/2013,N/A,ANDA,"100 CAPSULE in 1 BOTTLE, PLASTIC (52544-082-01)","Barbiturate [EPC],  Barbiturates [CS],  Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,52544008201,Codeine,300
Guaiatussin AC,55154-9627-5,"10 mg/5mL,                         100  mg/5mL",LIQUID,ORAL,part341,"Cardinal Health 107, LLC",55154-9627,guaifenesin and codeine phosphate,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,09/08/2010,N/A,OTC MONOGRAPH FINAL,"5 CUP, UNIT-DOSE in 1 BAG (55154-9627-5)  / 5 mL in 1 CUP, UNIT-DOSE","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2024,55154962705,Codeine,10
Guaiatussin AC,50090-2651-0,"10 mg/5mL,                         100  mg/5mL",LIQUID,ORAL,part341,A-S Medication Solutions,50090-2651,guaifenesin and codeine phosphate,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,11/28/2016,N/A,OTC MONOGRAPH FINAL,118 mL in 1 BOTTLE (50090-2651-0),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2024,50090265100,Codeine,10
Guaiatussin AC,50383-087-04,"10 mg/5mL,                         100  mg/5mL",LIQUID,ORAL,part341,Akorn Operating Company LLC,50383-087,guaifenesin and codeine phosphate,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,09/08/2010,N/A,OTC MONOGRAPH FINAL,118 mL in 1 BOTTLE (50383-087-04),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,50383008704,Codeine,10
Guaiatussin AC,50383-087-16,"10 mg/5mL,                         100  mg/5mL",LIQUID,ORAL,part341,Akorn Operating Company LLC,50383-087,guaifenesin and codeine phosphate,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,09/08/2010,N/A,OTC MONOGRAPH FINAL,473 mL in 1 BOTTLE (50383-087-16),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,50383008716,Codeine,10
Guaiatussin AC,50383-087-12,"10 mg/5mL,                         100  mg/5mL",LIQUID,ORAL,part341,Akorn Operating Company LLC,50383-087,guaifenesin and codeine phosphate,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,09/08/2010,N/A,OTC MONOGRAPH FINAL,"10 TRAY in 1 CASE (50383-087-12)  / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (50383-087-10)","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,50383008712,Codeine,10
Guaiatussin AC,50383-087-07,"10 mg/5mL,                         100  mg/5mL",LIQUID,ORAL,part341,Akorn Operating Company LLC,50383-087,guaifenesin and codeine phosphate,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,09/08/2010,N/A,OTC MONOGRAPH FINAL,"10 TRAY in 1 CASE (50383-087-07)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (50383-087-05)","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,50383008707,Codeine,10
Guaifenesin and Codeine Phosphate,0121-1550-00,"20 mg/10mL,                         200  mg/10mL",SOLUTION,ORAL,part341,"Pharmaceutical Associates, Inc.",0121-1550,Guaifenesin and Codeine Phosphate,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,10/01/2006,N/A,OTC MONOGRAPH FINAL,"10 TRAY in 1 CASE (0121-1550-00)  / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (0121-1550-10)","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,00121155000,Codeine,20
GUAIFENESIN and CODEINE PHOSPHATE,70752-177-06,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,QUAGEN PHARMACEUTICALS LLC,70752-177,GUAIFENESIN and CODEINE PHOSPHATE,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,05/23/2022,N/A,OTC MONOGRAPH FINAL,118 mL in 1 BOTTLE (70752-177-06),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,70752017706,Codeine,10
GUAIFENESIN and CODEINE PHOSPHATE,70752-177-12,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,QUAGEN PHARMACEUTICALS LLC,70752-177,GUAIFENESIN and CODEINE PHOSPHATE,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,05/23/2022,N/A,OTC MONOGRAPH FINAL,473 mL in 1 BOTTLE (70752-177-12),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,70752017712,Codeine,10
GUAIFENESIN and CODEINE PHOSPHATE,70752-177-15,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,QUAGEN PHARMACEUTICALS LLC,70752-177,GUAIFENESIN and CODEINE PHOSPHATE,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,05/23/2022,N/A,OTC MONOGRAPH FINAL,237 mL in 1 BOTTLE (70752-177-15),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,70752017715,Codeine,10
Guaifenesin and Codeine Phosphate,68788-8361-1,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,Preferred Pharmaceuticals Inc.,68788-8361,Guaifenesin and Codeine Phosphate,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,02/01/2023,N/A,OTC MONOGRAPH FINAL,118 mL in 1 BOTTLE (68788-8361-1),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2024,68788836101,Codeine,10
GUAIFENESIN and CODEINE PHOSPHATE,70752-180-06,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,QUAGEN PHARMACEUTICALS LLC,70752-180,GUAIFENESIN and CODEINE PHOSPHATE,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,05/23/2022,N/A,OTC MONOGRAPH FINAL,118 mL in 1 BOTTLE (70752-180-06),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,70752018006,Codeine,10
GUAIFENESIN and CODEINE PHOSPHATE,70752-180-12,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,QUAGEN PHARMACEUTICALS LLC,70752-180,GUAIFENESIN and CODEINE PHOSPHATE,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,05/23/2022,N/A,OTC MONOGRAPH FINAL,473 mL in 1 BOTTLE (70752-180-12),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,70752018012,Codeine,10
GUAIFENESIN and CODEINE PHOSPHATE,70752-180-15,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,QUAGEN PHARMACEUTICALS LLC,70752-180,GUAIFENESIN and CODEINE PHOSPHATE,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,05/23/2022,N/A,OTC MONOGRAPH FINAL,237 mL in 1 BOTTLE (70752-180-15),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,70752018015,Codeine,10
Guaifenesin and Codeine Phosphate,0121-1775-00,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,"Pharmaceutical Associates, Inc.",0121-1775,Guaifenesin and Codeine Phosphate,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,10/01/2006,N/A,OTC MONOGRAPH FINAL,"10 TRAY in 1 CASE (0121-1775-00)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-1775-05)","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,00121177500,Codeine,10
Guaifenesin and Codeine Phosphate,0121-1775-10,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,"Pharmaceutical Associates, Inc.",0121-1775,Guaifenesin and Codeine Phosphate,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,10/01/2006,N/A,OTC MONOGRAPH FINAL,"10 TRAY in 1 CASE (0121-1775-10)  / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE","Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,00121177510,Codeine,10
Guaifenesin and Codeine Phosphate,63187-117-04,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,Proficient Rx LP,63187-117,Guaifenesin and Codeine Phosphate,GUAIFENESIN;  CODEINE PHOSPHATE,HUMAN OTC DRUG,07/01/2014,N/A,OTC MONOGRAPH FINAL,118 mL in 1 BOTTLE (63187-117-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CV,No,12/31/2023,63187011704,Codeine,10
GUAIFENESIN and CODEINE PHOSPHATE,68071-2935-4,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,"NuCare Pharmaceuticals,Inc.",68071-2935,GUAIFENESIN and CODEINE PHOSPHATE,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,02/16/2023,N/A,OTC MONOGRAPH FINAL,118 mL in 1 BOTTLE (68071-2935-4),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2024,68071293504,Codeine,10
Guaifenesin and Codeine Phosphate,0121-0775-04,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,"Pharmaceutical Associates, Inc.",0121-0775,Guaifenesin and Codeine Phosphate,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,10/01/2006,N/A,OTC MONOGRAPH FINAL,118 mL in 1 BOTTLE (0121-0775-04),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,00121077504,Codeine,10
Guaifenesin and Codeine Phosphate,0121-0775-08,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,"Pharmaceutical Associates, Inc.",0121-0775,Guaifenesin and Codeine Phosphate,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,10/01/2006,N/A,OTC MONOGRAPH FINAL,237 mL in 1 BOTTLE (0121-0775-08),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,00121077508,Codeine,10
Guaifenesin and Codeine Phosphate,0121-0775-16,"10 mg/5mL,                         100  mg/5mL",SOLUTION,ORAL,part341,"Pharmaceutical Associates, Inc.",0121-0775,Guaifenesin and Codeine Phosphate,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,10/01/2006,N/A,OTC MONOGRAPH FINAL,473 mL in 1 BOTTLE (0121-0775-16),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,00121077516,Codeine,10
M-CLEAR,12830-717-16,"6.33 mg/5mL,                         100  mg/5mL",LIQUID,ORAL,part341,R.A. McNeil Company,12830-717,"Codeine Phosphate, Guaifenesin",CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,10/30/2008,N/A,OTC MONOGRAPH FINAL,473 mL in 1 BOTTLE (12830-717-16),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,12830071716,Codeine,6.33
M-CLEAR,12830-717-30,"6.33 mg/5mL,                         100  mg/5mL",LIQUID,ORAL,part341,R.A. McNeil Company,12830-717,"Codeine Phosphate, Guaifenesin",CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,10/30/2008,N/A,OTC MONOGRAPH FINAL,30 mL in 1 BOTTLE (12830-717-30),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,12830071730,Codeine,6.33
M-END,12830-754-12,"1.33 mg/5mL,                         6.33  mg/5mL,                         3.33  mg/5mL",LIQUID,ORAL,part341,R.A. McNeil Company,12830-754,"Codeine Phosphate, Phenylephrine Hydrochloride, Brompheniramine Maleate",BROMPHENIRAMINE MALEATE;  CODEINE PHOSPHATE;  PHENYLEPHRINE HYDROCHLORIDE,HUMAN OTC DRUG,12/19/2014,N/A,OTC MONOGRAPH FINAL,354 mL in 1 BOTTLE (12830-754-12),"Adrenergic alpha1-Agonists [MoA],  Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  alpha-1 Adrenergic Agonist [EPC]",CV,No,12/31/2023,12830075412,Codeine,1.33
M-END,12830-754-30,"1.33 mg/5mL,                         6.33  mg/5mL,                         3.33  mg/5mL",LIQUID,ORAL,part341,R.A. McNeil Company,12830-754,"Codeine Phosphate, Phenylephrine Hydrochloride, Brompheniramine Maleate",BROMPHENIRAMINE MALEATE;  CODEINE PHOSPHATE;  PHENYLEPHRINE HYDROCHLORIDE,HUMAN OTC DRUG,12/19/2014,N/A,OTC MONOGRAPH FINAL,30 mL in 1 BOTTLE (12830-754-30),"Adrenergic alpha1-Agonists [MoA],  Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  alpha-1 Adrenergic Agonist [EPC]",CV,No,12/31/2023,12830075430,Codeine,1.33
MAR-COF CG,0682-0475-16,"7.5 mg/5mL,                         225  mg/5mL",SYRUP,ORAL,part341,"Marnel Pharmaceuticals, LLC",0682-0475,CODEINE PHOSPHATE and GUAIFENESIN,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,12/01/2008,N/A,OTC MONOGRAPH FINAL,473 mL in 1 BOTTLE (0682-0475-16),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Full Opioid Agonists [MoA],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC]",CV,No,12/31/2023,00682047516,Codeine,7.5
Poly-Tussin AC,50991-723-15,"4 mg/5mL,                         10  mg/5mL,                         10  mg/5mL",LIQUID,ORAL,part341,"Poly Pharmaceuticals, Inc.",50991-723,"Brompheniramine Maleate, Codeine Phosphate, Phenylephrine Hydrochloride",BROMPHENIRAMINE MALEATE;  CODEINE PHOSPHATE;  PHENYLEPHRINE HYDROCHLORIDE,HUMAN OTC DRUG,06/02/2014,N/A,OTC MONOGRAPH FINAL,"12 BOTTLE, PLASTIC in 1 TRAY (50991-723-15)  / 15 mL in 1 BOTTLE, PLASTIC","Adrenergic alpha1-Agonists [MoA],  Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  alpha-1 Adrenergic Agonist [EPC]",CV,No,12/31/2023,50991072315,Codeine,4
Poly-Tussin AC,50991-723-16,"4 mg/5mL,                         10  mg/5mL,                         10  mg/5mL",LIQUID,ORAL,part341,"Poly Pharmaceuticals, Inc.",50991-723,"Brompheniramine Maleate, Codeine Phosphate, Phenylephrine Hydrochloride",BROMPHENIRAMINE MALEATE;  CODEINE PHOSPHATE;  PHENYLEPHRINE HYDROCHLORIDE,HUMAN OTC DRUG,06/02/2014,N/A,OTC MONOGRAPH FINAL,473 mL in 1 BOTTLE (50991-723-16),"Adrenergic alpha1-Agonists [MoA],  Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  alpha-1 Adrenergic Agonist [EPC]",CV,No,12/31/2023,50991072316,Codeine,4
"Promethazine HCl, Phenylephrine HCl, Codeine Phosphate",65162-694-86,"10 mg/5mL,                         5  mg/5mL,                         6.25  mg/5mL",SYRUP,ORAL,ANDA200963,Amneal Pharmaceuticals LLC,65162-694,"Promethazine, Phenylephrine, Codeine",CODEINE PHOSPHATE;  PHENYLEPHRINE HYDROCHLORIDE;  PROMETHAZINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/01/2013,N/A,ANDA,118 mL in 1 BOTTLE (65162-694-86),"Adrenergic alpha1-Agonists [MoA],  Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  Phenothiazine [EPC],  Phenothiazines [CS],  alpha-1 Adrenergic Agonist [EPC]",CV,No,12/31/2024,65162069486,Codeine,10
"Promethazine HCl, Phenylephrine HCl, Codeine Phosphate",65162-694-90,"10 mg/5mL,                         5  mg/5mL,                         6.25  mg/5mL",SYRUP,ORAL,ANDA200963,Amneal Pharmaceuticals LLC,65162-694,"Promethazine, Phenylephrine, Codeine",CODEINE PHOSPHATE;  PHENYLEPHRINE HYDROCHLORIDE;  PROMETHAZINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/01/2013,N/A,ANDA,473 mL in 1 BOTTLE (65162-694-90),"Adrenergic alpha1-Agonists [MoA],  Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  Phenothiazine [EPC],  Phenothiazines [CS],  alpha-1 Adrenergic Agonist [EPC]",CV,No,12/31/2024,65162069490,Codeine,10
Promethazine Hydrochloride and Codeine Phosphate,50383-804-16,"10 mg/5mL,                         6.25  mg/5mL",SOLUTION,ORAL,ANDA040151,Akorn,50383-804,Promethazine Hydrochloride and Codeine Phosphate,CODEINE PHOSPHATE;  PROMETHAZINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/26/1997,N/A,ANDA,473 mL in 1 BOTTLE (50383-804-16),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  Phenothiazine [EPC],  Phenothiazines [CS]",CV,No,12/31/2024,50383080416,Codeine,10
promethazine hydrochloride and codeine phosphate,70408-185-31,"10 mg/5mL,                         6.25  mg/5mL",SOLUTION,ORAL,ANDA090180,"Nostrum Laboratories, Inc.",70408-185,promethazine hydrochloride and codeine phosphate,PROMETHAZINE HYDROCHLORIDE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/17/2010,N/A,ANDA,118 mL in 1 BOTTLE (70408-185-31),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  Phenothiazine [EPC],  Phenothiazines [CS]",CV,No,12/31/2023,70408018531,Codeine,10
promethazine hydrochloride and codeine phosphate,70408-185-34,"10 mg/5mL,                         6.25  mg/5mL",SOLUTION,ORAL,ANDA090180,"Nostrum Laboratories, Inc.",70408-185,promethazine hydrochloride and codeine phosphate,PROMETHAZINE HYDROCHLORIDE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/17/2010,N/A,ANDA,473 mL in 1 BOTTLE (70408-185-34),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  Phenothiazine [EPC],  Phenothiazines [CS]",CV,No,12/31/2023,70408018534,Codeine,10
Promethazine Hydrochloride and Codeine Phosphate,70752-139-06,"10 mg/5mL,                         6.25  mg/5mL",SOLUTION,ORAL,ANDA214238,QUAGEN PHARMACEUTICALS LLC,70752-139,Promethazine Hydrochloride and Codeine Phosphate,CODEINE PHOSPHATE;  PROMETHAZINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2020,N/A,ANDA,"118 mL in 1 BOTTLE, PLASTIC (70752-139-06)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  Phenothiazine [EPC],  Phenothiazines [CS]",CV,No,12/31/2024,70752013906,Codeine,10
Promethazine Hydrochloride and Codeine Phosphate,70752-139-12,"10 mg/5mL,                         6.25  mg/5mL",SOLUTION,ORAL,ANDA214238,QUAGEN PHARMACEUTICALS LLC,70752-139,Promethazine Hydrochloride and Codeine Phosphate,CODEINE PHOSPHATE;  PROMETHAZINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2020,N/A,ANDA,"473 mL in 1 BOTTLE, PLASTIC (70752-139-12)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  Phenothiazine [EPC],  Phenothiazines [CS]",CV,No,12/31/2024,70752013912,Codeine,10
Promethazine Hydrochloride and Codeine Phosphate,27808-065-02,"10 mg/5mL,                         6.25  mg/5mL",SOLUTION,ORAL,ANDA200386,Tris Pharma Inc,27808-065,Promethazine Hydrochloride and Codeine Phosphate,PROMETHAZINE HYDROCHLORIDE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,03/12/2018,N/A,ANDA,"473 mL in 1 BOTTLE, PLASTIC (27808-065-02)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  Phenothiazine [EPC],  Phenothiazines [CS]",CV,No,12/31/2023,27808006502,Codeine,10
"promethazine hydrochloride, phenylephrine hydrochloride and codeine phosphate",50383-805-16,"10 mg/5mL,                         5  mg/5mL,                         6.25  mg/5mL",SOLUTION,ORAL,ANDA040674,Akorn,50383-805,"promethazine hydrochloride, phenylephrine hydrochloride and codeine phosphate",CODEINE PHOSPHATE;  PHENYLEPHRINE HYDROCHLORIDE;  PROMETHAZINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/06/2016,N/A,ANDA,473 mL in 1 BOTTLE (50383-805-16),"Adrenergic alpha1-Agonists [MoA],  Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  Phenothiazine [EPC],  Phenothiazines [CS],  alpha-1 Adrenergic Agonist [EPC]",CV,No,12/31/2024,50383080516,Codeine,10
"promethazine hydrochloride, phenylephrine hydrochloride and codeine phosphate",50383-805-04,"10 mg/5mL,                         5  mg/5mL,                         6.25  mg/5mL",SOLUTION,ORAL,ANDA040674,Akorn,50383-805,"promethazine hydrochloride, phenylephrine hydrochloride and codeine phosphate",CODEINE PHOSPHATE;  PHENYLEPHRINE HYDROCHLORIDE;  PROMETHAZINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/06/2016,N/A,ANDA,118 mL in 1 BOTTLE (50383-805-04),"Adrenergic alpha1-Agonists [MoA],  Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  Phenothiazine [EPC],  Phenothiazines [CS],  alpha-1 Adrenergic Agonist [EPC]",CV,No,12/31/2024,50383080504,Codeine,10
Promethazine VC with Codeine Oral Solution,0121-0925-16,"10 mg/5mL,                         5  mg/5mL,                         6.25  mg/5mL",SOLUTION,ORAL,ANDA040660,"PAI Holdings, LLC",0121-0925,Promethazine and Phenylephrine Hydrochloride and Codeine Phosphate,CODEINE PHOSPHATE;  PHENYLEPHRINE HYDROCHLORIDE;  PROMETHAZINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/18/2021,N/A,ANDA,473 mL in 1 BOTTLE (0121-0925-16),"Adrenergic alpha1-Agonists [MoA],  Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  Phenothiazine [EPC],  Phenothiazines [CS],  alpha-1 Adrenergic Agonist [EPC]",CV,No,12/31/2024,00121092516,Codeine,10
Promethazine with Codeine,0121-0928-16,"10 mg/5mL,                         6.25  mg/5mL",SOLUTION,ORAL,ANDA040650,"Pharmaceutical Associates, Inc.",0121-0928,Promethazine Hydrochloride and Codeine Phosphate,CODEINE PHOSPHATE;  PROMETHAZINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/18/2020,N/A,ANDA,473 mL in 1 BOTTLE (0121-0928-16),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  Phenothiazine [EPC],  Phenothiazines [CS]",CV,No,12/31/2023,00121092816,Codeine,10
Promethazine with Codeine,70166-555-05,"10 mg/5mL,                         6.25  mg/5mL",SOLUTION,ORAL,ANDA088875,Lohxa,70166-555,promethazine hydrochloride and codeine phosphate,PROMETHAZINE HYDROCHLORIDE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,02/22/2018,N/A,ANDA,30 BAG in 1 BOX (70166-555-05)  / 1 SYRINGE in 1 BAG / 5 mL in 1 SYRINGE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  Phenothiazine [EPC],  Phenothiazines [CS]",CV,No,12/31/2023,70166055505,Codeine,10
Promethazine with Codeine,63187-271-04,"10 mg/5mL,                         6.25  mg/5mL",SOLUTION,ORAL,ANDA040650,Proficient Rx LP,63187-271,Promethazine Hydrochloride and Codeine Phosphate,PROMETHAZINE HYDROCHLORIDE;  CODEINE PHOSPHATE,HUMAN PRESCRIPTION DRUG,06/01/2015,N/A,ANDA,4 mL in 1 BOTTLE (63187-271-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  Phenothiazine [EPC],  Phenothiazines [CS]",CV,No,12/31/2023,63187027104,Codeine,10
Trezix,63187-705-00,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Proficient Rx LP,63187-705,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,100 CAPSULE in 1 BOTTLE (63187-705-00),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63187070500,Codeine,320.5
Trezix,63187-705-60,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Proficient Rx LP,63187-705,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,60 CAPSULE in 1 BOTTLE (63187-705-60),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63187070560,Codeine,320.5
Trezix,63187-705-90,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Proficient Rx LP,63187-705,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,90 CAPSULE in 1 BOTTLE (63187-705-90),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63187070590,Codeine,320.5
Trezix,63187-705-72,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Proficient Rx LP,63187-705,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/01/2018,N/A,ANDA,120 CAPSULE in 1 BOTTLE (63187-705-72),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63187070572,Codeine,320.5
Trezix,63629-5637-1,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Bryant Ranch Prepack,63629-5637,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/20/2015,N/A,ANDA,30 CAPSULE in 1 BOTTLE (63629-5637-1),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629563701,Codeine,320.5
Trezix,63629-5637-2,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Bryant Ranch Prepack,63629-5637,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/30/2015,N/A,ANDA,60 CAPSULE in 1 BOTTLE (63629-5637-2),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629563702,Codeine,320.5
Trezix,63629-5637-3,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Bryant Ranch Prepack,63629-5637,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/10/2015,N/A,ANDA,90 CAPSULE in 1 BOTTLE (63629-5637-3),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629563703,Codeine,320.5
Trezix,63629-5637-4,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Bryant Ranch Prepack,63629-5637,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/22/2015,N/A,ANDA,120 CAPSULE in 1 BOTTLE (63629-5637-4),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629563704,Codeine,320.5
Trezix,63187-705-30,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Proficient Rx LP,63187-705,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,30 CAPSULE in 1 BOTTLE (63187-705-30),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63187070530,Codeine,320.5
Trezix,66992-840-10,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Wraser Llc,66992-840,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/01/2014,N/A,ANDA,100 CAPSULE in 1 BOTTLE (66992-840-10),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,66992084010,Codeine,320.5
Tusnel,54859-520-16,"10 mg/5mL,                         100  mg/5mL,                         30  mg/5mL",LIQUID,ORAL,part341,Llorens Pharmaceutical International Division,54859-520,"Codeine Phosphate, Guiafenesin, Pseudoephedrine HCl",CODEINE PHOSPHATE;  GUAIFENESIN;  PSEUDOEPHEDRINE HYDROCHLORIDE,HUMAN OTC DRUG,01/01/1995,N/A,OTC MONOGRAPH FINAL,473 mL in 1 BOTTLE (54859-520-16),"Adrenergic alpha-Agonists [MoA],  Full Opioid Agonists [MoA],  Opioid Agonist [EPC],  alpha-Adrenergic Agonist [EPC]",CV,No,12/31/2023,54859052016,Codeine,10
Virtussin A/C,71205-363-04,"10 mg/5mL,                         100  mg/5mL",LIQUID,ORAL,part341,Proficient Rx LP,71205-363,Codeine phosphate and Guaifenesin,CODEINE PHOSPHATE;  GUAIFENESIN,HUMAN OTC DRUG,11/21/2019,N/A,OTC MONOGRAPH FINAL,118 mL in 1 BOTTLE (71205-363-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CV,No,12/31/2023,71205036304,Codeine,10
"Acetaminophen, Caffeine, Dihydrocodeine Bitartrate",42195-840-10,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,"Xspire Pharma, Llc",42195-840,"Acetaminophen, Caffeine, Dihydrocodeine Bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/05/2015,N/A,ANDA,100 CAPSULE in 1 BOTTLE (42195-840-10),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,42195084010,dihydrocodeine,320.5
Trezix,66992-840-10,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Wraser Llc,66992-840,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/01/2014,N/A,ANDA,100 CAPSULE in 1 BOTTLE (66992-840-10),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,66992084010,dihydrocodeine,320.5
Trezix,63187-705-00,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Proficient Rx LP,63187-705,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,100 CAPSULE in 1 BOTTLE (63187-705-00),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63187070500,dihydrocodeine,320.5
Trezix,63187-705-60,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Proficient Rx LP,63187-705,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,60 CAPSULE in 1 BOTTLE (63187-705-60),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63187070560,dihydrocodeine,320.5
Trezix,63187-705-90,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Proficient Rx LP,63187-705,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,90 CAPSULE in 1 BOTTLE (63187-705-90),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63187070590,dihydrocodeine,320.5
Trezix,63629-5637-1,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Bryant Ranch Prepack,63629-5637,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/20/2015,N/A,ANDA,30 CAPSULE in 1 BOTTLE (63629-5637-1),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629563701,dihydrocodeine,320.5
Trezix,63629-5637-2,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Bryant Ranch Prepack,63629-5637,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/30/2015,N/A,ANDA,60 CAPSULE in 1 BOTTLE (63629-5637-2),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629563702,dihydrocodeine,320.5
Trezix,63629-5637-3,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Bryant Ranch Prepack,63629-5637,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/10/2015,N/A,ANDA,90 CAPSULE in 1 BOTTLE (63629-5637-3),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629563703,dihydrocodeine,320.5
Trezix,63629-5637-4,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Bryant Ranch Prepack,63629-5637,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/22/2015,N/A,ANDA,120 CAPSULE in 1 BOTTLE (63629-5637-4),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63629563704,dihydrocodeine,320.5
Trezix,63187-705-30,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Proficient Rx LP,63187-705,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,30 CAPSULE in 1 BOTTLE (63187-705-30),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63187070530,dihydrocodeine,320.5
Trezix,63187-705-72,"320.5 mg/1,                         30  mg/1,                         16  mg/1",CAPSULE,ORAL,ANDA204785,Proficient Rx LP,63187-705,"acetaminophen, caffeine, dihydrocodeine bitartrate",ACETAMINOPHEN;  CAFFEINE;  DIHYDROCODEINE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/01/2018,N/A,ANDA,120 CAPSULE in 1 BOTTLE (63187-705-72),"Central Nervous System Stimulant [EPC],  Central Nervous System Stimulation [PE],  Full Opioid Agonists [MoA],  Methylxanthine [EPC],  Opioid Agonist [EPC],  Xanthines [CS]",CIII,No,12/31/2023,63187070572,dihydrocodeine,320.5
ACTIQ,63459-502-30,200 ug/1,LOZENGE,ORAL; TRANSMUCOSAL,NDA020747,"Cephalon, LLC",63459-502,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,01/20/1999,N/A,NDA,30 BLISTER PACK in 1 CARTON (63459-502-30)  / 1 LOZENGE in 1 BLISTER PACK (63459-502-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63459050230,Fentanyl,200
ACTIQ,63459-512-30,1200 ug/1,LOZENGE,ORAL; TRANSMUCOSAL,NDA020747,"Cephalon, LLC",63459-512,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,01/20/1999,N/A,NDA,30 BLISTER PACK in 1 CARTON (63459-512-30)  / 1 LOZENGE in 1 BLISTER PACK (63459-512-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63459051230,Fentanyl,1200
ACTIQ,63459-516-30,1600 ug/1,LOZENGE,ORAL; TRANSMUCOSAL,NDA020747,"Cephalon, LLC",63459-516,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,01/20/1999,N/A,NDA,30 BLISTER PACK in 1 CARTON (63459-516-30)  / 1 LOZENGE in 1 BLISTER PACK (63459-516-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63459051630,Fentanyl,1600
ACTIQ,63459-506-30,600 ug/1,LOZENGE,ORAL; TRANSMUCOSAL,NDA020747,"Cephalon, LLC",63459-506,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,01/20/1999,N/A,NDA,30 BLISTER PACK in 1 CARTON (63459-506-30)  / 1 LOZENGE in 1 BLISTER PACK (63459-506-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63459050630,Fentanyl,600
ACTIQ,63459-504-30,400 ug/1,LOZENGE,ORAL; TRANSMUCOSAL,NDA020747,"Cephalon, LLC",63459-504,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,01/20/1999,N/A,NDA,30 BLISTER PACK in 1 CARTON (63459-504-30)  / 1 LOZENGE in 1 BLISTER PACK (63459-504-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63459050430,Fentanyl,400
ACTIQ,63459-508-30,800 ug/1,LOZENGE,ORAL; TRANSMUCOSAL,NDA020747,"Cephalon, LLC",63459-508,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,01/20/1999,N/A,NDA,30 BLISTER PACK in 1 CARTON (63459-508-30)  / 1 LOZENGE in 1 BLISTER PACK (63459-508-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63459050830,Fentanyl,800
FENTANYL,60505-7082-2,50 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7082,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,01/10/2018,02/28/2026,ANDA,5 POUCH in 1 CARTON (60505-7082-2)  / 1 PATCH in 1 POUCH (60505-7082-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505708202,Fentanyl,50
FENTANYL,60505-7087-2,87.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7087,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,01/10/2018,06/30/2025,ANDA,5 POUCH in 1 CARTON (60505-7087-2)  / 1 PATCH in 1 POUCH (60505-7087-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505708702,Fentanyl,87.5
FENTANYL,60505-7008-2,75 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7008,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,04/04/2013,01/31/2026,ANDA,5 POUCH in 1 CARTON (60505-7008-2)  / 1 PATCH in 1 POUCH (60505-7008-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505700802,Fentanyl,75
FENTANYL,60505-7009-2,100 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7009,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,04/04/2013,01/31/2026,ANDA,5 POUCH in 1 CARTON (60505-7009-2)  / 1 PATCH in 1 POUCH (60505-7009-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505700902,Fentanyl,100
FENTANYL,55700-772-05,75 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,"Quality Care Products, LLC",55700-772,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,07/19/2019,01/31/2026,ANDA,5 POUCH in 1 CARTON (55700-772-05)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,55700077205,Fentanyl,75
FENTANYL,55700-748-05,50 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,"Quality Care Products, LLC",55700-748,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,05/17/2019,02/28/2026,ANDA,5 POUCH in 1 CARTON (55700-748-05)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,55700074805,Fentanyl,50
FENTANYL,55700-749-05,12 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,"Quality Care Products, LLC",55700-749,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,04/26/2019,02/28/2026,ANDA,5 POUCH in 1 CARTON (55700-749-05)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,55700074905,Fentanyl,12
FENTANYL,55700-753-05,25 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,"Quality Care Products, LLC",55700-753,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,05/17/2019,12/31/2025,ANDA,5 POUCH in 1 CARTON (55700-753-05)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,55700075305,Fentanyl,25
FENTANYL,60505-7011-2,25 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7011,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,04/04/2013,12/31/2025,ANDA,5 POUCH in 1 CARTON (60505-7011-2)  / 1 PATCH in 1 POUCH (60505-7011-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505701102,Fentanyl,25
FENTANYL,60505-7013-2,75 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7013,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,04/04/2013,01/31/2026,ANDA,5 POUCH in 1 CARTON (60505-7013-2)  / 1 PATCH in 1 POUCH (60505-7013-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505701302,Fentanyl,75
FENTANYL,0378-9119-98,12 ug/h,PATCH,TRANSDERMAL,ANDA076258,Mylan Pharmaceuticals Inc.,0378-9119,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,01/23/2007,N/A,ANDA,5 POUCH in 1 CARTON (0378-9119-98)  / 1 PATCH in 1 POUCH (0378-9119-16)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00378911998,Fentanyl,12
FENTANYL,0378-9121-98,25 ug/h,PATCH,TRANSDERMAL,ANDA076258,Mylan Pharmaceuticals Inc.,0378-9121,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,01/31/2005,N/A,ANDA,5 POUCH in 1 CARTON (0378-9121-98)  / 1 PATCH in 1 POUCH (0378-9121-16)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00378912198,Fentanyl,25
FENTANYL,0378-9122-98,50 ug/h,PATCH,TRANSDERMAL,ANDA076258,Mylan Pharmaceuticals Inc.,0378-9122,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,01/31/2005,N/A,ANDA,5 POUCH in 1 CARTON (0378-9122-98)  / 1 PATCH in 1 POUCH (0378-9122-16)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00378912298,Fentanyl,50
FENTANYL,0378-9123-98,75 ug/h,PATCH,TRANSDERMAL,ANDA076258,Mylan Pharmaceuticals Inc.,0378-9123,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,01/31/2005,N/A,ANDA,5 POUCH in 1 CARTON (0378-9123-98)  / 1 PATCH in 1 POUCH (0378-9123-16)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00378912398,Fentanyl,75
FENTANYL,0378-9124-98,100 ug/h,PATCH,TRANSDERMAL,ANDA076258,Mylan Pharmaceuticals Inc.,0378-9124,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,01/31/2005,N/A,ANDA,5 POUCH in 1 CARTON (0378-9124-98)  / 1 PATCH in 1 POUCH (0378-9124-16)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00378912498,Fentanyl,100
FENTANYL,0378-9125-98,37.5 ug/h,PATCH,TRANSDERMAL,ANDA076258,Mylan Pharmaceuticals Inc.,0378-9125,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,02/26/2015,N/A,ANDA,5 POUCH in 1 CARTON (0378-9125-98)  / 1 PATCH in 1 POUCH (0378-9125-16)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00378912598,Fentanyl,37.5
FENTANYL,0378-9126-98,62.5 ug/h,PATCH,TRANSDERMAL,ANDA076258,Mylan Pharmaceuticals Inc.,0378-9126,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,02/26/2015,N/A,ANDA,5 POUCH in 1 CARTON (0378-9126-98)  / 1 PATCH in 1 POUCH (0378-9126-16)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00378912698,Fentanyl,62.5
FENTANYL,0378-9127-98,87.5 ug/h,PATCH,TRANSDERMAL,ANDA076258,Mylan Pharmaceuticals Inc.,0378-9127,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,02/26/2015,N/A,ANDA,5 POUCH in 1 CARTON (0378-9127-98)  / 1 PATCH in 1 POUCH (0378-9127-16)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00378912798,Fentanyl,87.5
FENTANYL,60505-7015-2,37.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7015,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,07/24/2019,06/30/2025,ANDA,5 POUCH in 1 CARTON (60505-7015-2)  / 1 PATCH in 1 POUCH (60505-7015-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505701502,Fentanyl,37.5
FENTANYL,60505-7016-2,62.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7016,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,07/24/2019,06/30/2025,ANDA,5 POUCH in 1 CARTON (60505-7016-2)  / 1 PATCH in 1 POUCH (60505-7016-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505701602,Fentanyl,62.5
FENTANYL,60505-7017-2,87.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7017,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,07/24/2019,06/30/2025,ANDA,5 POUCH in 1 CARTON (60505-7017-2)  / 1 PATCH in 1 POUCH (60505-7017-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505701702,Fentanyl,87.5
FENTANYL,60505-7014-2,100 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7014,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,04/04/2013,01/31/2026,ANDA,5 POUCH in 1 CARTON (60505-7014-2)  / 1 PATCH in 1 POUCH (60505-7014-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505701402,Fentanyl,100
FENTANYL,60505-7083-2,75 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7083,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,01/10/2018,01/31/2026,ANDA,5 POUCH in 1 CARTON (60505-7083-2)  / 1 PATCH in 1 POUCH (60505-7083-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505708302,Fentanyl,75
FENTANYL,60505-7086-2,62.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7086,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,01/10/2018,06/30/2025,ANDA,5 POUCH in 1 CARTON (60505-7086-2)  / 1 PATCH in 1 POUCH (60505-7086-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505708602,Fentanyl,62.5
FENTANYL,63629-4974-1,25 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Bryant Ranch Prepack,63629-4974,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,05/28/2013,12/31/2025,ANDA,1 PATCH in 1 POUCH (63629-4974-1)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,63629497401,Fentanyl,25
FENTANYL,63629-4974-2,25 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Bryant Ranch Prepack,63629-4974,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,05/28/2013,12/31/2025,ANDA,5 PATCH in 1 POUCH (63629-4974-2)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,63629497402,Fentanyl,25
FENTANYL,63629-4976-1,75 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Bryant Ranch Prepack,63629-4976,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,09/30/2013,01/31/2026,ANDA,1 PATCH in 1 POUCH (63629-4976-1)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,63629497601,Fentanyl,75
FENTANYL,63629-4976-2,75 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Bryant Ranch Prepack,63629-4976,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,09/30/2013,01/31/2026,ANDA,2 PATCH in 1 POUCH (63629-4976-2)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,63629497602,Fentanyl,75
FENTANYL,63629-4976-3,75 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Bryant Ranch Prepack,63629-4976,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,09/30/2013,01/31/2026,ANDA,5 PATCH in 1 POUCH (63629-4976-3)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,63629497603,Fentanyl,75
FENTANYL,60505-7010-2,12 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7010,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,01/22/2016,02/28/2026,ANDA,5 POUCH in 1 CARTON (60505-7010-2)  / 1 PATCH in 1 POUCH (60505-7010-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505701002,Fentanyl,12
FENTANYL,60505-7081-2,25 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7081,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,01/10/2018,12/31/2025,ANDA,5 POUCH in 1 CARTON (60505-7081-2)  / 1 PATCH in 1 POUCH (60505-7081-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505708102,Fentanyl,25
FENTANYL,60505-7084-2,100 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7084,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,01/10/2018,01/31/2026,ANDA,5 POUCH in 1 CARTON (60505-7084-2)  / 1 PATCH in 1 POUCH (60505-7084-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505708402,Fentanyl,100
FENTANYL,60505-7006-2,25 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7006,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,04/04/2013,12/31/2025,ANDA,5 POUCH in 1 CARTON (60505-7006-2)  / 1 PATCH in 1 POUCH (60505-7006-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505700602,Fentanyl,25
FENTANYL,60505-7007-2,50 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7007,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,04/04/2013,02/28/2026,ANDA,5 POUCH in 1 CARTON (60505-7007-2)  / 1 PATCH in 1 POUCH (60505-7007-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505700702,Fentanyl,50
FENTANYL,60505-7012-2,50 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7012,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,04/04/2013,02/28/2026,ANDA,5 POUCH in 1 CARTON (60505-7012-2)  / 1 PATCH in 1 POUCH (60505-7012-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505701202,Fentanyl,50
FENTANYL,63629-4813-1,100 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Bryant Ranch Prepack,63629-4813,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,06/10/2013,01/31/2026,ANDA,1 PATCH in 1 POUCH (63629-4813-1)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,63629481301,Fentanyl,100
FENTANYL,63629-4813-2,100 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Bryant Ranch Prepack,63629-4813,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,06/10/2013,01/31/2026,ANDA,2 PATCH in 1 POUCH (63629-4813-2)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,63629481302,Fentanyl,100
FENTANYL,63629-4813-3,100 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Bryant Ranch Prepack,63629-4813,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,06/10/2013,01/31/2026,ANDA,5 PATCH in 1 POUCH (63629-4813-3)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,63629481303,Fentanyl,100
FENTANYL,60505-7080-2,12 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7080,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,01/10/2018,02/28/2026,ANDA,5 POUCH in 1 CARTON (60505-7080-2)  / 1 PATCH in 1 POUCH (60505-7080-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505708002,Fentanyl,12
FENTANYL,60505-7085-2,37.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077449,Apotex Corp.,60505-7085,FENTANYL,FENTANYL,HUMAN PRESCRIPTION DRUG,01/10/2018,06/30/2025,ANDA,5 POUCH in 1 CARTON (60505-7085-2)  / 1 PATCH in 1 POUCH (60505-7085-0)  / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60505708502,Fentanyl,37.5
Fentanyl Buccal,51862-634-28,100 ug/1,TABLET,BUCCAL; SUBLINGUAL,NDA021947,Mayne Pharma,51862-634,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,06/14/2019,N/A,NDA AUTHORIZED GENERIC,28 BLISTER PACK in 1 CARTON (51862-634-28)  / 1 TABLET in 1 BLISTER PACK (51862-634-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,51862063428,Fentanyl,100
Fentanyl Buccal,51862-635-28,200 ug/1,TABLET,BUCCAL; SUBLINGUAL,NDA021947,Mayne Pharma,51862-635,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,06/14/2019,N/A,NDA AUTHORIZED GENERIC,28 BLISTER PACK in 1 CARTON (51862-635-28)  / 1 TABLET in 1 BLISTER PACK (51862-635-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,51862063528,Fentanyl,200
Fentanyl Buccal,51862-636-28,400 ug/1,TABLET,BUCCAL; SUBLINGUAL,NDA021947,Mayne Pharma,51862-636,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,06/14/2019,N/A,NDA AUTHORIZED GENERIC,28 BLISTER PACK in 1 CARTON (51862-636-28)  / 1 TABLET in 1 BLISTER PACK (51862-636-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,51862063628,Fentanyl,400
Fentanyl Buccal,51862-637-28,600 ug/1,TABLET,BUCCAL; SUBLINGUAL,NDA021947,Mayne Pharma,51862-637,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,06/14/2019,N/A,NDA AUTHORIZED GENERIC,28 BLISTER PACK in 1 CARTON (51862-637-28)  / 1 TABLET in 1 BLISTER PACK (51862-637-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,51862063728,Fentanyl,600
Fentanyl Buccal,51862-638-28,800 ug/1,TABLET,BUCCAL; SUBLINGUAL,NDA021947,Mayne Pharma,51862-638,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,06/14/2019,N/A,NDA AUTHORIZED GENERIC,28 BLISTER PACK in 1 CARTON (51862-638-28)  / 1 TABLET in 1 BLISTER PACK (51862-638-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,51862063828,Fentanyl,800
Fentanyl Citrate,0641-6024-10,50 ug/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA019101,Hikma Pharmaceuticals USA Inc.,0641-6024,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,07/11/1984,N/A,NDA,10 AMPULE in 1 CARTON (0641-6024-10)  / 2 mL in 1 AMPULE (0641-6024-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00641602410,Fentanyl,50
Fentanyl Citrate,0641-6025-10,50 ug/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA019101,Hikma Pharmaceuticals USA Inc.,0641-6025,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,07/11/1984,N/A,NDA,10 AMPULE in 1 CARTON (0641-6025-10)  / 5 mL in 1 AMPULE (0641-6025-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00641602510,Fentanyl,50
Fentanyl Citrate,0641-6026-05,50 ug/mL,INJECTION,INTRAVENOUS,NDA019101,Hikma Pharmaceuticals USA Inc.,0641-6026,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,07/11/1984,N/A,NDA,5 AMPULE in 1 CARTON (0641-6026-05)  / 20 mL in 1 AMPULE (0641-6026-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00641602605,Fentanyl,50
Fentanyl Citrate,0641-6027-25,50 ug/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA019101,Hikma Pharmaceuticals USA Inc.,0641-6027,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,07/11/1984,N/A,NDA,25 VIAL in 1 CARTON (0641-6027-25)  / 2 mL in 1 VIAL (0641-6027-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00641602725,Fentanyl,50
Fentanyl Citrate,0641-6028-25,50 ug/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA019101,Hikma Pharmaceuticals USA Inc.,0641-6028,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,07/11/1984,N/A,NDA,25 VIAL in 1 CARTON (0641-6028-25)  / 5 mL in 1 VIAL (0641-6028-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00641602825,Fentanyl,50
Fentanyl Citrate,0641-6029-25,50 ug/mL,INJECTION,INTRAVENOUS,NDA019101,Hikma Pharmaceuticals USA Inc.,0641-6029,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,07/11/1984,N/A,NDA,25 VIAL in 1 CARTON (0641-6029-25)  / 20 mL in 1 VIAL (0641-6029-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00641602925,Fentanyl,50
Fentanyl Citrate,0641-6030-01,50 ug/mL,INJECTION,INTRAVENOUS,NDA019101,Hikma Pharmaceuticals USA Inc.,0641-6030,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,07/11/1984,N/A,NDA,50 mL in 1 VIAL (0641-6030-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00641603001,Fentanyl,50
Fentanyl Citrate,0641-6029-01,50 ug/mL,INJECTION,INTRAVENOUS,NDA019101,Hikma Pharmaceuticals USA Inc.,0641-6029,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,07/11/1984,N/A,NDA,20 mL in 1 VIAL (0641-6029-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00641602901,Fentanyl,50
Fentanyl Citrate,0641-6247-25,50 ug/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA019101,Hikma Pharmaceuticals USA Inc.,0641-6247,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,03/18/2021,N/A,NDA,25 VIAL in 1 CARTON (0641-6247-25)  / 1 mL in 1 VIAL (0641-6247-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00641624725,Fentanyl,50
Fentanyl Citrate,72572-170-25,50 ug/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA019101,"Civica, Inc.",72572-170,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,12/10/2019,N/A,NDA,25 VIAL in 1 CARTON (72572-170-25)  / 2 mL in 1 VIAL (72572-170-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72572017025,Fentanyl,50
Fentanyl Citrate,72572-171-25,50 ug/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA019101,"Civica, Inc.",72572-171,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,12/10/2019,N/A,NDA,25 VIAL in 1 CARTON (72572-171-25)  / 5 mL in 1 VIAL (72572-171-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72572017125,Fentanyl,50
Fentanyl Citrate,72572-172-01,50 ug/mL,INJECTION,INTRAVENOUS,NDA019101,"Civica, Inc.",72572-172,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,10/07/2020,N/A,NDA,1 VIAL in 1 CARTON (72572-172-01)  / 50 mL in 1 VIAL,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72572017201,Fentanyl,50
Fentanyl Citrate,0641-6248-10,50 ug/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA019101,Hikma Pharmaceuticals USA Inc.,0641-6248,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,02/01/2023,N/A,NDA,"10 SYRINGE, GLASS in 1 CARTON (0641-6248-10)  / 1 mL in 1 SYRINGE, GLASS (0641-6248-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00641624810,Fentanyl,50
Fentanyl Citrate,0641-6249-10,50 ug/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA019101,Hikma Pharmaceuticals USA Inc.,0641-6249,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,02/01/2023,N/A,NDA,"10 SYRINGE, GLASS in 1 CARTON (0641-6249-10)  / .5 mL in 1 SYRINGE, GLASS (0641-6249-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00641624910,Fentanyl,50
Fentanyl Citrate,63323-808-11,50 ug/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA212086,"Fresenius Kabi USA, LLC",63323-808,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,09/30/2020,N/A,ANDA,10 SYRINGE in 1 CARTON (63323-808-11)  / 1 mL in 1 SYRINGE (63323-808-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63323080811,Fentanyl,50
FENTANYL CITRATE,0409-9093-11,50 ug/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA019115,"Hospira, Inc.",0409-9093,fentanyl citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,12/06/2016,N/A,NDA,10 AMPULE in 1 CELLO PACK (0409-9093-11)  / 2 mL in 1 AMPULE (0409-9093-09),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409909311,Fentanyl,50
FENTANYL CITRATE,0406-9202-30,200 ug/1,LOZENGE,TRANSMUCOSAL,ANDA078907,SpecGx LLC,0406-9202,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,10/30/2009,N/A,ANDA,30 BLISTER PACK in 1 CARTON (0406-9202-30)  / 1 LOZENGE in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406920230,Fentanyl,200
FENTANYL CITRATE,0406-9204-30,400 ug/1,LOZENGE,TRANSMUCOSAL,ANDA078907,SpecGx LLC,0406-9204,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,10/30/2009,N/A,ANDA,30 BLISTER PACK in 1 CARTON (0406-9204-30)  / 1 LOZENGE in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406920430,Fentanyl,400
FENTANYL CITRATE,0406-9206-30,600 ug/1,LOZENGE,TRANSMUCOSAL,ANDA078907,SpecGx LLC,0406-9206,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,10/30/2009,N/A,ANDA,30 BLISTER PACK in 1 CARTON (0406-9206-30)  / 1 LOZENGE in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406920630,Fentanyl,600
FENTANYL CITRATE,0406-9208-30,800 ug/1,LOZENGE,TRANSMUCOSAL,ANDA078907,SpecGx LLC,0406-9208,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,10/30/2009,N/A,ANDA,30 BLISTER PACK in 1 CARTON (0406-9208-30)  / 1 LOZENGE in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406920830,Fentanyl,800
FENTANYL CITRATE,0406-9212-30,1200 ug/1,LOZENGE,TRANSMUCOSAL,ANDA078907,SpecGx LLC,0406-9212,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,10/30/2009,N/A,ANDA,30 BLISTER PACK in 1 CARTON (0406-9212-30)  / 1 LOZENGE in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406921230,Fentanyl,1200
FENTANYL CITRATE,0406-9216-30,1600 ug/1,LOZENGE,TRANSMUCOSAL,ANDA078907,SpecGx LLC,0406-9216,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,10/30/2009,N/A,ANDA,30 BLISTER PACK in 1 CARTON (0406-9216-30)  / 1 LOZENGE in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406921630,Fentanyl,1600
Fentanyl Citrate,0409-1276-32,50 ug/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA072786,"Hospira, Inc.",0409-1276,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,07/20/2005,N/A,ANDA,10 CARTRIDGE in 1 CARTON (0409-1276-32)  / 2 mL in 1 CARTRIDGE (0409-1276-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409127632,Fentanyl,50
Fentanyl Citrate,63323-806-01,.05 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA210762,"Fresenius Kabi USA, LLC",63323-806,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,05/03/2019,N/A,ANDA,"25 VIAL, SINGLE-DOSE in 1 CARTON (63323-806-01)  / 1 mL in 1 VIAL, SINGLE-DOSE (63323-806-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323080601,Fentanyl,0.05
Fentanyl Citrate,63323-806-02,.05 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA210762,"Fresenius Kabi USA, LLC",63323-806,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,05/03/2019,N/A,ANDA,"25 VIAL, SINGLE-DOSE in 1 CARTON (63323-806-02)  / 2 mL in 1 VIAL, SINGLE-DOSE (63323-806-12)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323080602,Fentanyl,0.05
Fentanyl Citrate,63323-806-05,.05 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA210762,"Fresenius Kabi USA, LLC",63323-806,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,05/03/2019,N/A,ANDA,"25 VIAL, SINGLE-DOSE in 1 CARTON (63323-806-05)  / 5 mL in 1 VIAL, SINGLE-DOSE (63323-806-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323080605,Fentanyl,0.05
Fentanyl Citrate,63323-806-20,.05 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA210762,"Fresenius Kabi USA, LLC",63323-806,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,05/03/2019,N/A,ANDA,"25 VIAL, SINGLE-DOSE in 1 CARTON (63323-806-20)  / 20 mL in 1 VIAL, SINGLE-DOSE (63323-806-14)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323080620,Fentanyl,0.05
Fentanyl Citrate,63323-806-50,.05 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA210762,"Fresenius Kabi USA, LLC",63323-806,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,05/03/2019,N/A,ANDA,"1 VIAL, SINGLE-DOSE in 1 CARTON (63323-806-50)  / 50 mL in 1 VIAL, SINGLE-DOSE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323080650,Fentanyl,0.05
Fentanyl Citrate,0409-9093-32,50 ug/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA019115,"Hospira, Inc.",0409-9093,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,11/15/2005,N/A,NDA,10 AMPULE in 1 CELLO PACK (0409-9093-32)  / 2 mL in 1 AMPULE (0409-9093-37),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409909332,Fentanyl,50
Fentanyl Citrate,0409-9093-35,50 ug/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA019115,"Hospira, Inc.",0409-9093,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,12/14/2005,N/A,NDA,10 AMPULE in 1 CELLO PACK (0409-9093-35)  / 5 mL in 1 AMPULE (0409-9093-45),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409909335,Fentanyl,50
Fentanyl Citrate,0409-9094-22,50 ug/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA019115,"Hospira, Inc.",0409-9094,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,12/02/2010,N/A,NDA,"25 VIAL, SINGLE-DOSE in 1 TRAY (0409-9094-22)  / 2 mL in 1 VIAL, SINGLE-DOSE (0409-9094-12)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409909422,Fentanyl,50
Fentanyl Citrate,0409-9094-25,50 ug/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA019115,"Hospira, Inc.",0409-9094,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,11/09/2005,N/A,NDA,"25 VIAL, SINGLE-DOSE in 1 TRAY (0409-9094-25)  / 5 mL in 1 VIAL, SINGLE-DOSE (0409-9094-18)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409909425,Fentanyl,50
Fentanyl Citrate,0409-9094-28,50 ug/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA019115,"Hospira, Inc.",0409-9094,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,02/17/2006,N/A,NDA,"25 VIAL, SINGLE-DOSE in 1 TRAY (0409-9094-28)  / 10 mL in 1 VIAL, SINGLE-DOSE (0409-9094-17)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409909428,Fentanyl,50
Fentanyl Citrate,0409-9094-31,50 ug/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA019115,"Hospira, Inc.",0409-9094,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,09/27/2005,N/A,NDA,"25 VIAL, SINGLE-DOSE in 1 TRAY (0409-9094-31)  / 20 mL in 1 VIAL, SINGLE-DOSE (0409-9094-16)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409909431,Fentanyl,50
Fentanyl Citrate,0409-9094-61,50 ug/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA019115,"Hospira, Inc.",0409-9094,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,12/22/2005,N/A,NDA,"25 CARTON in 1 TRAY (0409-9094-61)  / 1 VIAL, SINGLE-DOSE in 1 CARTON / 50 mL in 1 VIAL, SINGLE-DOSE (0409-9094-41)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409909461,Fentanyl,50
Fentanyl Citrate,81565-205-02,50 ug/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA019101,Phlow Corp.,81565-205,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,01/11/2023,N/A,NDA,25 VIAL in 1 CARTON (81565-205-02)  / 2 mL in 1 VIAL (81565-205-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,81565020502,Fentanyl,50
Fentanyl Citrate,63323-810-20,100 ug/2mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA212086,"Fresenius Kabi USA, LLC",63323-810,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,02/17/2023,N/A,ANDA,20 SYRINGE in 1 CARTON (63323-810-20)  / 2 mL in 1 SYRINGE (63323-810-00),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63323081020,Fentanyl,100
FENTANYL CITRATE,17478-030-02,50 ug/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA016619,Akorn,17478-030,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,03/22/2012,N/A,NDA,10 AMPULE in 1 CARTON (17478-030-02)  / 2 mL in 1 AMPULE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17478003002,Fentanyl,50
FENTANYL CITRATE,17478-030-05,50 ug/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA016619,Akorn,17478-030,FENTANYL CITRATE,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,03/22/2012,N/A,NDA,10 AMPULE in 1 CARTON (17478-030-05)  / 5 mL in 1 AMPULE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17478003005,Fentanyl,50
Fentanyl Citrate,0093-7865-65,200 ug/1,LOZENGE,ORAL; TRANSMUCOSAL,NDA020747,"Teva Pharmaceuticals USA, Inc.",0093-7865,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,12/08/2015,N/A,NDA AUTHORIZED GENERIC,30 BLISTER PACK in 1 CARTON (0093-7865-65)  / 1 LOZENGE in 1 BLISTER PACK (0093-7865-19),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00093786565,Fentanyl,200
Fentanyl Citrate,0093-7866-65,400 ug/1,LOZENGE,ORAL; TRANSMUCOSAL,NDA020747,"Teva Pharmaceuticals USA, Inc.",0093-7866,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,12/08/2015,N/A,NDA AUTHORIZED GENERIC,30 BLISTER PACK in 1 CARTON (0093-7866-65)  / 1 LOZENGE in 1 BLISTER PACK (0093-7866-19),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00093786665,Fentanyl,400
Fentanyl Citrate,0093-7867-65,600 ug/1,LOZENGE,ORAL; TRANSMUCOSAL,NDA020747,"Teva Pharmaceuticals USA, Inc.",0093-7867,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,12/08/2015,N/A,NDA AUTHORIZED GENERIC,30 BLISTER PACK in 1 CARTON (0093-7867-65)  / 1 LOZENGE in 1 BLISTER PACK (0093-7867-19),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00093786765,Fentanyl,600
Fentanyl Citrate,0093-7868-65,800 ug/1,LOZENGE,ORAL; TRANSMUCOSAL,NDA020747,"Teva Pharmaceuticals USA, Inc.",0093-7868,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,12/08/2015,N/A,NDA AUTHORIZED GENERIC,30 BLISTER PACK in 1 CARTON (0093-7868-65)  / 1 LOZENGE in 1 BLISTER PACK (0093-7868-19),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00093786865,Fentanyl,800
Fentanyl Citrate,0093-7869-65,1200 ug/1,LOZENGE,ORAL; TRANSMUCOSAL,NDA020747,"Teva Pharmaceuticals USA, Inc.",0093-7869,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,12/08/2015,N/A,NDA AUTHORIZED GENERIC,30 BLISTER PACK in 1 CARTON (0093-7869-65)  / 1 LOZENGE in 1 BLISTER PACK (0093-7869-19),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00093786965,Fentanyl,1200
Fentanyl Citrate,0093-7870-65,1600 ug/1,LOZENGE,ORAL; TRANSMUCOSAL,NDA020747,"Teva Pharmaceuticals USA, Inc.",0093-7870,Fentanyl Citrate,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,12/08/2015,N/A,NDA AUTHORIZED GENERIC,30 BLISTER PACK in 1 CARTON (0093-7870-65)  / 1 LOZENGE in 1 BLISTER PACK (0093-7870-19),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00093787065,Fentanyl,1600
Fentanyl System,47781-424-47,25 ug/1,PATCH,TRANSDERMAL,ANDA202097,Alvogen,47781-424,Fentanyl,FENTANYL,HUMAN PRESCRIPTION DRUG,11/04/2016,N/A,ANDA,1 POUCH in 1 CARTON (47781-424-47)  / 5 PATCH in 1 POUCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781042447,Fentanyl,25
Fentanyl System,47781-428-47,100 ug/1,PATCH,TRANSDERMAL,ANDA202097,Alvogen,47781-428,Fentanyl,FENTANYL,HUMAN PRESCRIPTION DRUG,11/04/2016,N/A,ANDA,1 POUCH in 1 CARTON (47781-428-47)  / 5 PATCH in 1 POUCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781042847,Fentanyl,100
Fentanyl System,47781-423-47,12.5 ug/1,PATCH,TRANSDERMAL,ANDA202097,Alvogen,47781-423,Fentanyl,FENTANYL,HUMAN PRESCRIPTION DRUG,11/04/2016,N/A,ANDA,1 POUCH in 1 CARTON (47781-423-47)  / 5 PATCH in 1 POUCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781042347,Fentanyl,12.5
Fentanyl System,47781-426-47,50 ug/1,PATCH,TRANSDERMAL,ANDA202097,Alvogen,47781-426,Fentanyl,FENTANYL,HUMAN PRESCRIPTION DRUG,11/04/2016,N/A,ANDA,1 POUCH in 1 CARTON (47781-426-47)  / 5 PATCH in 1 POUCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781042647,Fentanyl,50
Fentanyl System,47781-427-47,75 ug/1,PATCH,TRANSDERMAL,ANDA202097,Alvogen,47781-427,Fentanyl,FENTANYL,HUMAN PRESCRIPTION DRUG,11/04/2016,N/A,ANDA,1 POUCH in 1 CARTON (47781-427-47)  / 5 PATCH in 1 POUCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781042747,Fentanyl,75
Fentanyl System,55700-597-05,25 ug/1,PATCH,TRANSDERMAL,ANDA202097,Lake Erie Medical DBA Quality Care Products LLC,55700-597,Fentanyl,FENTANYL,HUMAN PRESCRIPTION DRUG,04/13/2018,N/A,ANDA,1 POUCH in 1 CARTON (55700-597-05)  / 5 PATCH in 1 POUCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700059705,Fentanyl,25
Fentanyl System,55700-972-05,12.5 ug/1,PATCH,TRANSDERMAL,ANDA202097,"Quality Care Products, LLC",55700-972,Fentanyl,FENTANYL,HUMAN PRESCRIPTION DRUG,05/09/2022,N/A,ANDA,1 POUCH in 1 CARTON (55700-972-05)  / 5 PATCH in 1 POUCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700097205,Fentanyl,12.5
Fentanyl System,55700-973-05,50 ug/1,PATCH,TRANSDERMAL,ANDA202097,"Quality Care Products, LLC",55700-973,Fentanyl,FENTANYL,HUMAN PRESCRIPTION DRUG,05/09/2022,N/A,ANDA,1 POUCH in 1 CARTON (55700-973-05)  / 5 PATCH in 1 POUCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700097305,Fentanyl,50
FENTANYL TRANSDERMAL,63629-4764-1,100 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,Bryant Ranch Prepack,63629-4764,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/09/2011,N/A,ANDA,1 POUCH in 1 CARTON (63629-4764-1)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629476401,Fentanyl,100
FENTANYL TRANSDERMAL,63629-4764-2,100 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,Bryant Ranch Prepack,63629-4764,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/09/2011,N/A,ANDA,2 POUCH in 1 CARTON (63629-4764-2)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629476402,Fentanyl,100
FENTANYL TRANSDERMAL,63629-4764-3,100 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,Bryant Ranch Prepack,63629-4764,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/09/2011,N/A,ANDA,5 POUCH in 1 CARTON (63629-4764-3)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629476403,Fentanyl,100
FENTANYL TRANSDERMAL,63629-4773-1,75 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,Bryant Ranch Prepack,63629-4773,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/09/2011,N/A,ANDA,1 POUCH in 1 CARTON (63629-4773-1)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629477301,Fentanyl,75
FENTANYL TRANSDERMAL,63629-4773-2,75 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,Bryant Ranch Prepack,63629-4773,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/09/2011,N/A,ANDA,2 POUCH in 1 CARTON (63629-4773-2)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629477302,Fentanyl,75
FENTANYL TRANSDERMAL,63629-4773-3,75 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,Bryant Ranch Prepack,63629-4773,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/09/2011,N/A,ANDA,5 POUCH in 1 CARTON (63629-4773-3)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629477303,Fentanyl,75
FENTANYL TRANSDERMAL,0406-9037-76,37.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,SpecGx LLC,0406-9037,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/28/2020,N/A,ANDA,5 POUCH in 1 CARTON (0406-9037-76)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406903776,Fentanyl,37.5
FENTANYL TRANSDERMAL,0406-9062-76,62.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,SpecGx LLC,0406-9062,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/28/2020,N/A,ANDA,5 POUCH in 1 CARTON (0406-9062-76)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406906276,Fentanyl,62.5
FENTANYL TRANSDERMAL,0406-9100-76,100 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,SpecGx LLC,0406-9100,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,05/06/2020,N/A,ANDA,5 POUCH in 1 CARTON (0406-9100-76)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406910076,Fentanyl,100
FENTANYL TRANSDERMAL,0406-9112-76,12.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,SpecGx LLC,0406-9112,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,05/06/2020,N/A,ANDA,5 POUCH in 1 CARTON (0406-9112-76)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406911276,Fentanyl,12.5
FENTANYL TRANSDERMAL,0406-9125-76,25 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,SpecGx LLC,0406-9125,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,05/06/2020,N/A,ANDA,5 POUCH in 1 CARTON (0406-9125-76)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406912576,Fentanyl,25
FENTANYL TRANSDERMAL,0406-9150-76,50 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,SpecGx LLC,0406-9150,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,05/06/2020,N/A,ANDA,5 POUCH in 1 CARTON (0406-9150-76)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406915076,Fentanyl,50
FENTANYL TRANSDERMAL,0406-9175-76,75 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,SpecGx LLC,0406-9175,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,05/06/2020,N/A,ANDA,5 POUCH in 1 CARTON (0406-9175-76)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406917576,Fentanyl,75
FENTANYL TRANSDERMAL,0406-9000-76,100 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,SpecGx LLC,0406-9000,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/09/2011,N/A,ANDA,5 POUCH in 1 CARTON (0406-9000-76)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406900076,Fentanyl,100
FENTANYL TRANSDERMAL,0406-9012-76,12.5 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,SpecGx LLC,0406-9012,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/09/2011,N/A,ANDA,5 POUCH in 1 CARTON (0406-9012-76)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406901276,Fentanyl,12.5
FENTANYL TRANSDERMAL,0406-9025-76,25 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,SpecGx LLC,0406-9025,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/09/2011,N/A,ANDA,5 POUCH in 1 CARTON (0406-9025-76)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406902576,Fentanyl,25
FENTANYL TRANSDERMAL,0406-9050-76,50 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,SpecGx LLC,0406-9050,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/09/2011,N/A,ANDA,5 POUCH in 1 CARTON (0406-9050-76)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406905076,Fentanyl,50
FENTANYL TRANSDERMAL,0406-9075-76,75 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,SpecGx LLC,0406-9075,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/09/2011,N/A,ANDA,5 POUCH in 1 CARTON (0406-9075-76)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406907576,Fentanyl,75
FENTANYL TRANSDERMAL,63629-4771-1,50 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,Bryant Ranch Prepack,63629-4771,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/09/2011,N/A,ANDA,1 POUCH in 1 CARTON (63629-4771-1)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629477101,Fentanyl,50
FENTANYL TRANSDERMAL,63629-4771-2,50 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,Bryant Ranch Prepack,63629-4771,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/09/2011,N/A,ANDA,2 POUCH in 1 CARTON (63629-4771-2)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629477102,Fentanyl,50
FENTANYL TRANSDERMAL,63629-4771-3,50 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,Bryant Ranch Prepack,63629-4771,fentanyl transdermal,FENTANYL,HUMAN PRESCRIPTION DRUG,02/09/2011,N/A,ANDA,5 POUCH in 1 CARTON (63629-4771-3)  / 1 PATCH in 1 POUCH / 72 h in 1 PATCH,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629477103,Fentanyl,50
FENTANYL TRANSDERMAL system,71335-0683-1,25 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,Bryant Ranch Prepack,71335-0683,fentanyl transdermal system,FENTANYL,HUMAN PRESCRIPTION DRUG,04/15/2013,N/A,ANDA,1 h in 1 BOTTLE (71335-0683-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335068301,Fentanyl,25
FENTANYL TRANSDERMAL system,71335-0683-2,25 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,Bryant Ranch Prepack,71335-0683,fentanyl transdermal system,FENTANYL,HUMAN PRESCRIPTION DRUG,04/15/2013,N/A,ANDA,2 h in 1 BOTTLE (71335-0683-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335068302,Fentanyl,25
FENTANYL TRANSDERMAL system,71335-0683-3,25 ug/h,"PATCH, EXTENDED RELEASE",TRANSDERMAL,ANDA077154,Bryant Ranch Prepack,71335-0683,fentanyl transdermal system,FENTANYL,HUMAN PRESCRIPTION DRUG,04/15/2013,N/A,ANDA,5 h in 1 BOTTLE (71335-0683-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335068303,Fentanyl,25
FENTORA,63459-546-28,600 ug/1,TABLET,BUCCAL; SUBLINGUAL,NDA021947,"Cephalon, LLC",63459-546,Fentanyl,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,10/02/2006,N/A,NDA,28 BLISTER PACK in 1 CARTON (63459-546-28)  / 1 TABLET in 1 BLISTER PACK (63459-546-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63459054628,Fentanyl,600
FENTORA,63459-548-28,800 ug/1,TABLET,BUCCAL; SUBLINGUAL,NDA021947,"Cephalon, LLC",63459-548,Fentanyl,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,10/02/2006,N/A,NDA,28 BLISTER PACK in 1 CARTON (63459-548-28)  / 1 TABLET in 1 BLISTER PACK (63459-548-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63459054828,Fentanyl,800
FENTORA,63459-544-28,400 ug/1,TABLET,BUCCAL; SUBLINGUAL,NDA021947,"Cephalon, LLC",63459-544,Fentanyl,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,10/02/2006,N/A,NDA,28 BLISTER PACK in 1 CARTON (63459-544-28)  / 1 TABLET in 1 BLISTER PACK (63459-544-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63459054428,Fentanyl,400
FENTORA,63459-542-28,200 ug/1,TABLET,BUCCAL; SUBLINGUAL,NDA021947,"Cephalon, LLC",63459-542,Fentanyl,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,10/02/2006,N/A,NDA,28 BLISTER PACK in 1 CARTON (63459-542-28)  / 1 TABLET in 1 BLISTER PACK (63459-542-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63459054228,Fentanyl,200
FENTORA,63459-541-28,100 ug/1,TABLET,BUCCAL; SUBLINGUAL,NDA021947,"Cephalon, LLC",63459-541,Fentanyl,FENTANYL CITRATE,HUMAN PRESCRIPTION DRUG,10/02/2006,N/A,NDA,28 BLISTER PACK in 1 CARTON (63459-541-28)  / 1 TABLET in 1 BLISTER PACK (63459-541-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63459054128,Fentanyl,100
APADAZ,10702-340-01,"325 mg/1,                         4.08  mg/1",TABLET,ORAL,NDA208653,"KVK-Tech, Inc.",10702-340,Benzhydrocodone and Acetaminophen,BENZHYDROCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/28/2019,N/A,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (10702-340-01)",N/A,CII,No,12/31/2023,10702034001,Hydrocodone,325
APADAZ,10702-341-01,"325 mg/1,                         6.12  mg/1",TABLET,ORAL,NDA208653,"KVK-Tech, Inc.",10702-341,Benzhydrocodone and Acetaminophen,BENZHYDROCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/28/2019,N/A,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (10702-341-01)",N/A,CII,No,12/31/2023,10702034101,Hydrocodone,325
APADAZ,10702-342-01,"325 mg/1,                         8.16  mg/1",TABLET,ORAL,NDA208653,"KVK-Tech, Inc.",10702-342,Benzhydrocodone and Acetaminophen,BENZHYDROCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/28/2019,N/A,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (10702-342-01)",N/A,CII,No,12/31/2023,10702034201,Hydrocodone,325
Benzhydrocodone and Acetaminophen,10702-343-01,"325 mg/1,                         4.08  mg/1",TABLET,ORAL,NDA208653,"KVK-Tech, Inc.",10702-343,Benzhydrocodone and Acetaminophen,BENZHYDROCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/28/2019,N/A,NDA AUTHORIZED GENERIC,"100 TABLET in 1 BOTTLE, PLASTIC (10702-343-01)",N/A,CII,No,12/31/2023,10702034301,Hydrocodone,325
Benzhydrocodone and Acetaminophen,10702-344-01,"325 mg/1,                         6.12  mg/1",TABLET,ORAL,NDA208653,"KVK-Tech, Inc.",10702-344,Benzhydrocodone and Acetaminophen,BENZHYDROCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/28/2019,N/A,NDA AUTHORIZED GENERIC,"100 TABLET in 1 BOTTLE, PLASTIC (10702-344-01)",N/A,CII,No,12/31/2023,10702034401,Hydrocodone,325
Benzhydrocodone and Acetaminophen,10702-345-01,"325 mg/1,                         8.16  mg/1",TABLET,ORAL,NDA208653,"KVK-Tech, Inc.",10702-345,Benzhydrocodone and Acetaminophen,BENZHYDROCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/28/2019,N/A,NDA AUTHORIZED GENERIC,"100 TABLET in 1 BOTTLE, PLASTIC (10702-345-01)",N/A,CII,No,12/31/2023,10702034501,Hydrocodone,325
Hycodan,64950-205-03,"1.5 mg/1,                         5  mg/1",TABLET,ORAL,NDA005213,Genus Lifesciences Inc.,64950-205,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,11/01/2021,N/A,NDA,"30 TABLET in 1 BOTTLE, PLASTIC (64950-205-03)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,64950020503,Hydrocodone,1.5
Hycodan,64950-205-10,"1.5 mg/1,                         5  mg/1",TABLET,ORAL,NDA005213,Genus Lifesciences Inc.,64950-205,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,11/01/2021,N/A,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (64950-205-10)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,64950020510,Hydrocodone,1.5
Hycodan,64950-342-45,"1.5 mg/5mL,                         5  mg/5mL",SOLUTION,ORAL,NDA005213,Genus Lifesciences Inc.,64950-342,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,12/16/2019,N/A,NDA,"40 CUP, UNIT-DOSE in 1 CASE (64950-342-45)  / 5 mL in 1 CUP, UNIT-DOSE (64950-342-05)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,64950034245,Hydrocodone,1.5
Hycodan,64950-342-47,"1.5 mg/5mL,                         5  mg/5mL",SOLUTION,ORAL,NDA005213,Genus Lifesciences Inc.,64950-342,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,06/14/2019,N/A,NDA,473 mL in 1 BOTTLE (64950-342-47),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,64950034247,Hydrocodone,1.5
HYDROCODONE /APAP,61919-618-20,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,Direct_Rx,61919-618,HYDROCODONE /APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/22/2019,N/A,ANDA,20 TABLET in 1 BOTTLE (61919-618-20),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919061820,Hydrocodone,325
HYDROCODONE /APAP,61919-618-26,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,Direct_Rx,61919-618,HYDROCODONE /APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/22/2019,N/A,ANDA,26 TABLET in 1 BOTTLE (61919-618-26),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919061826,Hydrocodone,325
HYDROCODONE /APAP,61919-618-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,DIRECTRX,61919-618,HYDROCODONE /APAP,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/10/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (61919-618-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919061830,Hydrocodone,325
HYDROCODONE /APAP,61919-618-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,Direct_Rx,61919-618,HYDROCODONE /APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/17/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (61919-618-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919061860,Hydrocodone,325
HYDROCODONE /APAP,61919-618-72,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,Direct_Rx,61919-618,HYDROCODONE /APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/05/2019,N/A,ANDA,120 TABLET in 1 BOTTLE (61919-618-72),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919061872,Hydrocodone,325
HYDROCODONE /APAP,61919-618-90,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,Direct_Rx,61919-618,HYDROCODONE /APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/17/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (61919-618-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919061890,Hydrocodone,325
Hydrocodone APAP,72189-352-90,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Direct_Rx,72189-352,Hydrocodone APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/10/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (72189-352-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72189035290,Hydrocodone,325
Hydrocodone APAP,72189-352-60,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Direct_Rx,72189-352,Hydrocodone APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/10/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-352-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72189035260,Hydrocodone,325
Hydrocodone APAP,72189-352-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Direct_Rx,72189-352,Hydrocodone APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/10/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-352-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72189035230,Hydrocodone,325
HYDROCODONE BITARTRATE,61919-494-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,DIRECT RX,61919-494,HYDROCODONE BITARTRATE,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,60 TABLET in 1 BOTTLE (61919-494-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,61919049460,Hydrocodone,325
HYDROCODONE BITARTRATE,61919-494-90,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,DIRECT RX,61919-494,HYDROCODONE BITARTRATE,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,90 TABLET in 1 BOTTLE (61919-494-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,61919049490,Hydrocodone,325
Hydrocodone Bitartrate,47781-409-60,10 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA206986,Alvogen Inc.,47781-409,Hydrocodone Bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/21/2020,N/A,ANDA,"60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47781-409-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,47781040960,Hydrocodone,10
Hydrocodone Bitartrate,47781-410-60,15 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA206986,Alvogen Inc.,47781-410,Hydrocodone Bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/21/2020,N/A,ANDA,"60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47781-410-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,47781041060,Hydrocodone,15
Hydrocodone Bitartrate,47781-411-60,20 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA206986,Alvogen Inc.,47781-411,Hydrocodone Bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/21/2020,N/A,ANDA,"60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47781-411-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,47781041160,Hydrocodone,20
Hydrocodone Bitartrate,47781-412-60,30 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA206986,Alvogen Inc.,47781-412,Hydrocodone Bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/21/2020,N/A,ANDA,"60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47781-412-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,47781041260,Hydrocodone,30
Hydrocodone Bitartrate,47781-413-60,40 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA206986,Alvogen Inc.,47781-413,Hydrocodone Bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/21/2020,N/A,ANDA,"60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47781-413-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,47781041360,Hydrocodone,40
Hydrocodone Bitartrate,47781-414-60,50 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA206986,Alvogen Inc.,47781-414,Hydrocodone Bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/21/2020,N/A,ANDA,"60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47781-414-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,47781041460,Hydrocodone,50
HYDROCODONE BITARTRATE,61919-118-71,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040746,DIRECT RX,61919-118,HYDROCODONE BITARTRATE,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2015,N/A,ANDA,100 TABLET in 1 BOTTLE (61919-118-71),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919011871,Hydrocodone,325
Hydrocodone Bitartrate,47781-392-60,20 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA208269,Alvogen Inc.,47781-392,Hydrocodone Bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/03/2021,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (47781-392-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,47781039260,Hydrocodone,20
Hydrocodone Bitartrate,47781-393-60,30 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA208269,Alvogen Inc.,47781-393,Hydrocodone Bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/03/2021,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (47781-393-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,47781039360,Hydrocodone,30
Hydrocodone Bitartrate,47781-394-60,40 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA208269,Alvogen Inc.,47781-394,Hydrocodone Bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/03/2021,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (47781-394-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,47781039460,Hydrocodone,40
Hydrocodone Bitartrate,47781-395-60,60 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA208269,Alvogen Inc.,47781-395,Hydrocodone Bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/03/2021,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (47781-395-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,47781039560,Hydrocodone,60
Hydrocodone Bitartrate,47781-396-60,80 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA208269,Alvogen Inc.,47781-396,Hydrocodone Bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/03/2021,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (47781-396-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,47781039660,Hydrocodone,80
Hydrocodone Bitartrate,47781-397-60,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA208269,Alvogen Inc.,47781-397,Hydrocodone Bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/03/2021,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (47781-397-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,47781039760,Hydrocodone,100
Hydrocodone Bitartrate,47781-398-60,120 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA208269,Alvogen Inc.,47781-398,Hydrocodone Bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/03/2021,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (47781-398-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,47781039860,Hydrocodone,120
HYDROCODONE BITARTRATE,61919-494-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,DIRECT RX,61919-494,HYDROCODONE BITARTRATE,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,30 TABLET in 1 BOTTLE (61919-494-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,61919049430,Hydrocodone,325
HYDROCODONE BITARTRATE,61919-494-72,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,DIRECT RX,61919-494,HYDROCODONE BITARTRATE,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,120 TABLET in 1 BOTTLE (61919-494-72),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,61919049472,Hydrocodone,325
HYDROCODONE BITARTRATE,61919-118-20,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040746,DIRECT RX,61919-118,HYDROCODONE BITARTRATE,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,20 TABLET in 1 BOTTLE (61919-118-20),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919011820,Hydrocodone,325
HYDROCODONE BITARTRATE,61919-118-26,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040746,DIRECT RX,61919-118,HYDROCODONE BITARTRATE,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,26 TABLET in 1 BOTTLE (61919-118-26),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919011826,Hydrocodone,325
HYDROCODONE BITARTRATE,61919-118-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040746,DIRECT RX,61919-118,HYDROCODONE BITARTRATE,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,60 TABLET in 1 BOTTLE (61919-118-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919011860,Hydrocodone,325
HYDROCODONE BITARTRATE,61919-118-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040746,DIRECT RX,61919-118,HYDROCODONE BITARTRATE,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,90 TABLET in 1 BOTTLE (61919-118-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919011890,Hydrocodone,325
HYDROCODONE BITARTRATE,61919-118-84,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040746,DIRECT RX,61919-118,HYDROCODONE BITARTRATE,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,240 TABLET in 1 BOTTLE (61919-118-84),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919011884,Hydrocodone,325
HYDROCODONE BITARTRATE,61919-118-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040746,DIRECT RX,61919-118,HYDROCODONE BITARTRATE,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,30 TABLET in 1 BOTTLE (61919-118-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919011830,Hydrocodone,325
HYDROCODONE BITARTRATE,61919-118-72,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040746,DIRECT RX,61919-118,HYDROCODONE BITARTRATE,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,120 TABLET in 1 BOTTLE (61919-118-72),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919011872,Hydrocodone,325
HYDROCODONE BITARTRATE (U),61919-296-30,,,,,DIRECT RX,,,,,,N/A,,,N/A,N/A,N/A,,61919029630,Hydrocodone,NA
Hydrocodone Bitartrate and Acetaminophen,42858-202-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,Rhodes Pharmaceuticals L.P.,42858-202,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (42858-202-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,42858020201,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,42858-203-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Rhodes Pharmaceuticals L.P.,42858-203,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,1000 TABLET in 1 BOTTLE (42858-203-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,42858020390,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0121-2316-50,"325 mg/15mL,                         7.5  mg/15mL",SOLUTION,ORAL,ANDA040838,"Pharmaceutical Associates, Inc.",0121-2316,HYDROCODONE BITARTRATE and ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/21/2020,N/A,ANDA,"5 TRAY in 1 CASE (0121-2316-50)  / 10 CUP, UNIT-DOSE in 1 TRAY / 15 mL in 1 CUP, UNIT-DOSE","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00121231650,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0108-0,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-0108,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/12/2018,N/A,ANDA,8 TABLET in 1 BOTTLE (71335-0108-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335010800,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0108-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-0108,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2018,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0108-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335010801,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0108-2,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-0108,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/11/2018,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-0108-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335010802,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0108-3,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-0108,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/09/2018,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-0108-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335010803,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0108-4,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-0108,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/04/2019,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-0108-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335010804,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0108-5,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-0108,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/28/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0108-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335010805,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-652-14,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-652,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/07/2021,N/A,ANDA,14 TABLET in 1 BOTTLE (55700-652-14),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700065214,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1333-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,"RedPharm Drug, Inc.",67296-1333,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,50 TABLET in 1 BOTTLE (67296-1333-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296133305,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,40032-353-03,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206142,"Novel Laboratories, Inc.",40032-353,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (40032-353-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035303,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,40032-356-03,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206245,"Novel Laboratories, Inc.",40032-356,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (40032-356-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035603,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,40032-356-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206245,"Novel Laboratories, Inc.",40032-356,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (40032-356-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035605,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-0299-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,"RedPharm Drug, Inc.",67296-0299,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/18/2010,N/A,ANDA,15 TABLET in 1 BOTTLE (67296-0299-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296029903,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-0299-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,"RedPharm Drug, Inc.",67296-0299,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/18/2010,N/A,ANDA,50 TABLET in 1 BOTTLE (67296-0299-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296029906,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1579-3,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202214,"RedPharm Drug, Inc.",67296-1579,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (67296-1579-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296157903,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1333-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,"RedPharm Drug, Inc.",67296-1333,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,15 TABLET in 1 BOTTLE (67296-1333-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296133307,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,53746-110-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040746,Amneal Pharmaceuticals of New York LLC,53746-110,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/18/2010,N/A,ANDA,100 TABLET in 1 BOTTLE (53746-110-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,53746011001,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,53746-110-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040746,Amneal Pharmaceuticals of New York LLC,53746-110,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/18/2010,N/A,ANDA,500 TABLET in 1 BOTTLE (53746-110-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,53746011005,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,53746-110-10,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040746,Amneal Pharmaceuticals of New York LLC,53746-110,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/18/2010,N/A,ANDA,1000 TABLET in 1 BOTTLE (53746-110-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,53746011010,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0121-0772-04,"325 mg/15mL,                         7.5  mg/15mL",SOLUTION,ORAL,ANDA040838,"Pharmaceutical Associates, Inc.",0121-0772,HYDROCODONE BITARTRATE and ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/29/2013,N/A,ANDA,118 mL in 1 BOTTLE (0121-0772-04),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00121077204,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0121-0772-16,"325 mg/15mL,                         7.5  mg/15mL",SOLUTION,ORAL,ANDA040838,"Pharmaceutical Associates, Inc.",0121-0772,HYDROCODONE BITARTRATE and ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/29/2013,N/A,ANDA,473 mL in 1 BOTTLE (0121-0772-16),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00121077216,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0121-1544-40,"217 mg/10mL,                         5  mg/10mL",SOLUTION,ORAL,ANDA040838,"Pharmaceutical Associates, Inc.",0121-1544,HYDROCODONE BITARTRATE and ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/29/2013,N/A,ANDA,"4 TRAY in 1 CASE (0121-1544-40)  / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (0121-1544-10)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00121154440,Hydrocodone,217
Hydrocodone Bitartrate and Acetaminophen,0121-2316-40,"325 mg/15mL,                         7.5  mg/15mL",SOLUTION,ORAL,ANDA040838,"Pharmaceutical Associates, Inc.",0121-2316,HYDROCODONE BITARTRATE and ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/29/2013,N/A,ANDA,"4 TRAY in 1 CASE (0121-2316-40)  / 10 CUP, UNIT-DOSE in 1 TRAY / 15 mL in 1 CUP, UNIT-DOSE (0121-2316-15)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00121231640,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0121-4772-10,"108 mg/5mL,                         2.5  mg/5mL",SOLUTION,ORAL,ANDA040838,"Pharmaceutical Associates, Inc.",0121-4772,HYDROCODONE BITARTRATE and ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/29/2013,N/A,ANDA,"4 TRAY in 1 CASE (0121-4772-10)  / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00121477210,Hydrocodone,108
Hydrocodone Bitartrate and Acetaminophen,0121-4772-15,"108 mg/5mL,                         2.5  mg/5mL",SOLUTION,ORAL,ANDA040838,"Pharmaceutical Associates, Inc.",0121-4772,HYDROCODONE BITARTRATE and ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/29/2013,N/A,ANDA,"4 TRAY in 1 CASE (0121-4772-15)  / 10 CUP, UNIT-DOSE in 1 TRAY / 15 mL in 1 CUP, UNIT-DOSE","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00121477215,Hydrocodone,108
Hydrocodone Bitartrate and Acetaminophen,0121-4772-40,"108 mg/5mL,                         2.5  mg/5mL",SOLUTION,ORAL,ANDA040838,"Pharmaceutical Associates, Inc.",0121-4772,HYDROCODONE BITARTRATE and ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/29/2013,N/A,ANDA,"4 TRAY in 1 CASE (0121-4772-40)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-4772-05)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00121477240,Hydrocodone,108
Hydrocodone Bitartrate and Acetaminophen,43386-357-03,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206245,"Lupin Pharmaceuticals,Inc.",43386-357,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (43386-357-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035703,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,83008-002-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,"Quality Care Products, LLC",83008-002,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/25/2023,N/A,ANDA,30 TABLET in 1 BOTTLE (83008-002-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,83008000230,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,83008-002-60,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,"Quality Care Products, LLC",83008-002,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/25/2023,N/A,ANDA,60 TABLET in 1 BOTTLE (83008-002-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,83008000260,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,83008-002-90,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,"Quality Care Products, LLC",83008-002,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/25/2023,N/A,ANDA,90 TABLET in 1 BOTTLE (83008-002-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,83008000290,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,68071-2664-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,"NuCare Pharmaceuticals,Inc.",68071-2664,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/28/2022,N/A,ANDA,12 TABLET in 1 BOTTLE (68071-2664-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,68071266402,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,68071-2664-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,"NuCare Pharmaceuticals,Inc.",68071-2664,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/28/2022,N/A,ANDA,6 TABLET in 1 BOTTLE (68071-2664-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,68071266406,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,65162-115-03,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,Amneal Pharmaceuticals LLC,65162-115,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/30/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (65162-115-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,65162011503,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,65162-675-10,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206869,Amneal Pharmaceuticals LLC,65162-675,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/30/2015,N/A,ANDA,100 TABLET in 1 BOTTLE (65162-675-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,65162067510,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,65162-696-10,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207137,Amneal Pharmaceuticals LLC,65162-696,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2015,N/A,ANDA,100 TABLET in 1 BOTTLE (65162-696-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,65162069610,Hydrocodone,300
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,72189-343-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Direct Rx,72189-343,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/30/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-343-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72189034330,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,72189-348-72,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,DirectRx,72189-348,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/26/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (72189-348-72),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72189034872,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,42858-203-50,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Rhodes Pharmaceuticals L.P.,42858-203,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (42858-203-50),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,42858020350,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-598-14,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-598,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/13/2018,N/A,ANDA,14 TABLET in 1 BOTTLE (55700-598-14),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700059814,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-652-20,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-652,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/28/2018,N/A,ANDA,20 TABLET in 1 BOTTLE (55700-652-20),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700065220,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,68071-2668-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"NuCare Pharmaceuticals,Inc.",68071-2668,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/31/2022,N/A,ANDA,12 TABLET in 1 BOTTLE (68071-2668-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,68071266802,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-838-60,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA040148,Proficient Rx LP,63187-838,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/01/2017,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (63187-838-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187083860,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,68071-2668-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"NuCare Pharmaceuticals,Inc.",68071-2668,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/31/2022,N/A,ANDA,4 TABLET in 1 BOTTLE (68071-2668-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,68071266804,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,68071-2668-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"NuCare Pharmaceuticals,Inc.",68071-2668,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/31/2022,N/A,ANDA,6 TABLET in 1 BOTTLE (68071-2668-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,68071266806,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0904-6824-61,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206245,Major Pharmaceuticals,0904-6824,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,100 BLISTER PACK in 1 CARTON (0904-6824-61)  / 1 TABLET in 1 BLISTER PACK,"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00904682461,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0904-6825-61,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206245,Major Pharmaceuticals,0904-6825,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,100 BLISTER PACK in 1 CARTON (0904-6825-61)  / 1 TABLET in 1 BLISTER PACK,"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00904682561,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0904-6826-61,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206245,Major Pharmaceuticals,0904-6826,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,100 BLISTER PACK in 1 CARTON (0904-6826-61)  / 1 TABLET in 1 BLISTER PACK,"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00904682661,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,68084-895-09,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,American Health Packaging,68084-895,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/26/2014,N/A,ANDA,"80 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-895-09)  / 1 TABLET in 1 BLISTER PACK (68084-895-11)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,68084089509,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,50090-0843-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,A-S Medication Solutions,50090-0843,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/16/2021,N/A,ANDA,12 TABLET in 1 BOTTLE (50090-0843-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,50090084307,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1377-3,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,"RedPharm Drug, Inc.",67296-1377,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/30/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (67296-1377-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296137703,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,68071-2629-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA210211,"NuCare Pharmaceuticals,Inc.",68071-2629,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/27/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (68071-2629-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,68071262903,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,40032-356-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206245,"Novel Laboratories, Inc.",40032-356,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (40032-356-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035601,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,40032-357-10,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206245,"Novel Laboratories, Inc.",40032-357,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,1000 TABLET in 1 BOTTLE (40032-357-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035710,Hydrocodone,325
hydrocodone bitartrate and acetaminophen,63629-1180-1,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207509,Bryant Ranch Prepack,63629-1180,hydrocodone bitartrate and acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/09/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-1180-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629118001,Hydrocodone,300
hydrocodone bitartrate and acetaminophen,63629-1183-1,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207509,Bryant Ranch Prepack,63629-1183,hydrocodone bitartrate and acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/09/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-1183-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629118301,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,55700-652-15,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-652,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,15 TABLET in 1 BOTTLE (55700-652-15),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700065215,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,13107-019-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,"Aurolife Pharma, LLC",13107-019,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-019-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107001901,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,13107-019-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,"Aurolife Pharma, LLC",13107-019,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-019-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107001905,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,13107-019-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,"Aurolife Pharma, LLC",13107-019,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-019-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107001930,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,13107-019-99,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,"Aurolife Pharma, LLC",13107-019,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-019-99),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107001999,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,13107-020-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,"Aurolife Pharma, LLC",13107-020,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-020-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107002001,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,13107-020-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,"Aurolife Pharma, LLC",13107-020,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-020-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107002005,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,13107-020-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,"Aurolife Pharma, LLC",13107-020,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-020-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107002030,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,13107-020-99,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,"Aurolife Pharma, LLC",13107-020,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-020-99),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107002099,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,13107-021-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,"Aurolife Pharma, LLC",13107-021,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-021-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107002101,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,13107-021-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,"Aurolife Pharma, LLC",13107-021,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-021-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107002105,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,13107-021-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,"Aurolife Pharma, LLC",13107-021,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-021-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107002130,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,13107-021-99,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,"Aurolife Pharma, LLC",13107-021,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-021-99),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107002199,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,72189-348-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,DirectRx,72189-348,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/26/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-348-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72189034830,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-112-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,Proficient Rx LP,63187-112,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/02/2014,N/A,ANDA,30 TABLET in 1 BOTTLE (63187-112-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187011230,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-112-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,Proficient Rx LP,63187-112,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/02/2014,N/A,ANDA,60 TABLET in 1 BOTTLE (63187-112-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187011260,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,68071-2593-4,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040355,"NuCare Pharmaceuticals,Inc.",68071-2593,Hydrocodone Bitartrate And Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/31/2000,09/30/2023,ANDA,"4 TABLET in 1 BOTTLE, PLASTIC (68071-2593-4)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,68071259304,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,40032-352-03,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206142,"Novel Laboratories, Inc.",40032-352,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (40032-352-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035203,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,63187-375-20,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-375,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/01/2016,N/A,ANDA,20 TABLET in 1 BOTTLE (63187-375-20),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187037520,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-375-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-375,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/01/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (63187-375-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187037530,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-375-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-375,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/01/2016,N/A,ANDA,60 TABLET in 1 BOTTLE (63187-375-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187037560,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-778-12,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-778,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/01/2016,N/A,ANDA,12 TABLET in 1 BOTTLE (63187-778-12),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187077812,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1557-2,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1557,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/07/2021,N/A,ANDA,36 TABLET in 1 BOTTLE (71335-1557-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335155702,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,72189-343-90,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Direct Rx,72189-343,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/30/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (72189-343-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72189034390,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-598-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-598,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/13/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (55700-598-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700059860,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-598-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-598,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/13/2018,N/A,ANDA,120 TABLET in 1 BOTTLE (55700-598-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700059801,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-598-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-598,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/13/2018,N/A,ANDA,90 TABLET in 1 BOTTLE (55700-598-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700059890,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,65162-696-11,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207137,Amneal Pharmaceuticals LLC,65162-696,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2015,N/A,ANDA,1000 TABLET in 1 BOTTLE (65162-696-11),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,65162069611,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,71930-021-52,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA210211,Eywa Pharma Inc,71930-021,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (71930-021-52),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930002152,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2103-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2103,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-2103-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210301,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2103-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2103,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-2103-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210302,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2103-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2103,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-2103-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210303,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2103-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2103,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-2103-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210304,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2103-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2103,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-2103-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210305,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2104-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2104,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-2104-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210401,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2104-2,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2104,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-2104-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210402,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2104-3,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2104,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-2104-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210403,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2104-4,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2104,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-2104-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210404,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2104-5,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2104,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-2104-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210405,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2104-6,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2104,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-2104-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210406,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2104-7,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2104,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-2104-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210407,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2105-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2105,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-2105-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210501,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2105-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2105,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-2105-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210502,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2105-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2105,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-2105-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210503,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2105-4,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2105,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-2105-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210504,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2105-5,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2105,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-2105-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335210505,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0466-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,Bryant Ranch Prepack,71335-0466,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/16/2018,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0466-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335046601,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-598-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-598,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/13/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (55700-598-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700059830,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-8885-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,63629-8885,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/26/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (63629-8885-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,63629888505,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-8886-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,63629-8886,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (63629-8886-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,63629888601,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-8886-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,63629-8886,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/15/2023,N/A,ANDA,20 TABLET in 1 BOTTLE (63629-8886-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,63629888602,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-8886-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,63629-8886,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (63629-8886-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,63629888603,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-8885-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,63629-8885,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/07/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (63629-8885-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,63629888501,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-8885-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,63629-8885,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/08/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (63629-8885-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,63629888502,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-8885-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,63629-8885,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/26/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (63629-8885-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,63629888503,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-8885-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,63629-8885,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/15/2023,N/A,ANDA,40 TABLET in 1 BOTTLE (63629-8885-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,63629888504,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,67296-1542-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,"RedPharm Drug, Inc.",67296-1542,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/01/2014,N/A,ANDA,20 TABLET in 1 BOTTLE (67296-1542-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296154202,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1618-6,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA209037,"RedPharm Drug, Inc.",67296-1618,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2018,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-1618-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296161806,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0108-6,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-0108,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/30/2018,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-0108-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335010806,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0108-7,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-0108,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-0108-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335010807,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0108-8,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-0108,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/22/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0108-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335010808,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0108-9,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-0108,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/31/2018,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0108-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335010809,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71930-027-43,"325 mg/15mL,                         7.5  mg/15mL",SOLUTION,ORAL,ANDA211023,Eywa Pharma Inc,71930-027,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/08/2019,N/A,ANDA,473 mL in 1 BOTTLE (71930-027-43),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930002743,Hydrocodone,325
hydrocodone bitartrate and acetaminophen,71930-042-12,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207509,Eywa Pharma Inc,71930-042,hydrocodone bitartrate and acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/17/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (71930-042-12),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930004212,Hydrocodone,300
hydrocodone bitartrate and acetaminophen,71930-042-52,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207509,Eywa Pharma Inc,71930-042,hydrocodone bitartrate and acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/17/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (71930-042-52),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930004252,Hydrocodone,300
hydrocodone bitartrate and acetaminophen,71930-043-12,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207509,Eywa Pharma Inc,71930-043,hydrocodone bitartrate and acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/17/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (71930-043-12),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930004312,Hydrocodone,300
hydrocodone bitartrate and acetaminophen,71930-043-52,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207509,Eywa Pharma Inc,71930-043,hydrocodone bitartrate and acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/17/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (71930-043-52),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930004352,Hydrocodone,300
hydrocodone bitartrate and acetaminophen,71930-044-12,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207509,Eywa Pharma Inc,71930-044,hydrocodone bitartrate and acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/17/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (71930-044-12),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930004412,Hydrocodone,300
hydrocodone bitartrate and acetaminophen,71930-044-52,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207509,Eywa Pharma Inc,71930-044,hydrocodone bitartrate and acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/17/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (71930-044-52),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930004452,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,42806-113-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA203863,"Epic Pharma, LLC",42806-113,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/02/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-113-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,42806011301,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,31722-940-01,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA211487,"Camber Pharmaceuticals, Inc.",31722-940,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-940-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,31722094001,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,31722-941-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"Camber Pharmaceuticals, Inc.",31722-941,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-941-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,31722094101,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,31722-941-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"Camber Pharmaceuticals, Inc.",31722-941,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (31722-941-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,31722094105,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,31722-942-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,"Camber Pharmaceuticals, Inc.",31722-942,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-942-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,31722094201,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,31722-942-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,"Camber Pharmaceuticals, Inc.",31722-942,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (31722-942-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,31722094205,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,31722-943-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,"Camber Pharmaceuticals, Inc.",31722-943,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-943-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,31722094301,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,31722-943-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,"Camber Pharmaceuticals, Inc.",31722-943,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (31722-943-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,31722094305,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,72189-348-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,DirectRx,72189-348,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/26/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (72189-348-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72189034890,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,76420-215-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,"Asclemed USA, Inc.",76420-215,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/10/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (76420-215-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,76420021501,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,76420-215-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,"Asclemed USA, Inc.",76420-215,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/10/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (76420-215-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,76420021530,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,76420-215-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,"Asclemed USA, Inc.",76420-215,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/10/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (76420-215-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,76420021560,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,76420-215-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,"Asclemed USA, Inc.",76420-215,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/10/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (76420-215-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,76420021590,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0254-2036-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202935,"Par Pharmaceutical, Inc.",0254-2036,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/05/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (0254-2036-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00254203601,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-0299-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,"RedPharm Drug, Inc.",67296-0299,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/18/2010,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-0299-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296029902,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-0299-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,"RedPharm Drug, Inc.",67296-0299,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/18/2010,N/A,ANDA,20 TABLET in 1 BOTTLE (67296-0299-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296029904,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-0299-0,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,"RedPharm Drug, Inc.",67296-0299,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/18/2010,N/A,ANDA,40 TABLET in 1 BOTTLE (67296-0299-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296029900,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,13107-212-30,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207709,"Aurolife Pharma, LLC",13107-212,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/06/2015,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-212-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107021230,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,13107-211-30,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207709,"Aurolife Pharma, LLC",13107-211,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/06/2015,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-211-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107021130,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,13107-213-30,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207709,"Aurolife Pharma, LLC",13107-213,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/06/2015,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-213-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107021330,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,13107-212-99,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207709,"Aurolife Pharma, LLC",13107-212,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/06/2015,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-212-99),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107021299,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,13107-213-99,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207709,"Aurolife Pharma, LLC",13107-213,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/06/2015,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-213-99),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107021399,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,13107-213-05,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207709,"Aurolife Pharma, LLC",13107-213,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/06/2015,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-213-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107021305,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,63187-658-90,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-658,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/01/2016,N/A,ANDA,90 TABLET in 1 BOTTLE (63187-658-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187065890,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,65162-675-11,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206869,Amneal Pharmaceuticals LLC,65162-675,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/30/2015,N/A,ANDA,1000 TABLET in 1 BOTTLE (65162-675-11),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,65162067511,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0904-6824-45,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206245,Major Pharmaceuticals,0904-6824,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,80 BLISTER PACK in 1 CARTON (0904-6824-45)  / 1 TABLET in 1 BLISTER PACK,"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00904682445,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2195-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2195,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/01/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-2195-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335219501,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2195-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2195,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/01/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-2195-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335219502,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2195-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2195,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/01/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-2195-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335219503,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2195-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2195,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/01/2022,N/A,ANDA,8 TABLET in 1 BOTTLE (71335-2195-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335219504,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2195-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2195,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/01/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-2195-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335219505,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1571-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202214,"RedPharm Drug, Inc.",67296-1571,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2018,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-1571-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296157101,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63304-497-03,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040826,"Sun Pharmaceutical Industries, Inc.",63304-497,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/31/2018,N/A,ANDA,10 TABLET in 1 BOTTLE (63304-497-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63304049703,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63304-497-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040826,"Sun Pharmaceutical Industries, Inc.",63304-497,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/31/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (63304-497-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63304049705,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-652-40,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-652,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,40 TABLET in 1 BOTTLE (55700-652-40),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700065240,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-652-90,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-652,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,90 TABLET in 1 BOTTLE (55700-652-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700065290,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1970-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-1970,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/21/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1970-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335197001,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1970-2,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-1970,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/21/2021,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-1970-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335197002,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-8886-4,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,63629-8886,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/07/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (63629-8886-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,63629888604,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-8886-5,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,63629-8886,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/13/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (63629-8886-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,63629888605,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,31722-996-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"Camber Pharmaceuticals, Inc.",31722-996,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-996-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,31722099601,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,31722-996-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"Camber Pharmaceuticals, Inc.",31722-996,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (31722-996-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,31722099605,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1444-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1444,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,21 TABLET in 1 BOTTLE (71335-1444-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335144401,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1444-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1444,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-1444-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335144402,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1444-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1444,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,10 TABLET in 1 BOTTLE (71335-1444-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335144403,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-0299-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,"RedPharm Drug, Inc.",67296-0299,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/18/2010,N/A,ANDA,30 TABLET in 1 BOTTLE (67296-0299-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296029901,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1970-3,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-1970,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/21/2021,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1970-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335197003,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1970-4,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-1970,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/21/2021,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-1970-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335197004,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1970-5,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-1970,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/21/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1970-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335197005,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,66689-023-04,"325 mg/15mL,                         7.5  mg/15mL",SOLUTION,ORAL,ANDA200343,"VistaPharm, Inc.",66689-023,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/05/2017,N/A,ANDA,120 mL in 1 BOTTLE (66689-023-04),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,66689002304,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-112-15,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,Proficient Rx LP,63187-112,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/02/2014,N/A,ANDA,15 TABLET in 1 BOTTLE (63187-112-15),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187011215,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,68071-5201-6,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,"NuCare Pharmaceuticals,Inc.",68071-5201,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/11/2020,N/A,ANDA,6 TABLET in 1 BOTTLE (68071-5201-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,68071520106,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,31722-997-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,"Camber Pharmaceuticals, Inc.",31722-997,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-997-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,31722099701,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,31722-997-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,"Camber Pharmaceuticals, Inc.",31722-997,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (31722-997-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,31722099705,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-120-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040746,Proficient Rx LP,63187-120,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/01/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (63187-120-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187012030,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-375-12,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-375,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/08/2022,N/A,ANDA,12 TABLET in 1 BOTTLE (63187-375-12),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187037512,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,70518-2923-0,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,REMEDYREPACK INC.,70518-2923,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/26/2020,N/A,ANDA,"4 TABLET in 1 BOTTLE, PLASTIC (70518-2923-0)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,70518292300,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1970-6,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-1970,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/21/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1970-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335197006,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1970-7,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-1970,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/21/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1970-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335197007,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71205-660-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Proficient Rx LP,71205-660,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/16/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71205-660-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71205066030,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71205-660-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Proficient Rx LP,71205-660,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/16/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71205-660-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71205066060,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71205-660-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Proficient Rx LP,71205-660,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/16/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71205-660-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71205066090,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2144-0,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-2144,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/09/2022,N/A,ANDA,10 TABLET in 1 BOTTLE (71335-2144-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335214400,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2144-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-2144,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/09/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-2144-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335214401,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2144-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-2144,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/09/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-2144-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335214402,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2144-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-2144,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/09/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-2144-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335214403,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2144-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-2144,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/09/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-2144-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335214404,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2144-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-2144,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/09/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-2144-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335214405,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2144-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-2144,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/09/2022,N/A,ANDA,50 TABLET in 1 BOTTLE (71335-2144-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335214406,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2144-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-2144,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/09/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-2144-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335214407,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2144-8,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-2144,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/09/2022,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-2144-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335214408,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2144-9,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-2144,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/09/2022,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-2144-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335214409,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0245-0410-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206484,"Upsher-Smith Laboratories, LLC",0245-0410,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/27/2017,N/A,ANDA,100 BLISTER PACK in 1 CARTON (0245-0410-01)  / 1 TABLET in 1 BLISTER PACK (0245-0410-89),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,00245041001,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0245-0410-11,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206484,"Upsher-Smith Laboratories, LLC",0245-0410,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/27/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (0245-0410-11),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,00245041011,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0245-0410-50,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206484,"Upsher-Smith Laboratories, LLC",0245-0410,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/27/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (0245-0410-50),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,00245041050,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0245-0411-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206484,"Upsher-Smith Laboratories, LLC",0245-0411,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/27/2017,N/A,ANDA,100 BLISTER PACK in 1 CARTON (0245-0411-01)  / 1 TABLET in 1 BLISTER PACK (0245-0411-89),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,00245041101,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0245-0411-11,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206484,"Upsher-Smith Laboratories, LLC",0245-0411,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/27/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (0245-0411-11),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,00245041111,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0245-0411-50,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206484,"Upsher-Smith Laboratories, LLC",0245-0411,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/27/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (0245-0411-50),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,00245041150,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0245-0412-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206484,"Upsher-Smith Laboratories, LLC",0245-0412,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/27/2017,N/A,ANDA,100 BLISTER PACK in 1 CARTON (0245-0412-01)  / 1 TABLET in 1 BLISTER PACK (0245-0412-89),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,00245041201,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0245-0412-11,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206484,"Upsher-Smith Laboratories, LLC",0245-0412,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/27/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (0245-0412-11),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,00245041211,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0245-0412-50,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206484,"Upsher-Smith Laboratories, LLC",0245-0412,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/27/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (0245-0412-50),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,00245041250,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,65162-115-11,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,Amneal Pharmaceuticals LLC,65162-115,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/30/2016,N/A,ANDA,1000 TABLET in 1 BOTTLE (65162-115-11),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,65162011511,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-1938-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,63629-1938,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-1938-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,63629193801,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-1939-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,63629-1939,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-1939-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,63629193901,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-1940-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,63629-1940,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (63629-1940-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,63629194001,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0466-0,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,Bryant Ranch Prepack,71335-0466,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/12/2018,N/A,ANDA,8 TABLET in 1 BOTTLE (71335-0466-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335046600,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0466-2,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,Bryant Ranch Prepack,71335-0466,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/15/2019,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-0466-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335046602,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0466-7,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,Bryant Ranch Prepack,71335-0466,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-0466-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335046607,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,72189-348-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,DirectRx,72189-348,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/26/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-348-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72189034860,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1418-0,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1418,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1418-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141800,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1418-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1418,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1418-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141801,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1418-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1418,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1418-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141802,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1418-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1418,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-1418-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141803,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1418-4,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1418,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,45 TABLET in 1 BOTTLE (71335-1418-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141804,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1418-5,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1418,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-1418-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141805,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1418-6,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1418,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1418-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141806,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1418-7,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1418,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-1418-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141807,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1418-8,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1418,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1418-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141808,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1418-9,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1418,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1418-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141809,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1419-0,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1419,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,8 TABLET in 1 BOTTLE (71335-1419-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141900,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1419-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1419,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1419-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141901,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1419-2,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1419,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-1419-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141902,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1419-3,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1419,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1419-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141903,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1419-4,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1419,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1419-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141904,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1419-5,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1419,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1419-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141905,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1419-6,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1419,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-1419-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141906,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1419-7,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1419,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-1419-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141907,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1419-8,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1419,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1419-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141908,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1419-9,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1419,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1419-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141909,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,43386-352-05,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206142,"Lupin Pharmaceuticals,Inc.",43386-352,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-352-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035205,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,43386-356-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206245,"Lupin Pharmaceuticals,Inc.",43386-356,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-356-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035605,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1470-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1470,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,21 TABLET in 1 BOTTLE (71335-1470-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335147001,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1470-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1470,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,12 TABLET in 1 BOTTLE (71335-1470-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335147002,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,65162-115-50,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,Amneal Pharmaceuticals LLC,65162-115,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/30/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (65162-115-50),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,65162011550,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0527-1648-01,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207171,"Lannett Company, Inc.",0527-1648,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (0527-1648-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00527164801,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0527-1648-05,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207171,"Lannett Company, Inc.",0527-1648,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (0527-1648-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00527164805,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0527-1649-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207172,"Lannett Company, Inc.",0527-1649,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (0527-1649-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00527164901,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0527-1649-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207172,"Lannett Company, Inc.",0527-1649,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (0527-1649-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00527164905,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0527-1650-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207172,"Lannett Company, Inc.",0527-1650,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (0527-1650-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00527165001,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0527-1650-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207172,"Lannett Company, Inc.",0527-1650,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (0527-1650-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00527165005,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0527-1651-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207172,"Lannett Company, Inc.",0527-1651,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (0527-1651-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00527165101,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0527-1651-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207172,"Lannett Company, Inc.",0527-1651,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (0527-1651-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00527165105,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,40032-352-01,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206142,"Novel Laboratories, Inc.",40032-352,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (40032-352-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035201,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,40032-356-10,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206245,"Novel Laboratories, Inc.",40032-356,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,1000 TABLET in 1 BOTTLE (40032-356-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035610,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,72865-109-01,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA211487,"XLCare Pharmaceuticals, Inc.",72865-109,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-109-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72865010901,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,72865-110-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"XLCare Pharmaceuticals, Inc.",72865-110,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-110-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72865011001,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,72865-110-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"XLCare Pharmaceuticals, Inc.",72865-110,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2020,N/A,ANDA,500 TABLET in 1 BOTTLE (72865-110-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72865011005,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,72865-111-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,"XLCare Pharmaceuticals, Inc.",72865-111,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-111-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72865011101,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,72865-111-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,"XLCare Pharmaceuticals, Inc.",72865-111,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2020,N/A,ANDA,500 TABLET in 1 BOTTLE (72865-111-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72865011105,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,72865-112-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,"XLCare Pharmaceuticals, Inc.",72865-112,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-112-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72865011201,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,72865-112-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,"XLCare Pharmaceuticals, Inc.",72865-112,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2020,N/A,ANDA,500 TABLET in 1 BOTTLE (72865-112-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72865011205,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-652-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-652,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (55700-652-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700065230,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,45865-605-40,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040655,Medsource Pharmaceticals,45865-605,Hydrocodone Bitartrate And Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2014,N/A,ANDA,"40 TABLET in 1 BOTTLE, PLASTIC (45865-605-40)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,45865060540,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-823-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,"Quality Care Products, LLC",55700-823,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/27/2019,N/A,ANDA,120 TABLET in 1 BOTTLE (55700-823-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700082301,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-823-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,"Quality Care Products, LLC",55700-823,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/27/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (55700-823-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700082330,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-823-60,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,"Quality Care Products, LLC",55700-823,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/27/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (55700-823-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700082360,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-823-90,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,"Quality Care Products, LLC",55700-823,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/27/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (55700-823-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700082390,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,66689-023-16,"325 mg/15mL,                         7.5  mg/15mL",SOLUTION,ORAL,ANDA200343,"VistaPharm, Inc.",66689-023,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/05/2017,N/A,ANDA,473 mL in 1 BOTTLE (66689-023-16),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,66689002316,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1271-0,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-1271,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1271-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335127100,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1271-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-1271,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1271-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335127101,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1271-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-1271,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1271-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335127102,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1271-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-1271,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-1271-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335127103,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1271-4,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-1271,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,45 TABLET in 1 BOTTLE (71335-1271-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335127104,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1271-5,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-1271,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-1271-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335127105,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1271-6,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-1271,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1271-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335127106,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1271-7,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-1271,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-1271-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335127107,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1271-8,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-1271,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1271-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335127108,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1271-9,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-1271,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1271-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335127109,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,50090-0843-0,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,A-S Medication Solutions,50090-0843,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/28/2017,N/A,ANDA,20 TABLET in 1 BOTTLE (50090-0843-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,50090084300,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,50090-0843-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,A-S Medication Solutions,50090-0843,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/28/2017,N/A,ANDA,60 TABLET in 1 BOTTLE (50090-0843-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,50090084302,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,45865-605-15,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040655,Medsource Pharmaceticals,45865-605,Hydrocodone Bitartrate And Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2014,N/A,ANDA,"15 TABLET in 1 BOTTLE, PLASTIC (45865-605-15)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,45865060515,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-778-15,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-778,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/01/2017,N/A,ANDA,15 TABLET in 1 BOTTLE (63187-778-15),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187077815,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,63629-5432-0,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040355,Bryant Ranch Prepack,63629-5432,Hydrocodone Bitartrate And Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/23/2015,09/30/2023,ANDA,180 TABLET in 1 BOTTLE (63629-5432-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,63629543200,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,63629-5432-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040355,Bryant Ranch Prepack,63629-5432,Hydrocodone Bitartrate And Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/01/2014,09/30/2023,ANDA,10 TABLET in 1 BOTTLE (63629-5432-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,63629543201,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,63629-5432-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040355,Bryant Ranch Prepack,63629-5432,Hydrocodone Bitartrate And Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/23/2016,09/30/2023,ANDA,12 TABLET in 1 BOTTLE (63629-5432-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,63629543202,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,63629-5432-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040355,Bryant Ranch Prepack,63629-5432,Hydrocodone Bitartrate And Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/20/2014,09/30/2023,ANDA,20 TABLET in 1 BOTTLE (63629-5432-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,63629543203,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,63629-5432-4,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040355,Bryant Ranch Prepack,63629-5432,Hydrocodone Bitartrate And Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/14/2014,09/30/2023,ANDA,30 TABLET in 1 BOTTLE (63629-5432-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,63629543204,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,63629-5432-5,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040355,Bryant Ranch Prepack,63629-5432,Hydrocodone Bitartrate And Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/08/2022,09/30/2023,ANDA,45 TABLET in 1 BOTTLE (63629-5432-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,63629543205,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,63629-5432-6,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040355,Bryant Ranch Prepack,63629-5432,Hydrocodone Bitartrate And Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/10/2014,09/30/2023,ANDA,60 TABLET in 1 BOTTLE (63629-5432-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,63629543206,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,63629-5432-7,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040355,Bryant Ranch Prepack,63629-5432,Hydrocodone Bitartrate And Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/14/2014,09/30/2023,ANDA,90 TABLET in 1 BOTTLE (63629-5432-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,63629543207,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,63629-5432-8,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040355,Bryant Ranch Prepack,63629-5432,Hydrocodone Bitartrate And Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/08/2022,09/30/2023,ANDA,100 TABLET in 1 BOTTLE (63629-5432-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,63629543208,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,63629-5432-9,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040355,Bryant Ranch Prepack,63629-5432,Hydrocodone Bitartrate And Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/14/2014,09/30/2023,ANDA,120 TABLET in 1 BOTTLE (63629-5432-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,63629543209,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,0603-3887-28,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040355,"Par Pharmaceutical, Inc.",0603-3887,Hydrocodone Bitartrate And Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/31/2000,06/30/2023,ANDA,"500 TABLET in 1 BOTTLE, PLASTIC (0603-3887-28)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,00603388728,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,0603-3887-32,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040355,"Par Pharmaceutical, Inc.",0603-3887,Hydrocodone Bitartrate And Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/31/2000,09/30/2023,ANDA,"1000 TABLET in 1 BOTTLE, PLASTIC (0603-3887-32)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,00603388732,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,43386-352-01,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206142,"Lupin Pharmaceuticals,Inc.",43386-352,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-352-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035201,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,43386-352-03,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206142,"Lupin Pharmaceuticals,Inc.",43386-352,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (43386-352-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035203,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,43386-356-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206245,"Lupin Pharmaceuticals,Inc.",43386-356,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-356-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035601,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,43386-356-03,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206245,"Lupin Pharmaceuticals,Inc.",43386-356,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (43386-356-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035603,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-0299-9,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,"RedPharm Drug, Inc.",67296-0299,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/18/2010,N/A,ANDA,12 TABLET in 1 BOTTLE (67296-0299-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296029909,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,63187-137-60,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040656,Proficient Rx LP,63187-137,Hydrocodone Bitartrate And Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/01/2019,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (63187-137-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187013760,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-652-12,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-652,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,12 TABLET in 1 BOTTLE (55700-652-12),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700065212,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-652-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-652,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,120 TABLET in 1 BOTTLE (55700-652-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700065201,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,68071-2645-3,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210211,"NuCare Pharmaceuticals,Inc.",68071-2645,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/21/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (68071-2645-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,68071264503,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-112-20,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,Proficient Rx LP,63187-112,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/02/2014,N/A,ANDA,20 TABLET in 1 BOTTLE (63187-112-20),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187011220,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0904-6420-61,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040148,Major Pharmaceuticals,0904-6420,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/14/2013,N/A,ANDA,100 BLISTER PACK in 1 CARTON (0904-6420-61)  / 1 TABLET in 1 BLISTER PACK,"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00904642061,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0904-6421-61,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040148,Major Pharmaceuticals,0904-6421,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/07/2013,N/A,ANDA,100 BLISTER PACK in 1 CARTON (0904-6421-61)  / 1 TABLET in 1 BLISTER PACK,"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00904642161,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,68071-2762-6,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA210211,"NuCare Pharmaceuticals,Inc.",68071-2762,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/15/2022,N/A,ANDA,6 TABLET in 1 BOTTLE (68071-2762-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,68071276206,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-598-40,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-598,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,40 TABLET in 1 BOTTLE (55700-598-40),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700059840,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-652-10,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-652,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/14/2019,N/A,ANDA,10 TABLET in 1 BOTTLE (55700-652-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700065210,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,66689-023-50,"325 mg/15mL,                         7.5  mg/15mL",SOLUTION,ORAL,ANDA200343,"VistaPharm, Inc.",66689-023,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/05/2017,N/A,ANDA,"50 CUP, UNIT-DOSE in 1 CASE (66689-023-50)  / 15 mL in 1 CUP, UNIT-DOSE (66689-023-01)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,66689002350,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,72189-343-72,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Direct Rx,72189-343,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/30/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (72189-343-72),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72189034372,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,53746-109-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,Amneal Pharmaceuticals of New York LLC,53746-109,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/18/2010,N/A,ANDA,100 TABLET in 1 BOTTLE (53746-109-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,53746010901,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,53746-109-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,Amneal Pharmaceuticals of New York LLC,53746-109,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/18/2010,N/A,ANDA,500 TABLET in 1 BOTTLE (53746-109-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,53746010905,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,53746-109-10,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,Amneal Pharmaceuticals of New York LLC,53746-109,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/18/2010,N/A,ANDA,1000 TABLET in 1 BOTTLE (53746-109-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,53746010910,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,72189-343-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Direct Rx,72189-343,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/30/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-343-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72189034360,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0466-3,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,Bryant Ranch Prepack,71335-0466,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/15/2018,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-0466-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335046603,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0123-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040409,SpecGx LLC,0406-0123,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/20/2000,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-0123-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012301,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0123-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040409,SpecGx LLC,0406-0123,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/20/2000,N/A,ANDA,500 TABLET in 1 BOTTLE (0406-0123-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012305,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0123-10,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040409,SpecGx LLC,0406-0123,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/20/2000,N/A,ANDA,1000 TABLET in 1 BOTTLE (0406-0123-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012310,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0123-12,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040409,SpecGx LLC,0406-0123,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/20/2000,N/A,ANDA,120 TABLET in 1 BOTTLE (0406-0123-12),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012312,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0123-20,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040409,SpecGx LLC,0406-0123,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/20/2000,N/A,ANDA,20 TABLET in 1 BOTTLE (0406-0123-20),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012320,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0123-23,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040409,SpecGx LLC,0406-0123,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/20/2000,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-0123-23),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012323,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0123-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040409,SpecGx LLC,0406-0123,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/20/2000,N/A,ANDA,30 TABLET in 1 BOTTLE (0406-0123-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012330,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0123-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040409,SpecGx LLC,0406-0123,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/20/2000,N/A,ANDA,60 TABLET in 1 BOTTLE (0406-0123-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012360,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0123-62,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040409,SpecGx LLC,0406-0123,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/20/2000,N/A,ANDA,100 TABLET in 1 BLISTER PACK (0406-0123-62),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012362,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0123-90,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040409,SpecGx LLC,0406-0123,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/20/2000,N/A,ANDA,90 TABLET in 1 BOTTLE (0406-0123-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012390,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0124-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,SpecGx LLC,0406-0124,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,09/08/2000,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-0124-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012401,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0124-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,SpecGx LLC,0406-0124,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,09/08/2000,N/A,ANDA,500 TABLET in 1 BOTTLE (0406-0124-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012405,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0124-10,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,SpecGx LLC,0406-0124,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,09/08/2000,N/A,ANDA,1000 TABLET in 1 BOTTLE (0406-0124-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012410,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0124-12,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,SpecGx LLC,0406-0124,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,09/08/2000,N/A,ANDA,120 TABLET in 1 BOTTLE (0406-0124-12),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012412,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0124-20,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,SpecGx LLC,0406-0124,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,09/08/2000,N/A,ANDA,20 TABLET in 1 BOTTLE (0406-0124-20),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012420,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0124-23,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,SpecGx LLC,0406-0124,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,09/08/2000,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-0124-23),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012423,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0124-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,SpecGx LLC,0406-0124,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,09/08/2000,N/A,ANDA,30 TABLET in 1 BOTTLE (0406-0124-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012430,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0124-60,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,SpecGx LLC,0406-0124,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,09/08/2000,N/A,ANDA,60 TABLET in 1 BOTTLE (0406-0124-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012460,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0124-62,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,SpecGx LLC,0406-0124,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,09/08/2000,N/A,ANDA,100 TABLET in 1 BLISTER PACK (0406-0124-62),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012462,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0124-90,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,SpecGx LLC,0406-0124,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,09/08/2000,N/A,ANDA,90 TABLET in 1 BOTTLE (0406-0124-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012490,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0125-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,SpecGx LLC,0406-0125,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/26/2000,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-0125-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012501,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0125-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,SpecGx LLC,0406-0125,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/26/2000,N/A,ANDA,500 TABLET in 1 BOTTLE (0406-0125-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012505,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0125-10,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,SpecGx LLC,0406-0125,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/26/2000,N/A,ANDA,1000 TABLET in 1 BOTTLE (0406-0125-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012510,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0125-12,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,SpecGx LLC,0406-0125,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/26/2000,N/A,ANDA,120 TABLET in 1 BOTTLE (0406-0125-12),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012512,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0125-20,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,SpecGx LLC,0406-0125,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/26/2000,N/A,ANDA,20 TABLET in 1 BOTTLE (0406-0125-20),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012520,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0125-23,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,SpecGx LLC,0406-0125,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/26/2000,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-0125-23),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012523,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0125-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,SpecGx LLC,0406-0125,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/26/2000,N/A,ANDA,30 TABLET in 1 BOTTLE (0406-0125-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012530,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,45865-605-20,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040655,Medsource Pharmaceticals,45865-605,Hydrocodone Bitartrate And Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2014,N/A,ANDA,"20 TABLET in 1 BOTTLE, PLASTIC (45865-605-20)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,45865060520,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,45865-605-51,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040655,Medsource Pharmaceticals,45865-605,Hydrocodone Bitartrate And Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2014,N/A,ANDA,"120 TABLET in 1 BOTTLE, PLASTIC (45865-605-51)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,45865060551,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2112-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2112,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,21 TABLET in 1 BOTTLE (71335-2112-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211201,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2112-2,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2112,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,36 TABLET in 1 BOTTLE (71335-2112-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211202,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2115-0,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2115,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,8 TABLET in 1 BOTTLE (71335-2115-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211500,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-778-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-778,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/01/2017,N/A,ANDA,90 TABLET in 1 BOTTLE (63187-778-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187077890,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2115-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2115,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-2115-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211501,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2115-2,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2115,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-2115-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211502,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2115-3,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2115,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-2115-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211503,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2115-4,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2115,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-2115-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211504,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2115-5,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2115,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-2115-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211505,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2115-6,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2115,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-2115-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211506,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2115-7,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2115,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-2115-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211507,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2115-8,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2115,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-2115-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211508,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2115-9,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2115,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-2115-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211509,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2116-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-2116,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-2116-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335211601,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2116-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-2116,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-2116-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335211602,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2116-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-2116,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-2116-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335211603,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2116-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-2116,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,8 TABLET in 1 BOTTLE (71335-2116-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335211604,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2116-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Bryant Ranch Prepack,71335-2116,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-2116-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,71335211605,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2117-0,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2117,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,10 TABLET in 1 BOTTLE (71335-2117-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211700,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2117-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2117,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-2117-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211701,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2117-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2117,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-2117-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211702,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2117-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2117,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-2117-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211703,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2117-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2117,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-2117-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211704,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2117-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2117,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-2117-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211705,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2117-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2117,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,50 TABLET in 1 BOTTLE (71335-2117-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211706,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2117-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2117,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-2117-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211707,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2117-8,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2117,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-2117-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211708,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2117-9,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2117,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-2117-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211709,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2118-0,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2118,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-2118-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211800,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2118-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2118,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-2118-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211801,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2118-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2118,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-2118-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211802,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2118-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2118,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-2118-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211803,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2118-4,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2118,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,45 TABLET in 1 BOTTLE (71335-2118-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211804,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2118-5,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2118,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-2118-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211805,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2118-6,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2118,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-2118-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211806,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2118-7,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2118,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-2118-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211807,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2118-8,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2118,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-2118-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211808,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-2118-9,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-2118,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-2118-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335211809,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0527-1646-01,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207171,"Lannett Company, Inc.",0527-1646,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (0527-1646-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00527164601,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0527-1646-05,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207171,"Lannett Company, Inc.",0527-1646,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (0527-1646-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00527164605,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0527-1647-01,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207171,"Lannett Company, Inc.",0527-1647,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (0527-1647-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00527164701,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0527-1647-05,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207171,"Lannett Company, Inc.",0527-1647,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/20/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (0527-1647-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00527164705,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,63187-838-15,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA040148,Proficient Rx LP,63187-838,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/01/2017,N/A,ANDA,"15 TABLET in 1 BOTTLE, PLASTIC (63187-838-15)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187083815,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-838-20,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA040148,Proficient Rx LP,63187-838,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/01/2017,N/A,ANDA,"20 TABLET in 1 BOTTLE, PLASTIC (63187-838-20)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187083820,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-838-30,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA040148,Proficient Rx LP,63187-838,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/01/2017,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (63187-838-30)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187083830,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1476-7,"325 mg/15mL,                         7.5  mg/15mL",SOLUTION,ORAL,ANDA040838,"Redpharm Drug, Inc",67296-1476,HYDROCODONE BITARTRATE and ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/29/2013,N/A,ANDA,118 mL in 1 BOTTLE (67296-1476-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,67296147607,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1333-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,"RedPharm Drug, Inc.",67296-1333,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-1333-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296133301,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1333-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,"RedPharm Drug, Inc.",67296-1333,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (67296-1333-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296133303,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0254-2034-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202935,"Par Pharmaceutical, Inc.",0254-2034,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/05/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (0254-2034-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00254203401,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0254-2035-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202935,"Par Pharmaceutical, Inc.",0254-2035,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/05/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (0254-2035-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00254203501,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,72189-343-08,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,Direct Rx,72189-343,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/22/2022,N/A,ANDA,8 TABLET in 1 BOTTLE (72189-343-08),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72189034308,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-120-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040746,Proficient Rx LP,63187-120,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/01/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (63187-120-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187012060,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-2292-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202214,Bryant Ranch Prepack,63629-2292,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (63629-2292-1)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629229201,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-2293-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202214,Bryant Ranch Prepack,63629-2293,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"500 TABLET in 1 BOTTLE, PLASTIC (63629-2293-1)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629229301,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-2294-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202214,Bryant Ranch Prepack,63629-2294,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"1000 TABLET in 1 BOTTLE, PLASTIC (63629-2294-1)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629229401,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-2295-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202214,Bryant Ranch Prepack,63629-2295,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (63629-2295-1)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629229501,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-2296-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202214,Bryant Ranch Prepack,63629-2296,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"500 TABLET in 1 BOTTLE, PLASTIC (63629-2296-1)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629229601,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-2297-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202214,Bryant Ranch Prepack,63629-2297,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"1000 TABLET in 1 BOTTLE, PLASTIC (63629-2297-1)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629229701,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-2298-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202214,Bryant Ranch Prepack,63629-2298,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (63629-2298-1)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629229801,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-2299-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202214,Bryant Ranch Prepack,63629-2299,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"500 TABLET in 1 BOTTLE, PLASTIC (63629-2299-1)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629229901,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-2300-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202214,Bryant Ranch Prepack,63629-2300,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"1000 TABLET in 1 BOTTLE, PLASTIC (63629-2300-1)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629230001,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-2308-1,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202214,Bryant Ranch Prepack,63629-2308,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/07/2016,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (63629-2308-1)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629230801,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,63629-2309-1,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202214,Bryant Ranch Prepack,63629-2309,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/07/2016,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (63629-2309-1)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629230901,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,63629-2310-1,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202214,Bryant Ranch Prepack,63629-2310,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/07/2016,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (63629-2310-1)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629231001,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,67296-1415-0,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1415,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (67296-1415-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,67296141500,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1415-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1415,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/01/2021,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-1415-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,67296141501,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1415-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1415,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2021,N/A,ANDA,20 TABLET in 1 BOTTLE (67296-1415-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,67296141502,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1415-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1415,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (67296-1415-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,67296141503,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1415-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1415,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2021,N/A,ANDA,4 TABLET in 1 BOTTLE (67296-1415-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,67296141504,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1415-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1415,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-1415-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,67296141506,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1415-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1415,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/01/2021,N/A,ANDA,12 TABLET in 1 BOTTLE (67296-1415-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,67296141507,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1415-8,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1415,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/01/2021,N/A,ANDA,40 TABLET in 1 BOTTLE (67296-1415-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,67296141508,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,60429-590-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040409,"Golden State Medical Supply, Inc.",60429-590,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/09/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (60429-590-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,60429059001,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,60429-590-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040409,"Golden State Medical Supply, Inc.",60429-590,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/09/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (60429-590-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,60429059005,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,60429-591-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,"Golden State Medical Supply, Inc.",60429-591,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/09/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (60429-591-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,60429059101,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,60429-591-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,"Golden State Medical Supply, Inc.",60429-591,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/09/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (60429-591-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,60429059105,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,60429-592-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,"Golden State Medical Supply, Inc.",60429-592,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/09/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (60429-592-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,60429059201,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,60429-592-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,"Golden State Medical Supply, Inc.",60429-592,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/09/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (60429-592-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,60429059205,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,60687-407-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210211,American Health Packaging,60687-407,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/21/2019,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-407-01)  / 1 TABLET in 1 BLISTER PACK (60687-407-11)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,60687040701,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,60687-417-71,"325 mg/15mL,                         7.5  mg/15mL",SOLUTION,ORAL,ANDA211023,American Health Packaging,60687-417,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/19/2019,N/A,ANDA,"5 TRAY in 1 CASE (60687-417-71)  / 10 CUP, UNIT-DOSE in 1 TRAY (60687-417-50)  / 15 mL in 1 CUP, UNIT-DOSE (60687-417-44)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,60687041771,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,60687-418-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA210211,American Health Packaging,60687-418,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/22/2019,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-418-01)  / 1 TABLET in 1 BLISTER PACK (60687-418-11)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,60687041801,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,40032-353-01,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206142,"Novel Laboratories, Inc.",40032-353,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (40032-353-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035301,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,40032-358-03,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206245,"Novel Laboratories, Inc.",40032-358,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (40032-358-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035803,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,40032-358-10,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206245,"Novel Laboratories, Inc.",40032-358,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,1000 TABLET in 1 BOTTLE (40032-358-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035810,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1579-6,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202214,"RedPharm Drug, Inc.",67296-1579,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2018,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-1579-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296157906,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-838-12,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA040148,Proficient Rx LP,63187-838,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/01/2017,N/A,ANDA,"12 TABLET in 1 BOTTLE, PLASTIC (63187-838-12)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187083812,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-838-90,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA040148,Proficient Rx LP,63187-838,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/01/2017,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (63187-838-90)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187083890,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,40032-353-05,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206142,"Novel Laboratories, Inc.",40032-353,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (40032-353-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035305,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,40032-358-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206245,"Novel Laboratories, Inc.",40032-358,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (40032-358-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035801,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-375-15,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-375,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/01/2016,N/A,ANDA,15 TABLET in 1 BOTTLE (63187-375-15),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187037515,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,61919-828-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Direct_Rx,61919-828,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/21/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (61919-828-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919082830,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,61919-828-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Direct_Rx,61919-828,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/21/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (61919-828-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919082860,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,61919-828-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Direct_Rx,61919-828,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/21/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (61919-828-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919082890,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0125-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,SpecGx LLC,0406-0125,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/26/2000,N/A,ANDA,60 TABLET in 1 BOTTLE (0406-0125-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012560,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0125-62,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,SpecGx LLC,0406-0125,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/26/2000,N/A,ANDA,100 TABLET in 1 BLISTER PACK (0406-0125-62),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012562,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,0406-0125-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,SpecGx LLC,0406-0125,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/26/2000,N/A,ANDA,90 TABLET in 1 BOTTLE (0406-0125-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406012590,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,0406-0376-01,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206718,SpecGx LLC,0406-0376,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/31/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-0376-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406037601,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0406-0376-05,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206718,SpecGx LLC,0406-0376,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/31/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (0406-0376-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406037605,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0406-0376-23,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206718,SpecGx LLC,0406-0376,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/31/2017,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-0376-23),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406037623,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0406-0376-62,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206718,SpecGx LLC,0406-0376,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/31/2017,N/A,ANDA,10 BLISTER PACK in 1 CARTON (0406-0376-62)  / 10 TABLET in 1 BLISTER PACK,"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406037662,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0406-0377-01,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206718,SpecGx LLC,0406-0377,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/31/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-0377-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406037701,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0406-0377-05,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206718,SpecGx LLC,0406-0377,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/31/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (0406-0377-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406037705,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0406-0377-23,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206718,SpecGx LLC,0406-0377,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/31/2017,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-0377-23),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406037723,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0406-0377-62,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206718,SpecGx LLC,0406-0377,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/31/2017,N/A,ANDA,10 BLISTER PACK in 1 CARTON (0406-0377-62)  / 10 TABLET in 1 BLISTER PACK,"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406037762,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0406-0378-01,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206718,SpecGx LLC,0406-0378,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/31/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-0378-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406037801,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0406-0378-05,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206718,SpecGx LLC,0406-0378,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/31/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (0406-0378-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406037805,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0406-0378-23,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206718,SpecGx LLC,0406-0378,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/31/2017,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-0378-23),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406037823,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,0406-0378-62,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206718,SpecGx LLC,0406-0378,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/31/2017,N/A,ANDA,10 BLISTER PACK in 1 CARTON (0406-0378-62)  / 10 TABLET in 1 BLISTER PACK,"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00406037862,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,72865-201-01,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA211487,"XLCare Pharmaceuticals, Inc.",72865-201,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-201-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72865020101,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,72865-202-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"XLCare Pharmaceuticals, Inc.",72865-202,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-202-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72865020201,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,72865-202-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"XLCare Pharmaceuticals, Inc.",72865-202,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2020,N/A,ANDA,500 TABLET in 1 BOTTLE (72865-202-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72865020205,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,72865-203-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,"XLCare Pharmaceuticals, Inc.",72865-203,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-203-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72865020301,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,72865-203-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211487,"XLCare Pharmaceuticals, Inc.",72865-203,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2020,N/A,ANDA,500 TABLET in 1 BOTTLE (72865-203-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72865020305,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,72865-204-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,"XLCare Pharmaceuticals, Inc.",72865-204,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-204-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72865020401,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,72865-204-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,"XLCare Pharmaceuticals, Inc.",72865-204,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2020,N/A,ANDA,500 TABLET in 1 BOTTLE (72865-204-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72865020405,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-658-12,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-658,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/03/2021,N/A,ANDA,12 TABLET in 1 BOTTLE (63187-658-12),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187065812,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-2468-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,63629-2468,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (63629-2468-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,63629246801,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-2469-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,63629-2469,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-2469-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629246901,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-2470-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,63629-2470,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (63629-2470-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629247001,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-2471-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,63629-2471,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-2471-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629247101,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-120-20,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040746,Proficient Rx LP,63187-120,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/01/2019,N/A,ANDA,20 TABLET in 1 BOTTLE (63187-120-20),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187012020,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,40032-351-03,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206142,"Novel Laboratories, Inc.",40032-351,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (40032-351-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035103,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,40032-351-05,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206142,"Novel Laboratories, Inc.",40032-351,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (40032-351-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035105,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,40032-352-05,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206142,"Novel Laboratories, Inc.",40032-352,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (40032-352-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035205,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,40032-357-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206245,"Novel Laboratories, Inc.",40032-357,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (40032-357-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035701,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,40032-357-03,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206245,"Novel Laboratories, Inc.",40032-357,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (40032-357-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035703,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63304-497-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040826,"Sun Pharmaceutical Industries, Inc.",63304-497,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/31/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (63304-497-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63304049701,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,42858-203-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Rhodes Pharmaceuticals L.P.,42858-203,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (42858-203-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,42858020301,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,76420-133-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,"Asclemed USA, Inc.",76420-133,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/16/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (76420-133-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,76420013330,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,76420-257-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,"Asclemed USA, Inc.",76420-257,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/20/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (76420-257-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,76420025730,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,76420-257-60,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,"Asclemed USA, Inc.",76420-257,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/20/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (76420-257-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,76420025760,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,76420-257-90,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,"Asclemed USA, Inc.",76420-257,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/20/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (76420-257-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,76420025790,Hydrocodone,325
hydrocodone bitartrate and acetaminophen,63629-1177-1,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207509,Bryant Ranch Prepack,63629-1177,hydrocodone bitartrate and acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/17/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-1177-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629117701,Hydrocodone,300
hydrocodone bitartrate and acetaminophen,63629-1179-1,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207509,Bryant Ranch Prepack,63629-1179,hydrocodone bitartrate and acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/01/2020,N/A,ANDA,500 TABLET in 1 BOTTLE (63629-1179-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629117901,Hydrocodone,300
hydrocodone bitartrate and acetaminophen,63629-1181-1,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207509,Bryant Ranch Prepack,63629-1181,hydrocodone bitartrate and acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/01/2020,N/A,ANDA,500 TABLET in 1 BOTTLE (63629-1181-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629118101,Hydrocodone,300
hydrocodone bitartrate and acetaminophen,63629-1184-1,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207509,Bryant Ranch Prepack,63629-1184,hydrocodone bitartrate and acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/01/2020,N/A,ANDA,500 TABLET in 1 BOTTLE (63629-1184-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629118401,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,43386-356-10,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206245,"Lupin Pharmaceuticals,Inc.",43386-356,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,1000 TABLET in 1 BOTTLE (43386-356-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035610,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,68071-2857-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"NuCare Pharmaceuticals,Inc.",68071-2857,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/24/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (68071-2857-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,68071285703,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,10702-189-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209037,"KVK-Tech, Inc.",10702-189,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-189-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702018901,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,10702-189-03,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209037,"KVK-Tech, Inc.",10702-189,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (10702-189-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702018903,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,10702-189-10,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209037,"KVK-Tech, Inc.",10702-189,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,1000 TABLET in 1 BOTTLE (10702-189-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702018910,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,10702-189-50,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209037,"KVK-Tech, Inc.",10702-189,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (10702-189-50),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702018950,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,10702-190-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA209037,"KVK-Tech, Inc.",10702-190,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-190-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019001,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,10702-190-03,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA209037,"KVK-Tech, Inc.",10702-190,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (10702-190-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019003,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,10702-190-10,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA209037,"KVK-Tech, Inc.",10702-190,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,1000 TABLET in 1 BOTTLE (10702-190-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019010,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,10702-190-50,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA209037,"KVK-Tech, Inc.",10702-190,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (10702-190-50),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019050,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,10702-191-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209037,"KVK-Tech, Inc.",10702-191,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-191-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019101,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,10702-191-03,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209037,"KVK-Tech, Inc.",10702-191,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (10702-191-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019103,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,10702-191-10,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209037,"KVK-Tech, Inc.",10702-191,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,1000 TABLET in 1 BOTTLE (10702-191-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019110,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,10702-191-50,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209037,"KVK-Tech, Inc.",10702-191,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (10702-191-50),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019150,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,10702-192-01,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209036,"KVK-Tech, Inc.",10702-192,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-192-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019201,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,10702-192-03,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209036,"KVK-Tech, Inc.",10702-192,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (10702-192-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019203,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,10702-192-10,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209036,"KVK-Tech, Inc.",10702-192,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,1000 TABLET in 1 BOTTLE (10702-192-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019210,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,10702-192-50,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209036,"KVK-Tech, Inc.",10702-192,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (10702-192-50),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019250,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,10702-193-01,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA209036,"KVK-Tech, Inc.",10702-193,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-193-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019301,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,10702-193-03,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA209036,"KVK-Tech, Inc.",10702-193,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (10702-193-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019303,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,10702-193-10,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA209036,"KVK-Tech, Inc.",10702-193,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,1000 TABLET in 1 BOTTLE (10702-193-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019310,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,10702-193-50,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA209036,"KVK-Tech, Inc.",10702-193,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (10702-193-50),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019350,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,10702-194-01,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209036,"KVK-Tech, Inc.",10702-194,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-194-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019401,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,10702-194-03,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209036,"KVK-Tech, Inc.",10702-194,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (10702-194-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019403,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,10702-194-10,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209036,"KVK-Tech, Inc.",10702-194,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,1000 TABLET in 1 BOTTLE (10702-194-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019410,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,10702-194-50,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209036,"KVK-Tech, Inc.",10702-194,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (10702-194-50),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702019450,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,63187-778-20,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-778,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/01/2016,N/A,ANDA,20 TABLET in 1 BOTTLE (63187-778-20),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187077820,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-778-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-778,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/01/2016,N/A,ANDA,60 TABLET in 1 BOTTLE (63187-778-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187077860,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,42858-201-50,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Rhodes Pharmaceuticals L.P.,42858-201,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (42858-201-50),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,42858020150,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,42858-202-10,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,Rhodes Pharmaceuticals L.P.,42858-202,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (42858-202-10)  / 1 TABLET in 1 BLISTER PACK","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,42858020210,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,43386-353-05,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206142,"Lupin Pharmaceuticals,Inc.",43386-353,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-353-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035305,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,42858-203-10,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,Rhodes Pharmaceuticals L.P.,42858-203,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (42858-203-10)  / 1 TABLET in 1 BLISTER PACK","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,42858020310,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-9602-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-9602,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/12/2022,N/A,ANDA,21 TABLET in 1 BOTTLE (71335-9602-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335960201,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-9602-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-9602,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/12/2022,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-9602-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335960202,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-9602-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,Bryant Ranch Prepack,71335-9602,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/12/2022,N/A,ANDA,10 TABLET in 1 BOTTLE (71335-9602-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335960203,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,64950-343-16,"325 mg/15mL,                         7.5  mg/15mL",SOLUTION,ORAL,ANDA040894,Genus Lifesciences Inc.,64950-343,hydrocodone bitartrate and acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/20/2020,N/A,ANDA,473 mL in 1 BOTTLE (64950-343-16),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,64950034316,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1377-6,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,"RedPharm Drug, Inc.",67296-1377,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/30/2016,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-1377-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296137706,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,50268-400-15,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,AvPAK,50268-400,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/28/2016,N/A,ANDA,50 BLISTER PACK in 1 BOX (50268-400-15)  / 1 TABLET in 1 BLISTER PACK (50268-400-11),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,50268040015,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,50268-402-15,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040736,AvPAK,50268-402,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/15/2014,N/A,ANDA,"50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-402-15)  / 1 TABLET in 1 BLISTER PACK (50268-402-11)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,50268040215,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,66689-004-50,"108 mg/5mL,                         2.5  mg/5mL",SOLUTION,ORAL,ANDA200343,"VistaPharm, Inc.",66689-004,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/24/2019,N/A,ANDA,"50 CUP, UNIT-DOSE in 1 CASE (66689-004-50)  / 5 mL in 1 CUP, UNIT-DOSE (66689-004-01)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,66689000450,Hydrocodone,108
Hydrocodone Bitartrate and Acetaminophen,66689-005-50,"217 mg/10mL,                         5  mg/10mL",SOLUTION,ORAL,ANDA200343,"VistaPharm, Inc.",66689-005,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/24/2019,N/A,ANDA,"50 CUP, UNIT-DOSE in 1 CASE (66689-005-50)  / 10 mL in 1 CUP, UNIT-DOSE (66689-005-01)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,66689000550,Hydrocodone,217
Hydrocodone Bitartrate and Acetaminophen,63187-658-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-658,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/01/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (63187-658-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187065830,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1571-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202214,"RedPharm Drug, Inc.",67296-1571,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2018,N/A,ANDA,20 TABLET in 1 BOTTLE (67296-1571-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296157102,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1571-9,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202214,"RedPharm Drug, Inc.",67296-1571,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2018,N/A,ANDA,12 TABLET in 1 BOTTLE (67296-1571-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296157109,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1618-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA209037,"RedPharm Drug, Inc.",67296-1618,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2020,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-1618-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296161801,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1618-3,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA209037,"RedPharm Drug, Inc.",67296-1618,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (67296-1618-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296161803,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1695-0,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1695,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/31/2019,N/A,ANDA,12 TABLET in 1 BOTTLE (67296-1695-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296169500,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1695-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1695,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/31/2019,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-1695-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296169501,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1695-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1695,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/31/2019,N/A,ANDA,20 TABLET in 1 BOTTLE (67296-1695-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296169502,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1695-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1695,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/31/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (67296-1695-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296169503,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1695-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1695,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/31/2019,N/A,ANDA,4 TABLET in 1 BOTTLE (67296-1695-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296169504,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1695-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1695,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/31/2019,N/A,ANDA,50 TABLET in 1 BOTTLE (67296-1695-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296169505,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1695-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1695,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/31/2019,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-1695-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296169506,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1695-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1695,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/31/2019,N/A,ANDA,15 TABLET in 1 BOTTLE (67296-1695-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296169507,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1695-8,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1695,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/31/2019,N/A,ANDA,40 TABLET in 1 BOTTLE (67296-1695-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296169508,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1695-9,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1695,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/01/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (67296-1695-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296169509,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1618-9,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA209037,"RedPharm Drug, Inc.",67296-1618,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2018,N/A,ANDA,12 TABLET in 1 BOTTLE (67296-1618-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296161809,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1791-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,"RedPharm Drug, Inc.",67296-1791,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-1791-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296179101,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1791-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,"RedPharm Drug, Inc.",67296-1791,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/01/2020,N/A,ANDA,20 TABLET in 1 BOTTLE (67296-1791-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296179102,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1791-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,"RedPharm Drug, Inc.",67296-1791,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/01/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (67296-1791-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296179103,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1791-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,"RedPharm Drug, Inc.",67296-1791,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,50 TABLET in 1 BOTTLE (67296-1791-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296179105,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1791-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,"RedPharm Drug, Inc.",67296-1791,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/01/2020,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-1791-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296179106,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1791-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,"RedPharm Drug, Inc.",67296-1791,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/01/2020,N/A,ANDA,15 TABLET in 1 BOTTLE (67296-1791-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296179107,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1791-8,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,"RedPharm Drug, Inc.",67296-1791,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,12 TABLET in 1 BOTTLE (67296-1791-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296179108,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1791-9,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201013,"RedPharm Drug, Inc.",67296-1791,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/11/2012,N/A,ANDA,60 TABLET in 1 BOTTLE (67296-1791-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296179109,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1794-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1794,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-1794-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296179401,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1794-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211487,"RedPharm Drug, Inc.",67296-1794,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/08/2018,N/A,ANDA,20 TABLET in 1 BOTTLE (67296-1794-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296179402,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,27808-035-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202214,Tris Pharma Inc,27808-035,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (27808-035-01)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808003501,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,27808-035-02,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202214,Tris Pharma Inc,27808-035,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"500 TABLET in 1 BOTTLE, PLASTIC (27808-035-02)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808003502,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,27808-035-03,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202214,Tris Pharma Inc,27808-035,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"1000 TABLET in 1 BOTTLE, PLASTIC (27808-035-03)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808003503,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,27808-036-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202214,Tris Pharma Inc,27808-036,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (27808-036-01)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808003601,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,27808-036-02,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202214,Tris Pharma Inc,27808-036,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"500 TABLET in 1 BOTTLE, PLASTIC (27808-036-02)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808003602,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,27808-036-03,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202214,Tris Pharma Inc,27808-036,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"1000 TABLET in 1 BOTTLE, PLASTIC (27808-036-03)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808003603,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,27808-037-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202214,Tris Pharma Inc,27808-037,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (27808-037-01)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808003701,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,27808-037-02,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202214,Tris Pharma Inc,27808-037,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"500 TABLET in 1 BOTTLE, PLASTIC (27808-037-02)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808003702,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,27808-037-03,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202214,Tris Pharma Inc,27808-037,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"1000 TABLET in 1 BOTTLE, PLASTIC (27808-037-03)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808003703,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,27808-114-01,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202214,Tris Pharma Inc,27808-114,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/07/2016,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (27808-114-01)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808011401,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,27808-114-02,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202214,Tris Pharma Inc,27808-114,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/07/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (27808-114-02),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808011402,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,27808-115-01,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202214,Tris Pharma Inc,27808-115,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/07/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (27808-115-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808011501,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,27808-115-02,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202214,Tris Pharma Inc,27808-115,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/07/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (27808-115-02),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808011502,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,27808-116-01,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202214,Tris Pharma Inc,27808-116,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/07/2016,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (27808-116-01)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808011601,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,27808-116-02,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202214,Tris Pharma Inc,27808-116,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/07/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (27808-116-02),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808011602,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,55700-652-21,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-652,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,21 TABLET in 1 BOTTLE (55700-652-21),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700065221,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,50268-401-15,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,AvPAK,50268-401,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/15/2014,N/A,ANDA,"50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-401-15)  / 1 TABLET in 1 BLISTER PACK (50268-401-11)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,50268040115,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,55700-991-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,"Quality Care Products, LLC",55700-991,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/27/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (55700-991-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,55700099130,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,55700-991-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,"Quality Care Products, LLC",55700-991,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/27/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (55700-991-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,55700099160,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0466-5,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,Bryant Ranch Prepack,71335-0466,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/05/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0466-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335046605,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0466-8,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,Bryant Ranch Prepack,71335-0466,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/27/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0466-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335046608,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,43386-357-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206245,"Lupin Pharmaceuticals,Inc.",43386-357,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-357-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035701,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,43386-358-03,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206245,"Lupin Pharmaceuticals,Inc.",43386-358,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (43386-358-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035803,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,43386-358-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206245,"Lupin Pharmaceuticals,Inc.",43386-358,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-358-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035805,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,43386-358-10,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206245,"Lupin Pharmaceuticals,Inc.",43386-358,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,1000 TABLET in 1 BOTTLE (43386-358-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035810,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0466-4,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,Bryant Ranch Prepack,71335-0466,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-0466-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335046604,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0466-6,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,Bryant Ranch Prepack,71335-0466,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/18/2019,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-0466-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335046606,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-0466-9,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,Bryant Ranch Prepack,71335-0466,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/15/2018,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0466-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335046609,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,27808-049-01,"325 mg/15mL,                         7.5  mg/15mL",SOLUTION,ORAL,ANDA201295,Tris Pharma Inc,27808-049,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/30/2022,N/A,ANDA,"473 mL in 1 BOTTLE, PLASTIC (27808-049-01)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808004901,Hydrocodone,325
hydrocodone bitartrate and acetaminophen,27808-130-01,"300 mg/15mL,                         10  mg/15mL",SOLUTION,ORAL,ANDA201295,Tris Pharma Inc,27808-130,hydrocodone bitartrate and acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/30/2022,N/A,ANDA,"473 mL in 1 BOTTLE, PLASTIC (27808-130-01)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808013001,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,70010-672-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211729,Granules Pharmaceuticals Inc.,70010-672,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/18/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (70010-672-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,70010067201,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,70010-672-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211729,Granules Pharmaceuticals Inc.,70010-672,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/18/2021,N/A,ANDA,500 TABLET in 1 BOTTLE (70010-672-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,70010067205,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,70010-673-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211729,Granules Pharmaceuticals Inc.,70010-673,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/18/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (70010-673-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,70010067301,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,70010-673-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211729,Granules Pharmaceuticals Inc.,70010-673,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/18/2021,N/A,ANDA,500 TABLET in 1 BOTTLE (70010-673-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,70010067305,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,70010-674-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211729,Granules Pharmaceuticals Inc.,70010-674,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/18/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (70010-674-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,70010067401,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,70010-674-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211729,Granules Pharmaceuticals Inc.,70010-674,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/18/2021,N/A,ANDA,500 TABLET in 1 BOTTLE (70010-674-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,70010067405,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63629-8499-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,63629-8499,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/18/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-8499-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629849901,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-658-15,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-658,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/01/2016,N/A,ANDA,15 TABLET in 1 BOTTLE (63187-658-15),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187065815,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-658-20,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-658,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/01/2016,N/A,ANDA,20 TABLET in 1 BOTTLE (63187-658-20),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187065820,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-658-60,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-658,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/01/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (63187-658-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187065860,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,43386-351-03,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206142,"Lupin Pharmaceuticals,Inc.",43386-351,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (43386-351-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035103,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,43386-353-01,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206142,"Lupin Pharmaceuticals,Inc.",43386-353,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-353-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035301,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,43386-357-10,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206245,"Lupin Pharmaceuticals,Inc.",43386-357,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,1000 TABLET in 1 BOTTLE (43386-357-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035710,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,43386-358-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206245,"Lupin Pharmaceuticals,Inc.",43386-358,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-358-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035801,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1333-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,"RedPharm Drug, Inc.",67296-1333,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,4 TABLET in 1 BOTTLE (67296-1333-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296133304,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1333-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,"RedPharm Drug, Inc.",67296-1333,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-1333-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296133306,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71930-019-12,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Eywa Pharma Inc,71930-019,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (71930-019-12),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930001912,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71930-019-52,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Eywa Pharma Inc,71930-019,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (71930-019-52),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930001952,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,68084-895-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,American Health Packaging,68084-895,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/26/2014,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-895-01)  / 1 TABLET in 1 BLISTER PACK (68084-895-11)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,68084089501,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1811-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1811,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/20/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1811-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335181101,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1811-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1811,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/20/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1811-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335181102,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1811-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1811,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/20/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1811-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335181103,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1811-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1811,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/20/2021,N/A,ANDA,8 TABLET in 1 BOTTLE (71335-1811-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335181104,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1811-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1811,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/20/2021,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1811-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335181105,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63304-497-69,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040826,"Sun Pharmaceutical Industries, Inc.",63304-497,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/31/2018,N/A,ANDA,10 BLISTER PACK in 1 CARTON (63304-497-69)  / 1 TABLET in 1 BLISTER PACK (63304-497-11),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63304049769,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1333-9,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,"RedPharm Drug, Inc.",67296-1333,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,60 TABLET in 1 BOTTLE (67296-1333-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296133309,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1335-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202991,"RedPharm Drug, Inc.",67296-1335,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-1335-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296133501,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-0299-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,"RedPharm Drug, Inc.",67296-0299,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/18/2010,N/A,ANDA,4 TABLET in 1 BOTTLE (67296-0299-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296029907,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-0299-8,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,"RedPharm Drug, Inc.",67296-0299,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/18/2010,N/A,ANDA,60 TABLET in 1 BOTTLE (67296-0299-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296029908,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-598-15,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-598,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/13/2018,N/A,ANDA,15 TABLET in 1 BOTTLE (55700-598-15),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700059815,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71930-019-13,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210211,Eywa Pharma Inc,71930-019,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/06/2022,N/A,ANDA,1000 TABLET in 1 BOTTLE (71930-019-13),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930001913,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71930-020-13,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210211,Eywa Pharma Inc,71930-020,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/06/2022,N/A,ANDA,1000 TABLET in 1 BOTTLE (71930-020-13),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930002013,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71930-021-13,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA210211,Eywa Pharma Inc,71930-021,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/06/2022,N/A,ANDA,1000 TABLET in 1 BOTTLE (71930-021-13),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930002113,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,70518-3491-0,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA209036,REMEDYREPACK INC.,70518-3491,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/22/2022,N/A,ANDA,100 POUCH in 1 BOX (70518-3491-0)  / 1 TABLET in 1 POUCH (70518-3491-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,70518349100,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,71930-021-12,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA210211,Eywa Pharma Inc,71930-021,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (71930-021-12),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930002112,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,61919-828-26,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Direct_Rx,61919-828,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/21/2019,N/A,ANDA,26 TABLET in 1 BOTTLE (61919-828-26),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,61919082826,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,45865-605-25,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040655,Medsource Pharmaceticals,45865-605,Hydrocodone Bitartrate And Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2014,N/A,ANDA,"25 TABLET in 1 BOTTLE, PLASTIC (45865-605-25)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,45865060525,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,45865-605-90,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040655,Medsource Pharmaceticals,45865-605,Hydrocodone Bitartrate And Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2014,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (45865-605-90)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,45865060590,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,13107-211-01,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207709,"Aurolife Pharma, LLC",13107-211,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/06/2015,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-211-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107021101,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,13107-212-01,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207709,"Aurolife Pharma, LLC",13107-212,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/06/2015,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-212-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107021201,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,60760-220-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,St. Mary's Medical Park Pharmacy,60760-220,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/04/2017,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (60760-220-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,60760022060,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63304-497-10,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040826,"Sun Pharmaceutical Industries, Inc.",63304-497,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/31/2018,N/A,ANDA,1000 TABLET in 1 BOTTLE (63304-497-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63304049710,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,60760-220-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,St. Mary's Medical Park Pharmacy,60760-220,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/04/2017,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (60760-220-30)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,60760022030,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,60760-220-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,St. Mary's Medical Park Pharmacy,60760-220,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/04/2017,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (60760-220-90)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,60760022090,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,65162-675-50,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206869,Amneal Pharmaceuticals LLC,65162-675,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/30/2015,N/A,ANDA,500 TABLET in 1 BOTTLE (65162-675-50),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,65162067550,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,65162-696-50,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207137,Amneal Pharmaceuticals LLC,65162-696,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/27/2015,N/A,ANDA,500 TABLET in 1 BOTTLE (65162-696-50),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,65162069650,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,71930-020-12,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210211,Eywa Pharma Inc,71930-020,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (71930-020-12),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930002012,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71930-020-52,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210211,Eywa Pharma Inc,71930-020,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,07/13/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (71930-020-52),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71930002052,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,55700-991-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,"Quality Care Products, LLC",55700-991,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/27/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (55700-991-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,55700099190,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,42858-201-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Rhodes Pharmaceuticals L.P.,42858-201,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (42858-201-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,42858020101,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,42858-201-10,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Rhodes Pharmaceuticals L.P.,42858-201,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (42858-201-10)  / 1 TABLET in 1 BLISTER PACK","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,42858020110,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,40032-351-01,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206142,"Novel Laboratories, Inc.",40032-351,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (40032-351-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035101,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,40032-357-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206245,"Novel Laboratories, Inc.",40032-357,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (40032-357-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035705,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,40032-358-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206245,"Novel Laboratories, Inc.",40032-358,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (40032-358-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032035805,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,55700-598-21,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA209037,Lake Erie Medical DBA Quality Care Products LLC,55700-598,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/13/2018,N/A,ANDA,21 TABLET in 1 BOTTLE (55700-598-21),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,55700059821,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,13107-211-05,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207709,"Aurolife Pharma, LLC",13107-211,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/06/2015,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-211-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107021105,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,13107-211-99,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207709,"Aurolife Pharma, LLC",13107-211,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/06/2015,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-211-99),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107021199,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,13107-212-05,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207709,"Aurolife Pharma, LLC",13107-212,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/06/2015,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-212-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107021205,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,13107-213-01,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207709,"Aurolife Pharma, LLC",13107-213,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/06/2015,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-213-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107021301,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,42806-111-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA203863,"Epic Pharma, LLC",42806-111,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/02/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-111-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,42806011101,Hydrocodone,325
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,72189-191-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA209037,DirectRx,72189-191,HYDROCODONE BITARTRATE AND ACETAMINOPHEN,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,09/15/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-191-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,72189019130,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,63187-778-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Proficient Rx LP,63187-778,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/01/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (63187-778-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63187077830,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1248-0,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202935,Bryant Ranch Prepack,71335-1248,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,180 TABLET in 1 BOTTLE (71335-1248-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335124800,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1248-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202935,Bryant Ranch Prepack,71335-1248,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-1248-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335124801,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1248-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202935,Bryant Ranch Prepack,71335-1248,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,8 TABLET in 1 BOTTLE (71335-1248-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335124802,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1248-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202935,Bryant Ranch Prepack,71335-1248,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1248-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335124803,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1248-4,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202935,Bryant Ranch Prepack,71335-1248,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/05/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1248-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335124804,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1248-5,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202935,Bryant Ranch Prepack,71335-1248,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,45 TABLET in 1 BOTTLE (71335-1248-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335124805,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1248-6,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202935,Bryant Ranch Prepack,71335-1248,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/17/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1248-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335124806,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1248-7,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202935,Bryant Ranch Prepack,71335-1248,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/17/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1248-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335124807,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1248-8,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202935,Bryant Ranch Prepack,71335-1248,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1248-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335124808,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1248-9,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202935,Bryant Ranch Prepack,71335-1248,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1248-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335124809,Hydrocodone,325
Hydrocodone Bitartrate And Acetaminophen,45865-605-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040655,Medsource Pharmaceticals,45865-605,Hydrocodone Bitartrate And Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2014,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (45865-605-30)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,45865060530,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1339-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-1339,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/11/2019,N/A,ANDA,21 TABLET in 1 BOTTLE (71335-1339-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335133901,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1339-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-1339,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/25/2019,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-1339-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335133902,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1339-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201013,Bryant Ranch Prepack,71335-1339,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/21/2019,N/A,ANDA,10 TABLET in 1 BOTTLE (71335-1339-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335133903,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,43386-351-01,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206142,"Lupin Pharmaceuticals,Inc.",43386-351,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-351-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035101,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,43386-351-05,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA206142,"Lupin Pharmaceuticals,Inc.",43386-351,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-351-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035105,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,43386-353-03,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA206142,"Lupin Pharmaceuticals,Inc.",43386-353,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (43386-353-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035303,Hydrocodone,300
Hydrocodone Bitartrate and Acetaminophen,43386-357-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA206245,"Lupin Pharmaceuticals,Inc.",43386-357,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-357-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386035705,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1333-8,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,"RedPharm Drug, Inc.",67296-1333,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,12 TABLET in 1 BOTTLE (67296-1333-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296133308,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,65162-115-10,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040746,Amneal Pharmaceuticals LLC,65162-115,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/30/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (65162-115-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,65162011510,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-0299-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040736,"RedPharm Drug, Inc.",67296-0299,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/18/2010,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-0299-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296029905,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1417-0,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1417,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/10/2020,N/A,ANDA,10 TABLET in 1 BOTTLE (71335-1417-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141700,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1417-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1417,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/14/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1417-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141701,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1417-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1417,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/02/2020,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1417-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141702,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1417-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1417,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/06/2019,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1417-3),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141703,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1417-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1417,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/21/2020,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1417-4),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141704,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1417-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1417,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/15/2020,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1417-5),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141705,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1417-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1417,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,8 TABLET in 1 BOTTLE (71335-1417-6),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141706,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1417-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1417,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,05/18/2020,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-1417-7),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141707,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1417-8,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1417,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/09/2019,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-1417-8),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141708,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1417-9,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1417,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-1417-9),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335141709,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1333-0,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,"RedPharm Drug, Inc.",67296-1333,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,40 TABLET in 1 BOTTLE (67296-1333-0),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296133300,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,67296-1333-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202991,"RedPharm Drug, Inc.",67296-1333,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,20 TABLET in 1 BOTTLE (67296-1333-2),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,67296133302,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,42806-112-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA203863,"Epic Pharma, LLC",42806-112,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/02/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-112-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,42806011201,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen,71335-1557-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202991,Bryant Ranch Prepack,71335-1557,Hydrocodone Bitartrate and Acetaminophen,HYDROCODONE BITARTRATE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/02/2020,N/A,ANDA,21 TABLET in 1 BOTTLE (71335-1557-1),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,71335155701,Hydrocodone,325
Hydrocodone Bitartrate and Acetaminophen (E),67296-1334-3,,,,,"RedPharm Drug, Inc.",,,,,,N/A,,,N/A,N/A,N/A,,67296133403,Hydrocodone,NA
Hydrocodone Bitartrate and Acetaminophen (E),67296-1574-2,,,,,"RedPharm Drug, Inc.",,,,,,N/A,,,N/A,N/A,N/A,,67296157402,Hydrocodone,NA
Hydrocodone Bitartrate and Acetaminophen (E),67296-1574-9,,,,,"RedPharm Drug, Inc.",,,,,,N/A,,,N/A,N/A,N/A,,67296157409,Hydrocodone,NA
Hydrocodone Bitartrate and Acetaminophen (E),67296-1574-0,,,,,"RedPharm Drug, Inc.",,,,,,N/A,,,N/A,N/A,N/A,,67296157400,Hydrocodone,NA
Hydrocodone Bitartrate and Acetaminophen (E),67296-1574-4,,,,,"RedPharm Drug, Inc.",,,,,,N/A,,,N/A,N/A,N/A,,67296157404,Hydrocodone,NA
Hydrocodone Bitartrate and Acetaminophen (E),67296-1574-1,,,,,"RedPharm Drug, Inc.",,,,,,N/A,,,N/A,N/A,N/A,,67296157401,Hydrocodone,NA
Hydrocodone Bitartrate and Acetaminophen (E),67296-1574-7,,,,,"RedPharm Drug, Inc.",,,,,,N/A,,,N/A,N/A,N/A,,67296157407,Hydrocodone,NA
Hydrocodone Bitartrate and Acetaminophen (E),67296-1574-8,,,,,"RedPharm Drug, Inc.",,,,,,N/A,,,N/A,N/A,N/A,,67296157408,Hydrocodone,NA
Hydrocodone Bitartrate and Acetaminophen (E),67296-1574-3,,,,,"RedPharm Drug, Inc.",,,,,,N/A,,,N/A,N/A,N/A,,67296157403,Hydrocodone,NA
Hydrocodone Bitartrate and Acetaminophen (E),67296-1574-5,,,,,"RedPharm Drug, Inc.",,,,,,N/A,,,N/A,N/A,N/A,,67296157405,Hydrocodone,NA
Hydrocodone Bitartrate and Acetaminophen (E),67296-1574-6,,,,,"RedPharm Drug, Inc.",,,,,,N/A,,,N/A,N/A,N/A,,67296157406,Hydrocodone,NA
Hydrocodone Bitartrate and Aspirin,79739-7182-1,"500 mg/1,                         5  mg/1",TABLET,ORAL,ANDA205479,"LGM Pharma Solutions, LLC",79739-7182,Hydrocodone Bitartrate and Aspirin,HYDROCODONE BITARTRATE;  ASPIRIN,HUMAN PRESCRIPTION DRUG,05/28/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (79739-7182-1),"Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Decreased Platelet Aggregation [PE],  Decreased Prostaglandin Production [PE],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA],  Platelet Aggregation Inhibitor [EPC]",CII,No,12/31/2023,79739718201,Hydrocodone,500
Hydrocodone Bitartrate and Homatropine Methylbromide,0121-4811-40,"1.5 mg/5mL,                         5  mg/5mL",SYRUP,ORAL,ANDA088008,"Pharmaceutical Associates, Inc.",0121-4811,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,12/28/2009,N/A,ANDA,"4 TRAY in 1 CASE (0121-4811-40)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-4811-05)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00121481140,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,40032-118-03,"1.5 mg/1,                         5  mg/1",TABLET,ORAL,ANDA091528,"Novel Laboratories, Inc.",40032-118,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,09/23/2014,N/A,ANDA,30 TABLET in 1 BOTTLE (40032-118-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032011803,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,60432-455-28,"1.5 mg/5mL,                         5  mg/5mL",SYRUP,ORAL,ANDA088008,"Morton Grove Pharmaceuticals, Inc.",60432-455,hydrocodone bitartrate and homatropine methylbromide,HOMATROPINE METHYLBROMIDE;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/03/1983,N/A,ANDA,"3785 mL in 1 BOTTLE, PLASTIC (60432-455-28)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,60432045528,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,60432-455-16,"1.5 mg/5mL,                         5  mg/5mL",SYRUP,ORAL,ANDA088008,"Morton Grove Pharmaceuticals, Inc.",60432-455,hydrocodone bitartrate and homatropine methylbromide,HOMATROPINE METHYLBROMIDE;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/03/1983,N/A,ANDA,"473 mL in 1 BOTTLE, PLASTIC (60432-455-16)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,60432045516,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,40032-810-05,"1.5 mg/5mL,                         5  mg/5mL",SYRUP,ORAL,ANDA203535,"Novel Laboratories, Inc.",40032-810,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,02/13/2017,N/A,ANDA,473 mL in 1 BOTTLE (40032-810-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032081005,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,64950-206-03,"1.5 mg/1,                         5  mg/1",TABLET,ORAL,NDA005213,Genus Lifesciences Inc.,64950-206,Hydrocodone Bitartrate and Homatropine Methylbromide,HOMATROPINE METHYLBROMIDE;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/10/2022,N/A,NDA AUTHORIZED GENERIC,"30 TABLET in 1 BOTTLE, PLASTIC (64950-206-03)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,64950020603,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,64950-206-10,"1.5 mg/1,                         5  mg/1",TABLET,ORAL,NDA005213,Genus Lifesciences Inc.,64950-206,Hydrocodone Bitartrate and Homatropine Methylbromide,HOMATROPINE METHYLBROMIDE;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/10/2022,N/A,NDA AUTHORIZED GENERIC,"100 TABLET in 1 BOTTLE, PLASTIC (64950-206-10)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,64950020610,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,64950-371-47,"1.5 mg/5mL,                         5  mg/5mL",SOLUTION,ORAL,NDA005213,Genus Lifesciences Inc.,64950-371,Hydrocodone Bitartrate and Homatropine Methylbromide,HOMATROPINE METHYLBROMIDE;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,08/10/2022,N/A,NDA AUTHORIZED GENERIC,473 mL in 1 BOTTLE (64950-371-47),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,64950037147,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,40032-118-26,"1.5 mg/1,                         5  mg/1",TABLET,ORAL,ANDA091528,"Novel Laboratories, Inc.",40032-118,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,09/23/2014,N/A,ANDA,500 TABLET in 1 BOTTLE (40032-118-26),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032011826,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,60687-278-86,"1.5 mg/5mL,                         5  mg/5mL",SYRUP,ORAL,ANDA088008,American Health Packaging,60687-278,hydrocodone bitartrate and homatropine methylbromide,HOMATROPINE METHYLBROMIDE;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,06/03/2022,03/31/2024,ANDA,"3 TRAY in 1 CASE (60687-278-86)  / 10 CUP, UNIT-DOSE in 1 TRAY (60687-278-46)  / 5 mL in 1 CUP, UNIT-DOSE (60687-278-40)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,60687027886,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,50383-043-16,"1.5 mg/5mL,                         5  mg/5mL",SOLUTION,ORAL,ANDA040613,Akorn,50383-043,Hydrocodone Bitartrate and Homatropine Methylbromide,HOMATROPINE METHYLBROMIDE;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,02/08/2008,N/A,ANDA,473 mL in 1 BOTTLE (50383-043-16),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,50383004316,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,10702-055-01,"1.5 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207176,"KVK-Tech, Inc.",10702-055,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,08/07/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-055-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702005501,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,10702-055-03,"1.5 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207176,"KVK-Tech, Inc.",10702-055,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,08/07/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (10702-055-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702005503,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,10702-055-09,"1.5 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207176,"KVK-Tech, Inc.",10702-055,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,08/07/2017,N/A,ANDA,90 TABLET in 1 BOTTLE (10702-055-09),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702005509,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,10702-055-10,"1.5 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207176,"KVK-Tech, Inc.",10702-055,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,08/07/2017,N/A,ANDA,1000 TABLET in 1 BOTTLE (10702-055-10),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702005510,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,10702-150-16,"1.5 mg/5mL,                         5  mg/5mL",LIQUID,ORAL,ANDA207487,"KVK-Tech, Inc.",10702-150,hydrocodone bitartrate and homatropine methylbromide oral solution,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,02/21/2017,N/A,ANDA,473 mL in 1 BOTTLE (10702-150-16),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,10702015016,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,43386-118-03,"1.5 mg/1,                         5  mg/1",TABLET,ORAL,ANDA091528,"Lupin Pharmaceuticals,Inc.",43386-118,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,09/23/2014,N/A,ANDA,30 TABLET in 1 BOTTLE (43386-118-03),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386011803,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,43386-118-05,"1.5 mg/1,                         5  mg/1",TABLET,ORAL,ANDA091528,"Lupin Pharmaceuticals,Inc.",43386-118,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,09/23/2014,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-118-05),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386011805,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,43386-118-01,"1.5 mg/1,                         5  mg/1",TABLET,ORAL,ANDA091528,"Lupin Pharmaceuticals,Inc.",43386-118,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,09/23/2014,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-118-01),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,43386011801,Hydrocodone,1.5
Hydrocodone Bitartrate and Homatropine Methylbromide,40032-118-24,"1.5 mg/1,                         5  mg/1",TABLET,ORAL,ANDA091528,"Novel Laboratories, Inc.",40032-118,Hydrocodone Bitartrate and Homatropine Methylbromide,HYDROCODONE BITARTRATE;  HOMATROPINE METHYLBROMIDE,HUMAN PRESCRIPTION DRUG,09/23/2014,N/A,ANDA,100 TABLET in 1 BOTTLE (40032-118-24),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,40032011824,Hydrocodone,1.5
Hydrocodone Bitartrate and Ibuprofen,13107-004-01,"7.5 mg/1,                         200  mg/1","TABLET, FILM COATED",ORAL,ANDA204575,"Aurolife Pharma, LLC",13107-004,Hydrocodone Bitartrate and Ibuprofen,HYDROCODONE BITARTRATE;  IBUPROFEN,HUMAN PRESCRIPTION DRUG,06/02/2016,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (13107-004-01)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107000401,Hydrocodone,7.5
Hydrocodone Bitartrate and Ibuprofen,13107-004-05,"7.5 mg/1,                         200  mg/1","TABLET, FILM COATED",ORAL,ANDA204575,"Aurolife Pharma, LLC",13107-004,Hydrocodone Bitartrate and Ibuprofen,HYDROCODONE BITARTRATE;  IBUPROFEN,HUMAN PRESCRIPTION DRUG,06/02/2016,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (13107-004-05)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107000405,Hydrocodone,7.5
Hydrocodone Bitartrate and Ibuprofen,13107-004-11,"7.5 mg/1,                         200  mg/1","TABLET, FILM COATED",ORAL,ANDA204575,"Aurolife Pharma, LLC",13107-004,Hydrocodone Bitartrate and Ibuprofen,HYDROCODONE BITARTRATE;  IBUPROFEN,HUMAN PRESCRIPTION DRUG,06/02/2016,N/A,ANDA,"10 TABLET, FILM COATED in 1 BOTTLE (13107-004-11)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107000411,Hydrocodone,7.5
Hydrocodone Bitartrate and Ibuprofen,13107-004-99,"7.5 mg/1,                         200  mg/1","TABLET, FILM COATED",ORAL,ANDA204575,"Aurolife Pharma, LLC",13107-004,Hydrocodone Bitartrate and Ibuprofen,HYDROCODONE BITARTRATE;  IBUPROFEN,HUMAN PRESCRIPTION DRUG,06/02/2016,N/A,ANDA,"1000 TABLET, FILM COATED in 1 BOTTLE (13107-004-99)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,13107000499,Hydrocodone,7.5
Hydrocodone Bitartrate and Ibuprofen,53746-116-01,"2.5 mg/1,                         200  mg/1",TABLET,ORAL,ANDA076642,Amneal Pharmaceuticals of New York LLC,53746-116,Hydrocodone Bitartrate and Ibuprofen,HYDROCODONE BITARTRATE;  IBUPROFEN,HUMAN PRESCRIPTION DRUG,02/18/2010,N/A,ANDA,100 TABLET in 1 BOTTLE (53746-116-01),"Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,53746011601,Hydrocodone,2.5
Hydrocodone Bitartrate and Ibuprofen,53746-117-01,"10 mg/1,                         200  mg/1",TABLET,ORAL,ANDA076642,Amneal Pharmaceuticals of New York LLC,53746-117,Hydrocodone Bitartrate and Ibuprofen,HYDROCODONE BITARTRATE;  IBUPROFEN,HUMAN PRESCRIPTION DRUG,02/18/2010,N/A,ANDA,100 TABLET in 1 BOTTLE (53746-117-01),"Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,53746011701,Hydrocodone,10
Hydrocodone Bitartrate and Ibuprofen,53746-145-01,"7.5 mg/1,                         200  mg/1",TABLET,ORAL,ANDA076642,Amneal Pharmaceuticals of New York LLC,53746-145,Hydrocodone Bitartrate and Ibuprofen,HYDROCODONE BITARTRATE;  IBUPROFEN,HUMAN PRESCRIPTION DRUG,02/18/2010,N/A,ANDA,100 TABLET in 1 BOTTLE (53746-145-01),"Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,53746014501,Hydrocodone,7.5
Hydrocodone Bitartrate and Ibuprofen,53746-145-05,"7.5 mg/1,                         200  mg/1",TABLET,ORAL,ANDA076642,Amneal Pharmaceuticals of New York LLC,53746-145,Hydrocodone Bitartrate and Ibuprofen,HYDROCODONE BITARTRATE;  IBUPROFEN,HUMAN PRESCRIPTION DRUG,02/18/2010,N/A,ANDA,500 TABLET in 1 BOTTLE (53746-145-05),"Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,53746014505,Hydrocodone,7.5
Hydrocodone Bitartrate and Ibuprofen,53746-146-01,"5 mg/1,                         200  mg/1",TABLET,ORAL,ANDA076642,Amneal Pharmaceuticals of New York LLC,53746-146,Hydrocodone Bitartrate and Ibuprofen,HYDROCODONE BITARTRATE;  IBUPROFEN,HUMAN PRESCRIPTION DRUG,02/18/2010,N/A,ANDA,100 TABLET in 1 BOTTLE (53746-146-01),"Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,53746014601,Hydrocodone,5
Hydrocodone Bitartrate and Ibuprofen,68084-841-01,"7.5 mg/1,                         200  mg/1",TABLET,ORAL,ANDA076642,American Health Packaging,68084-841,Hydrocodone Bitartrate and Ibuprofen,HYDROCODONE BITARTRATE;  IBUPROFEN,HUMAN PRESCRIPTION DRUG,02/13/2015,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-841-01)  / 1 TABLET in 1 BLISTER PACK (68084-841-11)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,68084084101,Hydrocodone,7.5
Hydrocodone Polistirex and Chlorpheniramine Polistirex,27808-086-03,"8 mg/5mL,                         10  mg/5mL","SUSPENSION, EXTENDED RELEASE",ORAL,ANDA091632,Tris Pharma Inc,27808-086,Hydrocodone Polistirex and Chlorpheniramine Polistirex,CHLORPHENIRAMINE MALEATE;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,10/01/2019,N/A,ANDA,"1 BOTTLE, UNIT-DOSE in 1 CARTON (27808-086-03)  / 70 mL in 1 BOTTLE, UNIT-DOSE","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808008603,Hydrocodone,8
Hydrocodone Polistirex and Chlorpheniramine Polistirex,17856-0087-2,"8 mg/5mL,                         10  mg/5mL","SUSPENSION, EXTENDED RELEASE",ORAL,ANDA091632,ATLANTIC BIOLOGICALS CORP.,17856-0087,Hydrocodone Polistirex and Chlorpheniramine Polistirex,CHLORPHENIRAMINE MALEATE;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/10/2023,N/A,ANDA,"1 BOX, UNIT-DOSE in 1 CUP, UNIT-DOSE (17856-0087-2)  / 5 BOX, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0087-3)  / 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0087-1)  / 5 mL in 1 CUP, UNIT-DOSE","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,17856008702,Hydrocodone,8
Hydrocodone Polistirex and Chlorpheniramine Polistirex,63629-2303-1,"8 mg/5mL,                         10  mg/5mL","SUSPENSION, EXTENDED RELEASE",ORAL,ANDA091632,Bryant Ranch Prepack,63629-2303,Hydrocodone Polistirex and Chlorpheniramine Polistirex,CHLORPHENIRAMINE MALEATE;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/06/2015,N/A,ANDA,"1 BOTTLE, UNIT-DOSE in 1 CARTON (63629-2303-1)  / 115 mL in 1 BOTTLE, UNIT-DOSE","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629230301,Hydrocodone,8
Hydrocodone Polistirex and Chlorpheniramine Polistirex,63629-2304-1,"8 mg/5mL,                         10  mg/5mL","SUSPENSION, EXTENDED RELEASE",ORAL,ANDA091632,Bryant Ranch Prepack,63629-2304,Hydrocodone Polistirex and Chlorpheniramine Polistirex,CHLORPHENIRAMINE MALEATE;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/06/2015,N/A,ANDA,"473 mL in 1 BOTTLE, UNIT-DOSE (63629-2304-1)","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,63629230401,Hydrocodone,8
Hydrocodone Polistirex and Chlorpheniramine Polistirex,62542-301-03,"8 mg/5mL,                         10  mg/5mL","SUSPENSION, EXTENDED RELEASE",ORAL,ANDA091671,Neos Therapeutics LP,62542-301,Hydrocodone Polistirex and Chlorpheniramine Polistirex,CHLORPHENIRAMINE;  HYDROCODONE,HUMAN PRESCRIPTION DRUG,11/05/2019,05/31/2024,ANDA,"70 mL in 1 BOTTLE, GLASS (62542-301-03)","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,62542030103,Hydrocodone,8
Hydrocodone Polistirex and Chlorpheniramine Polistirex,27808-086-01,"8 mg/5mL,                         10  mg/5mL","SUSPENSION, EXTENDED RELEASE",ORAL,ANDA091632,Tris Pharma Inc,27808-086,Hydrocodone Polistirex and Chlorpheniramine Polistirex,CHLORPHENIRAMINE MALEATE;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/06/2015,N/A,ANDA,"1 BOTTLE, UNIT-DOSE in 1 CARTON (27808-086-01)  / 115 mL in 1 BOTTLE, UNIT-DOSE","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808008601,Hydrocodone,8
Hydrocodone Polistirex and Chlorpheniramine Polistirex,27808-086-02,"8 mg/5mL,                         10  mg/5mL","SUSPENSION, EXTENDED RELEASE",ORAL,ANDA091632,Tris Pharma Inc,27808-086,Hydrocodone Polistirex and Chlorpheniramine Polistirex,CHLORPHENIRAMINE MALEATE;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/06/2015,N/A,ANDA,473 mL in 1 BOTTLE (27808-086-02),"Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,27808008602,Hydrocodone,8
Hydrocodone Polistirex and Chlorpheniramine Polistirex,62542-301-04,"8 mg/5mL,                         10  mg/5mL","SUSPENSION, EXTENDED RELEASE",ORAL,ANDA091671,Neos Therapeutics LP,62542-301,Hydrocodone Polistirex and Chlorpheniramine Polistirex,CHLORPHENIRAMINE;  HYDROCODONE,HUMAN PRESCRIPTION DRUG,10/23/2014,05/31/2024,ANDA,"118 mL in 1 BOTTLE, GLASS (62542-301-04)","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,62542030104,Hydrocodone,8
Hydrocodone Polistirex and Chlorpheniramine Polistirex,62542-301-16,"8 mg/5mL,                         10  mg/5mL","SUSPENSION, EXTENDED RELEASE",ORAL,ANDA091671,Neos Therapeutics LP,62542-301,Hydrocodone Polistirex and Chlorpheniramine Polistirex,CHLORPHENIRAMINE;  HYDROCODONE,HUMAN PRESCRIPTION DRUG,10/23/2014,05/31/2024,ANDA,"473 mL in 1 BOTTLE, GLASS (62542-301-16)","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,62542030116,Hydrocodone,8
Hydrocodone Polistirex and Chlorpheniramine Polistirex,62542-301-17,"8 mg/5mL,                         10  mg/5mL","SUSPENSION, EXTENDED RELEASE",ORAL,ANDA091671,Neos Therapeutics LP,62542-301,Hydrocodone Polistirex and Chlorpheniramine Polistirex,CHLORPHENIRAMINE;  HYDROCODONE,HUMAN PRESCRIPTION DRUG,10/23/2014,05/31/2024,ANDA,"473 mL in 1 BOTTLE, GLASS (62542-301-17)","Histamine H1 Receptor Antagonists [MoA],  Histamine-1 Receptor Antagonist [EPC],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,N/A,62542030117,Hydrocodone,8
HYDROCODONE/APAP,72189-406-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,Direct_Rx,72189-406,HYDROCODONE/APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/15/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-406-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,72189040630,Hydrocodone,325
HYDROCODONE/APAP,72189-406-90,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040405,Direct_Rx,72189-406,HYDROCODONE/APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/15/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (72189-406-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,72189040690,Hydrocodone,325
Hydrocodone/APAP,72189-407-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040409,Direct_Rx,72189-407,Hydrocodone/APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/28/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-407-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,72189040760,Hydrocodone,325
Hydrocodone/APAP,72189-407-90,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040409,Direct_Rx,72189-407,Hydrocodone/APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/28/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (72189-407-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,72189040790,Hydrocodone,325
Hydromet,0472-1030-16,"1.5 mg/5mL,                         5  mg/5mL",SOLUTION,ORAL,ANDA088017,"Actavis Pharma, Inc.",0472-1030,hydrocodone bitartrate and homatropine methylbromide,HOMATROPINE METHYLBROMIDE;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,09/30/2002,N/A,ANDA,473 mL in 1 BOTTLE (0472-1030-16),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,00472103016,Hydrocodone,1.5
Hysingla ER,59011-271-60,20 mg/1,"TABLET, EXTENDED RELEASE",ORAL,NDA206627,Purdue Pharma LP,59011-271,hydrocodone bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/15/2015,N/A,NDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (59011-271-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,59011027160,Hydrocodone,20
Hysingla ER,59011-273-60,40 mg/1,"TABLET, EXTENDED RELEASE",ORAL,NDA206627,Purdue Pharma LP,59011-273,hydrocodone bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/15/2015,N/A,NDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (59011-273-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,59011027360,Hydrocodone,40
Hysingla ER,59011-272-60,30 mg/1,"TABLET, EXTENDED RELEASE",ORAL,NDA206627,Purdue Pharma LP,59011-272,hydrocodone bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/15/2015,N/A,NDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (59011-272-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,59011027260,Hydrocodone,30
Hysingla ER,59011-276-60,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,NDA206627,Purdue Pharma LP,59011-276,hydrocodone bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/02/2016,N/A,NDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (59011-276-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,59011027660,Hydrocodone,100
Hysingla ER,59011-275-60,80 mg/1,"TABLET, EXTENDED RELEASE",ORAL,NDA206627,Purdue Pharma LP,59011-275,hydrocodone bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/15/2015,N/A,NDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (59011-275-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,59011027560,Hydrocodone,80
Hysingla ER,59011-274-60,60 mg/1,"TABLET, EXTENDED RELEASE",ORAL,NDA206627,Purdue Pharma LP,59011-274,hydrocodone bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/15/2015,N/A,NDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (59011-274-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,59011027460,Hydrocodone,60
Hysingla ER,59011-277-60,120 mg/1,"TABLET, EXTENDED RELEASE",ORAL,NDA206627,Purdue Pharma LP,59011-277,hydrocodone bitartrate,HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,01/15/2015,N/A,NDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (59011-277-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,59011027760,Hydrocodone,120
Lortab,17478-450-16,"300 mg/15mL,                         10  mg/15mL",SYRUP,ORAL,ANDA040881,Akorn,17478-450,Hydrocodone Bitartrate and Acetaminophen,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,03/17/2015,N/A,ANDA,"473 mL in 1 BOTTLE, PLASTIC (17478-450-16)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,17478045016,Hydrocodone,300
Norco,72189-399-72,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,Direct_Rx,72189-399,Hydrocodone/APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/23/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (72189-399-72),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,72189039972,Hydrocodone,325
Norco,72189-399-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,Direct_Rx,72189-399,Hydrocodone/APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/23/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (72189-399-90),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,72189039990,Hydrocodone,325
Norco,72189-399-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,Direct_Rx,72189-399,Hydrocodone/APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/23/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-399-30),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,72189039930,Hydrocodone,325
Norco,72189-399-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040400,Direct_Rx,72189-399,Hydrocodone/APAP,ACETAMINOPHEN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,11/23/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-399-60),"Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2024,72189039960,Hydrocodone,325
OBREDON,58716-433-04,"200 mg/5mL,                         2.5  mg/5mL",SOLUTION,ORAL,NDA205474,"Sovereign Pharmaceuticals, LLC",58716-433,Hydrocodone Bitartrate and Guaifenesin,GUAIFENESIN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/30/2014,N/A,NDA,118 mL in 1 BOTTLE (58716-433-04),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,58716043304,Hydrocodone,200
OBREDON,58716-433-16,"200 mg/5mL,                         2.5  mg/5mL",SOLUTION,ORAL,NDA205474,"Sovereign Pharmaceuticals, LLC",58716-433,Hydrocodone Bitartrate and Guaifenesin,GUAIFENESIN;  HYDROCODONE BITARTRATE,HUMAN PRESCRIPTION DRUG,12/30/2014,N/A,NDA,473 mL in 1 BOTTLE (58716-433-16),"Decreased Respiratory Secretion Viscosity [PE],  Expectorant [EPC],  Increased Respiratory Secretions [PE],  Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,58716043316,Hydrocodone,200
Dilaudid,42858-122-01,2 mg/1,TABLET,ORAL,NDA019892,Rhodes Pharmaceuticals L.P.,42858-122,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/15/2017,N/A,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-122-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858012201,Hydromorphone,2
Dilaudid,42858-234-01,4 mg/1,TABLET,ORAL,NDA019892,Rhodes Pharmaceuticals L.P.,42858-234,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/15/2017,N/A,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-234-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858023401,Hydromorphone,4
Dilaudid,42858-234-50,4 mg/1,TABLET,ORAL,NDA019892,Rhodes Pharmaceuticals L.P.,42858-234,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/15/2017,N/A,NDA,"500 TABLET in 1 BOTTLE, PLASTIC (42858-234-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858023450,Hydromorphone,4
Dilaudid,42858-416-16,5 mg/5mL,SOLUTION,ORAL,NDA019891,Rhodes Pharmaceuticals L.P.,42858-416,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/15/2017,N/A,NDA,"473 mL in 1 BOTTLE, PLASTIC (42858-416-16)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858041616,Hydromorphone,5
Dilaudid,76045-009-05,1 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA019034,"Fresenius Kabi USA, LLC",76045-009,Hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/16/2016,N/A,NDA,24 SYRINGE in 1 CARTON (76045-009-05)  / .5 mL in 1 SYRINGE (76045-009-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045000905,Hydromorphone,1
Dilaudid,76045-009-10,1 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA019034,"Fresenius Kabi USA, LLC",76045-009,Hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/16/2016,N/A,NDA,24 SYRINGE in 1 CARTON (76045-009-10)  / 1 mL in 1 SYRINGE (76045-009-00),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045000910,Hydromorphone,1
Dilaudid,76045-009-06,1 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA019034,"Fresenius Kabi USA, LLC",76045-009,Hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/04/2018,N/A,NDA,10 SYRINGE in 1 CARTON (76045-009-06)  / .5 mL in 1 SYRINGE (76045-009-96),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045000906,Hydromorphone,1
Dilaudid,76045-009-11,1 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA019034,"Fresenius Kabi USA, LLC",76045-009,Hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/04/2018,N/A,NDA,10 SYRINGE in 1 CARTON (76045-009-11)  / 1 mL in 1 SYRINGE (76045-009-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045000911,Hydromorphone,1
Dilaudid,76045-010-11,2 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA019034,"Fresenius Kabi USA, LLC",76045-010,Hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/16/2016,N/A,NDA,10 SYRINGE in 1 CARTON (76045-010-11)  / 1 mL in 1 SYRINGE (76045-010-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045001011,Hydromorphone,2
Dilaudid,76045-121-11,.2 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA019034,"Fresenius Kabi USA, LLC",76045-121,Hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/16/2020,N/A,NDA,10 SYRINGE in 1 CARTON (76045-121-11)  / 1 mL in 1 SYRINGE (76045-121-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045012111,Hydromorphone,0.2
Dilaudid,42858-338-01,8 mg/1,TABLET,ORAL,NDA019892,Rhodes Pharmaceuticals L.P.,42858-338,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/15/2017,N/A,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-338-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858033801,Hydromorphone,8
Dilaudid,76045-010-10,2 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA019034,"Fresenius Kabi USA, LLC",76045-010,Hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/16/2016,N/A,NDA,24 SYRINGE in 1 CARTON (76045-010-10)  / 1 mL in 1 SYRINGE (76045-010-00),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045001010,Hydromorphone,2
Hydromorphone Hydrochloride,42858-301-25,2 mg/1,TABLET,ORAL,NDA019892,Rhodes Pharmaceuticals L.P.,42858-301,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/23/2009,N/A,NDA AUTHORIZED GENERIC,4 BLISTER PACK in 1 CARTON (42858-301-25)  / 25 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858030125,Hydromorphone,2
Hydromorphone Hydrochloride,42858-302-25,4 mg/1,TABLET,ORAL,NDA019892,Rhodes Pharmaceuticals L.P.,42858-302,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/23/2009,N/A,NDA AUTHORIZED GENERIC,4 BLISTER PACK in 1 CARTON (42858-302-25)  / 25 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858030225,Hydromorphone,4
Hydromorphone Hydrochloride,71335-0265-6,2 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0265,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/21/2010,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0265-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335026506,Hydromorphone,2
Hydromorphone Hydrochloride,42858-302-50,4 mg/1,TABLET,ORAL,NDA019892,Rhodes Pharmaceuticals L.P.,42858-302,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/23/2009,N/A,NDA AUTHORIZED GENERIC,"500 TABLET in 1 BOTTLE, PLASTIC (42858-302-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858030250,Hydromorphone,4
Hydromorphone Hydrochloride,0641-0121-25,2 mg/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NA,Hikma Pharmaceuticals USA Inc.,0641-0121,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/1972,N/A,UNAPPROVED DRUG OTHER,25 VIAL in 1 CARTON (0641-0121-25)  / 1 mL in 1 VIAL (0641-0121-21),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641012125,Hydromorphone,2
Hydromorphone Hydrochloride,0641-2341-41,2 mg/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NA,Hikma Pharmaceuticals USA Inc.,0641-2341,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/1972,N/A,UNAPPROVED DRUG OTHER,20 VIAL in 1 CARTON (0641-2341-41)  / 20 mL in 1 VIAL (0641-2341-39),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641234141,Hydromorphone,2
Hydromorphone Hydrochloride,0703-0018-01,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA078591,"Teva Parenteral Medicines, Inc.",0703-0018,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/18/2011,N/A,ANDA,1 VIAL in 1 CARTON (0703-0018-01)  / 50 mL in 1 VIAL,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00703001801,Hydromorphone,10
Hydromorphone Hydrochloride,0703-0110-03,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA078591,"Teva Parenteral Medicines, Inc.",0703-0110,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/18/2011,N/A,ANDA,10 VIAL in 1 CARTON (0703-0110-03)  / 1 mL in 1 VIAL (0703-0110-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00703011003,Hydromorphone,10
Hydromorphone Hydrochloride,0703-0113-03,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA078591,"Teva Parenteral Medicines, Inc.",0703-0113,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/18/2011,N/A,ANDA,10 VIAL in 1 CARTON (0703-0113-03)  / 5 mL in 1 VIAL (0703-0113-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00703011303,Hydromorphone,10
Hydromorphone Hydrochloride,71335-0303-5,4 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0303,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,25 TABLET in 1 BOTTLE (71335-0303-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335030305,Hydromorphone,4
Hydromorphone Hydrochloride,71335-0303-7,4 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0303,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0303-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335030307,Hydromorphone,4
Hydromorphone Hydrochloride,63323-851-10,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA019034,"Fresenius Kabi USA, LLC",63323-851,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/15/2017,N/A,NDA,"10 VIAL, SINGLE-DOSE in 1 CARTON (63323-851-10)  / 1 mL in 1 VIAL, SINGLE-DOSE (63323-851-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323085110,Hydromorphone,10
HYDROMORPHONE HYDROCHLORIDE,13107-107-01,2 mg/1,TABLET,ORAL,ANDA205814,"Aurolife Pharma, LLC",13107-107,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/17/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-107-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010701,Hydromorphone,2
HYDROMORPHONE HYDROCHLORIDE,13107-107-05,2 mg/1,TABLET,ORAL,ANDA205814,"Aurolife Pharma, LLC",13107-107,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/17/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-107-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010705,Hydromorphone,2
HYDROMORPHONE HYDROCHLORIDE,13107-107-20,2 mg/1,TABLET,ORAL,ANDA205814,"Aurolife Pharma, LLC",13107-107,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/17/2016,N/A,ANDA,20 TABLET in 1 BOTTLE (13107-107-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010720,Hydromorphone,2
HYDROMORPHONE HYDROCHLORIDE,13107-107-99,2 mg/1,TABLET,ORAL,ANDA205814,"Aurolife Pharma, LLC",13107-107,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/17/2016,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-107-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010799,Hydromorphone,2
HYDROMORPHONE HYDROCHLORIDE,13107-108-01,4 mg/1,TABLET,ORAL,ANDA205814,"Aurolife Pharma, LLC",13107-108,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/17/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-108-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010801,Hydromorphone,4
HYDROMORPHONE HYDROCHLORIDE,13107-108-05,4 mg/1,TABLET,ORAL,ANDA205814,"Aurolife Pharma, LLC",13107-108,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/17/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-108-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010805,Hydromorphone,4
HYDROMORPHONE HYDROCHLORIDE,13107-108-20,4 mg/1,TABLET,ORAL,ANDA205814,"Aurolife Pharma, LLC",13107-108,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/17/2016,N/A,ANDA,20 TABLET in 1 BOTTLE (13107-108-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010820,Hydromorphone,4
HYDROMORPHONE HYDROCHLORIDE,13107-108-99,4 mg/1,TABLET,ORAL,ANDA205814,"Aurolife Pharma, LLC",13107-108,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/17/2016,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-108-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010899,Hydromorphone,4
HYDROMORPHONE HYDROCHLORIDE,13107-109-01,8 mg/1,TABLET,ORAL,ANDA205814,"Aurolife Pharma, LLC",13107-109,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/17/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-109-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010901,Hydromorphone,8
HYDROMORPHONE HYDROCHLORIDE,13107-109-05,8 mg/1,TABLET,ORAL,ANDA205814,"Aurolife Pharma, LLC",13107-109,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/17/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-109-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010905,Hydromorphone,8
HYDROMORPHONE HYDROCHLORIDE,13107-109-20,8 mg/1,TABLET,ORAL,ANDA205814,"Aurolife Pharma, LLC",13107-109,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/17/2016,N/A,ANDA,20 TABLET in 1 BOTTLE (13107-109-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010920,Hydromorphone,8
HYDROMORPHONE HYDROCHLORIDE,13107-109-99,8 mg/1,TABLET,ORAL,ANDA205814,"Aurolife Pharma, LLC",13107-109,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/17/2016,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-109-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010999,Hydromorphone,8
Hydromorphone Hydrochloride,63323-854-10,4 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA019034,"Fresenius Kabi USA, LLC",63323-854,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/15/2017,N/A,NDA,"25 VIAL, SINGLE-DOSE in 1 CARTON (63323-854-10)  / 1 mL in 1 VIAL, SINGLE-DOSE (63323-854-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323085410,Hydromorphone,4
Hydromorphone Hydrochloride,0054-0264-24,4 mg/1,TABLET,ORAL,ANDA074597,Hikma Pharmaceuticals USA Inc.,0054-0264,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/29/2009,N/A,ANDA,10 CONTAINER in 1 CARTON (0054-0264-24)  / 10 TABLET in 1 CONTAINER,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054026424,Hydromorphone,4
Hydromorphone Hydrochloride,0054-0264-25,4 mg/1,TABLET,ORAL,ANDA074597,Hikma Pharmaceuticals USA Inc.,0054-0264,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/29/2009,N/A,ANDA,100 TABLET in 1 BOTTLE (0054-0264-25),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054026425,Hydromorphone,4
Hydromorphone Hydrochloride,0054-0265-25,8 mg/1,TABLET,ORAL,ANDA074597,Hikma Pharmaceuticals USA Inc.,0054-0265,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/29/2009,N/A,ANDA,100 TABLET in 1 BOTTLE (0054-0265-25),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054026525,Hydromorphone,8
Hydromorphone Hydrochloride,0054-0386-63,1 mg/mL,SOLUTION,ORAL,ANDA074653,Hikma Pharmaceuticals USA Inc.,0054-0386,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/01/2012,N/A,ANDA,473 mL in 1 BOTTLE (0054-0386-63),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054038663,Hydromorphone,1
Hydromorphone Hydrochloride,42858-303-01,8 mg/1,TABLET,ORAL,NDA019892,Rhodes Pharmaceuticals L.P.,42858-303,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/23/2009,N/A,NDA AUTHORIZED GENERIC,"100 TABLET in 1 BOTTLE, PLASTIC (42858-303-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858030301,Hydromorphone,8
Hydromorphone Hydrochloride,0409-1312-36,2 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA200403,"Hospira, Inc.",0409-1312,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/01/2021,N/A,NDA,10 SYRINGE in 1 CELLO PACK (0409-1312-36)  / 1 mL in 1 SYRINGE (0409-1312-16),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409131236,Hydromorphone,2
Hydromorphone Hydrochloride,63323-852-25,1 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA019034,"Fresenius Kabi USA, LLC",63323-852,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/15/2017,N/A,NDA,"25 VIAL, SINGLE-DOSE in 1 CARTON (63323-852-25)  / 1 mL in 1 VIAL, SINGLE-DOSE (63323-852-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323085225,Hydromorphone,1
Hydromorphone Hydrochloride,60687-579-01,2 mg/1,TABLET,ORAL,ANDA076855,American Health Packaging,60687-579,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/11/2021,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-579-01)  / 1 TABLET in 1 BLISTER PACK (60687-579-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60687057901,Hydromorphone,2
Hydromorphone Hydrochloride,60687-590-01,4 mg/1,TABLET,ORAL,ANDA076855,American Health Packaging,60687-590,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/11/2021,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-590-01)  / 1 TABLET in 1 BLISTER PACK (60687-590-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60687059001,Hydromorphone,4
Hydromorphone Hydrochloride,71335-0303-4,4 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0303,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-0303-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335030304,Hydromorphone,4
Hydromorphone Hydrochloride,0409-4264-01,.5 mg/.5mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA200403,"Hospira, Inc.",0409-4264,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/27/2022,N/A,NDA,10 SYRINGE in 1 CELLO PACK (0409-4264-01)  / .5 mL in 1 SYRINGE (0409-4264-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409426401,Hydromorphone,0.5
Hydromorphone Hydrochloride,71335-0265-3,2 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0265,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/21/2010,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0265-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335026503,Hydromorphone,2
hydromorphone hydrochloride,31722-119-01,8 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"Camber Pharmaceuticals, Inc.",31722-119,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-119-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722011901,Hydromorphone,8
hydromorphone hydrochloride,31722-120-01,12 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"Camber Pharmaceuticals, Inc.",31722-120,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-120-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722012001,Hydromorphone,12
hydromorphone hydrochloride,31722-121-01,16 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"Camber Pharmaceuticals, Inc.",31722-121,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-121-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722012101,Hydromorphone,16
hydromorphone hydrochloride,31722-122-01,32 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"Camber Pharmaceuticals, Inc.",31722-122,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-122-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722012201,Hydromorphone,32
Hydromorphone Hydrochloride,63323-853-25,2 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA019034,"Fresenius Kabi USA, LLC",63323-853,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/15/2017,N/A,NDA,"25 VIAL, SINGLE-DOSE in 1 CARTON (63323-853-25)  / 1 mL in 1 VIAL, SINGLE-DOSE (63323-853-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323085325,Hydromorphone,2
hydromorphone hydrochloride,43602-266-05,8 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"Ascent Pharmaceuticals, Inc.",43602-266,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-266-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43602026605,Hydromorphone,8
hydromorphone hydrochloride,43602-266-30,8 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"Ascent Pharmaceuticals, Inc.",43602-266,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-266-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43602026630,Hydromorphone,8
hydromorphone hydrochloride,43602-267-05,12 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"Ascent Pharmaceuticals, Inc.",43602-267,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-267-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43602026705,Hydromorphone,12
hydromorphone hydrochloride,43602-267-30,12 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"Ascent Pharmaceuticals, Inc.",43602-267,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-267-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43602026730,Hydromorphone,12
hydromorphone hydrochloride,43602-268-05,16 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"Ascent Pharmaceuticals, Inc.",43602-268,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-268-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43602026805,Hydromorphone,16
hydromorphone hydrochloride,43602-268-30,16 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"Ascent Pharmaceuticals, Inc.",43602-268,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-268-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43602026830,Hydromorphone,16
hydromorphone hydrochloride,43602-269-05,32 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"Ascent Pharmaceuticals, Inc.",43602-269,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-269-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43602026905,Hydromorphone,32
hydromorphone hydrochloride,43602-269-30,32 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"Ascent Pharmaceuticals, Inc.",43602-269,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-269-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43602026930,Hydromorphone,32
Hydromorphone Hydrochloride,71335-0303-1,4 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0303,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0303-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335030301,Hydromorphone,4
Hydromorphone Hydrochloride,71335-0303-3,4 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0303,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0303-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335030303,Hydromorphone,4
Hydromorphone Hydrochloride,0641-6151-25,2 mg/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA202159,Hikma Pharmaceuticals USA Inc.,0641-6151,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/01/2018,N/A,ANDA,"25 VIAL, SINGLE-DOSE in 1 CARTON (0641-6151-25)  / 1 mL in 1 VIAL, SINGLE-DOSE (0641-6151-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641615125,Hydromorphone,2
Hydromorphone Hydrochloride,0409-1283-37,1 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA200403,"Hospira, Inc.",0409-1283,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/11/2021,N/A,NDA,10 SYRINGE in 1 CELLO PACK (0409-1283-37)  / 1 mL in 1 SYRINGE (0409-1283-17),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409128337,Hydromorphone,1
Hydromorphone Hydrochloride,71335-0265-1,2 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0265,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/21/2010,N/A,ANDA,25 TABLET in 1 BOTTLE (71335-0265-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335026501,Hydromorphone,2
Hydromorphone Hydrochloride,71335-0265-7,2 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0265,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/21/2010,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-0265-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335026507,Hydromorphone,2
Hydromorphone Hydrochloride,71335-0303-6,4 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0303,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-0303-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335030306,Hydromorphone,4
hydromorphone hydrochloride,72865-168-01,8 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"XLCare Pharmaceuticals, Inc.",72865-168,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-168-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865016801,Hydromorphone,8
hydromorphone hydrochloride,72865-169-01,12 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"XLCare Pharmaceuticals, Inc.",72865-169,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-169-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865016901,Hydromorphone,12
hydromorphone hydrochloride,72865-170-01,16 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"XLCare Pharmaceuticals, Inc.",72865-170,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-170-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865017001,Hydromorphone,16
hydromorphone hydrochloride,72865-171-01,32 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA212133,"XLCare Pharmaceuticals, Inc.",72865-171,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/24/2020,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-171-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865017101,Hydromorphone,32
hydromorphone hydrochloride,0574-0293-01,8 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA204278,Padagis US LLC,0574-0293,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/22/2015,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0293-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00574029301,Hydromorphone,8
hydromorphone hydrochloride,0574-0294-01,12 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA204278,Padagis US LLC,0574-0294,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/22/2015,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0294-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00574029401,Hydromorphone,12
hydromorphone hydrochloride,0574-0295-01,16 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA204278,Padagis US LLC,0574-0295,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/22/2015,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0295-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00574029501,Hydromorphone,16
hydromorphone hydrochloride,0574-0297-01,32 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA204278,Padagis US LLC,0574-0297,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/29/2017,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0297-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00574029701,Hydromorphone,32
HYDROMORPHONE HYDROCHLORIDE,0574-7224-06,3 mg/1,SUPPOSITORY,RECTAL,NA,Padagis US LLC,0574-7224,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/31/1996,N/A,UNAPPROVED DRUG OTHER,6 PACKET in 1 BOX (0574-7224-06)  / 1 SUPPOSITORY in 1 PACKET,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00574722406,Hydromorphone,3
Hydromorphone Hydrochloride,71335-0233-1,8 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0233,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0233-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335023301,Hydromorphone,8
Hydromorphone Hydrochloride,71335-0265-8,2 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0265,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/21/2010,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-0265-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335026508,Hydromorphone,2
Hydromorphone Hydrochloride,71335-0265-9,2 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0265,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/21/2010,N/A,ANDA,10 TABLET in 1 BOTTLE (71335-0265-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335026509,Hydromorphone,2
Hydromorphone Hydrochloride,0527-1353-01,2 mg/1,TABLET,ORAL,ANDA077471,"Lannett Company, Inc.",0527-1353,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (0527-1353-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527135301,Hydromorphone,2
Hydromorphone Hydrochloride,0527-1354-01,4 mg/1,TABLET,ORAL,ANDA077471,"Lannett Company, Inc.",0527-1354,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (0527-1354-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527135401,Hydromorphone,4
Hydromorphone Hydrochloride,0527-1355-01,8 mg/1,TABLET,ORAL,ANDA077471,"Lannett Company, Inc.",0527-1355,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (0527-1355-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527135501,Hydromorphone,8
Hydromorphone Hydrochloride,71335-0233-4,8 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0233,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0233-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335023304,Hydromorphone,8
Hydromorphone Hydrochloride,17856-0386-1,1 mg/mL,SOLUTION,ORAL,ANDA074653,ATLANTIC BIOLOGICALS CORP.,17856-0386,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/22/2022,N/A,ANDA,72 CUP in 1 CASE (17856-0386-1)  / 5 mL in 1 CUP (17856-0386-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17856038601,Hydromorphone,1
Hydromorphone Hydrochloride,0406-3243-01,2 mg/1,TABLET,ORAL,ANDA076855,SpecGx LLC,0406-3243,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/23/2004,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-3243-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406324301,Hydromorphone,2
Hydromorphone Hydrochloride,0406-3244-01,4 mg/1,TABLET,ORAL,ANDA076855,SpecGx LLC,0406-3244,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/23/2004,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-3244-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406324401,Hydromorphone,4
Hydromorphone Hydrochloride,0406-3249-01,8 mg/1,TABLET,ORAL,ANDA076855,SpecGx LLC,0406-3249,hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/23/2004,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-3249-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406324901,Hydromorphone,8
HYDROMORPHONE HYDROCHLORIDE,71335-0723-0,4 mg/1,TABLET,ORAL,ANDA205814,Bryant Ranch Prepack,71335-0723,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/16/2018,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0723-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335072300,Hydromorphone,4
HYDROMORPHONE HYDROCHLORIDE,71335-0723-2,4 mg/1,TABLET,ORAL,ANDA205814,Bryant Ranch Prepack,71335-0723,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,180 TABLET in 1 BOTTLE (71335-0723-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335072302,Hydromorphone,4
HYDROMORPHONE HYDROCHLORIDE,71335-0723-9,4 mg/1,TABLET,ORAL,ANDA205814,Bryant Ranch Prepack,71335-0723,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,140 TABLET in 1 BOTTLE (71335-0723-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335072309,Hydromorphone,4
Hydromorphone Hydrochloride,71335-0265-5,2 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0265,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/21/2010,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0265-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335026505,Hydromorphone,2
Hydromorphone Hydrochloride,63323-851-15,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA019034,"Fresenius Kabi USA, LLC",63323-851,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/15/2017,N/A,NDA,"10 VIAL, SINGLE-DOSE in 1 CARTON (63323-851-15)  / 5 mL in 1 VIAL, SINGLE-DOSE (63323-851-07)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323085115,Hydromorphone,10
Hydromorphone Hydrochloride,0409-1283-05,1 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA200403,"Hospira, Inc.",0409-1283,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2011,N/A,NDA,10 SYRINGE in 1 CARTON (0409-1283-05)  / .5 mL in 1 SYRINGE (0409-1283-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409128305,Hydromorphone,1
Hydromorphone Hydrochloride,0409-1283-31,1 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA200403,"Hospira, Inc.",0409-1283,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2011,N/A,NDA,10 CARTRIDGE in 1 CARTON (0409-1283-31)  / 1 mL in 1 CARTRIDGE (0409-1283-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409128331,Hydromorphone,1
Hydromorphone Hydrochloride,0409-1304-31,4 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA200403,"Hospira, Inc.",0409-1304,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2011,N/A,NDA,10 CARTRIDGE in 1 CARTON (0409-1304-31)  / 1 mL in 1 CARTRIDGE (0409-1304-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409130431,Hydromorphone,4
Hydromorphone Hydrochloride,0409-1312-30,2 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA200403,"Hospira, Inc.",0409-1312,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2011,N/A,NDA,10 CARTRIDGE in 1 CARTON (0409-1312-30)  / 1 mL in 1 CARTRIDGE (0409-1312-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409131230,Hydromorphone,2
Hydromorphone Hydrochloride,0409-2552-01,1 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA200403,"Hospira, Inc.",0409-2552,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2011,N/A,NDA,10 AMPULE in 1 CARTON (0409-2552-01)  / 1 mL in 1 AMPULE (0409-2552-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409255201,Hydromorphone,1
Hydromorphone Hydrochloride,0409-2634-01,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA078591,"Hospira, Inc.",0409-2634,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2008,N/A,ANDA,"10 VIAL, SINGLE-DOSE in 1 BOX (0409-2634-01)  / 1 mL in 1 VIAL, SINGLE-DOSE (0409-2634-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409263401,Hydromorphone,10
Hydromorphone Hydrochloride,0409-2634-05,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA078591,"Hospira, Inc.",0409-2634,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/07/2008,N/A,ANDA,"10 VIAL, SINGLE-DOSE in 1 BOX (0409-2634-05)  / 5 mL in 1 VIAL, SINGLE-DOSE (0409-2634-25)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409263405,Hydromorphone,10
Hydromorphone Hydrochloride,0409-2634-50,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA078591,"Hospira, Inc.",0409-2634,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/31/2008,N/A,ANDA,"1 VIAL, SINGLE-DOSE in 1 BOX (0409-2634-50)  / 50 mL in 1 VIAL, SINGLE-DOSE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409263450,Hydromorphone,10
Hydromorphone Hydrochloride,71335-0303-8,4 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0303,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-0303-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335030308,Hydromorphone,4
Hydromorphone Hydrochloride,42858-301-01,2 mg/1,TABLET,ORAL,NDA019892,Rhodes Pharmaceuticals L.P.,42858-301,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/23/2009,N/A,NDA AUTHORIZED GENERIC,"100 TABLET in 1 BOTTLE, PLASTIC (42858-301-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858030101,Hydromorphone,2
Hydromorphone Hydrochloride,42858-304-16,5 mg/5mL,SOLUTION,ORAL,NDA019891,Rhodes Pharmaceuticals L.P.,42858-304,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/20/2012,N/A,NDA AUTHORIZED GENERIC,"473 mL in 1 BOTTLE, PLASTIC (42858-304-16)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858030416,Hydromorphone,5
Hydromorphone Hydrochloride,71335-0265-2,2 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0265,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/21/2010,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0265-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335026502,Hydromorphone,2
Hydromorphone Hydrochloride,63629-3798-0,4 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-3798,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/29/2011,N/A,NDA AUTHORIZED GENERIC,90 TABLET in 1 BOTTLE (63629-3798-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629379800,Hydromorphone,4
Hydromorphone Hydrochloride,63629-3798-1,4 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-3798,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/29/2011,N/A,NDA AUTHORIZED GENERIC,30 TABLET in 1 BOTTLE (63629-3798-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629379801,Hydromorphone,4
Hydromorphone Hydrochloride,63629-3798-2,4 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-3798,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,NDA AUTHORIZED GENERIC,180 TABLET in 1 BOTTLE (63629-3798-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629379802,Hydromorphone,4
Hydromorphone Hydrochloride,63629-3798-3,4 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-3798,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/04/2012,N/A,NDA AUTHORIZED GENERIC,15 TABLET in 1 BOTTLE (63629-3798-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629379803,Hydromorphone,4
Hydromorphone Hydrochloride,63629-3798-4,4 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-3798,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/22/2017,N/A,NDA AUTHORIZED GENERIC,20 TABLET in 1 BOTTLE (63629-3798-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629379804,Hydromorphone,4
Hydromorphone Hydrochloride,63629-3798-5,4 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-3798,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/21/2010,N/A,NDA AUTHORIZED GENERIC,25 TABLET in 1 BOTTLE (63629-3798-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629379805,Hydromorphone,4
Hydromorphone Hydrochloride,63629-3798-6,4 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-3798,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/12/2010,N/A,NDA AUTHORIZED GENERIC,100 TABLET in 1 BOTTLE (63629-3798-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629379806,Hydromorphone,4
Hydromorphone Hydrochloride,63629-3798-7,4 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-3798,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/25/2010,N/A,NDA AUTHORIZED GENERIC,60 TABLET in 1 BOTTLE (63629-3798-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629379807,Hydromorphone,4
Hydromorphone Hydrochloride,63629-3798-8,4 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-3798,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/08/2011,N/A,NDA AUTHORIZED GENERIC,56 TABLET in 1 BOTTLE (63629-3798-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629379808,Hydromorphone,4
Hydromorphone Hydrochloride,63629-3798-9,4 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-3798,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,NDA AUTHORIZED GENERIC,140 TABLET in 1 BOTTLE (63629-3798-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629379809,Hydromorphone,4
Hydromorphone Hydrochloride,63629-4284-1,2 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-4284,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/21/2010,N/A,NDA AUTHORIZED GENERIC,25 TABLET in 1 BOTTLE (63629-4284-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629428401,Hydromorphone,2
Hydromorphone Hydrochloride,63629-4284-2,2 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-4284,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/23/2011,N/A,NDA AUTHORIZED GENERIC,60 TABLET in 1 BOTTLE (63629-4284-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629428402,Hydromorphone,2
Hydromorphone Hydrochloride,63629-4284-3,2 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-4284,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/22/2010,N/A,NDA AUTHORIZED GENERIC,30 TABLET in 1 BOTTLE (63629-4284-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629428403,Hydromorphone,2
Hydromorphone Hydrochloride,63629-4284-4,2 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-4284,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/12/2010,N/A,NDA AUTHORIZED GENERIC,28 TABLET in 1 BOTTLE (63629-4284-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629428404,Hydromorphone,2
Hydromorphone Hydrochloride,63629-4284-5,2 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-4284,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/11/2014,N/A,NDA AUTHORIZED GENERIC,90 TABLET in 1 BOTTLE (63629-4284-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629428405,Hydromorphone,2
Hydromorphone Hydrochloride,63629-4284-6,2 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-4284,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/25/2012,N/A,NDA AUTHORIZED GENERIC,120 TABLET in 1 BOTTLE (63629-4284-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629428406,Hydromorphone,2
Hydromorphone Hydrochloride,63629-4284-7,2 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-4284,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/27/2014,N/A,NDA AUTHORIZED GENERIC,40 TABLET in 1 BOTTLE (63629-4284-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629428407,Hydromorphone,2
Hydromorphone Hydrochloride,63629-4284-8,2 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-4284,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/01/2012,N/A,NDA AUTHORIZED GENERIC,20 TABLET in 1 BOTTLE (63629-4284-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629428408,Hydromorphone,2
Hydromorphone Hydrochloride,63629-4284-9,2 mg/1,TABLET,ORAL,NDA019892,Bryant Ranch Prepack,63629-4284,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/24/2020,N/A,NDA AUTHORIZED GENERIC,10 TABLET in 1 BOTTLE (63629-4284-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629428409,Hydromorphone,2
HYDROMORPHONE HYDROCHLORIDE,71335-0723-5,4 mg/1,TABLET,ORAL,ANDA205814,Bryant Ranch Prepack,71335-0723,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,25 TABLET in 1 BOTTLE (71335-0723-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335072305,Hydromorphone,4
HYDROMORPHONE HYDROCHLORIDE,71335-0723-6,4 mg/1,TABLET,ORAL,ANDA205814,Bryant Ranch Prepack,71335-0723,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-0723-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335072306,Hydromorphone,4
HYDROMORPHONE HYDROCHLORIDE,71335-0723-3,4 mg/1,TABLET,ORAL,ANDA205814,Bryant Ranch Prepack,71335-0723,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0723-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335072303,Hydromorphone,4
Hydromorphone Hydrochloride,42858-302-01,4 mg/1,TABLET,ORAL,NDA019892,Rhodes Pharmaceuticals L.P.,42858-302,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/23/2009,N/A,NDA AUTHORIZED GENERIC,"100 TABLET in 1 BOTTLE, PLASTIC (42858-302-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858030201,Hydromorphone,4
Hydromorphone Hydrochloride,71335-0265-4,2 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0265,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/21/2010,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-0265-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335026504,Hydromorphone,2
Hydromorphone Hydrochloride,17478-540-01,10 mg/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA078228,Akorn,17478-540,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/15/2010,N/A,ANDA,10 AMPULE in 1 CARTON (17478-540-01)  / 1 mL in 1 AMPULE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17478054001,Hydromorphone,10
Hydromorphone Hydrochloride,17478-540-05,10 mg/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA078228,Akorn,17478-540,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/15/2010,N/A,ANDA,10 AMPULE in 1 CARTON (17478-540-05)  / 5 mL in 1 AMPULE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17478054005,Hydromorphone,10
Hydromorphone Hydrochloride,17478-540-50,10 mg/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA078228,Akorn,17478-540,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/15/2010,N/A,ANDA,1 VIAL in 1 CARTON (17478-540-50)  / 50 mL in 1 VIAL,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17478054050,Hydromorphone,10
HYDROMORPHONE HYDROCHLORIDE,63629-2532-1,3 mg/1,SUPPOSITORY,RECTAL,NA,Bryant Ranch Prepack,63629-2532,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/28/2021,N/A,UNAPPROVED DRUG OTHER,6 PACKET in 1 BOX (63629-2532-1)  / 1 SUPPOSITORY in 1 PACKET,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629253201,Hydromorphone,3
Hydromorphone Hydrochloride,71335-0303-2,4 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0303,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,180 TABLET in 1 BOTTLE (71335-0303-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335030302,Hydromorphone,4
Hydromorphone Hydrochloride,71335-0303-9,4 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0303,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,140 TABLET in 1 BOTTLE (71335-0303-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335030309,Hydromorphone,4
Hydromorphone Hydrochloride,13811-701-10,8 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA205629,"Trigen Laboratories, LLC",13811-701,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/15/2016,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-701-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13811070110,Hydromorphone,8
Hydromorphone Hydrochloride,13811-702-10,12 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA205629,"Trigen Laboratories, LLC",13811-702,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/15/2016,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-702-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13811070210,Hydromorphone,12
Hydromorphone Hydrochloride,13811-703-10,16 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA205629,"Trigen Laboratories, LLC",13811-703,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/15/2016,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-703-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13811070310,Hydromorphone,16
Hydromorphone Hydrochloride,13811-704-10,32 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA205629,"Trigen Laboratories, LLC",13811-704,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/15/2016,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-704-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13811070410,Hydromorphone,32
Hydromorphone Hydrochloride,0409-3365-10,2 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA200403,"Hospira, Inc.",0409-3365,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/14/2021,N/A,NDA,"10 VIAL, SINGLE-DOSE in 1 CARTON (0409-3365-10)  / 1 mL in 1 VIAL, SINGLE-DOSE (0409-3365-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409336510,Hydromorphone,2
Hydromorphone Hydrochloride,60687-566-86,5 mg/5mL,SOLUTION,ORAL,NDA019891,American Health Packaging,60687-566,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/01/2021,N/A,NDA AUTHORIZED GENERIC,"3 TRAY in 1 CASE (60687-566-86)  / 10 CUP, UNIT-DOSE in 1 TRAY (60687-566-46)  / 5 mL in 1 CUP, UNIT-DOSE (60687-566-40)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60687056686,Hydromorphone,5
Hydromorphone Hydrochloride,71335-0233-2,8 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0233,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0233-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335023302,Hydromorphone,8
HYDROMORPHONE HYDROCHLORIDE,71335-0723-4,4 mg/1,TABLET,ORAL,ANDA205814,Bryant Ranch Prepack,71335-0723,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-0723-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335072304,Hydromorphone,4
HYDROMORPHONE HYDROCHLORIDE,71335-0723-7,4 mg/1,TABLET,ORAL,ANDA205814,Bryant Ranch Prepack,71335-0723,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/16/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0723-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335072307,Hydromorphone,4
HYDROMORPHONE HYDROCHLORIDE,71335-0723-1,4 mg/1,TABLET,ORAL,ANDA205814,Bryant Ranch Prepack,71335-0723,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/08/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0723-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335072301,Hydromorphone,4
Hydromorphone Hydrochloride,71335-0303-0,4 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0303,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0303-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335030300,Hydromorphone,4
Hydromorphone Hydrochloride,71335-0233-3,8 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0233,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0233-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335023303,Hydromorphone,8
Hydromorphone Hydrochloride,71335-0233-5,8 mg/1,TABLET,ORAL,ANDA077471,Bryant Ranch Prepack,71335-0233,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/09/2009,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-0233-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335023305,Hydromorphone,8
HYDROMORPHONE HYDROCHLORIDE,71335-0723-8,4 mg/1,TABLET,ORAL,ANDA205814,Bryant Ranch Prepack,71335-0723,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-0723-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335072308,Hydromorphone,4
Hydromorphone Hydrochloride,63323-851-50,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA019034,"Fresenius Kabi USA, LLC",63323-851,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/15/2017,N/A,NDA,"50 mL in 1 VIAL, SINGLE-DOSE (63323-851-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323085150,Hydromorphone,10
Levorphanol Tartrate,0406-2224-01,2 mg/1,TABLET,ORAL,ANDA212024,SpecGx LLC,0406-2224,Levorphanol Tartrate,LEVORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,12/13/2019,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (0406-2224-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406222401,Levorphanol,2
Levorphanol Tartrate,0527-3236-37,2 mg/1,TABLET,ORAL,ANDA213479,"Lannett Company, Inc.",0527-3236,Levorphanol Tartrate,LEVORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,05/20/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (0527-3236-37),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527323637,Levorphanol,2
Levorphanol Tartrate,57664-762-88,2 mg/1,TABLET,ORAL,ANDA213906,"Sun Pharmaceutical Industries, Inc.",57664-762,Levorphanol Tartrate,LEVORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,06/17/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (57664-762-88),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,57664076288,Levorphanol,2
Levorphanol Tartrate,63629-2093-1,2 mg/1,TABLET,ORAL,ANDA213479,Bryant Ranch Prepack,63629-2093,Levorphanol Tartrate,LEVORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,02/15/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-2093-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629209301,Levorphanol,2
LEVORPHANOL TARTRATE,0054-0438-25,2 mg/1,TABLET,ORAL,ANDA074278,Hikma Pharmaceuticals USA Inc.,0054-0438,LEVORPHANOL TARTRATE,LEVORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,02/02/2023,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (0054-0438-25)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00054043825,Levorphanol,2
Levorphanol Tartrate,0527-3237-37,3 mg/1,TABLET,ORAL,ANDA213479,"Lannett Company, Inc.",0527-3237,Levorphanol Tartrate,LEVORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,01/12/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (0527-3237-37),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527323737,Levorphanol,3
Levorphanol Tartrate,69543-412-10,2 mg/1,TABLET,ORAL,ANDA211484,"Virtus Pharmaceuticals, LLC",69543-412,Levorphanol Tartrate,LEVORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,12/13/2018,02/28/2024,ANDA,100 TABLET in 1 BOTTLE (69543-412-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,69543041210,Levorphanol,2
Levorphanol Tartrate,42358-102-10,2 mg/1,TABLET,ORAL,ANDA074278,"Sentynl Therapeutics, Inc.",42358-102,Levorphanol Tartrate,LEVORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,06/22/2015,10/31/2023,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (42358-102-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,42358010210,Levorphanol,2
Levorphanol Tartrate,69543-417-10,2 mg/1,TABLET,ORAL,ANDA211484,"Virtus Pharmaceuticals, LLC",69543-417,Levorphanol Tartrate,LEVORPHANOL TARTRATE,HUMAN PRESCRIPTION DRUG,09/01/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (69543-417-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,69543041710,Levorphanol,2
DEMEROL,0409-1176-30,25 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA021171,"Hospira, Inc.",0409-1176,MEPERIDINE HYDROCHLORIDE,MEPERIDINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/25/2005,N/A,NDA,10 CARTRIDGE in 1 CARTON (0409-1176-30)  / 1 mL in 1 CARTRIDGE (0409-1176-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409117630,Meperidine,25
DEMEROL,0409-1178-30,50 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA021171,"Hospira, Inc.",0409-1178,MEPERIDINE HYDROCHLORIDE,MEPERIDINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/13/2005,N/A,NDA,10 CARTRIDGE in 1 CARTON (0409-1178-30)  / 1 mL in 1 CARTRIDGE (0409-1178-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409117830,Meperidine,50
DEMEROL,0409-1179-30,75 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA021171,"Hospira, Inc.",0409-1179,MEPERIDINE HYDROCHLORIDE,MEPERIDINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/12/2005,N/A,NDA,10 CARTRIDGE in 1 CARTON (0409-1179-30)  / 1 mL in 1 CARTRIDGE (0409-1179-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409117930,Meperidine,75
DEMEROL,0409-1180-69,100 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA021171,"Hospira, Inc.",0409-1180,MEPERIDINE HYDROCHLORIDE,MEPERIDINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/15/2005,N/A,NDA,10 CARTRIDGE in 1 CARTON (0409-1180-69)  / 1 mL in 1 CARTRIDGE (0409-1180-59),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409118069,Meperidine,100
DEMEROL,0409-1181-30,50 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA021171,"Hospira, Inc.",0409-1181,MEPERIDINE HYDROCHLORIDE,MEPERIDINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/24/2006,N/A,NDA,"1 VIAL, MULTI-DOSE in 1 CARTON (0409-1181-30)  / 30 mL in 1 VIAL, MULTI-DOSE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409118130,Meperidine,50
DEMEROL,0409-1362-01,25 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA021171,"Hospira, Inc.",0409-1362,MEPERIDINE HYDROCHLORIDE,MEPERIDINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/16/2021,N/A,NDA,10 SYRINGE in 1 CELLO PACK (0409-1362-01)  / 1 mL in 1 SYRINGE (0409-1362-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409136201,Meperidine,25
DEMEROL,0409-1418-01,50 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA021171,"Hospira, Inc.",0409-1418,MEPERIDINE HYDROCHLORIDE,MEPERIDINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/16/2021,N/A,NDA,10 SYRINGE in 1 CELLO PACK (0409-1418-01)  / 1 mL in 1 SYRINGE (0409-1418-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409141801,Meperidine,50
MEPERIDINE HYDROCHLORIDE,0641-6052-25,25 mg/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA080445,Hikma Pharmaceuticals USA Inc.,0641-6052,MEPERIDINE HYDROCHLORIDE,MEPERIDINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/22/1975,N/A,ANDA,25 VIAL in 1 CARTON (0641-6052-25)  / 1 mL in 1 VIAL (0641-6052-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641605225,Meperidine,25
MEPERIDINE HYDROCHLORIDE,0641-6053-25,50 mg/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA080445,Hikma Pharmaceuticals USA Inc.,0641-6053,MEPERIDINE HYDROCHLORIDE,MEPERIDINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/22/1975,N/A,ANDA,25 VIAL in 1 CARTON (0641-6053-25)  / 1 mL in 1 VIAL (0641-6053-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641605325,Meperidine,50
MEPERIDINE HYDROCHLORIDE,0641-6054-25,100 mg/mL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA080445,Hikma Pharmaceuticals USA Inc.,0641-6054,MEPERIDINE HYDROCHLORIDE,MEPERIDINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/22/1975,N/A,ANDA,25 VIAL in 1 CARTON (0641-6054-25)  / 1 mL in 1 VIAL (0641-6054-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641605425,Meperidine,100
Meperidine Hydrochloride,42806-050-30,50 mg/1,TABLET,ORAL,ANDA040331,"EPIC PHARMA, LLC",42806-050,Meperidine Hydrochloride,MEPERIDINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (42806-050-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42806005030,Meperidine,50
Meperidine Hydrochloride,42806-051-01,100 mg/1,TABLET,ORAL,ANDA040331,"EPIC PHARMA, LLC",42806-051,Meperidine Hydrochloride,MEPERIDINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/05/2011,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-051-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42806005101,Meperidine,100
Meperidine Hydrochloride,42806-050-01,50 mg/1,TABLET,ORAL,ANDA040331,"EPIC PHARMA, LLC",42806-050,Meperidine Hydrochloride,MEPERIDINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/05/2011,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-050-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42806005001,Meperidine,50
Meperidine Hydrochloride,0054-3545-63,50 mg/5mL,SOLUTION,ORAL,ANDA088744,West-Ward Pharmaceuticals Corp.,0054-3545,Meperidine Hydrochloride,MEPERIDINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/30/1985,N/A,ANDA,500 mL in 1 BOTTLE (0054-3545-63),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054354563,Meperidine,50
DISKETS,0054-4538-25,40 mg/1,TABLET,ORAL,NDA017058,Hikma Pharmaceuticals USA Inc.,0054-4538,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/14/1973,N/A,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (0054-4538-25)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054453825,Methadone,40
METHADONE HYDROCHLORIDE,0054-0709-20,5 mg/1,TABLET,ORAL,ANDA088108,Hikma Pharmaceuticals USA Inc.,0054-0709,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/08/1983,N/A,ANDA,1 BLISTER PACK in 1 CARTON (0054-0709-20)  / 100 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00054070920,Methadone,5
METHADONE HYDROCHLORIDE,0054-0709-25,5 mg/1,TABLET,ORAL,ANDA088108,Hikma Pharmaceuticals USA Inc.,0054-0709,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/08/1983,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (0054-0709-25)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00054070925,Methadone,5
METHADONE HYDROCHLORIDE,0054-0710-20,10 mg/1,TABLET,ORAL,ANDA088109,Hikma Pharmaceuticals USA Inc.,0054-0710,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/08/1983,N/A,ANDA,1 BLISTER PACK in 1 CARTON (0054-0710-20)  / 100 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00054071020,Methadone,10
METHADONE HYDROCHLORIDE,0054-0710-25,10 mg/1,TABLET,ORAL,ANDA088109,Hikma Pharmaceuticals USA Inc.,0054-0710,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/08/1983,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (0054-0710-25)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00054071025,Methadone,10
Methadone Hydrochloride,17856-0392-3,10 mg/mL,CONCENTRATE,ORAL,ANDA040180,ATLANTIC BIOLOGICALS CORP.,17856-0392,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/14/2022,N/A,ANDA,"72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0392-3)  / 2.5 mL in 1 CUP, UNIT-DOSE (17856-0392-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17856039203,Methadone,10
Methadone Hydrochloride,13107-088-01,5 mg/1,TABLET,ORAL,ANDA203502,"Aurolife Pharma, LLC",13107-088,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/15/2015,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-088-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107008801,Methadone,5
Methadone Hydrochloride,13107-088-30,5 mg/1,TABLET,ORAL,ANDA203502,"Aurolife Pharma, LLC",13107-088,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/15/2015,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-088-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107008830,Methadone,5
Methadone Hydrochloride,13107-088-99,5 mg/1,TABLET,ORAL,ANDA203502,"Aurolife Pharma, LLC",13107-088,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/15/2015,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-088-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107008899,Methadone,5
Methadone Hydrochloride,13107-089-01,10 mg/1,TABLET,ORAL,ANDA203502,"Aurolife Pharma, LLC",13107-089,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/15/2015,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-089-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107008901,Methadone,10
Methadone Hydrochloride,13107-089-30,10 mg/1,TABLET,ORAL,ANDA203502,"Aurolife Pharma, LLC",13107-089,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/15/2015,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-089-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107008930,Methadone,10
Methadone Hydrochloride,13107-089-99,10 mg/1,TABLET,ORAL,ANDA203502,"Aurolife Pharma, LLC",13107-089,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/15/2015,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-089-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107008999,Methadone,10
Methadone Hydrochloride,60687-214-01,5 mg/1,TABLET,ORAL,ANDA203502,American Health Packaging,60687-214,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/20/2016,04/30/2023,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-214-01)  / 1 TABLET in 1 BLISTER PACK (60687-214-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,60687021401,Methadone,5
Methadone Hydrochloride,17856-0392-1,10 mg/mL,CONCENTRATE,ORAL,ANDA040180,ATLANTIC BIOLOGICALS CORP.,17856-0392,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/18/2021,N/A,ANDA,"60 SYRINGE in 1 BOX, UNIT-DOSE (17856-0392-1)  / .5 mL in 1 SYRINGE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17856039201,Methadone,10
Methadone Hydrochloride,0054-0391-68,10 mg/mL,CONCENTRATE,ORAL,ANDA089897,Hikma Pharmaceuticals USA,0054-0391,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/23/2010,N/A,ANDA,1000 mL in 1 BOTTLE (0054-0391-68),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054039168,Methadone,10
Methadone Hydrochloride,0054-0392-68,10 mg/mL,CONCENTRATE,ORAL,ANDA040180,Hikma Pharmaceuticals USA,0054-0392,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/16/2010,N/A,ANDA,1000 mL in 1 BOTTLE (0054-0392-68),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054039268,Methadone,10
METHADONE HYDROCHLORIDE,71335-0119-0,10 mg/1,TABLET,ORAL,NDA006134,Bryant Ranch Prepack,71335-0119,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,08/31/2023,NDA,168 TABLET in 1 BOTTLE (71335-0119-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,71335011900,Methadone,10
METHADONE HYDROCHLORIDE,71335-0119-1,10 mg/1,TABLET,ORAL,NDA006134,Bryant Ranch Prepack,71335-0119,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,08/31/2023,NDA,15 TABLET in 1 BOTTLE (71335-0119-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,71335011901,Methadone,10
METHADONE HYDROCHLORIDE,71335-0119-2,10 mg/1,TABLET,ORAL,NDA006134,Bryant Ranch Prepack,71335-0119,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,08/31/2023,NDA,30 TABLET in 1 BOTTLE (71335-0119-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,71335011902,Methadone,10
METHADONE HYDROCHLORIDE,71335-0119-3,10 mg/1,TABLET,ORAL,NDA006134,Bryant Ranch Prepack,71335-0119,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,08/31/2023,NDA,90 TABLET in 1 BOTTLE (71335-0119-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,71335011903,Methadone,10
Methadone Hydrochloride,31722-946-01,5 mg/1,TABLET,ORAL,ANDA211228,"Camber Pharmaceuticals, Inc",31722-946,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/03/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-946-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722094601,Methadone,5
Methadone Hydrochloride,31722-947-01,10 mg/1,TABLET,ORAL,ANDA211228,"Camber Pharmaceuticals, Inc",31722-947,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/03/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-947-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722094701,Methadone,10
Methadone Hydrochloride,71335-0493-2,5 mg/1,TABLET,ORAL,ANDA203502,Bryant Ranch Prepack,71335-0493,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/27/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0493-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335049302,Methadone,5
Methadone Hydrochloride,71335-0493-5,5 mg/1,TABLET,ORAL,ANDA203502,Bryant Ranch Prepack,71335-0493,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0493-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335049305,Methadone,5
Methadone Hydrochloride,66689-694-30,10 mg/mL,CONCENTRATE,ORAL,ANDA040088,"VistaPharm, Inc.",66689-694,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2009,N/A,ANDA,"30 mL in 1 BOTTLE, DROPPER (66689-694-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,66689069430,Methadone,10
Methadone Hydrochloride,68094-031-62,5 mg/5mL,SOLUTION,ORAL,ANDA087393,"Precision Dose, Inc.",68094-031,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/23/2020,N/A,ANDA,"3 TRAY in 1 CASE (68094-031-62)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (68094-031-59)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68094003162,Methadone,5
METHADONE HYDROCHLORIDE,71335-0119-4,10 mg/1,TABLET,ORAL,NDA006134,Bryant Ranch Prepack,71335-0119,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,08/31/2023,NDA,120 TABLET in 1 BOTTLE (71335-0119-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,71335011904,Methadone,10
METHADONE HYDROCHLORIDE,71335-0119-5,10 mg/1,TABLET,ORAL,NDA006134,Bryant Ranch Prepack,71335-0119,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,08/31/2023,NDA,180 TABLET in 1 BOTTLE (71335-0119-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,71335011905,Methadone,10
METHADONE HYDROCHLORIDE,71335-0119-6,10 mg/1,TABLET,ORAL,NDA006134,Bryant Ranch Prepack,71335-0119,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,08/31/2023,NDA,60 TABLET in 1 BOTTLE (71335-0119-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,71335011906,Methadone,10
Methadone Hydrochloride,63629-1905-1,10 mg/1,TABLET,ORAL,ANDA211228,Bryant Ranch Prepack,63629-1905,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/21/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-1905-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629190501,Methadone,10
Methadone Hydrochloride,63629-1906-1,5 mg/1,TABLET,ORAL,ANDA211228,Bryant Ranch Prepack,63629-1906,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/21/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-1906-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629190601,Methadone,5
Methadone Hydrochloride,72865-120-01,5 mg/1,TABLET,ORAL,ANDA211228,"XLCare Pharmaceuticals, Inc",72865-120,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-120-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865012001,Methadone,5
Methadone Hydrochloride,72865-121-01,10 mg/1,TABLET,ORAL,ANDA211228,"XLCare Pharmaceuticals, Inc",72865-121,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-121-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865012101,Methadone,10
Methadone Hydrochloride,66689-695-79,10 mg/mL,CONCENTRATE,ORAL,ANDA040088,"VistaPharm, Inc.",66689-695,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/29/2017,N/A,ANDA,1000 mL in 1 BOTTLE (66689-695-79),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,66689069579,Methadone,10
Methadone Hydrochloride,66689-711-16,5 mg/5mL,SOLUTION,ORAL,ANDA090707,"VistaPharm, Inc.",66689-711,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/01/2010,N/A,ANDA,500 mL in 1 BOTTLE (66689-711-16),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,66689071116,Methadone,5
Methadone Hydrochloride,66689-695-30,10 mg/mL,CONCENTRATE,ORAL,ANDA040088,"VistaPharm, Inc.",66689-695,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/29/2017,N/A,ANDA,"30 mL in 1 BOTTLE, DROPPER (66689-695-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,66689069530,Methadone,10
Methadone Hydrochloride,66689-820-10,10 mg/1,TABLET,ORAL,ANDA040241,"VistaPharm, LLC",66689-820,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/22/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (66689-820-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,66689082010,Methadone,10
Methadone Hydrochloride,67457-217-20,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA021624,Mylan Institutional LLC,67457-217,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/20/2012,N/A,NDA,"1 VIAL, MULTI-DOSE in 1 CARTON (67457-217-20)  / 20 mL in 1 VIAL, MULTI-DOSE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67457021720,Methadone,10
METHADONE HYDROCHLORIDE,0406-6221-05,10 mg/5mL,SOLUTION,ORAL,ANDA207537,SpecGx LLC,0406-6221,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/18/2021,N/A,ANDA,500 mL in 1 BOTTLE (0406-6221-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406622105,Methadone,10
METHADONE HYDROCHLORIDE,0406-6225-05,5 mg/5mL,SOLUTION,ORAL,ANDA207537,SpecGx LLC,0406-6225,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/18/2021,N/A,ANDA,500 mL in 1 BOTTLE (0406-6225-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406622505,Methadone,5
Methadone Hydrochloride,67877-659-01,5 mg/1,TABLET,ORAL,ANDA090635,"Ascend Laboratories, LLC",67877-659,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/11/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (67877-659-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67877065901,Methadone,5
Methadone Hydrochloride,67877-660-01,10 mg/1,TABLET,ORAL,ANDA090635,"Ascend Laboratories, LLC",67877-660,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/11/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (67877-660-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67877066001,Methadone,10
METHADONE HYDROCHLORIDE,67877-116-01,10 mg/1,TABLET,ORAL,ANDA090635,"Ascend Laboratories, LLC",67877-116,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/16/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (67877-116-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67877011601,Methadone,10
Methadone Hydrochloride,17856-0392-7,10 mg/mL,CONCENTRATE,ORAL,ANDA040180,ATLANTIC BIOLOGICALS CORP.,17856-0392,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/14/2022,N/A,ANDA,"5 BOX, UNIT-DOSE in 1 SYRINGE (17856-0392-7)  / 60 SYRINGE in 1 BOX, UNIT-DOSE (17856-0392-2)  / 1 mL in 1 SYRINGE (17856-0392-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17856039207,Methadone,10
Methadone Hydrochloride,0904-6530-61,10 mg/1,TABLET,ORAL,ANDA090635,Major Pharmaceuticals,0904-6530,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/16/2012,N/A,ANDA,100 BLISTER PACK in 1 CARTON (0904-6530-61)  / 1 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00904653061,Methadone,10
Methadone Hydrochloride,55700-882-01,10 mg/1,TABLET,ORAL,ANDA090635,"Quality Care Products, LLC",55700-882,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/02/2020,N/A,ANDA,120 TABLET in 1 BOTTLE (55700-882-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700088201,Methadone,10
Methadone Hydrochloride,55700-882-30,10 mg/1,TABLET,ORAL,ANDA090635,"Quality Care Products, LLC",55700-882,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/02/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (55700-882-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700088230,Methadone,10
Methadone Hydrochloride,55700-882-60,10 mg/1,TABLET,ORAL,ANDA090635,"Quality Care Products, LLC",55700-882,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/02/2020,N/A,ANDA,60 TABLET in 1 BOTTLE (55700-882-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700088260,Methadone,10
Methadone Hydrochloride,55700-882-90,10 mg/1,TABLET,ORAL,ANDA090635,"Quality Care Products, LLC",55700-882,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/02/2020,N/A,ANDA,90 TABLET in 1 BOTTLE (55700-882-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700088290,Methadone,10
Methadone Hydrochloride,71335-0493-7,5 mg/1,TABLET,ORAL,ANDA203502,Bryant Ranch Prepack,71335-0493,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-0493-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335049307,Methadone,5
METHADONE HYDROCHLORIDE,0406-2540-01,40 mg/1,TABLET,ORAL,ANDA077142,SpecGx LLC,0406-2540,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/12/2005,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-2540-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406254001,Methadone,40
METHADONE HYDROCHLORIDE,0406-5755-01,5 mg/1,TABLET,ORAL,ANDA040517,SpecGx LLC,0406-5755,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/27/2004,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-5755-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406575501,Methadone,5
METHADONE HYDROCHLORIDE,0406-5755-23,5 mg/1,TABLET,ORAL,ANDA040517,SpecGx LLC,0406-5755,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/27/2004,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-5755-23),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406575523,Methadone,5
METHADONE HYDROCHLORIDE,0406-5755-62,5 mg/1,TABLET,ORAL,ANDA040517,SpecGx LLC,0406-5755,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/27/2004,N/A,ANDA,100 TABLET in 1 BLISTER PACK (0406-5755-62),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406575562,Methadone,5
METHADONE HYDROCHLORIDE,0406-5771-01,10 mg/1,TABLET,ORAL,ANDA040517,SpecGx LLC,0406-5771,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/27/2004,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-5771-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406577101,Methadone,10
METHADONE HYDROCHLORIDE,0406-5771-23,10 mg/1,TABLET,ORAL,ANDA040517,SpecGx LLC,0406-5771,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/27/2004,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-5771-23),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406577123,Methadone,10
METHADONE HYDROCHLORIDE,0406-5771-62,10 mg/1,TABLET,ORAL,ANDA040517,SpecGx LLC,0406-5771,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/27/2004,N/A,ANDA,100 TABLET in 1 BLISTER PACK (0406-5771-62),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406577162,Methadone,10
METHADONE HYDROCHLORIDE,71335-0119-7,10 mg/1,TABLET,ORAL,NDA006134,Bryant Ranch Prepack,71335-0119,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,08/31/2023,NDA,28 TABLET in 1 BOTTLE (71335-0119-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,71335011907,Methadone,10
METHADONE HYDROCHLORIDE,71335-0119-8,10 mg/1,TABLET,ORAL,NDA006134,Bryant Ranch Prepack,71335-0119,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,08/31/2023,NDA,112 TABLET in 1 BOTTLE (71335-0119-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,71335011908,Methadone,10
METHADONE HYDROCHLORIDE,71335-0119-9,10 mg/1,TABLET,ORAL,NDA006134,Bryant Ranch Prepack,71335-0119,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,08/31/2023,NDA,56 TABLET in 1 BOTTLE (71335-0119-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,71335011909,Methadone,10
METHADONE HYDROCHLORIDE,63629-1027-1,10 mg/1,TABLET,ORAL,ANDA090635,Bryant Ranch Prepack,63629-1027,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/16/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-1027-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629102701,Methadone,10
Methadone Hydrochloride,71335-0493-3,5 mg/1,TABLET,ORAL,ANDA203502,Bryant Ranch Prepack,71335-0493,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0493-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335049303,Methadone,5
Methadone Hydrochloride,71335-0493-4,5 mg/1,TABLET,ORAL,ANDA203502,Bryant Ranch Prepack,71335-0493,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,112 TABLET in 1 BOTTLE (71335-0493-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335049304,Methadone,5
Methadone Hydrochloride,71335-0493-1,5 mg/1,TABLET,ORAL,ANDA203502,Bryant Ranch Prepack,71335-0493,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/16/2018,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0493-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335049301,Methadone,5
Methadone Hydrochloride,17478-380-20,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA208306,Akorn,17478-380,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2017,N/A,ANDA,"20 mL in 1 VIAL, MULTI-DOSE (17478-380-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17478038020,Methadone,10
Methadone Hydrochloride,66689-836-99,10 mg/1,TABLET,ORAL,ANDA204166,"VistaPharm, Inc.",66689-836,Methadone,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/11/2020,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (66689-836-99)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,66689083699,Methadone,10
METHADONE HYDROCHLORIDE,68084-738-01,10 mg/1,TABLET,ORAL,ANDA090635,American Health Packaging,68084-738,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/11/2014,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-738-01)  / 1 TABLET in 1 BLISTER PACK (68084-738-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68084073801,Methadone,10
Methadone Hydrochloride,71335-0493-6,5 mg/1,TABLET,ORAL,ANDA203502,Bryant Ranch Prepack,71335-0493,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,180 TABLET in 1 BOTTLE (71335-0493-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335049306,Methadone,5
Methadone Hydrochloride,66689-694-79,10 mg/mL,CONCENTRATE,ORAL,ANDA040088,"VistaPharm, Inc.",66689-694,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2009,N/A,ANDA,1000 mL in 1 BOTTLE (66689-694-79),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,66689069479,Methadone,10
Methadone Hydrochloride,66689-712-16,10 mg/5mL,SOLUTION,ORAL,ANDA090707,"VistaPharm, Inc.",66689-712,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/01/2010,N/A,ANDA,500 mL in 1 BOTTLE (66689-712-16),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,66689071216,Methadone,10
Methadone Hydrochloride,66689-898-40,40 mg/1,TABLET,ORAL,ANDA075082,"VistaPharm, Inc.",66689-898,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/25/1998,N/A,ANDA,100 TABLET in 1 BOTTLE (66689-898-40),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,66689089840,Methadone,40
METHADONE HYDROCHLORIDE,0054-4570-25,5 mg/1,TABLET,ORAL,NDA006134,Hikma Pharmaceuticals USA Inc.,0054-4570,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/11/2001,08/31/2023,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (0054-4570-25)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,00054457025,Methadone,5
METHADONE HYDROCHLORIDE,0054-4571-25,10 mg/1,TABLET,ORAL,NDA006134,Hikma Pharmaceuticals USA Inc.,0054-4571,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/11/2001,08/31/2023,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (0054-4571-25)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,00054457125,Methadone,10
METHADONE HYDROCHLORIDE,0054-8553-24,5 mg/1,TABLET,ORAL,NDA006134,Hikma Pharmaceuticals USA Inc.,0054-8553,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/11/2001,08/31/2023,NDA,100 BLISTER PACK in 1 CARTON (0054-8553-24)  / 1 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,00054855324,Methadone,5
METHADONE HYDROCHLORIDE,0054-8554-24,10 mg/1,TABLET,ORAL,NDA006134,Hikma Pharmaceuticals USA Inc.,0054-8554,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/11/2001,08/31/2023,NDA,100 BLISTER PACK in 1 CARTON (0054-8554-24)  / 1 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,00054855424,Methadone,10
Methadone Hydrochloride,0406-4123-03,10 mg/mL,CONCENTRATE,ORAL,ANDA207368,SpecGx LLC,0406-4123,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/18/2021,N/A,ANDA,"1 BOTTLE, DROPPER in 1 CARTON (0406-4123-03)  / 30 mL in 1 BOTTLE, DROPPER","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406412303,Methadone,10
Methadone Hydrochloride,0406-4123-10,10 mg/mL,CONCENTRATE,ORAL,ANDA207368,SpecGx LLC,0406-4123,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/18/2021,N/A,ANDA,1000 mL in 1 BOTTLE (0406-4123-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406412310,Methadone,10
Methadone Hydrochloride,42806-317-01,5 mg/1,TABLET,ORAL,ANDA090065,"Epic Pharma, LLC",42806-317,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/11/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-317-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42806031701,Methadone,5
Methadone Hydrochloride,42806-318-01,10 mg/1,TABLET,ORAL,ANDA090065,"Epic Pharma, LLC",42806-318,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/11/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-318-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42806031801,Methadone,10
METHADONE HYDROCHLORIDE,71335-1360-0,10 mg/1,TABLET,ORAL,ANDA090635,Bryant Ranch Prepack,71335-1360,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,168 TABLET in 1 BOTTLE (71335-1360-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136000,Methadone,10
METHADONE HYDROCHLORIDE,71335-1360-1,10 mg/1,TABLET,ORAL,ANDA090635,Bryant Ranch Prepack,71335-1360,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-1360-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136001,Methadone,10
METHADONE HYDROCHLORIDE,71335-1360-2,10 mg/1,TABLET,ORAL,ANDA090635,Bryant Ranch Prepack,71335-1360,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/01/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1360-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136002,Methadone,10
METHADONE HYDROCHLORIDE,71335-1360-3,10 mg/1,TABLET,ORAL,ANDA090635,Bryant Ranch Prepack,71335-1360,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/14/2020,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1360-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136003,Methadone,10
METHADONE HYDROCHLORIDE,71335-1360-4,10 mg/1,TABLET,ORAL,ANDA090635,Bryant Ranch Prepack,71335-1360,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1360-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136004,Methadone,10
METHADONE HYDROCHLORIDE,71335-1360-5,10 mg/1,TABLET,ORAL,ANDA090635,Bryant Ranch Prepack,71335-1360,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,180 TABLET in 1 BOTTLE (71335-1360-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136005,Methadone,10
METHADONE HYDROCHLORIDE,71335-1360-6,10 mg/1,TABLET,ORAL,ANDA090635,Bryant Ranch Prepack,71335-1360,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1360-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136006,Methadone,10
METHADONE HYDROCHLORIDE,71335-1360-7,10 mg/1,TABLET,ORAL,ANDA090635,Bryant Ranch Prepack,71335-1360,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1360-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136007,Methadone,10
METHADONE HYDROCHLORIDE,71335-1360-8,10 mg/1,TABLET,ORAL,ANDA090635,Bryant Ranch Prepack,71335-1360,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,112 TABLET in 1 BOTTLE (71335-1360-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136008,Methadone,10
METHADONE HYDROCHLORIDE,71335-1360-9,10 mg/1,TABLET,ORAL,ANDA090635,Bryant Ranch Prepack,71335-1360,METHADONE HYDROCHLORIDE,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-1360-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136009,Methadone,10
Methadone Hydrochloride,0054-3553-44,10 mg/mL,CONCENTRATE,ORAL,ANDA089897,Hikma Pharmaceuticals USA Inc.,0054-3553,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/06/1988,N/A,ANDA,"30 mL in 1 BOTTLE, DROPPER (0054-3553-44)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00054355344,Methadone,10
Methadone Hydrochloride,0054-3555-63,5 mg/5mL,SOLUTION,ORAL,ANDA087393,Hikma Pharmaceuticals USA Inc.,0054-3555,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/22/1981,N/A,ANDA,500 mL in 1 BOTTLE (0054-3555-63),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00054355563,Methadone,5
Methadone Hydrochloride,0054-3556-63,10 mg/5mL,SOLUTION,ORAL,ANDA087997,Hikma Pharmaceuticals USA Inc.,0054-3556,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/30/1982,N/A,ANDA,500 mL in 1 BOTTLE (0054-3556-63),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00054355663,Methadone,10
Methadone Hydrocloride,0527-1927-36,10 mg/mL,CONCENTRATE,ORAL,ANDA212093,"Lannett Company, Inc.",0527-1927,methadone hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/02/2020,N/A,ANDA,"1 BOTTLE, PLASTIC in 1 CARTON (0527-1927-36)  / 30 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527192736,Methadone,10
Methadone Hydrocloride,0527-1927-39,10 mg/mL,CONCENTRATE,ORAL,ANDA212093,"Lannett Company, Inc.",0527-1927,methadone hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/02/2020,N/A,ANDA,"1000 mL in 1 BOTTLE, PLASTIC (0527-1927-39)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527192739,Methadone,10
Methadone Hydrocloride,17856-1929-1,10 mg/mL,CONCENTRATE,ORAL,ANDA212093,ATLANTIC BIOLOGICALS CORP.,17856-1929,methadone hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/13/2023,N/A,ANDA,"48 SYRINGE in 1 BOX, UNIT-DOSE (17856-1929-1)  / 5 mL in 1 SYRINGE (17856-1929-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,17856192901,Methadone,10
Methadone Hydrocloride,63629-2098-1,10 mg/mL,CONCENTRATE,ORAL,ANDA212093,Bryant Ranch Prepack,63629-2098,methadone hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2021,N/A,ANDA,"30 mL in 1 BOTTLE, PLASTIC (63629-2098-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629209801,Methadone,10
Methadone Hydrocloride,17856-1928-4,10 mg/mL,CONCENTRATE,ORAL,ANDA212093,ATLANTIC BIOLOGICALS CORP.,17856-1928,methadone hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/09/2022,N/A,ANDA,"5 BOX, UNIT-DOSE in 1 SYRINGE (17856-1928-4)  / 60 SYRINGE in 1 BOX, UNIT-DOSE (17856-1928-1)  / 1 mL in 1 SYRINGE (17856-1928-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17856192804,Methadone,10
Methadone Hydrocloride,17856-1928-5,10 mg/mL,CONCENTRATE,ORAL,ANDA212093,ATLANTIC BIOLOGICALS CORP.,17856-1928,methadone hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/09/2022,N/A,ANDA,"5 BOX, UNIT-DOSE in 1 SYRINGE (17856-1928-5)  / 60 SYRINGE in 1 BOX, UNIT-DOSE (17856-1928-2)  / .5 mL in 1 SYRINGE (17856-1928-8)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17856192805,Methadone,10
Methadone Hydrocloride,17856-1928-6,10 mg/mL,CONCENTRATE,ORAL,ANDA212093,ATLANTIC BIOLOGICALS CORP.,17856-1928,methadone hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/09/2022,N/A,ANDA,"5 BOX, UNIT-DOSE in 1 SYRINGE (17856-1928-6)  / 60 SYRINGE in 1 BOX, UNIT-DOSE (17856-1928-3)  / .25 mL in 1 SYRINGE (17856-1928-9)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17856192806,Methadone,10
Methadone Hydrocloride,0527-1926-36,10 mg/mL,CONCENTRATE,ORAL,ANDA212094,"Lannett Company, Inc.",0527-1926,methadone hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/03/2021,N/A,ANDA,"1 BOTTLE, PLASTIC in 1 CARTON (0527-1926-36)  / 30 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527192636,Methadone,10
Methadone Hydrocloride,0527-1926-39,10 mg/mL,CONCENTRATE,ORAL,ANDA212094,"Lannett Company, Inc.",0527-1926,methadone hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/03/2021,N/A,ANDA,"1000 mL in 1 BOTTLE, PLASTIC (0527-1926-39)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527192639,Methadone,10
METHADOSE,0406-0527-10,10 mg/mL,CONCENTRATE,ORAL,NDA017116,SpecGx LLC,0406-0527,methadone hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/14/1973,N/A,NDA,"1000 mL in 1 BOTTLE, PLASTIC (0406-0527-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406052710,Methadone,10
METHADOSE,0406-8725-10,10 mg/mL,CONCENTRATE,ORAL,NDA017116,SpecGx LLC,0406-8725,methadone hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/14/1973,N/A,NDA,"1000 mL in 1 BOTTLE, PLASTIC (0406-8725-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406872510,Methadone,10
METHADOSE DISPERSIBLE,0406-0540-34,40 mg/1,TABLET,ORAL,ANDA074184,SpecGx LLC,0406-0540,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/29/1993,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-0540-34),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406054034,Methadone,40
APOKYN,27505-004-05,30 mg/3mL,INJECTION,SUBCUTANEOUS,NDA021264,"MDD US Operations, LLC",27505-004,APOMORPHINE HYDROCHLORIDE,APOMORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/02/2004,N/A,NDA,5 CARTRIDGE in 1 CARTON (27505-004-05)  / 3 mL in 1 CARTRIDGE (27505-004-01),"Dopamine Agonists [MoA],  Dopaminergic Agonist [EPC]",N/A,No,12/31/2023,27505000405,Morphine,30
apomorphine hydrocloride,52817-720-05,30 mg/3mL,INJECTION,SUBCUTANEOUS,ANDA212025,"TruPharma, LLC",52817-720,APOMORPHINE HYDROCHLORIDE,APOMORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/24/2022,N/A,ANDA,5 CARTRIDGE in 1 CARTON (52817-720-05)  / 3 mL in 1 CARTRIDGE (52817-720-01),"Dopamine Agonists [MoA],  Dopaminergic Agonist [EPC]",N/A,No,12/31/2023,52817072005,Morphine,30
Duramorph,0641-6019-10,1 mg/mL,INJECTION,EPIDURAL; INTRATHECAL; INTRAVENOUS,NDA018565,Hikma Pharmaceuticals USA Inc.,0641-6019,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/18/1984,N/A,NDA,10 AMPULE in 1 CARTON (0641-6019-10)  / 10 mL in 1 AMPULE (0641-6019-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641601910,Morphine,1
Duramorph,0641-6020-10,.5 mg/mL,INJECTION,EPIDURAL; INTRATHECAL; INTRAVENOUS,NDA018565,Hikma Pharmaceuticals USA Inc.,0641-6020,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/18/1984,N/A,NDA,10 AMPULE in 1 CARTON (0641-6020-10)  / 10 mL in 1 AMPULE (0641-6020-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641602010,Morphine,0.5
INFUMORPH 200,0641-6039-01,10 mg/mL,"INJECTION, SOLUTION",EPIDURAL; INTRATHECAL,NDA018565,Hikma Pharmaceuticals USA Inc.,0641-6039,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/18/1984,N/A,NDA,20 mL in 1 AMPULE (0641-6039-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641603901,Morphine,10
INFUMORPH 500,0641-6040-01,25 mg/mL,"INJECTION, SOLUTION",EPIDURAL; INTRATHECAL,NDA018565,Hikma Pharmaceuticals USA Inc.,0641-6040,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/18/1984,N/A,NDA,20 mL in 1 AMPULE (0641-6040-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641604001,Morphine,25
Kadian,0023-6011-60,10 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA020616,"Allergan, Inc.",0023-6011,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/07/2009,06/30/2023,NDA,"60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0023-6011-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,00023601160,Morphine,10
KYNMOBI,63402-010-30,10 mg/1,"FILM, SOLUBLE",SUBLINGUAL,NDA210875,Sunovion Pharmaceuticals Inc.,63402-010,apomorphine hydrochloride,APOMORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/21/2020,N/A,NDA,"30 POUCH in 1 CARTON (63402-010-30)  / 1 FILM, SOLUBLE in 1 POUCH (63402-010-01)","Dopamine Agonists [MoA],  Dopaminergic Agonist [EPC]",N/A,No,12/31/2023,63402001030,Morphine,10
KYNMOBI,63402-015-30,15 mg/1,"FILM, SOLUBLE",SUBLINGUAL,NDA210875,Sunovion Pharmaceuticals Inc.,63402-015,apomorphine hydrochloride,APOMORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/21/2020,N/A,NDA,"30 POUCH in 1 CARTON (63402-015-30)  / 1 FILM, SOLUBLE in 1 POUCH (63402-015-01)","Dopamine Agonists [MoA],  Dopaminergic Agonist [EPC]",N/A,No,12/31/2023,63402001530,Morphine,15
KYNMOBI,63402-020-30,20 mg/1,"FILM, SOLUBLE",SUBLINGUAL,NDA210875,Sunovion Pharmaceuticals Inc.,63402-020,apomorphine hydrochloride,APOMORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/21/2020,N/A,NDA,"30 POUCH in 1 CARTON (63402-020-30)  / 1 FILM, SOLUBLE in 1 POUCH (63402-020-01)","Dopamine Agonists [MoA],  Dopaminergic Agonist [EPC]",N/A,No,12/31/2023,63402002030,Morphine,20
KYNMOBI,63402-025-30,25 mg/1,"FILM, SOLUBLE",SUBLINGUAL,NDA210875,Sunovion Pharmaceuticals Inc.,63402-025,apomorphine hydrochloride,APOMORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/21/2020,N/A,NDA,"30 POUCH in 1 CARTON (63402-025-30)  / 1 FILM, SOLUBLE in 1 POUCH (63402-025-01)","Dopamine Agonists [MoA],  Dopaminergic Agonist [EPC]",N/A,No,12/31/2023,63402002530,Morphine,25
KYNMOBI,63402-030-30,30 mg/1,"FILM, SOLUBLE",SUBLINGUAL,NDA210875,Sunovion Pharmaceuticals Inc.,63402-030,apomorphine hydrochloride,APOMORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/21/2020,N/A,NDA,"30 POUCH in 1 CARTON (63402-030-30)  / 1 FILM, SOLUBLE in 1 POUCH (63402-030-01)","Dopamine Agonists [MoA],  Dopaminergic Agonist [EPC]",N/A,No,12/31/2023,63402003030,Morphine,30
KYNMOBI,63402-110-30,10 mg/1,"FILM, SOLUBLE",SUBLINGUAL,NDA210875,Sunovion Pharmaceuticals Inc.,63402-110,apomorphine hydrochloride,APOMORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/21/2020,N/A,NDA,"30 POUCH in 1 CARTON (63402-110-30)  / 1 FILM, SOLUBLE in 1 POUCH (63402-110-01)","Dopamine Agonists [MoA],  Dopaminergic Agonist [EPC]",N/A,Yes,12/31/2023,63402011030,Morphine,10
KYNMOBI,63402-115-30,15 mg/1,"FILM, SOLUBLE",SUBLINGUAL,NDA210875,Sunovion Pharmaceuticals Inc.,63402-115,apomorphine hydrochloride,APOMORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/21/2020,N/A,NDA,"30 POUCH in 1 CARTON (63402-115-30)  / 1 FILM, SOLUBLE in 1 POUCH (63402-115-01)","Dopamine Agonists [MoA],  Dopaminergic Agonist [EPC]",N/A,Yes,12/31/2023,63402011530,Morphine,15
KYNMOBI,63402-120-30,20 mg/1,"FILM, SOLUBLE",SUBLINGUAL,NDA210875,Sunovion Pharmaceuticals Inc.,63402-120,apomorphine hydrochloride,APOMORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/21/2020,N/A,NDA,"30 POUCH in 1 CARTON (63402-120-30)  / 1 FILM, SOLUBLE in 1 POUCH (63402-120-01)","Dopamine Agonists [MoA],  Dopaminergic Agonist [EPC]",N/A,Yes,12/31/2023,63402012030,Morphine,20
KYNMOBI,63402-125-30,25 mg/1,"FILM, SOLUBLE",SUBLINGUAL,NDA210875,Sunovion Pharmaceuticals Inc.,63402-125,apomorphine hydrochloride,APOMORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/21/2020,N/A,NDA,"30 POUCH in 1 CARTON (63402-125-30)  / 1 FILM, SOLUBLE in 1 POUCH (63402-125-01)","Dopamine Agonists [MoA],  Dopaminergic Agonist [EPC]",N/A,Yes,12/31/2023,63402012530,Morphine,25
KYNMOBI,63402-130-30,30 mg/1,"FILM, SOLUBLE",SUBLINGUAL,NDA210875,Sunovion Pharmaceuticals Inc.,63402-130,apomorphine hydrochloride,APOMORPHINE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/21/2020,N/A,NDA,"30 POUCH in 1 CARTON (63402-130-30)  / 1 FILM, SOLUBLE in 1 POUCH (63402-130-01)","Dopamine Agonists [MoA],  Dopaminergic Agonist [EPC]",N/A,Yes,12/31/2023,63402013030,Morphine,30
MITIGO,66794-160-02,200 mg/20mL,INJECTION,EPIDURAL; INTRATHECAL,ANDA204393,"Piramal Critical Care, Inc.",66794-160,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/25/2019,N/A,ANDA,"1 mL in 1 VIAL, SINGLE-USE (66794-160-02)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,66794016002,Morphine,200
MITIGO,66794-162-02,500 mg/20mL,INJECTION,EPIDURAL; INTRATHECAL,ANDA204393,"Piramal Critical Care, Inc.",66794-162,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,10/15/2018,N/A,ANDA,"1 mL in 1 VIAL, SINGLE-USE (66794-162-02)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,66794016202,Morphine,500
Morphine Sulfate,0121-0904-94,10 mg/5mL,SOLUTION,ORAL,NDA022195,"PAI Holdings, LLC",0121-0904,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,10/09/2020,N/A,NDA,"3 TRAY in 1 CASE (0121-0904-94)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-0904-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00121090494,Morphine,10
Morphine sulfate,63629-1087-1,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,63629-1087,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/26/2022,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-1087-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629108701,Morphine,15
Morphine sulfate,63629-1088-1,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,63629-1088,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/26/2022,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-1088-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629108801,Morphine,30
Morphine sulfate,63629-1089-1,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,63629-1089,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/26/2022,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-1089-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629108901,Morphine,60
Morphine sulfate,63629-1091-1,200 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,63629-1091,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/26/2022,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-1091-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629109101,Morphine,200
Morphine sulfate,63304-453-03,200 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-453,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-453-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304045303,Morphine,200
Morphine Sulfate,40032-543-01,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA203602,"Novel Laboratories, Inc.",40032-543,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (40032-543-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,40032054301,Morphine,100
Morphine Sulfate,60687-617-01,15 mg/1,TABLET,ORAL,ANDA212451,American Health Packaging,60687-617,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,10/18/2021,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-617-01)  / 1 TABLET in 1 BLISTER PACK (60687-617-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60687061701,Morphine,15
Morphine Sulfate,42858-811-17,20 mg/5mL,SOLUTION,ORAL,ANDA206420,Rhodes Pharmaceuticals L.P.,42858-811,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/12/2016,N/A,ANDA,"500 mL in 1 BOTTLE, PLASTIC (42858-811-17)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858081117,Morphine,20
Morphine Sulfate,0115-1277-01,20 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1277,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1277-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115127701,Morphine,20
Morphine Sulfate,0115-1277-03,20 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1277,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1277-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115127703,Morphine,20
Morphine Sulfate,0115-1277-08,20 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1277,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1277-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115127708,Morphine,20
Morphine Sulfate,0115-1278-01,30 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1278,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1278-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115127801,Morphine,30
Morphine Sulfate,0115-1278-03,30 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1278,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1278-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115127803,Morphine,30
Morphine Sulfate,0115-1278-08,30 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1278,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1278-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115127808,Morphine,30
Morphine Sulfate,0115-1279-01,50 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1279,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1279-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115127901,Morphine,50
Morphine Sulfate,0115-1279-03,50 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1279,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1279-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115127903,Morphine,50
Morphine Sulfate,0115-1279-08,50 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1279,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1279-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115127908,Morphine,50
Morphine Sulfate,0115-1280-01,60 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1280,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1280-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115128001,Morphine,60
Morphine Sulfate,0115-1280-03,60 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1280,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1280-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115128003,Morphine,60
Morphine Sulfate,0115-1280-08,60 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1280,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1280-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115128008,Morphine,60
Morphine Sulfate,0115-1281-01,80 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1281,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1281-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115128101,Morphine,80
Morphine Sulfate,0115-1281-03,80 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1281,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1281-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115128103,Morphine,80
Morphine Sulfate,0115-1281-08,80 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1281,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1281-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115128108,Morphine,80
Morphine Sulfate,0115-1282-01,100 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1282,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1282-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115128201,Morphine,100
Morphine Sulfate,0115-1282-03,100 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1282,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1282-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115128203,Morphine,100
Morphine Sulfate,0115-1282-08,100 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1282,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/12/2016,N/A,ANDA,"30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1282-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115128208,Morphine,100
Morphine Sulfate,0121-0825-01,100 mg/5mL,SOLUTION,ORAL,ANDA206573,PAI,0121-0825,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,30 mL in 1 BOTTLE (0121-0825-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00121082501,Morphine,100
Morphine Sulfate,0121-0825-04,100 mg/5mL,SOLUTION,ORAL,ANDA206573,PAI,0121-0825,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,118 mL in 1 BOTTLE (0121-0825-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00121082504,Morphine,100
Morphine Sulfate,0121-0825-08,100 mg/5mL,SOLUTION,ORAL,ANDA206573,PAI,0121-0825,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/14/2016,N/A,ANDA,240 mL in 1 BOTTLE (0121-0825-08),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00121082508,Morphine,100
MORPHINE SULFATE,71335-9662-1,30 mg/1,TABLET,ORAL,ANDA212451,Bryant Ranch Prepack,71335-9662,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/13/2023,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-9662-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335966201,Morphine,30
MORPHINE SULFATE,71335-9662-2,30 mg/1,TABLET,ORAL,ANDA212451,Bryant Ranch Prepack,71335-9662,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/13/2023,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-9662-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335966202,Morphine,30
MORPHINE SULFATE,71335-9662-3,30 mg/1,TABLET,ORAL,ANDA212451,Bryant Ranch Prepack,71335-9662,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/13/2023,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-9662-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335966203,Morphine,30
MORPHINE SULFATE,71335-9662-4,30 mg/1,TABLET,ORAL,ANDA212451,Bryant Ranch Prepack,71335-9662,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/13/2023,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-9662-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335966204,Morphine,30
MORPHINE SULFATE,71335-9662-5,30 mg/1,TABLET,ORAL,ANDA212451,Bryant Ranch Prepack,71335-9662,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/13/2023,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-9662-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335966205,Morphine,30
MORPHINE SULFATE,71335-9662-6,30 mg/1,TABLET,ORAL,ANDA212451,Bryant Ranch Prepack,71335-9662,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/13/2023,N/A,ANDA,180 TABLET in 1 BOTTLE (71335-9662-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335966206,Morphine,30
MORPHINE SULFATE,71335-9662-7,30 mg/1,TABLET,ORAL,ANDA212451,Bryant Ranch Prepack,71335-9662,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/13/2023,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-9662-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335966207,Morphine,30
Morphine Sulfate,51862-615-01,15 mg/1,TABLET,ORAL,ANDA207270,Mayne Pharma Inc,51862-615,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/14/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (51862-615-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,51862061501,Morphine,15
Morphine sulfate,71335-0239-6,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203849,Bryant Ranch Prepack,71335-0239,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0239-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335023906,Morphine,15
Morphine Sulfate,42858-803-01,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Rhodes Pharmaceuticals L. P.,42858-803,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/14/2011,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42858-803-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858080301,Morphine,60
Morphine Sulfate,0641-6125-25,4 mg/mL,INJECTION,INTRAVENOUS,ANDA205758,Hikma Pharmaceuticals USA Inc.,0641-6125,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/03/2015,N/A,ANDA,"25 VIAL, SINGLE-DOSE in 1 PACKAGE (0641-6125-25)  / 1 mL in 1 VIAL, SINGLE-DOSE (0641-6125-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641612525,Morphine,4
Morphine Sulfate,0641-6126-25,8 mg/mL,INJECTION,INTRAVENOUS,ANDA205758,Hikma Pharmaceuticals USA Inc.,0641-6126,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/03/2015,N/A,ANDA,"25 VIAL, SINGLE-DOSE in 1 PACKAGE (0641-6126-25)  / 1 mL in 1 VIAL, SINGLE-DOSE (0641-6126-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641612625,Morphine,8
Morphine Sulfate,0641-6127-25,10 mg/mL,INJECTION,INTRAVENOUS,ANDA205758,Hikma Pharmaceuticals USA Inc.,0641-6127,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/03/2015,N/A,ANDA,"25 VIAL, SINGLE-DOSE in 1 PACKAGE (0641-6127-25)  / 1 mL in 1 VIAL, SINGLE-DOSE (0641-6127-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641612725,Morphine,10
Morphine Sulfate,0832-0273-11,15 mg/1,TABLET,ORAL,ANDA210610,"Upsher-Smith Laboratories, LLC",0832-0273,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/22/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (0832-0273-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832027311,Morphine,15
Morphine Sulfate,0832-0274-11,30 mg/1,TABLET,ORAL,ANDA210610,"Upsher-Smith Laboratories, LLC",0832-0274,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/22/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (0832-0274-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832027411,Morphine,30
Morphine Sulfate,51862-187-01,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA205386,Mayne Pharma Inc.,51862-187,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/01/2016,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51862-187-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,51862018701,Morphine,60
Morphine Sulfate,51862-617-01,30 mg/1,TABLET,ORAL,ANDA207270,Mayne Pharma Inc,51862-617,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/14/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (51862-617-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,51862061701,Morphine,30
Morphine Sulfate,68084-158-01,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,American Health Packaging,68084-158,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,08/27/2013,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-158-01)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (68084-158-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68084015801,Morphine,30
Morphine Sulfate,40032-541-05,30 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA203602,"Novel Laboratories, Inc.",40032-541,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"500 TABLET, EXTENDED RELEASE in 1 BOTTLE (40032-541-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,40032054105,Morphine,30
Morphine Sulfate,75826-129-05,10 mg/5mL,SOLUTION,ORAL,ANDA211454,Winder Laboratories LLC,75826-129,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/15/2019,N/A,ANDA,"100 mL in 1 BOTTLE, PLASTIC (75826-129-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,75826012905,Morphine,10
Morphine Sulfate,75826-129-17,10 mg/5mL,SOLUTION,ORAL,ANDA211454,Winder Laboratories LLC,75826-129,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/15/2019,N/A,ANDA,"500 mL in 1 BOTTLE, PLASTIC (75826-129-17)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,75826012917,Morphine,10
Morphine Sulfate,75826-130-05,20 mg/5mL,SOLUTION,ORAL,ANDA211454,Winder Laboratories LLC,75826-130,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/15/2019,N/A,ANDA,"100 mL in 1 BOTTLE, PLASTIC (75826-130-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,75826013005,Morphine,20
Morphine Sulfate,75826-130-17,20 mg/5mL,SOLUTION,ORAL,ANDA211454,Winder Laboratories LLC,75826-130,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/15/2019,N/A,ANDA,"500 mL in 1 BOTTLE, PLASTIC (75826-130-17)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,75826013017,Morphine,20
Morphine Sulfate,75826-131-01,100 mg/5mL,SOLUTION,ORAL,ANDA211454,Winder Laboratories LLC,75826-131,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/01/2022,N/A,ANDA,"30 mL in 1 BOTTLE, PLASTIC (75826-131-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,75826013101,Morphine,100
Morphine Sulfate,75826-131-04,100 mg/5mL,SOLUTION,ORAL,ANDA211454,Winder Laboratories LLC,75826-131,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/15/2019,N/A,ANDA,"120 mL in 1 BOTTLE, PLASTIC (75826-131-04)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,75826013104,Morphine,100
Morphine sulfate,71335-0676-0,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0676,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,"40 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067600,Morphine,30
Morphine Sulfate,0054-0235-24,15 mg/1,TABLET,ORAL,NDA022207,Hikma Pharmaceuticals USA Inc.,0054-0235,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/17/2008,N/A,NDA,100 BLISTER PACK in 1 CARTON (0054-0235-24)  / 1 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054023524,Morphine,15
Morphine Sulfate,0054-0235-25,15 mg/1,TABLET,ORAL,NDA022207,Hikma Pharmaceuticals USA Inc.,0054-0235,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/17/2008,N/A,NDA,100 TABLET in 1 BOTTLE (0054-0235-25),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054023525,Morphine,15
Morphine Sulfate,0054-0236-24,30 mg/1,TABLET,ORAL,NDA022207,Hikma Pharmaceuticals USA Inc.,0054-0236,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/17/2008,N/A,NDA,100 BLISTER PACK in 1 CARTON (0054-0236-24)  / 1 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054023624,Morphine,30
Morphine Sulfate,0054-0236-25,30 mg/1,TABLET,ORAL,NDA022207,Hikma Pharmaceuticals USA Inc.,0054-0236,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/17/2008,N/A,NDA,100 TABLET in 1 BOTTLE (0054-0236-25),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054023625,Morphine,30
Morphine Sulfate,0054-0237-49,10 mg/5mL,SOLUTION,ORAL,NDA022195,Hikma Pharmaceuticals USA Inc.,0054-0237,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/17/2008,N/A,NDA,100 mL in 1 BOTTLE (0054-0237-49),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054023749,Morphine,10
Morphine Sulfate,0054-0237-63,10 mg/5mL,SOLUTION,ORAL,NDA022195,Hikma Pharmaceuticals USA Inc.,0054-0237,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/17/2008,N/A,NDA,500 mL in 1 BOTTLE (0054-0237-63),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054023763,Morphine,10
Morphine Sulfate,0054-0238-49,20 mg/5mL,SOLUTION,ORAL,NDA022195,Hikma Pharmaceuticals USA Inc.,0054-0238,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/17/2008,N/A,NDA,100 mL in 1 BOTTLE (0054-0238-49),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054023849,Morphine,20
Morphine Sulfate,0054-0238-63,20 mg/5mL,SOLUTION,ORAL,NDA022195,Hikma Pharmaceuticals USA Inc.,0054-0238,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/17/2008,N/A,NDA,500 mL in 1 BOTTLE (0054-0238-63),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054023863,Morphine,20
Morphine sulfate,63629-1090-1,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,63629-1090,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-1090-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629109001,Morphine,100
Morphine Sulfate,63323-454-01,4 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA204223,"Fresenius Kabi USA, LLC",63323-454,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/10/2018,N/A,NDA,"25 VIAL, SINGLE-DOSE in 1 BOX (63323-454-01)  / 1 mL in 1 VIAL, SINGLE-DOSE (63323-454-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323045401,Morphine,4
Morphine Sulfate,0409-1891-23,4 mg/mL,"INJECTION, SOLUTION",INTRAVENOUS,NDA202515,"Hospira, Inc.",0409-1891,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/01/2021,N/A,NDA,10 SYRINGE in 1 CELLO PACK (0409-1891-23)  / 1 mL in 1 SYRINGE (0409-1891-13),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00409189123,Morphine,4
Morphine Sulfate,0409-1893-23,10 mg/mL,"INJECTION, SOLUTION",INTRAVENOUS,NDA202515,"Hospira, Inc.",0409-1893,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/01/2021,N/A,NDA,10 SYRINGE in 1 CELLO PACK (0409-1893-23)  / 1 mL in 1 SYRINGE (0409-1893-13),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00409189323,Morphine,10
Morphine Sulfate,70166-101-20,100 mg/5mL,"SOLUTION, CONCENTRATE",ORAL,NDA201517,Lohxa,70166-101,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/29/2018,N/A,NDA,"30 BAG in 1 BOX (70166-101-20)  / 1 SYRINGE, PLASTIC in 1 BAG / 1 mL in 1 SYRINGE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,70166010120,Morphine,100
Morphine sulfate,71335-0676-2,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0676,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/20/2018,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067602,Morphine,30
Morphine sulfate,71335-0676-5,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0676,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067605,Morphine,30
Morphine Sulfate,76329-1912-1,1 mg/30mL,INJECTION,INTRAVENOUS,ANDA202861,"International Medication Systems, Limited",76329-1912,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/20/2022,N/A,ANDA,1 VIAL in 1 CARTON (76329-1912-1)  / 30 mL in 1 VIAL,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76329191201,Morphine,1
Morphine Sulfate,75826-131-15,100 mg/5mL,SOLUTION,ORAL,ANDA211454,Winder Laboratories LLC,75826-131,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/15/2019,N/A,ANDA,"15 mL in 1 BOTTLE, PLASTIC (75826-131-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,75826013115,Morphine,100
Morphine Sulfate,40032-543-05,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA203602,"Novel Laboratories, Inc.",40032-543,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"500 TABLET, EXTENDED RELEASE in 1 BOTTLE (40032-543-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,40032054305,Morphine,100
Morphine Sulfate,67296-1522-1,15 mg/1,TABLET,ORAL,NDA022207,"RedPharm Drug, Inc.",67296-1522,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/17/2008,N/A,NDA,10 TABLET in 1 BOTTLE (67296-1522-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296152201,Morphine,15
Morphine Sulfate,67296-1561-2,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,"RedPharm Drug, Inc.",67296-1561,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/14/2011,N/A,ANDA,"20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67296-1561-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296156102,Morphine,15
Morphine sulfate,63304-450-01,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-450,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-450-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304045001,Morphine,15
Morphine sulfate,63304-450-03,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-450,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-450-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304045003,Morphine,15
Morphine sulfate,63304-452-05,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-452,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-452-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304045205,Morphine,100
Morphine sulfate,63304-453-05,200 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-453,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-453-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304045305,Morphine,200
Morphine Sulfate,70166-101-10,100 mg/5mL,"SOLUTION, CONCENTRATE",ORAL,NDA201517,Lohxa,70166-101,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/29/2018,N/A,NDA,"30 BAG in 1 BOX (70166-101-10)  / 1 SYRINGE, PLASTIC in 1 BAG / .5 mL in 1 SYRINGE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,70166010110,Morphine,100
Morphine Sulfate,51862-185-01,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA205386,Mayne Pharma Inc.,51862-185,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/01/2016,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51862-185-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,51862018501,Morphine,15
Morphine sulfate,71335-0676-4,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0676,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,"120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067604,Morphine,30
Morphine sulfate,71335-0676-7,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0676,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,"15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067607,Morphine,30
morphine sulfate,50383-965-04,100 mg/5mL,SOLUTION,ORAL,ANDA208809,Akorn,50383-965,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/06/2017,N/A,ANDA,1 BOTTLE in 1 CARTON (50383-965-04)  / 120 mL in 1 BOTTLE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,50383096504,Morphine,100
Morphine Sulfate,72572-440-25,4 mg/mL,INJECTION,INTRAVENOUS,ANDA205758,"Civica, Inc.",72572-440,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/11/2019,N/A,ANDA,"25 VIAL, SINGLE-DOSE in 1 PACKAGE (72572-440-25)  / 1 mL in 1 VIAL, SINGLE-DOSE (72572-440-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72572044025,Morphine,4
Morphine Sulfate,63629-4515-1,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4515,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4515-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629451501,Morphine,60
Morphine Sulfate,63629-4515-2,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4515,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4515-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629451502,Morphine,60
Morphine Sulfate,63629-4515-3,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4515,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4515-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629451503,Morphine,60
Morphine Sulfate,63629-4515-4,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4515,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4515-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629451504,Morphine,60
Morphine Sulfate,63629-4515-5,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4515,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4515-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629451505,Morphine,60
Morphine Sulfate,63629-4515-6,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4515,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4515-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629451506,Morphine,60
Morphine Sulfate,63629-4515-7,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4515,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"28 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4515-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629451507,Morphine,60
Morphine Sulfate,63629-4515-8,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4515,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"8 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4515-8)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629451508,Morphine,60
Morphine Sulfate,49999-848-60,15 mg/1,TABLET,ORAL,NDA022207,Lake Erie Medical DBA Quality Care Products LLC,49999-848,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/19/2012,N/A,NDA,60 TABLET in 1 BOTTLE (49999-848-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,49999084860,Morphine,15
Morphine sulfate,71335-0239-0,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203849,Bryant Ranch Prepack,71335-0239,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"26 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0239-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335023900,Morphine,15
Morphine sulfate,0228-3090-11,30 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA079040,"Actavis Pharma, Inc.",0228-3090,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/04/2014,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3090-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00228309011,Morphine,30
Morphine sulfate,0228-3091-11,60 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA079040,"Actavis Pharma, Inc.",0228-3091,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/04/2014,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3091-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00228309111,Morphine,60
Morphine sulfate,0228-3092-11,90 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA079040,"Actavis Pharma, Inc.",0228-3092,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/04/2014,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3092-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00228309211,Morphine,90
Morphine sulfate,0228-3093-11,120 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA079040,"Actavis Pharma, Inc.",0228-3093,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/04/2014,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3093-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00228309311,Morphine,120
Morphine sulfate,0228-3116-11,45 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA079040,"Actavis Pharma, Inc.",0228-3116,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/04/2014,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3116-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00228311611,Morphine,45
Morphine sulfate,0228-3117-11,75 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA079040,"Actavis Pharma, Inc.",0228-3117,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/04/2014,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3117-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00228311711,Morphine,75
Morphine sulfate,0228-3501-06,10 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA020616,"Actavis Pharma, Inc.",0228-3501,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/11/2011,06/30/2023,NDA AUTHORIZED GENERIC,"60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3501-06)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,00228350106,Morphine,10
Morphine sulfate,0228-4270-11,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203849,"Actavis Pharma, Inc.",0228-4270,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,10/26/2015,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0228-4270-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00228427011,Morphine,15
Morphine sulfate,0228-4271-11,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203849,"Actavis Pharma, Inc.",0228-4271,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,10/26/2015,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0228-4271-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00228427111,Morphine,30
Morphine sulfate,0228-4311-11,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203849,"Actavis Pharma, Inc.",0228-4311,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,10/26/2015,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0228-4311-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00228431111,Morphine,60
Morphine sulfate,0228-4323-11,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203849,"Actavis Pharma, Inc.",0228-4323,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,10/26/2015,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0228-4323-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00228432311,Morphine,100
Morphine sulfate,0228-4347-11,200 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203849,"Actavis Pharma, Inc.",0228-4347,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,10/26/2015,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0228-4347-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00228434711,Morphine,200
Morphine Sulfate,0409-1890-23,2 mg/mL,"INJECTION, SOLUTION",INTRAVENOUS,NDA202515,"Hospira, Inc.",0409-1890,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/11/2021,N/A,NDA,10 SYRINGE in 1 CELLO PACK (0409-1890-23)  / 1 mL in 1 SYRINGE (0409-1890-13),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00409189023,Morphine,2
Morphine Sulfate,63629-2535-1,10 mg/1,SUPPOSITORY,RECTAL,NA,Bryant Ranch Prepack,63629-2535,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/01/2021,N/A,UNAPPROVED DRUG OTHER,12 PACKET in 1 BOX (63629-2535-1)  / 1 SUPPOSITORY in 1 PACKET,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629253501,Morphine,10
Morphine Sulfate,63629-2536-1,20 mg/1,SUPPOSITORY,RECTAL,NA,Bryant Ranch Prepack,63629-2536,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/01/2021,N/A,UNAPPROVED DRUG OTHER,12 PACKET in 1 BOX (63629-2536-1)  / 1 SUPPOSITORY in 1 PACKET,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629253601,Morphine,20
Morphine Sulfate,63629-2537-1,5 mg/1,SUPPOSITORY,RECTAL,NA,Bryant Ranch Prepack,63629-2537,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/01/2021,N/A,UNAPPROVED DRUG OTHER,12 PACKET in 1 BOX (63629-2537-1)  / 1 SUPPOSITORY in 1 PACKET,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629253701,Morphine,5
Morphine Sulfate,49999-848-90,15 mg/1,TABLET,ORAL,NDA022207,Lake Erie Medical DBA Quality Care Products LLC,49999-848,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/27/2015,N/A,NDA,90 TABLET in 1 BOTTLE (49999-848-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,49999084890,Morphine,15
Morphine Sulfate,63629-4484-1,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4484,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/18/2011,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448401,Morphine,30
Morphine Sulfate,63629-4484-2,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4484,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/18/2011,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448402,Morphine,30
Morphine Sulfate,63629-4484-3,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4484,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/03/2011,N/A,ANDA,"90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448403,Morphine,30
Morphine Sulfate,63629-4484-4,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4484,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/07/2012,N/A,ANDA,"120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448404,Morphine,30
Morphine Sulfate,63629-4484-5,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4484,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,08/25/2011,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448405,Morphine,30
Morphine Sulfate,63629-4484-6,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4484,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,"5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448406,Morphine,30
Morphine Sulfate,63629-4484-7,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4484,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/29/2014,N/A,ANDA,"15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448407,Morphine,30
Morphine Sulfate,63629-4484-8,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4484,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,"20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-8)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448408,Morphine,30
Morphine Sulfate,40032-540-05,15 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA203602,"Novel Laboratories, Inc.",40032-540,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"500 TABLET, EXTENDED RELEASE in 1 BOTTLE (40032-540-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,40032054005,Morphine,15
Morphine Sulfate,76329-1911-1,1 mg/mL,INJECTION,INTRAVENOUS,NA,"International Medication Systems, Limited",76329-1911,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/27/1987,10/31/2023,UNAPPROVED DRUG OTHER,10 SYRINGE in 1 PACKAGE (76329-1911-1)  / 30 mL in 1 SYRINGE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,76329191101,Morphine,1
Morphine Sulfate,0574-7110-12,5 mg/1,SUPPOSITORY,RECTAL,NA,Padagis US LLC,0574-7110,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/01/1990,N/A,UNAPPROVED DRUG OTHER,12 PACKET in 1 BOX (0574-7110-12)  / 1 SUPPOSITORY in 1 PACKET,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00574711012,Morphine,5
Morphine Sulfate,0574-7112-12,10 mg/1,SUPPOSITORY,RECTAL,NA,Padagis US LLC,0574-7112,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/01/1990,N/A,UNAPPROVED DRUG OTHER,12 PACKET in 1 BOX (0574-7112-12)  / 1 SUPPOSITORY in 1 PACKET,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00574711212,Morphine,10
Morphine Sulfate,0574-7114-12,20 mg/1,SUPPOSITORY,RECTAL,NA,Padagis US LLC,0574-7114,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/01/1990,N/A,UNAPPROVED DRUG OTHER,12 PACKET in 1 BOX (0574-7114-12)  / 1 SUPPOSITORY in 1 PACKET,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00574711412,Morphine,20
Morphine Sulfate,0574-7116-12,30 mg/1,SUPPOSITORY,RECTAL,NA,Padagis US LLC,0574-7116,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/01/1990,N/A,UNAPPROVED DRUG OTHER,12 PACKET in 1 BOX (0574-7116-12)  / 1 SUPPOSITORY in 1 PACKET,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00574711612,Morphine,30
Morphine sulfate,71335-0239-2,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203849,Bryant Ranch Prepack,71335-0239,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0239-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335023902,Morphine,15
Morphine sulfate,71335-0239-5,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203849,Bryant Ranch Prepack,71335-0239,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"40 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0239-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335023905,Morphine,15
Morphine sulfate,71335-0239-8,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203849,Bryant Ranch Prepack,71335-0239,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0239-8)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335023908,Morphine,15
Morphine sulfate,63304-758-01,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-758,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-758-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304075801,Morphine,60
Morphine sulfate,63304-758-50,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-758,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"50 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-758-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304075850,Morphine,60
Morphine sulfate,71335-0707-1,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0707,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0707-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335070701,Morphine,60
Morphine sulfate,71335-0707-2,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0707,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0707-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335070702,Morphine,60
Morphine sulfate,71335-0707-3,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0707,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0707-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335070703,Morphine,60
Morphine sulfate,71335-0707-4,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0707,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0707-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335070704,Morphine,60
Morphine sulfate,71335-0707-5,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0707,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0707-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335070705,Morphine,60
Morphine sulfate,71335-0707-6,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0707,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0707-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335070706,Morphine,60
Morphine sulfate,71335-0707-7,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0707,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"28 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0707-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335070707,Morphine,60
Morphine sulfate,71335-0707-8,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0707,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"8 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0707-8)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335070708,Morphine,60
Morphine sulfate,71335-0736-0,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0736,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"26 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0736-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335073600,Morphine,15
Morphine sulfate,71335-0736-1,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0736,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0736-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335073601,Morphine,15
Morphine sulfate,71335-0736-2,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0736,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0736-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335073602,Morphine,15
Morphine sulfate,71335-0736-3,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0736,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0736-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335073603,Morphine,15
Morphine sulfate,71335-0736-4,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0736,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0736-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335073604,Morphine,15
Morphine sulfate,71335-0736-5,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0736,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"40 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0736-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335073605,Morphine,15
Morphine sulfate,71335-0736-6,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0736,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0736-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335073606,Morphine,15
Morphine sulfate,71335-0736-7,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0736,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0736-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335073607,Morphine,15
Morphine sulfate,71335-0736-8,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0736,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0736-8)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335073608,Morphine,15
Morphine sulfate,71335-0736-9,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0736,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"84 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0736-9)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335073609,Morphine,15
Morphine Sulfate,63629-2538-1,30 mg/1,SUPPOSITORY,RECTAL,NA,Bryant Ranch Prepack,63629-2538,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/01/2021,N/A,UNAPPROVED DRUG OTHER,12 PACKET in 1 BOX (63629-2538-1)  / 1 SUPPOSITORY in 1 PACKET,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629253801,Morphine,30
Morphine Sulfate,43386-543-01,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203602,"Lupin Pharmaceuticals,Inc.",43386-543,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43386-543-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386054301,Morphine,100
Morphine Sulfate,43386-544-01,200 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203602,"Lupin Pharmaceuticals,Inc.",43386-544,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43386-544-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386054401,Morphine,200
Morphine Sulfate,0904-6557-61,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Major Pharmaceuticals,0904-6557,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/14/2011,N/A,ANDA,"100 BLISTER PACK in 1 CARTON (0904-6557-61)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00904655761,Morphine,15
Morphine Sulfate,0904-6558-61,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Major Pharmaceuticals,0904-6558,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/14/2011,N/A,ANDA,"100 BLISTER PACK in 1 CARTON (0904-6558-61)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00904655861,Morphine,30
Morphine Sulfate,0904-6559-61,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Major Pharmaceuticals,0904-6559,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/14/2011,N/A,ANDA,"100 BLISTER PACK in 1 CARTON (0904-6559-61)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00904655961,Morphine,60
Morphine Sulfate,0904-6560-61,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074769,Major Pharmaceuticals,0904-6560,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/14/2011,N/A,ANDA,"100 BLISTER PACK in 1 CARTON (0904-6560-61)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00904656061,Morphine,100
Morphine sulfate,55700-824-30,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Quality Care Products, LLC",55700-824,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/15/2019,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55700-824-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700082430,Morphine,15
Morphine sulfate,55700-824-60,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Quality Care Products, LLC",55700-824,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/15/2019,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55700-824-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700082460,Morphine,15
Morphine sulfate,55700-824-90,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Quality Care Products, LLC",55700-824,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/15/2019,N/A,ANDA,"90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55700-824-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700082490,Morphine,15
Morphine sulfate,55700-825-30,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Quality Care Products, LLC",55700-825,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/06/2020,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55700-825-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700082530,Morphine,30
Morphine sulfate,55700-825-60,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Quality Care Products, LLC",55700-825,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/06/2020,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55700-825-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700082560,Morphine,30
Morphine sulfate,55700-825-90,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Quality Care Products, LLC",55700-825,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/21/2020,N/A,ANDA,"90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55700-825-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700082590,Morphine,30
Morphine Sulfate,76045-004-11,2 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA204223,"Fresenius Kabi, USA LLC",76045-004,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/25/2019,N/A,NDA,"10 SYRINGE, GLASS in 1 CARTON (76045-004-11)  / 1 mL in 1 SYRINGE, GLASS (76045-004-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045000411,Morphine,2
Morphine Sulfate,76045-005-11,4 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA204223,"Fresenius Kabi, USA LLC",76045-005,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/25/2019,N/A,NDA,"10 SYRINGE, GLASS in 1 CARTON (76045-005-11)  / 1 mL in 1 SYRINGE, GLASS (76045-005-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045000511,Morphine,4
Morphine Sulfate,76045-006-11,5 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA204223,"Fresenius Kabi, USA LLC",76045-006,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/25/2019,N/A,NDA,"10 SYRINGE, GLASS in 1 CARTON (76045-006-11)  / 1 mL in 1 SYRINGE, GLASS (76045-006-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045000611,Morphine,5
Morphine Sulfate,76045-007-11,8 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA204223,"Fresenius Kabi, USA LLC",76045-007,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/25/2019,N/A,NDA,"10 SYRINGE, GLASS in 1 CARTON (76045-007-11)  / 1 mL in 1 SYRINGE, GLASS (76045-007-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045000711,Morphine,8
Morphine Sulfate,76045-008-11,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA204223,"Fresenius Kabi, USA LLC",76045-008,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/25/2019,N/A,NDA,"10 SYRINGE, GLASS in 1 CARTON (76045-008-11)  / 1 mL in 1 SYRINGE, GLASS (76045-008-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045000811,Morphine,10
Morphine sulfate,63304-453-01,200 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-453,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-453-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304045301,Morphine,200
Morphine Sulfate,70166-101-02,100 mg/5mL,"SOLUTION, CONCENTRATE",ORAL,NDA201517,Lohxa,70166-101,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/29/2018,N/A,NDA,"30 BAG in 1 BOX (70166-101-02)  / 1 SYRINGE, PLASTIC in 1 BAG / .125 mL in 1 SYRINGE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,70166010102,Morphine,100
Morphine sulfate,71335-0239-4,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203849,Bryant Ranch Prepack,71335-0239,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0239-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335023904,Morphine,15
Morphine sulfate,71335-0239-9,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203849,Bryant Ranch Prepack,71335-0239,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"84 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0239-9)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335023909,Morphine,15
Morphine Sulfate,76045-004-12,2 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA204223,"Fresenius Kabi USA, LLC",76045-004,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/11/2020,N/A,NDA,"24 BLISTER PACK in 1 CARTON (76045-004-12)  / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-004-02)  / 1 mL in 1 SYRINGE, GLASS","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045000412,Morphine,2
Morphine Sulfate,76045-005-12,4 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA204223,"Fresenius Kabi USA, LLC",76045-005,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/11/2020,N/A,NDA,"24 BLISTER PACK in 1 CARTON (76045-005-12)  / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-005-02)  / 1 mL in 1 SYRINGE, GLASS","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045000512,Morphine,4
Morphine Sulfate,76045-006-12,5 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA204223,"Fresenius Kabi USA, LLC",76045-006,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/11/2020,N/A,NDA,"24 BLISTER PACK in 1 CARTON (76045-006-12)  / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-006-02)  / 1 mL in 1 SYRINGE, GLASS","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045000612,Morphine,5
Morphine Sulfate,76045-007-10,8 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA204223,"Fresenius Kabi USA, LLC",76045-007,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,10/30/2013,N/A,NDA,"24 BLISTER PACK in 1 CARTON (76045-007-10)  / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-007-00)  / 1 mL in 1 SYRINGE, GLASS","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045000710,Morphine,8
Morphine Sulfate,76045-008-10,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA204223,"Fresenius Kabi USA, LLC",76045-008,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,10/30/2013,N/A,NDA,"24 BLISTER PACK in 1 CARTON (76045-008-10)  / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-008-00)  / 1 mL in 1 SYRINGE, GLASS","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76045000810,Morphine,10
Morphine Sulfate,68094-001-62,10 mg/5mL,SOLUTION,ORAL,NDA022195,Precision Dose Inc.,68094-001,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/29/2016,N/A,NDA,"3 TRAY in 1 CASE (68094-001-62)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (68094-001-59)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68094000162,Morphine,10
Morphine Sulfate,51862-188-01,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA205386,Mayne Pharma Inc.,51862-188,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/01/2016,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51862-188-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,51862018801,Morphine,100
Morphine Sulfate,0832-0225-00,10 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,"Upsher-Smith Laboratories, LLC",0832-0225,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/30/2013,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0225-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832022500,Morphine,10
Morphine Sulfate,0832-0225-50,10 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,"Upsher-Smith Laboratories, LLC",0832-0225,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/30/2013,N/A,ANDA,"500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0225-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832022550,Morphine,10
Morphine Sulfate,0832-0226-00,20 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,"Upsher-Smith Laboratories, LLC",0832-0226,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/30/2013,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0226-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832022600,Morphine,20
Morphine Sulfate,0832-0226-50,20 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,"Upsher-Smith Laboratories, LLC",0832-0226,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/30/2013,N/A,ANDA,"500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0226-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832022650,Morphine,20
Morphine Sulfate,0832-0227-00,30 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,"Upsher-Smith Laboratories, LLC",0832-0227,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/30/2013,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0227-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832022700,Morphine,30
Morphine Sulfate,0832-0227-50,30 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,"Upsher-Smith Laboratories, LLC",0832-0227,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/30/2013,N/A,ANDA,"500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0227-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832022750,Morphine,30
Morphine Sulfate,0832-0228-00,50 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,"Upsher-Smith Laboratories, LLC",0832-0228,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/30/2013,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0228-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832022800,Morphine,50
Morphine Sulfate,0832-0228-50,50 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,"Upsher-Smith Laboratories, LLC",0832-0228,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/30/2013,N/A,ANDA,"500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0228-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832022850,Morphine,50
Morphine Sulfate,0832-0229-00,60 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,"Upsher-Smith Laboratories, LLC",0832-0229,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/30/2013,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0229-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832022900,Morphine,60
Morphine Sulfate,0832-0229-50,60 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,"Upsher-Smith Laboratories, LLC",0832-0229,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/30/2013,N/A,ANDA,"500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0229-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832022950,Morphine,60
Morphine Sulfate,0832-0230-00,80 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,"Upsher-Smith Laboratories, LLC",0832-0230,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/30/2013,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0230-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832023000,Morphine,80
Morphine Sulfate,0832-0230-50,80 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,"Upsher-Smith Laboratories, LLC",0832-0230,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/30/2013,N/A,ANDA,"500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0230-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832023050,Morphine,80
Morphine Sulfate,0832-0233-00,100 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,"Upsher-Smith Laboratories, LLC",0832-0233,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/30/2013,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0233-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832023300,Morphine,100
Morphine Sulfate,0832-0233-50,100 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,"Upsher-Smith Laboratories, LLC",0832-0233,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/30/2013,N/A,ANDA,"500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0233-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00832023350,Morphine,100
Morphine Sulfate,63629-2302-1,20 mg/mL,SOLUTION,ORAL,ANDA203518,Bryant Ranch Prepack,63629-2302,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/21/2015,N/A,ANDA,"1 BOTTLE, UNIT-DOSE in 1 CARTON (63629-2302-1)  / 120 mL in 1 BOTTLE, UNIT-DOSE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629230201,Morphine,20
Morphine Sulfate,40032-542-01,60 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA203602,"Novel Laboratories, Inc.",40032-542,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (40032-542-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,40032054201,Morphine,60
Morphine Sulfate,40032-544-01,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA203602,"Novel Laboratories, Inc.",40032-544,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (40032-544-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,40032054401,Morphine,200
Morphine Sulfate,67296-1522-6,15 mg/1,TABLET,ORAL,NDA022207,"RedPharm Drug, Inc.",67296-1522,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/17/2008,N/A,NDA,6 TABLET in 1 BOTTLE (67296-1522-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296152206,Morphine,15
MORPHINE SULFATE,61919-413-30,30 mg/1,TABLET,ORAL,NDA022207,DIRECTRX,61919-413,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/04/2019,N/A,NDA,30 TABLET in 1 BOTTLE (61919-413-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,61919041330,Morphine,30
Morphine Sulfate,0406-8003-12,20 mg/mL,SOLUTION,ORAL,ANDA202348,SpecGx LLC,0406-8003,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/15/2011,N/A,ANDA,"6 CARTON in 1 CASE (0406-8003-12)  / 1 BOTTLE, PLASTIC in 1 CARTON / 120 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406800312,Morphine,20
Morphine Sulfate,0406-8003-15,20 mg/mL,SOLUTION,ORAL,ANDA202348,SpecGx LLC,0406-8003,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/15/2011,N/A,ANDA,"6 CARTON in 1 CASE (0406-8003-15)  / 1 BOTTLE, PLASTIC in 1 CARTON / 15 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406800315,Morphine,20
Morphine Sulfate,0406-8003-24,20 mg/mL,SOLUTION,ORAL,ANDA202348,SpecGx LLC,0406-8003,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/15/2011,N/A,ANDA,"6 CARTON in 1 CASE (0406-8003-24)  / 1 BOTTLE, PLASTIC in 1 CARTON / 240 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406800324,Morphine,20
Morphine Sulfate,0406-8003-30,20 mg/mL,SOLUTION,ORAL,ANDA202348,SpecGx LLC,0406-8003,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/15/2011,N/A,ANDA,"6 CARTON in 1 CASE (0406-8003-30)  / 1 BOTTLE, PLASTIC in 1 CARTON / 30 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406800330,Morphine,20
MORPHINE SULFATE,0406-8315-01,15 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA076412,SpecGx LLC,0406-8315,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/31/2003,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0406-8315-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406831501,Morphine,15
MORPHINE SULFATE,0406-8315-23,15 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA076412,SpecGx LLC,0406-8315,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/31/2003,N/A,ANDA,"1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8315-23)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406831523,Morphine,15
MORPHINE SULFATE,0406-8315-62,15 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA076412,SpecGx LLC,0406-8315,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/31/2003,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8315-62)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406831562,Morphine,15
MORPHINE SULFATE,0406-8320-01,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA076438,SpecGx LLC,0406-8320,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/03/2003,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0406-8320-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406832001,Morphine,200
MORPHINE SULFATE,0406-8330-01,30 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA076412,SpecGx LLC,0406-8330,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/31/2003,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0406-8330-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406833001,Morphine,30
MORPHINE SULFATE,0406-8330-23,30 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA076412,SpecGx LLC,0406-8330,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/31/2003,N/A,ANDA,"1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8330-23)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406833023,Morphine,30
MORPHINE SULFATE,0406-8330-62,30 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA076412,SpecGx LLC,0406-8330,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/31/2003,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8330-62)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406833062,Morphine,30
MORPHINE SULFATE,0406-8380-01,60 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA076412,SpecGx LLC,0406-8380,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/31/2003,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0406-8380-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406838001,Morphine,60
MORPHINE SULFATE,0406-8380-23,60 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA076412,SpecGx LLC,0406-8380,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/31/2003,N/A,ANDA,"1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8380-23)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406838023,Morphine,60
MORPHINE SULFATE,0406-8380-62,60 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA076412,SpecGx LLC,0406-8380,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/31/2003,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8380-62)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406838062,Morphine,60
MORPHINE SULFATE,0406-8390-01,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA076438,SpecGx LLC,0406-8390,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/03/2003,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0406-8390-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406839001,Morphine,100
MORPHINE SULFATE,0406-8390-23,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA076438,SpecGx LLC,0406-8390,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/03/2003,N/A,ANDA,"1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8390-23)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406839023,Morphine,100
MORPHINE SULFATE,0406-8390-62,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA076438,SpecGx LLC,0406-8390,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/03/2003,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8390-62)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406839062,Morphine,100
Morphine Sulfate,0409-1134-03,50 mg/mL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NA,"Hospira, Inc.",0409-1134,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/27/2005,N/A,UNAPPROVED DRUG OTHER,"1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1134-03)  / 20 mL in 1 VIAL, SINGLE-DOSE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409113403,Morphine,50
Morphine Sulfate,0409-1134-05,50 mg/mL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NA,"Hospira, Inc.",0409-1134,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,08/11/2005,N/A,UNAPPROVED DRUG OTHER,"1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1134-05)  / 50 mL in 1 VIAL, SINGLE-DOSE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409113405,Morphine,50
Morphine Sulfate,0409-1890-01,2 mg/mL,"INJECTION, SOLUTION",INTRAVENOUS,NDA202515,"Hospira, Inc.",0409-1890,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,08/23/2012,N/A,NDA,10 CARTRIDGE in 1 CARTON (0409-1890-01)  / 1 mL in 1 CARTRIDGE (0409-1890-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00409189001,Morphine,2
Morphine Sulfate,0409-1891-01,4 mg/mL,"INJECTION, SOLUTION",INTRAVENOUS,NDA202515,"Hospira, Inc.",0409-1891,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,08/07/2012,N/A,NDA,10 CARTRIDGE in 1 CARTON (0409-1891-01)  / 1 mL in 1 CARTRIDGE (0409-1891-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00409189101,Morphine,4
Morphine Sulfate,0409-1892-01,8 mg/mL,"INJECTION, SOLUTION",INTRAVENOUS,NDA202515,"Hospira, Inc.",0409-1892,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/24/2012,N/A,NDA,10 CARTRIDGE in 1 CARTON (0409-1892-01)  / 1 mL in 1 CARTRIDGE (0409-1892-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00409189201,Morphine,8
Morphine Sulfate,0409-1893-01,10 mg/mL,"INJECTION, SOLUTION",INTRAVENOUS,NDA202515,"Hospira, Inc.",0409-1893,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,08/20/2012,N/A,NDA,10 CARTRIDGE in 1 CARTON (0409-1893-01)  / 1 mL in 1 CARTRIDGE (0409-1893-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00409189301,Morphine,10
Morphine sulfate,71335-0239-3,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203849,Bryant Ranch Prepack,71335-0239,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0239-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335023903,Morphine,15
Morphine Sulfate,0409-3814-12,.5 mg/mL,"INJECTION, SOLUTION",EPIDURAL; INTRATHECAL; INTRAVENOUS,ANDA073509,"Hospira, Inc.",0409-3814,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,08/10/2005,N/A,ANDA,"5 VIAL, GLASS in 1 CARTON (0409-3814-12)  / 10 mL in 1 VIAL, GLASS (0409-3814-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409381412,Morphine,0.5
Morphine Sulfate,0409-3815-12,1 mg/mL,"INJECTION, SOLUTION",EPIDURAL; INTRATHECAL; INTRAVENOUS,ANDA073510,"Hospira, Inc.",0409-3815,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/29/2005,N/A,ANDA,"5 VIAL, GLASS in 1 CARTON (0409-3815-12)  / 10 mL in 1 VIAL, GLASS (0409-3815-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409381512,Morphine,1
Morphine Sulfate,49999-848-30,15 mg/1,TABLET,ORAL,NDA022207,Lake Erie Medical DBA Quality Care Products LLC,49999-848,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/19/2012,N/A,NDA,30 TABLET in 1 BOTTLE (49999-848-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,49999084830,Morphine,15
Morphine Sulfate,68094-056-58,100 mg/5mL,SOLUTION,ORAL,NDA022195,"Precision Dose, Inc.",68094-056,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/30/2022,N/A,NDA,50 BAG in 1 CASE (68094-056-58)  / 1 SYRINGE in 1 BAG / .5 mL in 1 SYRINGE (68094-056-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68094005658,Morphine,100
Morphine Sulfate,40032-542-05,60 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA203602,"Novel Laboratories, Inc.",40032-542,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"500 TABLET, EXTENDED RELEASE in 1 BOTTLE (40032-542-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,40032054205,Morphine,60
Morphine Sulfate,63629-2301-1,20 mg/mL,SOLUTION,ORAL,ANDA203518,Bryant Ranch Prepack,63629-2301,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/21/2015,N/A,ANDA,"1 BOTTLE, UNIT-DOSE in 1 CARTON (63629-2301-1)  / 30 mL in 1 BOTTLE, UNIT-DOSE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629230101,Morphine,20
MORPHINE SULFATE,55700-905-60,30 mg/1,TABLET,ORAL,ANDA212451,"Quality Care Products, LLC",55700-905,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/18/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (55700-905-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700090560,Morphine,30
Morphine Sulfate,63323-452-01,2 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA204223,"Fresenius Kabi USA, LLC",63323-452,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/10/2018,N/A,NDA,"25 VIAL, SINGLE-DOSE in 1 BOX (63323-452-01)  / 1 mL in 1 VIAL, SINGLE-DOSE (63323-452-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323045201,Morphine,2
morphine sulfate,50383-965-30,100 mg/5mL,SOLUTION,ORAL,ANDA208809,Akorn,50383-965,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/06/2017,N/A,ANDA,1 BOTTLE in 1 CARTON (50383-965-30)  / 30 mL in 1 BOTTLE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,50383096530,Morphine,100
Morphine Sulfate,42858-802-01,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Rhodes Pharmaceuticals L. P.,42858-802,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/14/2011,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42858-802-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858080201,Morphine,30
Morphine Sulfate,42858-812-15,100 mg/5mL,SOLUTION,ORAL,ANDA206308,Rhodes Pharmaceuticals L.P.,42858-812,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,"30 mL in 1 BOTTLE, PLASTIC (42858-812-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858081215,Morphine,100
Morphine sulfate,63304-758-05,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-758,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-758-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304075805,Morphine,60
Morphine Sulfate,42858-810-17,10 mg/5mL,SOLUTION,ORAL,ANDA206308,Rhodes Pharmaceuticals L.P.,42858-810,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,"500 mL in 1 BOTTLE, PLASTIC (42858-810-17)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858081017,Morphine,10
Morphine Sulfate,63629-4484-0,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4484,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,"40 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448400,Morphine,30
Morphine Sulfate,63629-4484-9,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4484,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,"26 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-9)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448409,Morphine,30
Morphine Sulfate,43386-541-01,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203602,"Lupin Pharmaceuticals,Inc.",43386-541,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43386-541-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386054101,Morphine,30
Morphine sulfate,71335-0676-1,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0676,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/26/2018,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067601,Morphine,30
Morphine sulfate,71335-0676-6,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0676,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,"5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067606,Morphine,30
Morphine Sulfate,42858-801-01,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Rhodes Pharmaceuticals L. P.,42858-801,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/14/2011,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42858-801-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858080101,Morphine,15
Morphine Sulfate,0121-0825-15,100 mg/5mL,SOLUTION,ORAL,ANDA206573,PAI,0121-0825,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,10/12/2022,N/A,ANDA,1 BOTTLE in 1 CARTON (0121-0825-15)  / 15 mL in 1 BOTTLE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00121082515,Morphine,100
Morphine Sulfate,40032-544-05,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA203602,"Novel Laboratories, Inc.",40032-544,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"500 TABLET, EXTENDED RELEASE in 1 BOTTLE (40032-544-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,40032054405,Morphine,200
Morphine Sulfate,55700-349-30,20 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,Quality Care Products LLC,55700-349,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,"30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (55700-349-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700034930,Morphine,20
Morphine Sulfate,42858-804-01,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074769,Rhodes Pharmaceuticals L. P.,42858-804,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/14/2011,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42858-804-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858080401,Morphine,100
Morphine Sulfate,67296-1522-3,15 mg/1,TABLET,ORAL,NDA022207,"RedPharm Drug, Inc.",67296-1522,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/17/2008,N/A,NDA,30 TABLET in 1 BOTTLE (67296-1522-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296152203,Morphine,15
Morphine Sulfate,67296-1522-9,15 mg/1,TABLET,ORAL,NDA022207,"RedPharm Drug, Inc.",67296-1522,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/17/2008,N/A,NDA,12 TABLET in 1 BOTTLE (67296-1522-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296152209,Morphine,15
Morphine Sulfate,63323-455-01,5 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA204223,"Fresenius Kabi USA, LLC",63323-455,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/10/2018,N/A,NDA,"25 VIAL, SINGLE-DOSE in 1 BOX (63323-455-01)  / 1 mL in 1 VIAL, SINGLE-DOSE (63323-455-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323045501,Morphine,5
Morphine Sulfate,63629-4175-1,15 mg/1,TABLET,ORAL,NDA022207,Bryant Ranch Prepack,63629-4175,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/19/2010,N/A,NDA,60 TABLET in 1 BOTTLE (63629-4175-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629417501,Morphine,15
Morphine Sulfate,63629-4175-2,15 mg/1,TABLET,ORAL,NDA022207,Bryant Ranch Prepack,63629-4175,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/26/2010,N/A,NDA,90 TABLET in 1 BOTTLE (63629-4175-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629417502,Morphine,15
Morphine Sulfate,63629-4175-3,15 mg/1,TABLET,ORAL,NDA022207,Bryant Ranch Prepack,63629-4175,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/14/2011,N/A,NDA,30 TABLET in 1 BOTTLE (63629-4175-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629417503,Morphine,15
Morphine Sulfate,63629-4175-4,15 mg/1,TABLET,ORAL,NDA022207,Bryant Ranch Prepack,63629-4175,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,08/09/2012,N/A,NDA,120 TABLET in 1 BOTTLE (63629-4175-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629417504,Morphine,15
Morphine Sulfate,63629-4175-5,15 mg/1,TABLET,ORAL,NDA022207,Bryant Ranch Prepack,63629-4175,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/26/2013,N/A,NDA,45 TABLET in 1 BOTTLE (63629-4175-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629417505,Morphine,15
Morphine Sulfate,63629-4175-6,15 mg/1,TABLET,ORAL,NDA022207,Bryant Ranch Prepack,63629-4175,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,NDA,15 TABLET in 1 BOTTLE (63629-4175-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629417506,Morphine,15
Morphine Sulfate,63629-4175-7,15 mg/1,TABLET,ORAL,NDA022207,Bryant Ranch Prepack,63629-4175,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,NDA,20 TABLET in 1 BOTTLE (63629-4175-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629417507,Morphine,15
MORPHINE SULFATE,67877-670-01,15 mg/1,TABLET,ORAL,ANDA212451,"Ascend Laboratories, LLC",67877-670,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/11/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (67877-670-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67877067001,Morphine,15
MORPHINE SULFATE,67877-671-01,30 mg/1,TABLET,ORAL,ANDA212451,"Ascend Laboratories, LLC",67877-671,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/11/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (67877-671-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67877067101,Morphine,30
Morphine Sulfate,67296-1753-1,15 mg/1,TABLET,ORAL,ANDA210610,"RedPharm Drug, Inc.",67296-1753,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/22/2019,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-1753-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296175301,Morphine,15
Morphine Sulfate,67296-1753-6,15 mg/1,TABLET,ORAL,ANDA210610,"RedPharm Drug, Inc.",67296-1753,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/22/2019,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-1753-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296175306,Morphine,15
Morphine Sulfate,67296-1753-7,15 mg/1,TABLET,ORAL,ANDA210610,"RedPharm Drug, Inc.",67296-1753,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/22/2019,N/A,ANDA,12 TABLET in 1 BOTTLE (67296-1753-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296175307,Morphine,15
Morphine Sulfate,27808-082-01,20 mg/mL,SOLUTION,ORAL,ANDA203518,Tris Pharma Inc,27808-082,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/21/2015,N/A,ANDA,"1 BOTTLE, UNIT-DOSE in 1 CARTON (27808-082-01)  / 30 mL in 1 BOTTLE, UNIT-DOSE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,27808008201,Morphine,20
Morphine Sulfate,27808-082-02,20 mg/mL,SOLUTION,ORAL,ANDA203518,Tris Pharma Inc,27808-082,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/21/2015,N/A,ANDA,"1 BOTTLE, UNIT-DOSE in 1 CARTON (27808-082-02)  / 120 mL in 1 BOTTLE, UNIT-DOSE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,27808008202,Morphine,20
Morphine Sulfate,42858-805-01,200 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074769,Rhodes Pharmaceuticals L. P.,42858-805,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/14/2011,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42858-805-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858080501,Morphine,200
Morphine sulfate,71335-0676-3,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0676,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,03/09/2018,N/A,ANDA,"90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067603,Morphine,30
Morphine Sulfate,43386-543-05,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203602,"Lupin Pharmaceuticals,Inc.",43386-543,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43386-543-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386054305,Morphine,100
Morphine Sulfate,63629-4483-0,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4483,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/03/2022,N/A,ANDA,"26 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448300,Morphine,15
Morphine Sulfate,63629-4483-1,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4483,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/20/2011,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448301,Morphine,15
Morphine Sulfate,63629-4483-2,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4483,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/14/2011,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448302,Morphine,15
Morphine Sulfate,63629-4483-3,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4483,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/11/2011,N/A,ANDA,"90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448303,Morphine,15
Morphine Sulfate,63629-4483-4,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4483,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/03/2022,N/A,ANDA,"120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448304,Morphine,15
Morphine Sulfate,63629-4483-5,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4483,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/03/2022,N/A,ANDA,"40 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448305,Morphine,15
Morphine Sulfate,63629-4483-6,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4483,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,08/13/2012,N/A,ANDA,"14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448306,Morphine,15
Morphine Sulfate,63629-4483-7,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4483,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/29/2014,N/A,ANDA,"15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448307,Morphine,15
Morphine Sulfate,63629-4483-8,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4483,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/03/2022,N/A,ANDA,"20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-8)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448308,Morphine,15
Morphine Sulfate,63629-4483-9,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,Bryant Ranch Prepack,63629-4483,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/15/2015,N/A,ANDA,"84 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-9)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629448309,Morphine,15
Morphine Sulfate,0115-1479-01,40 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA200411,Amneal Pharmaceuticals of New York LLC,0115-1479,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,10/05/2018,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1479-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115147901,Morphine,40
Morphine Sulfate,68094-045-58,100 mg/5mL,SOLUTION,ORAL,NDA022195,"Precision Dose, Inc.",68094-045,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/01/2020,N/A,NDA,50 BAG in 1 CASE (68094-045-58)  / 1 SYRINGE in 1 BAG / .5 mL in 1 SYRINGE (68094-045-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68094004558,Morphine,100
Morphine Sulfate,43386-540-05,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203602,"Lupin Pharmaceuticals,Inc.",43386-540,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43386-540-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386054005,Morphine,15
Morphine Sulfate,43386-541-05,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203602,"Lupin Pharmaceuticals,Inc.",43386-541,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43386-541-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386054105,Morphine,30
Morphine Sulfate,43386-542-01,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203602,"Lupin Pharmaceuticals,Inc.",43386-542,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43386-542-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386054201,Morphine,60
Morphine sulfate,63304-451-01,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-451,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-451-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304045101,Morphine,30
Morphine sulfate,63304-451-03,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-451,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-451-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304045103,Morphine,30
Morphine sulfate,63304-451-05,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-451,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-451-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304045105,Morphine,30
Morphine Sulfate,42689-005-01,20 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA203158,"Nortec Development Associates, Inc.",42689-005,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/07/2009,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42689-005-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,42689000501,Morphine,20
Morphine Sulfate,42689-006-01,30 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA203158,"Nortec Development Associates, Inc.",42689-006,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/07/2009,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42689-006-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,42689000601,Morphine,30
Morphine Sulfate,42689-007-01,50 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA203158,"Nortec Development Associates, Inc.",42689-007,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/07/2009,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42689-007-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,42689000701,Morphine,50
Morphine Sulfate,42689-008-01,60 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA203158,"Nortec Development Associates, Inc.",42689-008,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/07/2009,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42689-008-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,42689000801,Morphine,60
Morphine Sulfate,42689-009-01,80 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA203158,"Nortec Development Associates, Inc.",42689-009,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/07/2009,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42689-009-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,42689000901,Morphine,80
Morphine Sulfate,42689-010-01,100 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA203158,"Nortec Development Associates, Inc.",42689-010,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/07/2009,N/A,ANDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42689-010-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,42689001001,Morphine,100
Morphine Sulfate,63323-451-01,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA204223,"Fresenius Kabi USA, LLC",63323-451,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/10/2018,N/A,NDA,"25 VIAL, SINGLE-DOSE in 1 BOX (63323-451-01)  / 1 mL in 1 VIAL, SINGLE-DOSE (63323-451-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323045101,Morphine,10
Morphine Sulfate,43386-540-01,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203602,"Lupin Pharmaceuticals,Inc.",43386-540,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43386-540-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386054001,Morphine,15
Morphine Sulfate,43386-542-05,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203602,"Lupin Pharmaceuticals,Inc.",43386-542,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43386-542-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386054205,Morphine,60
Morphine sulfate,71335-0676-9,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0676,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,"26 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-9)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067609,Morphine,30
Morphine Sulfate,68084-157-01,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074862,American Health Packaging,68084-157,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,10/21/2013,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-157-01)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (68084-157-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68084015701,Morphine,15
MORPHINE SULFATE,63629-8459-1,15 mg/1,TABLET,ORAL,ANDA212451,Bryant Ranch Prepack,63629-8459,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/18/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-8459-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629845901,Morphine,15
MORPHINE SULFATE,63629-8460-1,30 mg/1,TABLET,ORAL,ANDA212451,Bryant Ranch Prepack,63629-8460,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/18/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-8460-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629846001,Morphine,30
Morphine Sulfate,63323-458-01,8 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA204223,"Fresenius Kabi USA, LLC",63323-458,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/10/2018,N/A,NDA,"25 VIAL, SINGLE-DOSE in 1 BOX (63323-458-01)  / 1 mL in 1 VIAL, SINGLE-DOSE (63323-458-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323045801,Morphine,8
Morphine Sulfate,40032-540-01,15 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA203602,"Novel Laboratories, Inc.",40032-540,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (40032-540-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,40032054001,Morphine,15
MORPHINE SULFATE,55700-905-30,30 mg/1,TABLET,ORAL,ANDA212451,"Quality Care Products, LLC",55700-905,MORPHINE SULFATE,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,04/16/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (55700-905-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700090530,Morphine,30
Morphine sulfate,63304-450-05,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-450,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-450-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304045005,Morphine,15
Morphine sulfate,63304-452-01,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-452,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-452-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304045201,Morphine,100
Morphine sulfate,63304-452-03,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-452,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-452-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304045203,Morphine,100
Morphine Sulfate,63629-3789-1,30 mg/1,TABLET,ORAL,NDA022207,Bryant Ranch Prepack,63629-3789,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,09/12/2008,N/A,NDA,60 TABLET in 1 BOTTLE (63629-3789-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629378901,Morphine,30
Morphine Sulfate,63629-3789-2,30 mg/1,TABLET,ORAL,NDA022207,Bryant Ranch Prepack,63629-3789,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,10/17/2011,N/A,NDA,30 TABLET in 1 BOTTLE (63629-3789-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629378902,Morphine,30
Morphine Sulfate,63629-3789-3,30 mg/1,TABLET,ORAL,NDA022207,Bryant Ranch Prepack,63629-3789,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/20/2009,N/A,NDA,90 TABLET in 1 BOTTLE (63629-3789-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629378903,Morphine,30
Morphine Sulfate,63629-3789-4,30 mg/1,TABLET,ORAL,NDA022207,Bryant Ranch Prepack,63629-3789,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,08/09/2012,N/A,NDA,120 TABLET in 1 BOTTLE (63629-3789-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629378904,Morphine,30
Morphine Sulfate,63629-3789-5,30 mg/1,TABLET,ORAL,NDA022207,Bryant Ranch Prepack,63629-3789,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,NDA,15 TABLET in 1 BOTTLE (63629-3789-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629378905,Morphine,30
Morphine Sulfate,63629-3789-6,30 mg/1,TABLET,ORAL,NDA022207,Bryant Ranch Prepack,63629-3789,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/19/2013,N/A,NDA,180 TABLET in 1 BOTTLE (63629-3789-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629378906,Morphine,30
Morphine Sulfate,63629-3789-7,30 mg/1,TABLET,ORAL,NDA022207,Bryant Ranch Prepack,63629-3789,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,NDA,20 TABLET in 1 BOTTLE (63629-3789-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629378907,Morphine,30
Morphine Sulfate,63629-8505-1,200 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074769,Bryant Ranch Prepack,63629-8505,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/18/2021,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63629-8505-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629850501,Morphine,200
Morphine Sulfate,55700-349-60,20 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,ANDA202104,Quality Care Products LLC,55700-349,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/23/2015,N/A,ANDA,"60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (55700-349-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700034960,Morphine,20
Morphine Sulfate,63629-4514-1,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074769,Bryant Ranch Prepack,63629-4514,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/24/2011,N/A,ANDA,"90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4514-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629451401,Morphine,100
Morphine Sulfate,63629-4514-2,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074769,Bryant Ranch Prepack,63629-4514,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/02/2011,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4514-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629451402,Morphine,100
Morphine Sulfate,63629-4514-3,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074769,Bryant Ranch Prepack,63629-4514,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/23/2011,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4514-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629451403,Morphine,100
Morphine Sulfate,63629-4514-4,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA074769,Bryant Ranch Prepack,63629-4514,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,07/05/2016,N/A,ANDA,"120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4514-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629451404,Morphine,100
Morphine sulfate,71335-0676-8,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,Bryant Ranch Prepack,71335-0676,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,"20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0676-8)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067608,Morphine,30
Morphine Sulfate,40032-541-01,30 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA203602,"Novel Laboratories, Inc.",40032-541,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (40032-541-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,40032054101,Morphine,30
Morphine Sulfate,70166-101-05,100 mg/5mL,"SOLUTION, CONCENTRATE",ORAL,NDA201517,Lohxa,70166-101,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/29/2018,N/A,NDA,"30 BAG in 1 BOX (70166-101-05)  / 1 SYRINGE, PLASTIC in 1 BAG / .25 mL in 1 SYRINGE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,70166010105,Morphine,100
Morphine Sulfate,42858-812-12,100 mg/5mL,SOLUTION,ORAL,ANDA206308,Rhodes Pharmaceuticals L.P.,42858-812,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,06/22/2017,N/A,ANDA,"120 mL in 1 BOTTLE, PLASTIC (42858-812-12)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858081212,Morphine,100
Morphine sulfate,71335-0239-7,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203849,Bryant Ranch Prepack,71335-0239,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0239-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335023907,Morphine,15
Morphine Sulfate,51862-186-01,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA205386,Mayne Pharma Inc.,51862-186,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,11/01/2016,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51862-186-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,51862018601,Morphine,30
Morphine sulfate,63304-758-03,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA078761,"Sun Pharmaceutical Industries, Inc.",63304-758,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/11/2012,N/A,ANDA,"10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-758-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63304075803,Morphine,60
Morphine Sulfate,43386-544-05,200 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203602,"Lupin Pharmaceuticals,Inc.",43386-544,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,12/16/2015,N/A,ANDA,"500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43386-544-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386054405,Morphine,200
Morphine sulfate,71335-0239-1,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA203849,Bryant Ranch Prepack,71335-0239,Morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0239-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335023901,Morphine,15
Morphine Sulfate,0054-0404-41,100 mg/5mL,SOLUTION,ORAL,NDA022195,Hikma Pharmaceuticals USA Inc.,0054-0404,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/24/2011,N/A,NDA,15 mL in 1 BOTTLE (0054-0404-41),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054040441,Morphine,100
Morphine Sulfate,0054-0404-44,100 mg/5mL,SOLUTION,ORAL,NDA022195,Hikma Pharmaceuticals USA Inc.,0054-0404,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/25/2010,N/A,NDA,30 mL in 1 BOTTLE (0054-0404-44),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054040444,Morphine,100
Morphine Sulfate,0054-0404-50,100 mg/5mL,SOLUTION,ORAL,NDA022195,Hikma Pharmaceuticals USA Inc.,0054-0404,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,01/25/2010,N/A,NDA,120 mL in 1 BOTTLE (0054-0404-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054040450,Morphine,100
Morphine Sulfate,0054-0517-41,100 mg/5mL,SOLUTION,ORAL,NDA022195,Hikma Pharmaceuticals USA Inc.,0054-0517,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,08/10/2015,N/A,NDA,15 mL in 1 BOTTLE (0054-0517-41),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054051741,Morphine,100
Morphine Sulfate,0054-0517-44,100 mg/5mL,SOLUTION,ORAL,NDA022195,Hikma Pharmaceuticals USA Inc.,0054-0517,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,08/10/2015,N/A,NDA,30 mL in 1 BOTTLE (0054-0517-44),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054051744,Morphine,100
Morphine Sulfate,0054-0517-50,100 mg/5mL,SOLUTION,ORAL,NDA022195,Hikma Pharmaceuticals USA Inc.,0054-0517,Morphine Sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,08/10/2015,N/A,NDA,120 mL in 1 BOTTLE (0054-0517-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054051750,Morphine,100
Morphine sulfate (E),67296-1375-2,,,,,"RedPharm Drug, Inc.",,,,,,N/A,,,N/A,N/A,N/A,,67296137502,Morphine,NA
MS Contin,42858-631-01,30 mg/1,TABLET,ORAL,NDA019516,Rhodes Pharmaceuticals L.P.,42858-631,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/15/2017,N/A,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-631-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858063101,Morphine,30
MS Contin,42858-515-01,15 mg/1,TABLET,ORAL,NDA019516,Rhodes Pharmaceuticals L.P.,42858-515,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/15/2017,N/A,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-515-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858051501,Morphine,15
MS Contin,42858-799-01,100 mg/1,TABLET,ORAL,NDA019516,Rhodes Pharmaceuticals L.P.,42858-799,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/15/2017,N/A,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-799-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858079901,Morphine,100
MS Contin,42858-900-01,200 mg/1,TABLET,ORAL,NDA019516,Rhodes Pharmaceuticals L.P.,42858-900,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/15/2017,N/A,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-900-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858090001,Morphine,200
MS Contin,42858-760-01,60 mg/1,TABLET,ORAL,NDA019516,Rhodes Pharmaceuticals L.P.,42858-760,morphine sulfate,MORPHINE SULFATE,HUMAN PRESCRIPTION DRUG,05/15/2017,N/A,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-760-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858076001,Morphine,60
Opium Tincture Deodorized,62559-153-04,1 g/100mL,SOLUTION,ORAL,NA,"ANI Pharmaceuticals, Inc.",62559-153,morphine tincture,MORPHINE,HUMAN PRESCRIPTION DRUG,02/25/2011,N/A,UNAPPROVED DRUG OTHER,118 mL in 1 BOTTLE (62559-153-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,62559015304,Morphine,1
Opium Tincture Deodorized,63629-1965-1,10 g/1000mL,SOLUTION,ORAL,NA,Bryant Ranch Prepack,63629-1965,morphine tincture,MORPHINE,HUMAN PRESCRIPTION DRUG,02/08/2021,N/A,UNAPPROVED DRUG OTHER,118 mL in 1 BOTTLE (63629-1965-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629196501,Morphine,10
Opium Tincture Deodorized,42799-217-01,10 mg/mL,TINCTURE,ORAL,NA,"Edenbridge Pharmaceuticals, LLC",42799-217,Morphine,MORPHINE,HUMAN PRESCRIPTION DRUG,07/15/2010,N/A,UNAPPROVED DRUG OTHER,"118 mL in 1 BOTTLE, PLASTIC (42799-217-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42799021701,Morphine,10
Opium Tincture Deodorized,42799-217-02,10 mg/mL,TINCTURE,ORAL,NA,"Edenbridge Pharmaceuticals, LLC",42799-217,Morphine,MORPHINE,HUMAN PRESCRIPTION DRUG,07/15/2010,N/A,UNAPPROVED DRUG OTHER,"473 mL in 1 BOTTLE, PLASTIC (42799-217-02)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42799021702,Morphine,10
"NALBUPHINE HCI",51662-1418-1,20 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA070918,"HF Acquisition Co LLC, DBA HealthFirst",51662-1418,"NALBUPHINE HCI","NALBUPHINE HYDROCHLORIDE",HUMAN PRESCRIPTION DRUG,10/29/2019,N/A,ANDA,"1 VIAL, MULTI-DOSE in 1 CARTON (51662-1418-1)  / 10 mL in 1 VIAL, MULTI-DOSE","Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",N/A,No,12/31/2023,51662141801,Nalbuphine,20
"NALBUPHINE HCI",51662-1420-1,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA070915,"HF Acquisition Co LLC, DBA HealthFirst",51662-1420,"NALBUPHINE HCI","NALBUPHINE HYDROCHLORIDE",HUMAN PRESCRIPTION DRUG,10/29/2019,N/A,ANDA,"1 VIAL, MULTI-DOSE in 1 CARTON (51662-1420-1)  / 10 mL in 1 VIAL, MULTI-DOSE","Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",N/A,No,12/31/2023,51662142001,Nalbuphine,10
Nalbuphine Hydrochloride,52584-464-61,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA070915,"General Injectables and Vaccines, Inc.",52584-464,nalbuphine hydrochloride,"NALBUPHINE HYDROCHLORIDE",HUMAN PRESCRIPTION DRUG,04/19/2021,07/01/2023,ANDA,"1 VIAL, MULTI-DOSE in 1 BAG (52584-464-61)  / 10 mL in 1 VIAL, MULTI-DOSE","Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",N/A,No,N/A,52584046461,Nalbuphine,10
Nalbuphine Hydrochloride,0409-1463-01,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA070914,"Hospira, Inc.",0409-1463,"NALBUPHINE HYDROCHLORIDE","NALBUPHINE HYDROCHLORIDE",HUMAN PRESCRIPTION DRUG,03/31/2005,N/A,ANDA,10 AMPULE in 1 TRAY (0409-1463-01)  / 1 mL in 1 AMPULE (0409-1463-71),"Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",N/A,No,12/31/2023,00409146301,Nalbuphine,10
Nalbuphine Hydrochloride,0409-1463-49,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA070914,"Hospira, Inc.",0409-1463,"NALBUPHINE HYDROCHLORIDE","NALBUPHINE HYDROCHLORIDE",HUMAN PRESCRIPTION DRUG,06/27/2008,N/A,ANDA,10 AMPULE in 1 TRAY (0409-1463-49)  / 1 mL in 1 AMPULE (0409-1463-69),"Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",N/A,No,12/31/2023,00409146349,Nalbuphine,10
Nalbuphine Hydrochloride,0409-1464-01,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA070915,"Hospira, Inc.",0409-1464,"NALBUPHINE HYDROCHLORIDE","NALBUPHINE HYDROCHLORIDE",HUMAN PRESCRIPTION DRUG,07/19/2005,N/A,ANDA,"25 CARTON in 1 CASE (0409-1464-01)  / 1 VIAL, MULTI-DOSE in 1 CARTON (0409-1464-61)  / 10 mL in 1 VIAL, MULTI-DOSE","Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",N/A,No,12/31/2023,00409146401,Nalbuphine,10
Nalbuphine Hydrochloride,0409-1465-01,20 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA070916,"Hospira, Inc.",0409-1465,"NALBUPHINE HYDROCHLORIDE","NALBUPHINE HYDROCHLORIDE",HUMAN PRESCRIPTION DRUG,12/31/2004,N/A,ANDA,10 AMPULE in 1 TRAY (0409-1465-01)  / 1 mL in 1 AMPULE (0409-1465-71),"Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",N/A,No,12/31/2023,00409146501,Nalbuphine,20
Nalbuphine Hydrochloride,0409-1467-01,20 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA070918,"Hospira, Inc.",0409-1467,"NALBUPHINE HYDROCHLORIDE","NALBUPHINE HYDROCHLORIDE",HUMAN PRESCRIPTION DRUG,05/16/2005,N/A,ANDA,"25 CARTON in 1 CASE (0409-1467-01)  / 1 VIAL, MULTI-DOSE in 1 CARTON (0409-1467-61)  / 10 mL in 1 VIAL, MULTI-DOSE","Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",N/A,No,12/31/2023,00409146701,Nalbuphine,20
Nalbuphine Hydrochloride,71872-7114-1,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA070915,"Medical Purchasing Solutions, LLC",71872-7114,"NALBUPHINE HYDROCHLORIDE","NALBUPHINE HYDROCHLORIDE",HUMAN PRESCRIPTION DRUG,05/03/2018,N/A,ANDA,"1 VIAL, MULTI-DOSE in 1 BAG (71872-7114-1)  / 10 mL in 1 VIAL, MULTI-DOSE","Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",N/A,No,12/31/2023,71872711401,Nalbuphine,10
Nalbuphine Hydrochloride,52584-463-01,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA070914,"General Injectables & Vaccines, Inc",52584-463,Nalbuphine Hydrochloride,"NALBUPHINE HYDROCHLORIDE",HUMAN PRESCRIPTION DRUG,03/01/2010,09/01/2023,ANDA,1 AMPULE in 1 BAG (52584-463-01)  / 1 mL in 1 AMPULE,"Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",N/A,No,N/A,52584046301,Nalbuphine,10
Nalbuphine Hydrochloride,0404-9917-10,20 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA070918,"Henry Schein, Inc.",0404-9917,nalbuphine hydrochloride,"NALBUPHINE HYDROCHLORIDE",HUMAN PRESCRIPTION DRUG,01/13/2022,N/A,ANDA,"1 VIAL, MULTI-DOSE in 1 BAG (0404-9917-10)  / 10 mL in 1 VIAL, MULTI-DOSE","Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",N/A,No,12/31/2023,00404991710,Nalbuphine,20
Nalbuphine Hydrochloride,0404-9918-01,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA070914,"Henry Schein, Inc.",0404-9918,Nalbuphine Hydrochloride,"NALBUPHINE HYDROCHLORIDE",HUMAN PRESCRIPTION DRUG,01/13/2022,N/A,ANDA,1 AMPULE in 1 BAG (0404-9918-01)  / 1 mL in 1 AMPULE,"Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",N/A,No,12/31/2023,00404991801,Nalbuphine,10
Nalbuphine Hydrochloride,0404-9919-10,10 mg/mL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,ANDA070915,"Henry Schein, Inc.",0404-9919,nalbuphine hydrochloride,"NALBUPHINE HYDROCHLORIDE",HUMAN PRESCRIPTION DRUG,01/13/2022,N/A,ANDA,"1 VIAL, MULTI-DOSE in 1 BAG (0404-9919-10)  / 10 mL in 1 VIAL, MULTI-DOSE","Competitive Opioid Antagonists [MoA],  Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",N/A,No,12/31/2023,00404991910,Nalbuphine,10
Atrovent,0597-0087-17,17 ug/1,"AEROSOL, METERED",RESPIRATORY (INHALATION),NDA021527,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0087,ipratropium bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,05/01/2005,N/A,NDA,"1 CANISTER in 1 CARTON (0597-0087-17)  / 200 AEROSOL, METERED in 1 CANISTER","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00597008717,Opium,17
Belladonna and Opium,63629-8436-1,"16.2 mg/1,                         30  mg/1",SUPPOSITORY,RECTAL,NA,Bryant Ranch Prepack,63629-8436,ATROPA BELLADONNA and OPIUM,ATROPA BELLADONNA;  OPIUM,HUMAN PRESCRIPTION DRUG,06/01/2021,N/A,UNAPPROVED DRUG OTHER,4 PACKET in 1 BOX (63629-8436-1)  / 1 SUPPOSITORY in 1 PACKET,N/A,CII,No,12/31/2023,63629843601,Opium,16.2
Belladonna and Opium,0574-7040-12,"16.2 mg/1,                         60  mg/1",SUPPOSITORY,RECTAL,NA,Padagis US LLC,0574-7040,ATROPA BELLADONNA and OPIUM,ATROPA BELLADONNA;  OPIUM,HUMAN PRESCRIPTION DRUG,04/22/1997,N/A,UNAPPROVED DRUG OTHER,12 PACKET in 1 BOX (0574-7040-12)  / 1 SUPPOSITORY in 1 PACKET,N/A,CII,No,12/31/2023,00574704012,Opium,16.2
Belladonna and Opium,0574-7045-12,"16.2 mg/1,                         30  mg/1",SUPPOSITORY,RECTAL,NA,Padagis US LLC,0574-7045,ATROPA BELLADONNA and OPIUM,ATROPA BELLADONNA;  OPIUM,HUMAN PRESCRIPTION DRUG,05/01/1994,N/A,UNAPPROVED DRUG OTHER,12 PACKET in 1 BOX (0574-7045-12)  / 1 SUPPOSITORY in 1 PACKET,N/A,CII,No,12/31/2023,00574704512,Opium,16.2
Belladonna and Opium,0574-7045-04,"16.2 mg/1,                         30  mg/1",SUPPOSITORY,RECTAL,NA,Padagis US LLC,0574-7045,ATROPA BELLADONNA and OPIUM,ATROPA BELLADONNA;  OPIUM,HUMAN PRESCRIPTION DRUG,08/22/2018,N/A,UNAPPROVED DRUG OTHER,4 PACKET in 1 BOX (0574-7045-04)  / 1 SUPPOSITORY in 1 PACKET,N/A,CII,No,12/31/2023,00574704504,Opium,16.2
Belladonna and Opium,63629-8435-1,"16.2 mg/1,                         30  mg/1",SUPPOSITORY,RECTAL,NA,Bryant Ranch Prepack,63629-8435,ATROPA BELLADONNA and OPIUM,ATROPA BELLADONNA;  OPIUM,HUMAN PRESCRIPTION DRUG,04/28/2021,N/A,UNAPPROVED DRUG OTHER,12 PACKET in 1 BOX (63629-8435-1)  / 1 SUPPOSITORY in 1 PACKET,N/A,CII,No,12/31/2023,63629843501,Opium,16.2
Belladonna and Opium,0574-7040-04,"16.2 mg/1,                         60  mg/1",SUPPOSITORY,RECTAL,NA,Padagis US LLC,0574-7040,ATROPA BELLADONNA and OPIUM,ATROPA BELLADONNA;  OPIUM,HUMAN PRESCRIPTION DRUG,08/22/2018,N/A,UNAPPROVED DRUG OTHER,4 PACKET in 1 BOX (0574-7040-04)  / 1 SUPPOSITORY in 1 PACKET,N/A,CII,No,12/31/2023,00574704004,Opium,16.2
Combivent Respimat,0597-0024-02,"100 ug/1,                         20  ug/1","SPRAY, METERED",RESPIRATORY (INHALATION),NDA021747,Boehringer Ingelheim Pharmaceuticals Inc.,0597-0024,ipratropium bromide and albuterol,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,07/01/2012,N/A,NDA,"1 CARTRIDGE in 1 CARTON (0597-0024-02)  / 120 SPRAY, METERED in 1 CARTRIDGE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,00597002402,Opium,100
Ipratropium Bromide,0054-0045-44,21 ug/1,SPRAY,"NASAL",ANDA076664,West-Ward Pharmaceuticals Corp.,0054-0045,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,11/05/2003,N/A,ANDA,"1 BOTTLE, SPRAY in 1 CARTON (0054-0045-44)  / 345 SPRAY in 1 BOTTLE, SPRAY","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2024,00054004544,Opium,21
Ipratropium Bromide,0054-0046-41,42 ug/1,SPRAY,"NASAL",ANDA076598,West-Ward Pharmaceuticals Corp.,0054-0046,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,11/05/2003,N/A,ANDA,"1 BOTTLE, SPRAY in 1 CARTON (0054-0046-41)  / 165 SPRAY in 1 BOTTLE, SPRAY","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2024,00054004641,Opium,42
Ipratropium Bromide,50090-5968-0,42 ug/1,"SPRAY, METERED","NASAL",ANDA076155,A-S Medication Solutions,50090-5968,ipratropium bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,04/28/2022,N/A,ANDA,"1 BOTTLE, PUMP in 1 CARTON (50090-5968-0)  / 165 SPRAY, METERED in 1 BOTTLE, PUMP","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,50090596800,Opium,42
Ipratropium Bromide,55154-2134-5,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075693,"Cardinal Health 107, LLC",55154-2134,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,12/26/2018,N/A,ANDA,5 POUCH in 1 BAG (55154-2134-5)  / 1 AMPULE in 1 POUCH / 2.5 mL in 1 AMPULE,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2024,55154213405,Opium,0.5
Ipratropium bromide,65862-905-60,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA206543,Aurobindo Pharma Limited,65862-905,Ipratropium bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,10/27/2016,N/A,ANDA,"2 POUCH in 1 CARTON (65862-905-60)  / 30 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,65862090560,Opium,0.5
Ipratropium Bromide,76204-100-25,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075693,"Ritedose Pharmaceuticals, LLC",76204-100,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,11/21/2011,N/A,ANDA,1 POUCH in 1 CARTON (76204-100-25)  / 25 AMPULE in 1 POUCH / 2.5 mL in 1 AMPULE,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,76204010025,Opium,0.5
Ipratropium Bromide,76204-100-60,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075693,"Ritedose Pharmaceuticals, LLC",76204-100,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,11/21/2011,N/A,ANDA,2 POUCH in 1 CARTON (76204-100-60)  / 30 AMPULE in 1 POUCH / 2.5 mL in 1 AMPULE,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,76204010060,Opium,0.5
Ipratropium Bromide,47335-706-49,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA207903,"Sun Pharmaceutical Industries, Inc.",47335-706,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,02/04/2020,N/A,ANDA,5 POUCH in 1 CARTON (47335-706-49)  / 5 VIAL in 1 POUCH (47335-706-48)  / 2.5 mL in 1 VIAL,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,47335070649,Opium,0.5
Ipratropium Bromide,47335-706-52,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA207903,"Sun Pharmaceutical Industries, Inc.",47335-706,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,02/04/2020,N/A,ANDA,6 POUCH in 1 CARTON (47335-706-52)  / 5 VIAL in 1 POUCH / 2.5 mL in 1 VIAL,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,47335070652,Opium,0.5
Ipratropium Bromide,47335-706-54,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA207903,"Sun Pharmaceutical Industries, Inc.",47335-706,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,02/04/2020,N/A,ANDA,12 POUCH in 1 CARTON (47335-706-54)  / 5 VIAL in 1 POUCH / 2.5 mL in 1 VIAL,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,47335070654,Opium,0.5
Ipratropium bromide,65862-905-03,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA206543,Aurobindo Pharma Limited,65862-905,Ipratropium bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,10/27/2016,N/A,ANDA,"30 POUCH in 1 CARTON (65862-905-03)  / 1 VIAL, SINGLE-DOSE in 1 POUCH (65862-905-01)  / 2.5 mL in 1 VIAL, SINGLE-DOSE","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,65862090503,Opium,0.5
Ipratropium bromide,65862-905-25,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA206543,Aurobindo Pharma Limited,65862-905,Ipratropium bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,10/27/2016,N/A,ANDA,"1 POUCH in 1 CARTON (65862-905-25)  / 25 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,65862090525,Opium,0.5
Ipratropium Bromide,76204-100-30,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075693,"Ritedose Pharmaceuticals, LLC",76204-100,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,11/21/2011,N/A,ANDA,1 POUCH in 1 CARTON (76204-100-30)  / 30 AMPULE in 1 POUCH / 2.5 mL in 1 AMPULE,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,76204010030,Opium,0.5
Ipratropium Bromide,76204-100-01,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075693,"Ritedose Pharmaceuticals, LLC",76204-100,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,11/21/2011,N/A,ANDA,30 POUCH in 1 CARTON (76204-100-01)  / 1 AMPULE in 1 POUCH / 2.5 mL in 1 AMPULE,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,76204010001,Opium,0.5
Ipratropium Bromide,50090-0668-0,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075693,A-S Medication Solutions,50090-0668,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,11/28/2014,N/A,ANDA,1 POUCH in 1 CARTON (50090-0668-0)  / 25 mL in 1 POUCH,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2024,50090066800,Opium,0.5
Ipratropium Bromide,16714-526-01,21 ug/1,"SPRAY, METERED","NASAL",ANDA076156,NORTHSTAR RX LLC,16714-526,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,02/22/2022,N/A,ANDA,"1 BOTTLE, SPRAY in 1 CARTON (16714-526-01)  / 345 SPRAY, METERED in 1 BOTTLE, SPRAY","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,16714052601,Opium,21
Ipratropium Bromide,16714-527-01,42 ug/1,"SPRAY, METERED","NASAL",ANDA076155,NORTHSTAR RX LLC,16714-527,ipratropium bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,02/22/2022,N/A,ANDA,"1 BOTTLE, PUMP in 1 CARTON (16714-527-01)  / 165 SPRAY, METERED in 1 BOTTLE, PUMP","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,16714052701,Opium,42
Ipratropium Bromide,69238-2016-3,21 ug/1,SPRAY,"NASAL",ANDA215104,Amneal Pharmaceuticals NY LLC,69238-2016,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,08/18/2022,N/A,ANDA,"1 BOTTLE, SPRAY in 1 CARTON (69238-2016-3)  / 345 SPRAY in 1 BOTTLE, SPRAY","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,69238201603,Opium,21
Ipratropium Bromide,69238-2017-2,42 ug/1,SPRAY,"NASAL",ANDA215105,Amneal Pharmaceuticals NY LLC,69238-2017,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,08/18/2022,N/A,ANDA,"1 BOTTLE, SPRAY in 1 CARTON (69238-2017-2)  / 165 SPRAY in 1 BOTTLE, SPRAY","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,69238201702,Opium,42
Ipratropium Bromide,0378-7970-52,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075693,Mylan Pharmaceuticals Inc.,0378-7970,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,11/09/2010,N/A,ANDA,1 POUCH in 1 CARTON (0378-7970-52)  / 25 AMPULE in 1 POUCH (0378-7970-62)  / 2.5 mL in 1 AMPULE,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00378797052,Opium,0.5
Ipratropium Bromide,0378-7970-55,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075693,Mylan Pharmaceuticals Inc.,0378-7970,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,11/09/2010,N/A,ANDA,30 POUCH in 1 CARTON (0378-7970-55)  / 1 AMPULE in 1 POUCH (0378-7970-31)  / 2.5 mL in 1 AMPULE,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00378797055,Opium,0.5
Ipratropium Bromide,0378-7970-91,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075693,Mylan Pharmaceuticals Inc.,0378-7970,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,11/09/2010,N/A,ANDA,2 POUCH in 1 CARTON (0378-7970-91)  / 30 AMPULE in 1 POUCH / 2.5 mL in 1 AMPULE,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00378797091,Opium,0.5
Ipratropium Bromide,0378-7970-93,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075693,Mylan Pharmaceuticals Inc.,0378-7970,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,11/09/2010,N/A,ANDA,1 POUCH in 1 CARTON (0378-7970-93)  / 30 AMPULE in 1 POUCH (0378-7970-64)  / 2.5 mL in 1 AMPULE,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00378797093,Opium,0.5
Ipratropium Bromide,0487-9801-01,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075562,Nephron Pharmaceuticals Corporation,0487-9801,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,09/27/2001,N/A,ANDA,"30 POUCH in 1 CARTON (0487-9801-01)  / 1 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00487980101,Opium,0.5
Ipratropium Bromide,0487-9801-02,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075562,Nephron Pharmaceuticals Corporation,0487-9801,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,09/27/2001,N/A,ANDA,"30 BAG in 1 BOX (0487-9801-02)  / 1 POUCH in 1 BAG / 1 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00487980102,Opium,0.5
Ipratropium Bromide,0487-9801-25,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075562,Nephron Pharmaceuticals Corporation,0487-9801,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,09/27/2001,N/A,ANDA,"1 POUCH in 1 CARTON (0487-9801-25)  / 25 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00487980125,Opium,0.5
Ipratropium Bromide,0487-9801-30,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075562,Nephron Pharmaceuticals Corporation,0487-9801,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,09/27/2001,N/A,ANDA,"1 POUCH in 1 CARTON (0487-9801-30)  / 30 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00487980130,Opium,0.5
Ipratropium Bromide,0487-9801-60,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075562,Nephron Pharmaceuticals Corporation,0487-9801,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,09/27/2001,N/A,ANDA,"2 POUCH in 1 CARTON (0487-9801-60)  / 30 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00487980160,Opium,0.5
Ipratropium Bromide,63187-188-25,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075693,Proficient Rx LP,63187-188,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,01/01/2019,N/A,ANDA,1 POUCH in 1 CARTON (63187-188-25)  / 25 VIAL in 1 POUCH / 2.5 mL in 1 VIAL,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,63187018825,Opium,0.5
Ipratropium Bromide,60505-0826-1,21 ug/1,"SPRAY, METERED","NASAL",ANDA076156,Apotex Corp.,60505-0826,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,05/26/2020,N/A,ANDA,"1 BOTTLE, SPRAY in 1 CARTON (60505-0826-1)  / 345 SPRAY, METERED in 1 BOTTLE, SPRAY","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,60505082601,Opium,21
Ipratropium Bromide,60505-0827-1,42 ug/1,"SPRAY, METERED","NASAL",ANDA076155,Apotex Corp.,60505-0827,ipratropium bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,05/26/2020,N/A,ANDA,"1 BOTTLE, PUMP in 1 CARTON (60505-0827-1)  / 165 SPRAY, METERED in 1 BOTTLE, PUMP","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,60505082701,Opium,42
Ipratropium Bromide,60687-394-83,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075693,American Health Packaging,60687-394,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,12/26/2018,N/A,ANDA,30 POUCH in 1 CARTON (60687-394-83)  / 1 AMPULE in 1 POUCH (60687-394-79)  / 2.5 mL in 1 AMPULE,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,60687039483,Opium,0.5
Ipratropium Bromide,50090-6373-0,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075693,A-S Medication Solutions,50090-6373,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,02/14/2023,N/A,ANDA,25 POUCH in 1 CARTON (50090-6373-0)  / 2.5 mL in 1 POUCH,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2024,50090637300,Opium,0.5
Ipratropium bromide,65862-905-30,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA206543,Aurobindo Pharma Limited,65862-905,Ipratropium bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,10/27/2016,N/A,ANDA,"1 POUCH in 1 CARTON (65862-905-30)  / 30 VIAL, SINGLE-DOSE in 1 POUCH (65862-905-33)  / 2.5 mL in 1 VIAL, SINGLE-DOSE","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,65862090530,Opium,0.5
Ipratropium Bromide,70518-3558-0,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075693,REMEDYREPACK INC.,70518-3558,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,10/21/2022,N/A,ANDA,2 POUCH in 1 CARTON (70518-3558-0)  / 30 AMPULE in 1 POUCH / 2.5 mL in 1 AMPULE,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,70518355800,Opium,0.5
Ipratropium Bromide,55154-4351-5,.5 mg/2.5mL,SOLUTION,RESPIRATORY (INHALATION),ANDA075562,"Cardinal Health 107, LLC",55154-4351,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,09/27/2001,02/29/2024,ANDA,"5 POUCH in 1 BAG (55154-4351-5)  / 1 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,N/A,55154435105,Opium,0.5
Ipratropium bromide,24208-398-30,21 ug/1,"SPRAY, METERED","NASAL",ANDA076025,Bausch & Lomb Incorporated,24208-398,Ipratropium bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,03/31/2003,N/A,ANDA,"1 BOTTLE, SPRAY in 1 CARTON (24208-398-30)  / 345 SPRAY, METERED in 1 BOTTLE, SPRAY","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2024,24208039830,Opium,21
Ipratropium Bromide,24208-399-15,42 ug/1,"SPRAY, METERED","NASAL",ANDA076103,Bausch & Lomb Incorporated,24208-399,Ipratropium Bromide,IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,03/31/2003,N/A,ANDA,"1 BOTTLE, SPRAY in 1 CARTON (24208-399-15)  / 165 SPRAY, METERED in 1 BOTTLE, SPRAY","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,24208039915,Opium,42
Ipratropium Bromide and Albuterol Sulfate,69097-840-87,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,Cipla USA Inc.,69097-840,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,06/01/2020,N/A,ANDA,1 POUCH in 1 CARTON (69097-840-87)  / 30 VIAL in 1 POUCH / 3 mL in 1 VIAL,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,69097084087,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,70518-2250-1,"3 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA076749,REMEDYREPACK INC.,70518-2250,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,03/08/2022,N/A,ANDA,"5 POUCH in 1 CARTON (70518-2250-1)  / 6 VIAL, SINGLE-USE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-USE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,70518225001,Opium,3
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE,55154-2133-5,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,"Cardinal Health 107, LLC",55154-2133,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,12/15/2018,N/A,ANDA,5 POUCH in 1 BAG (55154-2133-5)  / 1 AMPULE in 1 POUCH / 3 mL in 1 AMPULE,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2024,55154213305,Opium,2.5
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE,60429-975-30,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,"Golden State Medical Supply, Inc.",60429-975,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,10/17/2017,N/A,ANDA,1 POUCH in 1 CARTON (60429-975-30)  / 30 AMPULE in 1 POUCH / 3 mL in 1 AMPULE,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2024,60429097530,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,68788-8103-3,"3 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA076749,Preferred Pharmaceuticals Inc.,68788-8103,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,10/14/2021,N/A,ANDA,"30 POUCH in 1 CARTON (68788-8103-3)  / 1 VIAL, SINGLE-USE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-USE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,68788810303,Opium,3
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE,76204-600-12,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,"Ritedose Pharmaceuticals, LLC",76204-600,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,10/15/2012,N/A,ANDA,12 POUCH in 1 CARTON (76204-600-12)  / 5 AMPULE in 1 POUCH / 3 mL in 1 AMPULE,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,76204060012,Opium,2.5
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE,76204-600-60,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,"Ritedose Pharmaceuticals, LLC",76204-600,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,10/15/2012,N/A,ANDA,2 POUCH in 1 CARTON (76204-600-60)  / 30 AMPULE in 1 POUCH / 3 mL in 1 AMPULE,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,76204060060,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,70518-3347-0,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,REMEDYREPACK INC.,70518-3347,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,01/28/2022,N/A,ANDA,60 POUCH in 1 CARTON (70518-3347-0)  / 1 AMPULE in 1 POUCH / 3 mL in 1 AMPULE,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,70518334700,Opium,2.5
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE,76204-600-01,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,"Ritedose Pharmaceuticals, LLC",76204-600,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,10/15/2012,N/A,ANDA,30 POUCH in 1 CARTON (76204-600-01)  / 1 AMPULE in 1 POUCH / 3 mL in 1 AMPULE,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,76204060001,Opium,2.5
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE,50090-1382-0,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,A-S Medication Solutions,50090-1382,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,11/28/2014,N/A,ANDA,30 VIAL in 1 CARTON (50090-1382-0)  / 3 mL in 1 VIAL,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2024,50090138200,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,50090-1669-0,"3 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA076749,A-S Medication Solutions,50090-1669,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,01/28/2015,N/A,ANDA,"30 VIAL, SINGLE-DOSE in 1 POUCH (50090-1669-0)  / 3 mL in 1 VIAL, SINGLE-DOSE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2024,50090166900,Opium,3
Ipratropium Bromide and Albuterol Sulfate,0487-0201-01,"3 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA076749,Nephron Pharmaceuticals Corporation,0487-0201,Ipratropium Bromide and Albuterol Sulfate,IPRATROPIUM BROMIDE;  ALBUTEROL SULFATE,HUMAN PRESCRIPTION DRUG,12/31/2007,N/A,ANDA,"30 POUCH in 1 CARTON (0487-0201-01)  / 1 VIAL, SINGLE-USE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-USE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,00487020101,Opium,3
Ipratropium Bromide and Albuterol Sulfate,0487-0201-02,"3 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA076749,Nephron Pharmaceuticals Corporation,0487-0201,Ipratropium Bromide and Albuterol Sulfate,IPRATROPIUM BROMIDE;  ALBUTEROL SULFATE,HUMAN PRESCRIPTION DRUG,12/31/2007,N/A,ANDA,"30 POUCH in 1 CARTON (0487-0201-02)  / 1 VIAL, SINGLE-USE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-USE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,00487020102,Opium,3
Ipratropium Bromide and Albuterol Sulfate,0487-0201-03,"3 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA076749,Nephron Pharmaceuticals Corporation,0487-0201,Ipratropium Bromide and Albuterol Sulfate,IPRATROPIUM BROMIDE;  ALBUTEROL SULFATE,HUMAN PRESCRIPTION DRUG,12/31/2007,N/A,ANDA,"5 POUCH in 1 CARTON (0487-0201-03)  / 6 VIAL, SINGLE-USE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-USE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,00487020103,Opium,3
Ipratropium Bromide and Albuterol Sulfate,0487-0201-60,"3 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA076749,Nephron Pharmaceuticals Corporation,0487-0201,Ipratropium Bromide and Albuterol Sulfate,IPRATROPIUM BROMIDE;  ALBUTEROL SULFATE,HUMAN PRESCRIPTION DRUG,12/31/2007,N/A,ANDA,"10 POUCH in 1 CARTON (0487-0201-60)  / 6 VIAL, SINGLE-USE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-USE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,00487020160,Opium,3
Ipratropium Bromide and Albuterol Sulfate,0378-9671-30,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,Mylan Pharmaceuticals Inc.,0378-9671,Ipratropium Bromide and Albuterol Sulfate,IPRATROPIUM BROMIDE;  ALBUTEROL SULFATE,HUMAN PRESCRIPTION DRUG,03/01/2013,N/A,ANDA,1 POUCH in 1 CARTON (0378-9671-30)  / 30 AMPULE in 1 POUCH (0378-9671-64)  / 3 mL in 1 AMPULE,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,00378967130,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,0378-9671-60,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,Mylan Pharmaceuticals Inc.,0378-9671,Ipratropium Bromide and Albuterol Sulfate,IPRATROPIUM BROMIDE;  ALBUTEROL SULFATE,HUMAN PRESCRIPTION DRUG,03/01/2013,N/A,ANDA,2 POUCH in 1 CARTON (0378-9671-60)  / 30 AMPULE in 1 POUCH / 3 mL in 1 AMPULE,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,00378967160,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,0378-9671-93,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,Mylan Pharmaceuticals Inc.,0378-9671,Ipratropium Bromide and Albuterol Sulfate,IPRATROPIUM BROMIDE;  ALBUTEROL SULFATE,HUMAN PRESCRIPTION DRUG,03/01/2013,N/A,ANDA,30 POUCH in 1 CARTON (0378-9671-93)  / 1 AMPULE in 1 POUCH (0378-9671-31)  / 3 mL in 1 AMPULE,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,00378967193,Opium,2.5
ipratropium bromide and albuterol sulfate,63187-529-30,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,Proficient Rx LP,63187-529,ipratropium bromide and albuterol sulfate,IPRATROPIUM BROMIDE;  ALBUTEROL SULFATE,HUMAN PRESCRIPTION DRUG,08/01/2015,N/A,ANDA,6 POUCH in 1 CARTON (63187-529-30)  / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,63187052930,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,47335-756-49,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA207875,"Sun Pharmaceutical Industries, Inc.",47335-756,Ipratropium Bromide and Albuterol Sulfate,IPRATROPIUM BROMIDE;  ALBUTEROL SULFATE,HUMAN PRESCRIPTION DRUG,11/15/2021,N/A,ANDA,6 POUCH in 1 CARTON (47335-756-49)  / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,47335075649,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,47335-756-52,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA207875,"Sun Pharmaceutical Industries, Inc.",47335-756,Ipratropium Bromide and Albuterol Sulfate,IPRATROPIUM BROMIDE;  ALBUTEROL SULFATE,HUMAN PRESCRIPTION DRUG,11/15/2021,N/A,ANDA,12 POUCH in 1 CARTON (47335-756-52)  / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,47335075652,Opium,2.5
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE,60687-405-83,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,American Health Packaging,60687-405,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,12/15/2018,N/A,ANDA,30 POUCH in 1 CARTON (60687-405-83)  / 1 AMPULE in 1 POUCH (60687-405-79)  / 3 mL in 1 AMPULE,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,60687040583,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,69097-173-53,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA077559,Cipla USA Inc.,69097-173,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,12/31/2007,N/A,ANDA,6 POUCH in 1 CARTON (69097-173-53)  / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,69097017353,Opium,2.5
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE,76204-600-05,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,"Ritedose Pharmaceuticals, LLC",76204-600,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,10/15/2012,N/A,ANDA,6 POUCH in 1 CARTON (76204-600-05)  / 5 AMPULE in 1 POUCH / 3 mL in 1 AMPULE,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,76204060005,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,71205-726-15,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA207875,Proficient Rx LP,71205-726,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,12/01/2022,N/A,ANDA,1 POUCH in 1 BAG (71205-726-15)  / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,71205072615,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,65862-906-03,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA206532,Aurobindo Pharma Limited,65862-906,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,07/09/2020,N/A,ANDA,"30 POUCH in 1 CARTON (65862-906-03)  / 1 VIAL, SINGLE-DOSE in 1 POUCH (65862-906-01)  / 3 mL in 1 VIAL, SINGLE-DOSE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,65862090603,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,65862-906-30,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA206532,Aurobindo Pharma Limited,65862-906,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,07/09/2020,N/A,ANDA,"6 POUCH in 1 CARTON (65862-906-30)  / 5 VIAL, SINGLE-DOSE in 1 POUCH (65862-906-05)  / 3 mL in 1 VIAL, SINGLE-DOSE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,65862090630,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,65862-906-60,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA206532,Aurobindo Pharma Limited,65862-906,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,07/09/2020,N/A,ANDA,"12 POUCH in 1 CARTON (65862-906-60)  / 5 VIAL, SINGLE-DOSE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-DOSE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,65862090660,Opium,2.5
ipratropium bromide and albuterol sulfate,63187-529-60,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,Proficient Rx LP,63187-529,ipratropium bromide and albuterol sulfate,IPRATROPIUM BROMIDE;  ALBUTEROL SULFATE,HUMAN PRESCRIPTION DRUG,08/01/2015,N/A,ANDA,12 POUCH in 1 CARTON (63187-529-60)  / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,63187052960,Opium,2.5
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE,76204-600-30,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,"Ritedose Pharmaceuticals, LLC",76204-600,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,10/15/2012,N/A,ANDA,1 POUCH in 1 CARTON (76204-600-30)  / 30 AMPULE in 1 POUCH / 3 mL in 1 AMPULE,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,76204060030,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,50090-6288-0,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA207875,A-S Medication Solutions,50090-6288,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,12/19/2022,N/A,ANDA,30 VIAL in 1 CARTON (50090-6288-0)  / 3 mL in 1 VIAL,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,50090628800,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,69097-840-64,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,Cipla USA Inc.,69097-840,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,06/01/2020,N/A,ANDA,2 POUCH in 1 CARTON (69097-840-64)  / 30 VIAL in 1 POUCH / 3 mL in 1 VIAL,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,69097084064,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,69097-840-53,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,Cipla USA Inc.,69097-840,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,06/01/2020,N/A,ANDA,30 POUCH in 1 CARTON (69097-840-53)  / 1 VIAL in 1 POUCH (69097-840-34)  / 3 mL in 1 VIAL,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,69097084053,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,70518-2250-0,"3 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA076749,REMEDYREPACK INC.,70518-2250,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,08/02/2019,N/A,ANDA,"10 POUCH in 1 CARTON (70518-2250-0)  / 6 VIAL, SINGLE-USE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-USE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,70518225000,Opium,3
Ipratropium Bromide and Albuterol Sulfate,55154-4357-5,"3 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA076749,"Cardinal Health 107, LLC",55154-4357,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,12/31/2007,04/30/2024,ANDA,"5 POUCH in 1 BAG (55154-4357-5)  / 1 VIAL, SINGLE-USE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-USE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,N/A,55154435705,Opium,3
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE,60429-975-60,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA202496,"Golden State Medical Supply, Inc.",60429-975,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,10/17/2017,N/A,ANDA,2 POUCH in 1 CARTON (60429-975-60)  / 30 AMPULE in 1 POUCH / 3 mL in 1 AMPULE,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2024,60429097560,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,69097-173-64,"2.5 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA077559,Cipla USA Inc.,69097-173,Ipratropium Bromide and Albuterol Sulfate,ALBUTEROL SULFATE;  IPRATROPIUM BROMIDE,HUMAN PRESCRIPTION DRUG,12/31/2007,N/A,ANDA,12 POUCH in 1 CARTON (69097-173-64)  / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL,"Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,69097017364,Opium,2.5
Ipratropium Bromide and Albuterol Sulfate,71205-051-15,"3 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA076749,Proficient Rx LP,71205-051,Ipratropium Bromide and Albuterol Sulfate,IPRATROPIUM BROMIDE;  ALBUTEROL SULFATE,HUMAN PRESCRIPTION DRUG,04/01/2019,N/A,ANDA,"15 POUCH in 1 CARTON (71205-051-15)  / 1 VIAL, SINGLE-USE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-USE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,71205005115,Opium,3
Ipratropium Bromide and Albuterol Sulfate,71205-051-30,"3 mg/3mL,                         .5  mg/3mL",SOLUTION,RESPIRATORY (INHALATION),ANDA076749,Proficient Rx LP,71205-051,Ipratropium Bromide and Albuterol Sulfate,IPRATROPIUM BROMIDE;  ALBUTEROL SULFATE,HUMAN PRESCRIPTION DRUG,06/01/2018,N/A,ANDA,"30 POUCH in 1 CARTON (71205-051-30)  / 1 VIAL, SINGLE-USE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-USE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,71205005130,Opium,3
Spiriva,0597-0075-41,18 ug/1,CAPSULE,ORAL; RESPIRATORY (INHALATION),NDA021395,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0075,TIOTROPIUM BROMIDE,TIOTROPIUM BROMIDE MONOHYDRATE,HUMAN PRESCRIPTION DRUG,10/11/2005,N/A,NDA,3 BLISTER PACK in 1 CARTON (0597-0075-41)  / 10 CAPSULE in 1 BLISTER PACK,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00597007541,Opium,18
Spiriva,0597-0075-47,18 ug/1,CAPSULE,ORAL; RESPIRATORY (INHALATION),NDA021395,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0075,TIOTROPIUM BROMIDE,TIOTROPIUM BROMIDE MONOHYDRATE,HUMAN PRESCRIPTION DRUG,10/11/2005,N/A,NDA,9 BLISTER PACK in 1 CARTON (0597-0075-47)  / 10 CAPSULE in 1 BLISTER PACK,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00597007547,Opium,18
Spiriva,0597-0075-75,18 ug/1,CAPSULE,ORAL; RESPIRATORY (INHALATION),NDA021395,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0075,TIOTROPIUM BROMIDE,TIOTROPIUM BROMIDE MONOHYDRATE,HUMAN PRESCRIPTION DRUG,10/11/2005,N/A,NDA,1 BLISTER PACK in 1 CARTON (0597-0075-75)  / 5 CAPSULE in 1 BLISTER PACK,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00597007575,Opium,18
Spiriva,50090-4248-0,18 ug/1,CAPSULE,ORAL; RESPIRATORY (INHALATION),NDA021395,A-S Medication Solutions,50090-4248,TIOTROPIUM BROMIDE,TIOTROPIUM BROMIDE MONOHYDRATE,HUMAN PRESCRIPTION DRUG,04/02/2019,N/A,NDA,3 BLISTER PACK in 1 CARTON (50090-4248-0)  / 10 CAPSULE in 1 BLISTER PACK,"Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2024,50090424800,Opium,18
Spiriva Respimat,0597-0100-51,3.124 ug/1,"SPRAY, METERED",RESPIRATORY (INHALATION),NDA021936,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0100,tiotropium bromide inhalation spray,TIOTROPIUM BROMIDE ANHYDROUS,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,NDA,"1 CARTRIDGE in 1 CARTON (0597-0100-51)  / 10 SPRAY, METERED in 1 CARTRIDGE","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00597010051,Opium,3.124
Spiriva Respimat,0597-0100-28,3.124 ug/1,"SPRAY, METERED",RESPIRATORY (INHALATION),NDA021936,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0100,tiotropium bromide inhalation spray,TIOTROPIUM BROMIDE ANHYDROUS,HUMAN PRESCRIPTION DRUG,09/30/2014,N/A,NDA,"1 CARTRIDGE in 1 CARTON (0597-0100-28)  / 28 SPRAY, METERED in 1 CARTRIDGE","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00597010028,Opium,3.124
Spiriva Respimat,0597-0100-61,3.124 ug/1,"SPRAY, METERED",RESPIRATORY (INHALATION),NDA021936,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0100,tiotropium bromide inhalation spray,TIOTROPIUM BROMIDE ANHYDROUS,HUMAN PRESCRIPTION DRUG,09/30/2014,N/A,NDA,"1 CARTRIDGE in 1 CARTON (0597-0100-61)  / 60 SPRAY, METERED in 1 CARTRIDGE","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00597010061,Opium,3.124
Spiriva Respimat,0597-0160-28,1.562 ug/1,"SPRAY, METERED",RESPIRATORY (INHALATION),NDA207070,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0160,tiotropium bromide inhalation spray,TIOTROPIUM BROMIDE ANHYDROUS,HUMAN PRESCRIPTION DRUG,09/15/2015,N/A,NDA,"1 CARTRIDGE in 1 CARTON (0597-0160-28)  / 28 SPRAY, METERED in 1 CARTRIDGE","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00597016028,Opium,1.562
Spiriva Respimat,0597-0160-61,1.562 ug/1,"SPRAY, METERED",RESPIRATORY (INHALATION),NDA207070,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0160,tiotropium bromide inhalation spray,TIOTROPIUM BROMIDE ANHYDROUS,HUMAN PRESCRIPTION DRUG,09/15/2015,N/A,NDA,"1 CARTRIDGE in 1 CARTON (0597-0160-61)  / 60 SPRAY, METERED in 1 CARTRIDGE","Anticholinergic [EPC],  Cholinergic Antagonists [MoA]",N/A,No,12/31/2023,00597016061,Opium,1.562
Stiolto Respimat,0597-0155-70,"2.736 ug/1,                         3.124  ug/1","SPRAY, METERED",RESPIRATORY (INHALATION),NDA206756,Boehringer Ingelheim Pharmaceuticals Inc.,0597-0155,tiotropium bromide and olodaterol,OLODATEROL HYDROCHLORIDE;  TIOTROPIUM BROMIDE MONOHYDRATE,HUMAN PRESCRIPTION DRUG,03/22/2019,N/A,NDA,"1 CARTRIDGE in 1 CARTON (0597-0155-70)  / 10 SPRAY, METERED in 1 CARTRIDGE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,00597015570,Opium,2.7359999999999998
Stiolto Respimat,0597-0155-28,"2.736 ug/1,                         3.124  ug/1","SPRAY, METERED",RESPIRATORY (INHALATION),NDA206756,Boehringer Ingelheim Pharmaceuticals Inc.,0597-0155,tiotropium bromide and olodaterol,OLODATEROL HYDROCHLORIDE;  TIOTROPIUM BROMIDE MONOHYDRATE,HUMAN PRESCRIPTION DRUG,05/21/2015,N/A,NDA,"1 CARTRIDGE in 1 CARTON (0597-0155-28)  / 28 SPRAY, METERED in 1 CARTRIDGE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,00597015528,Opium,2.7359999999999998
Stiolto Respimat,0597-0155-61,"2.736 ug/1,                         3.124  ug/1","SPRAY, METERED",RESPIRATORY (INHALATION),NDA206756,Boehringer Ingelheim Pharmaceuticals Inc.,0597-0155,tiotropium bromide and olodaterol,OLODATEROL HYDROCHLORIDE;  TIOTROPIUM BROMIDE MONOHYDRATE,HUMAN PRESCRIPTION DRUG,05/21/2015,N/A,NDA,"1 CARTRIDGE in 1 CARTON (0597-0155-61)  / 60 SPRAY, METERED in 1 CARTRIDGE","Adrenergic beta2-Agonists [MoA],  Anticholinergic [EPC],  Cholinergic Antagonists [MoA],  beta2-Adrenergic Agonist [EPC]",N/A,No,12/31/2023,00597015561,Opium,2.7359999999999998
ENDOCET,63629-2187-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040330,Bryant Ranch Prepack,63629-2187,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2021,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (63629-2187-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629218701,Oxycodone,325
ENDOCET,63629-2188-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040330,Bryant Ranch Prepack,63629-2188,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-2188-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629218801,Oxycodone,325
ENDOCET,63629-2189-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040330,Bryant Ranch Prepack,63629-2189,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2021,N/A,ANDA,500 TABLET in 1 BOTTLE (63629-2189-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629218901,Oxycodone,325
ENDOCET,63629-2190-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040330,Bryant Ranch Prepack,63629-2190,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2021,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (63629-2190-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629219001,Oxycodone,325
ENDOCET,60951-602-70,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040330,"Par Pharmaceutical, Inc.",60951-602,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/26/2000,N/A,ANDA,100 TABLET in 1 BOTTLE (60951-602-70),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60951060270,Oxycodone,325
ENDOCET,60951-602-85,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040330,"Par Pharmaceutical, Inc.",60951-602,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/26/2000,N/A,ANDA,500 TABLET in 1 BOTTLE (60951-602-85),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60951060285,Oxycodone,325
ENDOCET,60951-700-70,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040330,"Par Pharmaceutical, Inc.",60951-700,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/06/2003,N/A,ANDA,100 TABLET in 1 BOTTLE (60951-700-70),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60951070070,Oxycodone,325
ENDOCET,60951-701-70,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA040330,"Par Pharmaceutical, Inc.",60951-701,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/06/2003,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (60951-701-70)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60951070170,Oxycodone,325
ENDOCET,60951-712-70,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040330,"Par Pharmaceutical, Inc.",60951-712,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/06/2003,N/A,ANDA,100 TABLET in 1 BOTTLE (60951-712-70),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60951071270,Oxycodone,325
ENDOCET,71335-2182-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040330,Bryant Ranch Prepack,71335-2182,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/25/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-2182-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335218201,Oxycodone,325
ENDOCET,71335-2182-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040330,Bryant Ranch Prepack,71335-2182,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/25/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-2182-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335218202,Oxycodone,325
ENDOCET,71335-2182-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040330,Bryant Ranch Prepack,71335-2182,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/25/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-2182-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335218203,Oxycodone,325
ENDOCET,71335-2182-4,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040330,Bryant Ranch Prepack,71335-2182,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/25/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-2182-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335218204,Oxycodone,325
ENDOCET,71335-2182-5,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040330,Bryant Ranch Prepack,71335-2182,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/25/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-2182-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335218205,Oxycodone,325
ENDOCET,71335-2182-6,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040330,Bryant Ranch Prepack,71335-2182,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/25/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-2182-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335218206,Oxycodone,325
ENDOCET,71335-2182-7,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040330,Bryant Ranch Prepack,71335-2182,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/25/2022,N/A,ANDA,45 TABLET in 1 BOTTLE (71335-2182-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335218207,Oxycodone,325
ENDOCET,71335-2182-8,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040330,Bryant Ranch Prepack,71335-2182,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/25/2022,N/A,ANDA,75 TABLET in 1 BOTTLE (71335-2182-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335218208,Oxycodone,325
ENDOCET,71335-2182-9,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040330,Bryant Ranch Prepack,71335-2182,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/25/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-2182-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335218209,Oxycodone,325
Nalocet,72245-193-03,"300 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA040608,Forte Bio-Pharma LLC,72245-193,oxycodone and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/23/2018,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (72245-193-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72245019303,Oxycodone,300
Nalocet,72245-193-10,"300 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA040608,Forte Bio-Pharma LLC,72245-193,oxycodone and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/23/2018,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (72245-193-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72245019310,Oxycodone,300
OXAYDO,69344-213-11,7.5 mg/1,TABLET,ORAL,NDA202080,Zyla Life Sciences US Inc.,69344-213,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/01/2015,N/A,NDA,100 TABLET in 1 BOTTLE (69344-213-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,69344021311,Oxycodone,7.5
OXAYDO,69344-113-11,5 mg/1,TABLET,ORAL,NDA202080,Zyla Life Sciences US Inc.,69344-113,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/01/2015,N/A,NDA,100 TABLET in 1 BOTTLE (69344-113-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,69344011311,Oxycodone,5
Oxycodone,67877-623-19,5 mg/5mL,SOLUTION,ORAL,ANDA211748,"Ascend Laboratories, LLC",67877-623,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2019,N/A,ANDA,"15 mL in 1 BOTTLE, PLASTIC (67877-623-19)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67877062319,Oxycodone,5
Oxycodone,67877-623-88,5 mg/5mL,SOLUTION,ORAL,ANDA211748,"Ascend Laboratories, LLC",67877-623,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2019,N/A,ANDA,"100 mL in 1 BOTTLE, PLASTIC (67877-623-88)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67877062388,Oxycodone,5
Oxycodone,67877-623-91,5 mg/5mL,SOLUTION,ORAL,ANDA211748,"Ascend Laboratories, LLC",67877-623,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2019,N/A,ANDA,"500 mL in 1 BOTTLE, PLASTIC (67877-623-91)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67877062391,Oxycodone,5
Oxycodone,67877-625-19,100 mg/5mL,SOLUTION,ORAL,ANDA211749,"Ascend Laboratories, LLC",67877-625,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/06/2019,N/A,ANDA,"1 BOTTLE, PLASTIC in 1 CARTON (67877-625-19)  / 15 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67877062519,Oxycodone,100
Oxycodone,67877-625-59,100 mg/5mL,SOLUTION,ORAL,ANDA211749,"Ascend Laboratories, LLC",67877-625,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/06/2019,N/A,ANDA,"30 BOTTLE, PLASTIC in 1 CARTON (67877-625-59)  / 30 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67877062559,Oxycodone,100
Oxycodone and Acetaminophen,42858-103-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Rhodes Pharmaceuticals L.P.,42858-103,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/28/2014,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-103-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858010301,Oxycodone,325
oxycodone and acetaminophen,43598-546-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,Dr. Reddys Laboratories Inc.,43598-546,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/09/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (43598-546-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43598054601,Oxycodone,325
Oxycodone and Acetaminophen,63187-823-15,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Proficient Rx LP,63187-823,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,15 TABLET in 1 BOTTLE (63187-823-15),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187082315,Oxycodone,325
Oxycodone and Acetaminophen,63187-823-20,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Proficient Rx LP,63187-823,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,20 TABLET in 1 BOTTLE (63187-823-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187082320,Oxycodone,325
Oxycodone and Acetaminophen,63187-824-10,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Proficient Rx LP,63187-824,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2017,N/A,ANDA,"10 TABLET in 1 BOTTLE, PLASTIC (63187-824-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187082410,Oxycodone,325
Oxycodone and Acetaminophen,67296-1392-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,"RedPharm Drug, Inc.",67296-1392,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,20 TABLET in 1 BOTTLE (67296-1392-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296139202,Oxycodone,325
Oxycodone and Acetaminophen,67296-1531-8,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"RedPharm Drug, Inc.",67296-1531,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/11/2017,N/A,ANDA,12 TABLET in 1 BOTTLE (67296-1531-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296153108,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,67296-0355-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,"RedPharm Drug, Inc.",67296-0355,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/08/2011,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-0355-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296035503,Oxycodone,325
Oxycodone and Acetaminophen,53746-203-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040777,Amneal Pharmaceuticals of New York LLC,53746-203,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/27/2007,N/A,ANDA,500 TABLET in 1 BOTTLE (53746-203-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,53746020305,Oxycodone,325
Oxycodone and Acetaminophen,53746-204-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040778,Amneal Pharmaceuticals of New York LLC,53746-204,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/27/2007,N/A,ANDA,100 TABLET in 1 BOTTLE (53746-204-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,53746020401,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,67296-1855-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,"Redpharm Drug, Inc",67296-1855,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (67296-1855-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,67296185507,Oxycodone,325
Oxycodone and Acetaminophen,55700-498-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-498,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (55700-498-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049830,Oxycodone,325
Oxycodone and Acetaminophen,55700-497-60,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-497,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2017,N/A,ANDA,60 TABLET in 1 BOTTLE (55700-497-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049760,Oxycodone,325
Oxycodone and Acetaminophen,55700-498-14,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-498,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/14/2017,N/A,ANDA,14 TABLET in 1 BOTTLE (55700-498-14),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049814,Oxycodone,325
Oxycodone and Acetaminophen,55700-498-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-498,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2017,N/A,ANDA,60 TABLET in 1 BOTTLE (55700-498-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049860,Oxycodone,325
Oxycodone and Acetaminophen,42858-103-50,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Rhodes Pharmaceuticals L.P.,42858-103,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/28/2014,N/A,ANDA,"500 TABLET in 1 BOTTLE, PLASTIC (42858-103-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858010350,Oxycodone,325
Oxycodone and Acetaminophen,68071-5054-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"NuCare Pharmaceuticals,Inc.",68071-5054,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/12/2019,N/A,ANDA,4 TABLET in 1 BOTTLE (68071-5054-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68071505404,Oxycodone,325
Oxycodone and Acetaminophen,47781-196-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202677,"Alvogen, Inc.",47781-196,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/09/2016,N/A,ANDA,500 TABLET in 1 BOTTLE (47781-196-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781019605,Oxycodone,325
Oxycodone and Acetaminophen,47781-196-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202677,"Alvogen, Inc.",47781-196,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/09/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (47781-196-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781019601,Oxycodone,325
Oxycodone and Acetaminophen,47781-230-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202677,"Alvogen, Inc.",47781-230,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/17/2012,N/A,ANDA,500 TABLET in 1 BOTTLE (47781-230-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781023005,Oxycodone,325
Oxycodone and Acetaminophen,72189-368-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Direct_Rx,72189-368,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/28/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-368-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189036830,Oxycodone,325
Oxycodone and Acetaminophen,42858-104-50,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Rhodes Pharmaceuticals L.P.,42858-104,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/28/2014,N/A,ANDA,"500 TABLET in 1 BOTTLE, PLASTIC (42858-104-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858010450,Oxycodone,325
Oxycodone and Acetaminophen,55700-498-21,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-498,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/14/2017,N/A,ANDA,21 TABLET in 1 BOTTLE (55700-498-21),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049821,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9674-0,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9674,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,25 TABLET in 1 BOTTLE (71335-9674-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967400,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9674-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9674,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,10 TABLET in 1 BOTTLE (71335-9674-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967401,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9674-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9674,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-9674-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967402,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9674-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9674,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-9674-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967403,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9674-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9674,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,12 TABLET in 1 BOTTLE (71335-9674-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967404,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9674-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9674,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-9674-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967405,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9674-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9674,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-9674-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967406,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9674-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9674,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-9674-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967407,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9674-8,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9674,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-9674-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967408,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9674-9,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9674,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-9674-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967409,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9675-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9675,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,21 TABLET in 1 BOTTLE (71335-9675-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967501,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9675-2,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9675,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,36 TABLET in 1 BOTTLE (71335-9675-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967502,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9675-3,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9675,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-9675-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967503,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9675-4,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9675,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-9675-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967504,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9675-5,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9675,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,45 TABLET in 1 BOTTLE (71335-9675-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967505,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9675-6,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9675,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-9675-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967506,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9675-7,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9675,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-9675-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967507,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-9675-8,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-9675,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-9675-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335967508,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,10702-238-50,"325 mg/5mL,                         5  mg/5mL",SOLUTION,ORAL,ANDA211499,"KVK-Tech, Inc.",10702-238,oxycodone and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/05/2019,N/A,ANDA,500 mL in 1 BOTTLE (10702-238-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702023850,Oxycodone,325
Oxycodone and Acetaminophen,55700-497-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-497,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2017,N/A,ANDA,120 TABLET in 1 BOTTLE (55700-497-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049701,Oxycodone,325
Oxycodone and Acetaminophen,67296-1392-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,"RedPharm Drug, Inc.",67296-1392,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,15 TABLET in 1 BOTTLE (67296-1392-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296139207,Oxycodone,325
Oxycodone and Acetaminophen,13107-043-01,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-043,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-043-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004301,Oxycodone,325
Oxycodone and Acetaminophen,13107-043-05,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-043,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-043-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004305,Oxycodone,325
Oxycodone and Acetaminophen,13107-043-30,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-043,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-043-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004330,Oxycodone,325
Oxycodone and Acetaminophen,13107-043-99,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-043,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-043-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004399,Oxycodone,325
Oxycodone and Acetaminophen,13107-044-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-044,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-044-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004401,Oxycodone,325
Oxycodone and Acetaminophen,13107-044-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-044,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-044-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004405,Oxycodone,325
Oxycodone and Acetaminophen,13107-044-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-044,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-044-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004430,Oxycodone,325
Oxycodone and Acetaminophen,13107-044-99,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-044,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-044-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004499,Oxycodone,325
Oxycodone and Acetaminophen,13107-045-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-045,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-045-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004501,Oxycodone,325
Oxycodone and Acetaminophen,13107-045-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-045,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-045-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004505,Oxycodone,325
Oxycodone and Acetaminophen,13107-045-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-045,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-045-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004530,Oxycodone,325
Oxycodone and Acetaminophen,13107-045-99,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-045,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-045-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004599,Oxycodone,325
Oxycodone and Acetaminophen,13107-046-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-046,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-046-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004601,Oxycodone,325
Oxycodone and Acetaminophen,13107-046-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-046,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,500 TABLET in 1 BOTTLE (13107-046-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004605,Oxycodone,325
Oxycodone and Acetaminophen,13107-046-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-046,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-046-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004630,Oxycodone,325
Oxycodone and Acetaminophen,13107-046-99,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,"Aurolife Pharma, LLC",13107-046,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2013,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-046-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107004699,Oxycodone,325
Oxycodone and Acetaminophen,72189-357-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Direct_Rx,72189-357,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/18/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-357-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189035730,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-2049-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-2049,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/28/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-2049-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335204901,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-2049-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-2049,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/28/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-2049-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335204902,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-2049-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-2049,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/28/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-2049-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335204903,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-2049-4,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-2049,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/28/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-2049-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335204904,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-2049-5,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-2049,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/28/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-2049-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335204905,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-2049-6,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-2049,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/28/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-2049-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335204906,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-2049-7,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-2049,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/28/2022,N/A,ANDA,45 TABLET in 1 BOTTLE (71335-2049-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335204907,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-2049-8,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-2049,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/28/2022,N/A,ANDA,75 TABLET in 1 BOTTLE (71335-2049-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335204908,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71335-2049-9,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,71335-2049,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/28/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-2049-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335204909,Oxycodone,325
Oxycodone and Acetaminophen,63187-363-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202677,Proficient Rx LP,63187-363,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/01/2016,N/A,ANDA,60 TABLET in 1 BOTTLE (63187-363-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187036360,Oxycodone,325
Oxycodone and Acetaminophen,63187-406-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040105,Proficient Rx LP,63187-406,Oxycodone hydrochloride and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/01/2019,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (63187-406-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187040630,Oxycodone,325
oxycodone and acetaminophen,43598-547-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,Dr. Reddys Laboratories Inc.,43598-547,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/09/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (43598-547-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43598054705,Oxycodone,325
Oxycodone and Acetaminophen,63187-823-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Proficient Rx LP,63187-823,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/01/2017,N/A,ANDA,90 TABLET in 1 BOTTLE (63187-823-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187082390,Oxycodone,325
Oxycodone and Acetaminophen,63187-984-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Proficient Rx LP,63187-984,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/01/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (63187-984-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187098460,Oxycodone,325
Oxycodone and Acetaminophen,71335-2106-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2106,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-2106-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335210601,Oxycodone,325
Oxycodone and Acetaminophen,71335-2106-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2106,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-2106-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335210602,Oxycodone,325
Oxycodone and Acetaminophen,71335-2106-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2106,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-2106-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335210603,Oxycodone,325
Oxycodone and Acetaminophen,71335-2106-4,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2106,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-2106-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335210604,Oxycodone,325
Oxycodone and Acetaminophen,71335-2106-5,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2106,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-2106-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335210605,Oxycodone,325
Oxycodone and Acetaminophen,71335-2106-6,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2106,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-2106-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335210606,Oxycodone,325
Oxycodone and Acetaminophen,71335-2106-7,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2106,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,45 TABLET in 1 BOTTLE (71335-2106-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335210607,Oxycodone,325
Oxycodone and Acetaminophen,71335-2106-8,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2106,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,75 TABLET in 1 BOTTLE (71335-2106-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335210608,Oxycodone,325
Oxycodone and Acetaminophen,71335-2106-9,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2106,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/06/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-2106-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335210609,Oxycodone,325
Oxycodone and Acetaminophen,68071-5054-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"NuCare Pharmaceuticals,Inc.",68071-5054,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/12/2019,N/A,ANDA,12 TABLET in 1 BOTTLE (68071-5054-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68071505402,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,55700-984-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040545,"Quality Care Products, LLC",55700-984,oxycodone hydrochloride and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (55700-984-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700098430,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,55700-984-60,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040545,"Quality Care Products, LLC",55700-984,oxycodone hydrochloride and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (55700-984-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700098460,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,55700-984-90,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040545,"Quality Care Products, LLC",55700-984,oxycodone hydrochloride and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/28/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (55700-984-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700098490,Oxycodone,325
Oxycodone and Acetaminophen,71335-1959-7,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1959,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1959-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195907,Oxycodone,325
Oxycodone and Acetaminophen,71335-1959-8,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1959,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1959-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195908,Oxycodone,325
Oxycodone and Acetaminophen,71335-1959-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1959,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,21 TABLET in 1 BOTTLE (71335-1959-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195901,Oxycodone,325
Oxycodone and Acetaminophen,71335-1959-2,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1959,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,36 TABLET in 1 BOTTLE (71335-1959-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195902,Oxycodone,325
Oxycodone and Acetaminophen,71335-1959-3,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1959,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1959-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195903,Oxycodone,325
Oxycodone and Acetaminophen,71335-1959-4,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1959,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1959-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195904,Oxycodone,325
Oxycodone and Acetaminophen,71335-1959-5,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1959,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,45 TABLET in 1 BOTTLE (71335-1959-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195905,Oxycodone,325
Oxycodone and Acetaminophen,71335-1959-6,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1959,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1959-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195906,Oxycodone,325
Oxycodone and Acetaminophen,55700-967-90,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,"Quality Care Products, LLC",55700-967,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/03/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (55700-967-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700096790,Oxycodone,325
Oxycodone and Acetaminophen,63629-8879-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,63629-8879,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/04/2021,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (63629-8879-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629887901,Oxycodone,325
Oxycodone and Acetaminophen,63629-8879-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,63629-8879,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/04/2021,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (63629-8879-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629887902,Oxycodone,325
Oxycodone and Acetaminophen,63629-8876-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,63629-8876,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/01/2021,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (63629-8876-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629887601,Oxycodone,325
Oxycodone and Acetaminophen,60760-276-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,St. Mary's Medical Park Pharmacy,60760-276,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/15/2017,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (60760-276-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60760027690,Oxycodone,325
Oxycodone and Acetaminophen,50268-646-15,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040778,AvPAK,50268-646,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/09/2018,N/A,ANDA,50 BLISTER PACK in 1 BOX (50268-646-15)  / 1 TABLET in 1 BLISTER PACK (50268-646-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,50268064615,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71930-045-12,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,Eywa Pharma Inc,71930-045,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (71930-045-12),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71930004512,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71930-045-52,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,Eywa Pharma Inc,71930-045,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (71930-045-52),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71930004552,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71930-046-12,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,Eywa Pharma Inc,71930-046,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (71930-046-12),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71930004612,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71930-046-52,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,Eywa Pharma Inc,71930-046,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (71930-046-52),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71930004652,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71930-047-12,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,Eywa Pharma Inc,71930-047,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (71930-047-12),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71930004712,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,71930-047-52,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,Eywa Pharma Inc,71930-047,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (71930-047-52),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71930004752,Oxycodone,325
Oxycodone and Acetaminophen,42806-114-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA203864,"Epic Pharma, LLC",42806-114,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/02/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-114-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42806011401,Oxycodone,325
Oxycodone and Acetaminophen,31722-948-01,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-948,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-948-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,31722094801,Oxycodone,325
Oxycodone and Acetaminophen,31722-948-05,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-948,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (31722-948-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,31722094805,Oxycodone,325
Oxycodone and Acetaminophen,31722-949-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-949,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-949-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,31722094901,Oxycodone,325
Oxycodone and Acetaminophen,31722-949-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-949,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (31722-949-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,31722094905,Oxycodone,325
Oxycodone and Acetaminophen,31722-950-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-950,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-950-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,31722095001,Oxycodone,325
Oxycodone and Acetaminophen,31722-950-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-950,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (31722-950-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,31722095005,Oxycodone,325
Oxycodone and Acetaminophen,31722-951-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-951,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-951-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,31722095101,Oxycodone,325
Oxycodone and Acetaminophen,31722-951-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-951,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (31722-951-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,31722095105,Oxycodone,325
Oxycodone and Acetaminophen,72189-357-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Direct_Rx,72189-357,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/18/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-357-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189035760,Oxycodone,325
Oxycodone and Acetaminophen,76420-209-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,"Asclemed USA, Inc.",76420-209,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/05/2022,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (76420-209-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76420020901,Oxycodone,325
Oxycodone and Acetaminophen,76420-209-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,"Asclemed USA, Inc.",76420-209,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/05/2022,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (76420-209-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76420020930,Oxycodone,325
Oxycodone and Acetaminophen,76420-209-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,"Asclemed USA, Inc.",76420-209,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/05/2022,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (76420-209-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76420020960,Oxycodone,325
Oxycodone and Acetaminophen,76420-209-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,"Asclemed USA, Inc.",76420-209,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/05/2022,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (76420-209-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76420020990,Oxycodone,325
Oxycodone and Acetaminophen,71205-329-28,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Proficient Rx LP,71205-329,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/29/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71205-329-28),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71205032928,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,67296-0355-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,"RedPharm Drug, Inc.",67296-0355,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/08/2011,N/A,ANDA,15 TABLET in 1 BOTTLE (67296-0355-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296035504,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,67296-0355-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,"RedPharm Drug, Inc.",67296-0355,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/08/2011,N/A,ANDA,30 TABLET in 1 BOTTLE (67296-0355-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296035502,Oxycodone,325
Oxycodone and Acetaminophen,55700-498-40,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-498,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2017,N/A,ANDA,40 TABLET in 1 BOTTLE (55700-498-40),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049840,Oxycodone,325
Oxycodone and Acetaminophen,55700-498-90,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-498,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2017,N/A,ANDA,90 TABLET in 1 BOTTLE (55700-498-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049890,Oxycodone,325
Oxycodone and Acetaminophen,0527-1671-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207333,"Lannett Company, Inc.",0527-1671,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/25/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (0527-1671-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527167105,Oxycodone,325
Oxycodone and Acetaminophen,10702-187-10,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA210644,"KVK-Tech, Inc.",10702-187,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,1000 TABLET in 1 BOTTLE (10702-187-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702018710,Oxycodone,325
Oxycodone and Acetaminophen,10702-185-50,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210644,"KVK-Tech, Inc.",10702-185,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (10702-185-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702018550,Oxycodone,325
Oxycodone and Acetaminophen,10702-186-10,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210644,"KVK-Tech, Inc.",10702-186,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,1000 TABLET in 1 BOTTLE (10702-186-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702018610,Oxycodone,325
Oxycodone and Acetaminophen,10702-184-10,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA210644,"KVK-Tech, Inc.",10702-184,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,1000 TABLET in 1 BOTTLE (10702-184-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702018410,Oxycodone,325
Oxycodone and Acetaminophen,10702-187-50,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA210644,"KVK-Tech, Inc.",10702-187,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (10702-187-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702018750,Oxycodone,325
Oxycodone and Acetaminophen,63187-719-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202677,Proficient Rx LP,63187-719,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (63187-719-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187071930,Oxycodone,325
Oxycodone and Acetaminophen,63187-721-20,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040778,Proficient Rx LP,63187-721,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,20 TABLET in 1 BOTTLE (63187-721-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187072120,Oxycodone,325
Oxycodone and Acetaminophen,10702-184-50,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA210644,"KVK-Tech, Inc.",10702-184,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (10702-184-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702018450,Oxycodone,325
Oxycodone and Acetaminophen,71335-1953-0,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1953,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/13/2022,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-1953-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195300,Oxycodone,325
Oxycodone and Acetaminophen,71335-1953-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1953,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/29/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1953-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195301,Oxycodone,325
Oxycodone and Acetaminophen,71335-1953-2,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1953,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/29/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1953-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195302,Oxycodone,325
Oxycodone and Acetaminophen,71335-1953-3,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1953,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/17/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1953-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195303,Oxycodone,325
Oxycodone and Acetaminophen,71335-1953-4,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1953,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/07/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1953-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195304,Oxycodone,325
Oxycodone and Acetaminophen,71335-1953-5,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1953,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/13/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1953-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195305,Oxycodone,325
Oxycodone and Acetaminophen,71335-1953-6,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1953,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/13/2022,N/A,ANDA,45 TABLET in 1 BOTTLE (71335-1953-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195306,Oxycodone,325
Oxycodone and Acetaminophen,67296-1392-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,"RedPharm Drug, Inc.",67296-1392,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (67296-1392-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296139203,Oxycodone,325
Oxycodone and Acetaminophen,67296-1392-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,"RedPharm Drug, Inc.",67296-1392,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,50 TABLET in 1 BOTTLE (67296-1392-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296139205,Oxycodone,325
Oxycodone and Acetaminophen,67296-1531-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"RedPharm Drug, Inc.",67296-1531,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/11/2017,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-1531-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296153101,Oxycodone,325
Oxycodone and Acetaminophen,67296-1531-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"RedPharm Drug, Inc.",67296-1531,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/11/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (67296-1531-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296153103,Oxycodone,325
Oxycodone and Acetaminophen,63629-8879-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,63629-8879,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/04/2021,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (63629-8879-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629887903,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,67296-0355-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,"RedPharm Drug, Inc.",67296-0355,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/08/2011,N/A,ANDA,20 TABLET in 1 BOTTLE (67296-0355-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296035501,Oxycodone,325
Oxycodone and Acetaminophen,47781-229-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202677,"Alvogen, Inc.",47781-229,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/17/2012,N/A,ANDA,500 TABLET in 1 BOTTLE (47781-229-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781022905,Oxycodone,325
Oxycodone and Acetaminophen,47781-230-63,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202677,"Alvogen, Inc.",47781-230,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/17/2012,N/A,ANDA,250 TABLET in 1 BOTTLE (47781-230-63),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781023063,Oxycodone,325
Oxycodone and Acetaminophen,71335-1909-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1909,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2021,N/A,ANDA,"21 TABLET in 1 BOTTLE, PLASTIC (71335-1909-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335190901,Oxycodone,325
Oxycodone and Acetaminophen,71335-1909-2,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1909,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,07/15/2021,N/A,ANDA,"36 TABLET in 1 BOTTLE, PLASTIC (71335-1909-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335190902,Oxycodone,325
Oxycodone and Acetaminophen,71335-1953-7,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1953,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/13/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1953-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195307,Oxycodone,325
Oxycodone and Acetaminophen,71335-1953-8,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1953,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/13/2022,N/A,ANDA,168 TABLET in 1 BOTTLE (71335-1953-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195308,Oxycodone,325
Oxycodone and Acetaminophen,71335-1953-9,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-1953,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/13/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1953-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335195309,Oxycodone,325
Oxycodone and Acetaminophen,63187-406-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040105,Proficient Rx LP,63187-406,Oxycodone hydrochloride and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/01/2019,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (63187-406-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187040660,Oxycodone,325
Oxycodone and Acetaminophen,43386-490-01,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA204407,"Lupin Pharmaceuticals,Inc.",43386-490,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/24/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-490-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386049001,Oxycodone,325
Oxycodone and Acetaminophen,43386-490-05,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA204407,"Lupin Pharmaceuticals,Inc.",43386-490,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/24/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-490-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386049005,Oxycodone,325
Oxycodone and Acetaminophen,43386-490-10,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA204407,"Lupin Pharmaceuticals,Inc.",43386-490,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/24/2017,N/A,ANDA,1000 TABLET in 1 BOTTLE (43386-490-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386049010,Oxycodone,325
Oxycodone and Acetaminophen,43386-491-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA204407,"Lupin Pharmaceuticals,Inc.",43386-491,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/24/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-491-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386049101,Oxycodone,325
Oxycodone and Acetaminophen,43386-491-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA204407,"Lupin Pharmaceuticals,Inc.",43386-491,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/24/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-491-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386049105,Oxycodone,325
Oxycodone and Acetaminophen,43386-491-10,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA204407,"Lupin Pharmaceuticals,Inc.",43386-491,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/24/2017,N/A,ANDA,1000 TABLET in 1 BOTTLE (43386-491-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386049110,Oxycodone,325
Oxycodone and Acetaminophen,43386-492-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA204407,"Lupin Pharmaceuticals,Inc.",43386-492,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/24/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-492-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386049201,Oxycodone,325
Oxycodone and Acetaminophen,43386-492-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA204407,"Lupin Pharmaceuticals,Inc.",43386-492,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/24/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-492-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386049205,Oxycodone,325
Oxycodone and Acetaminophen,43386-492-10,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA204407,"Lupin Pharmaceuticals,Inc.",43386-492,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/24/2017,N/A,ANDA,1000 TABLET in 1 BOTTLE (43386-492-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386049210,Oxycodone,325
Oxycodone and Acetaminophen,43386-493-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA204407,"Lupin Pharmaceuticals,Inc.",43386-493,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/24/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-493-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386049301,Oxycodone,325
Oxycodone and Acetaminophen,43386-493-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA204407,"Lupin Pharmaceuticals,Inc.",43386-493,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/24/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-493-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386049305,Oxycodone,325
Oxycodone and Acetaminophen,43386-493-10,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA204407,"Lupin Pharmaceuticals,Inc.",43386-493,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/24/2017,N/A,ANDA,1000 TABLET in 1 BOTTLE (43386-493-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386049310,Oxycodone,325
Oxycodone and Acetaminophen,72189-357-90,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Direct_Rx,72189-357,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/18/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (72189-357-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189035790,Oxycodone,325
Oxycodone and Acetaminophen,67296-1392-8,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,"RedPharm Drug, Inc.",67296-1392,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,60 TABLET in 1 BOTTLE (67296-1392-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296139208,Oxycodone,325
Oxycodone and Acetaminophen,63629-8888-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-8888,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/07/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (63629-8888-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629888801,Oxycodone,325
Oxycodone and Acetaminophen,63629-8888-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-8888,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2023,N/A,ANDA,12 TABLET in 1 BOTTLE (63629-8888-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629888802,Oxycodone,325
Oxycodone and Acetaminophen,55700-967-28,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,"Quality Care Products, LLC",55700-967,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/13/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (55700-967-28),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700096728,Oxycodone,325
Oxycodone and Acetaminophen,55700-498-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-498,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2017,N/A,ANDA,120 TABLET in 1 BOTTLE (55700-498-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049801,Oxycodone,325
Oxycodone and Acetaminophen,63187-719-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202677,Proficient Rx LP,63187-719,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,60 TABLET in 1 BOTTLE (63187-719-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187071960,Oxycodone,325
Oxycodone and Acetaminophen,63187-721-15,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040778,Proficient Rx LP,63187-721,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,15 TABLET in 1 BOTTLE (63187-721-15),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187072115,Oxycodone,325
Oxycodone and Acetaminophen,63187-721-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040778,Proficient Rx LP,63187-721,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (63187-721-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187072130,Oxycodone,325
Oxycodone and Acetaminophen,63187-721-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040778,Proficient Rx LP,63187-721,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,60 TABLET in 1 BOTTLE (63187-721-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187072160,Oxycodone,325
Oxycodone and Acetaminophen,50268-644-15,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040777,AvPAK,50268-644,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/09/2018,N/A,ANDA,50 BLISTER PACK in 1 BOX (50268-644-15)  / 1 TABLET in 1 BLISTER PACK (50268-644-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,50268064415,Oxycodone,325
Oxycodone and Acetaminophen,63629-1907-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-1907,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-1907-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629190701,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,63629-1942-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,63629-1942,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2021,N/A,ANDA,500 TABLET in 1 BOTTLE (63629-1942-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629194201,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,63629-1943-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,Bryant Ranch Prepack,63629-1943,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2021,N/A,ANDA,500 TABLET in 1 BOTTLE (63629-1943-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629194301,Oxycodone,325
Oxycodone and Acetaminophen,10702-185-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210644,"KVK-Tech, Inc.",10702-185,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-185-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702018501,Oxycodone,325
Oxycodone and Acetaminophen,10702-186-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210644,"KVK-Tech, Inc.",10702-186,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-186-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702018601,Oxycodone,325
Oxycodone and Acetaminophen,10702-184-01,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA210644,"KVK-Tech, Inc.",10702-184,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-184-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702018401,Oxycodone,325
Oxycodone and Acetaminophen,10702-187-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA210644,"KVK-Tech, Inc.",10702-187,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-187-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702018701,Oxycodone,325
oxycodone and acetaminophen,72887-682-03,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040608,FH2 Pharma LLC,72887-682,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/02/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (72887-682-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72887068203,Oxycodone,300
Oxycodone and Acetaminophen,42858-102-50,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Rhodes Pharmaceuticals L.P.,42858-102,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/28/2014,N/A,ANDA,"500 TABLET in 1 BOTTLE, PLASTIC (42858-102-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858010250,Oxycodone,325
Oxycodone and Acetaminophen,47781-229-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202677,"Alvogen, Inc.",47781-229,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/17/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (47781-229-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781022901,Oxycodone,325
Oxycodone and Acetaminophen,71335-1472-0,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1472,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-1472-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335147200,Oxycodone,325
Oxycodone and Acetaminophen,71335-1472-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1472,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1472-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335147201,Oxycodone,325
Oxycodone and Acetaminophen,71335-1472-2,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1472,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1472-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335147202,Oxycodone,325
Oxycodone and Acetaminophen,71335-1472-3,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1472,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (71335-1472-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335147203,Oxycodone,325
Oxycodone and Acetaminophen,71335-1472-4,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1472,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1472-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335147204,Oxycodone,325
Oxycodone and Acetaminophen,71335-1472-5,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1472,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1472-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335147205,Oxycodone,325
Oxycodone and Acetaminophen,71335-1472-6,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1472,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,45 TABLET in 1 BOTTLE (71335-1472-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335147206,Oxycodone,325
Oxycodone and Acetaminophen,71335-1472-7,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1472,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1472-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335147207,Oxycodone,325
Oxycodone and Acetaminophen,71335-1472-8,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1472,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,168 TABLET in 1 BOTTLE (71335-1472-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335147208,Oxycodone,325
Oxycodone and Acetaminophen,71335-1472-9,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1472,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1472-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335147209,Oxycodone,325
Oxycodone and Acetaminophen,71335-1473-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1473,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,21 TABLET in 1 BOTTLE (71335-1473-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335147301,Oxycodone,325
Oxycodone and Acetaminophen,65162-207-03,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040778,Amneal Pharmaceuticals LLC,65162-207,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/01/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (65162-207-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162020703,Oxycodone,325
Oxycodone and Acetaminophen,49999-852-14,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,Quality Care products LLC,49999-852,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/10/2022,N/A,ANDA,"14 TABLET in 1 BOTTLE, PLASTIC (49999-852-14)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,49999085214,Oxycodone,325
Oxycodone and Acetaminophen,0527-1669-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207333,"Lannett Company, Inc.",0527-1669,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/25/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (0527-1669-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527166901,Oxycodone,325
Oxycodone and Acetaminophen,0527-1669-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207333,"Lannett Company, Inc.",0527-1669,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/25/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (0527-1669-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527166905,Oxycodone,325
Oxycodone and Acetaminophen,0527-1671-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207333,"Lannett Company, Inc.",0527-1671,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/25/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (0527-1671-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527167101,Oxycodone,325
Oxycodone and Acetaminophen,72865-113-01,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA207419,"XLCare Pharmaceuticals, Inc.",72865-113,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-113-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865011301,Oxycodone,325
Oxycodone and Acetaminophen,72865-113-05,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA207419,"XLCare Pharmaceuticals, Inc.",72865-113,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,500 TABLET in 1 BOTTLE (72865-113-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865011305,Oxycodone,325
Oxycodone and Acetaminophen,72865-114-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"XLCare Pharmaceuticals, Inc.",72865-114,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-114-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865011401,Oxycodone,325
Oxycodone and Acetaminophen,72865-114-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"XLCare Pharmaceuticals, Inc.",72865-114,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,500 TABLET in 1 BOTTLE (72865-114-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865011405,Oxycodone,325
Oxycodone and Acetaminophen,63187-363-20,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202677,Proficient Rx LP,63187-363,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/01/2016,N/A,ANDA,20 TABLET in 1 BOTTLE (63187-363-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187036320,Oxycodone,325
Oxycodone and Acetaminophen,72865-115-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,"XLCare Pharmaceuticals, Inc.",72865-115,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-115-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865011501,Oxycodone,325
Oxycodone and Acetaminophen,72865-115-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,"XLCare Pharmaceuticals, Inc.",72865-115,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,500 TABLET in 1 BOTTLE (72865-115-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865011505,Oxycodone,325
Oxycodone and Acetaminophen,72865-116-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,"XLCare Pharmaceuticals, Inc.",72865-116,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-116-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865011601,Oxycodone,325
Oxycodone and Acetaminophen,72865-116-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,"XLCare Pharmaceuticals, Inc.",72865-116,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,500 TABLET in 1 BOTTLE (72865-116-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865011605,Oxycodone,325
Oxycodone and Acetaminophen,71335-2041-0,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2041,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2022,N/A,ANDA,25 TABLET in 1 BOTTLE (71335-2041-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335204100,Oxycodone,325
Oxycodone and Acetaminophen,71335-2041-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2041,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2022,N/A,ANDA,10 TABLET in 1 BOTTLE (71335-2041-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335204101,Oxycodone,325
Oxycodone and Acetaminophen,71335-2041-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2041,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-2041-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335204102,Oxycodone,325
Oxycodone and Acetaminophen,71335-2041-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2041,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-2041-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335204103,Oxycodone,325
Oxycodone and Acetaminophen,71335-2041-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2041,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2022,N/A,ANDA,12 TABLET in 1 BOTTLE (71335-2041-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335204104,Oxycodone,325
Oxycodone and Acetaminophen,71335-2041-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2041,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-2041-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335204105,Oxycodone,325
Oxycodone and Acetaminophen,71335-2041-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2041,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-2041-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335204106,Oxycodone,325
Oxycodone and Acetaminophen,71335-2041-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2041,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-2041-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335204107,Oxycodone,325
Oxycodone and Acetaminophen,71335-2041-8,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2041,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-2041-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335204108,Oxycodone,325
Oxycodone and Acetaminophen,71335-2041-9,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,71335-2041,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2022,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-2041-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335204109,Oxycodone,325
oxycodone and acetaminophen,72887-193-03,"300 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA040608,FH2 Pharma LLC,72887-193,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/03/2019,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (72887-193-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72887019303,Oxycodone,300
oxycodone and acetaminophen,72887-681-03,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040608,FH2 Pharma LLC,72887-681,oxycodone and acetaminophen tablets,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/25/2020,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (72887-681-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72887068103,Oxycodone,300
oxycodone and acetaminophen,72887-683-03,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040608,FH2 Pharma LLC,72887-683,oxycodone and acetaminophen tablets,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/25/2020,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (72887-683-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72887068303,Oxycodone,300
Oxycodone and Acetaminophen,63187-719-15,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202677,Proficient Rx LP,63187-719,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,15 TABLET in 1 BOTTLE (63187-719-15),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187071915,Oxycodone,325
Oxycodone and Acetaminophen,63187-721-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040778,Proficient Rx LP,63187-721,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,05/30/2017,N/A,ANDA,90 TABLET in 1 BOTTLE (63187-721-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187072190,Oxycodone,325
Oxycodone and Acetaminophen,63187-719-20,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202677,Proficient Rx LP,63187-719,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/01/2016,N/A,ANDA,20 TABLET in 1 BOTTLE (63187-719-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187071920,Oxycodone,325
Oxycodone and Acetaminophen,63187-406-20,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040105,Proficient Rx LP,63187-406,Oxycodone hydrochloride and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/01/2019,N/A,ANDA,"20 TABLET in 1 BOTTLE, PLASTIC (63187-406-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187040620,Oxycodone,325
Oxycodone and Acetaminophen,63187-719-12,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202677,Proficient Rx LP,63187-719,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/01/2016,N/A,ANDA,12 TABLET in 1 BOTTLE (63187-719-12),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187071912,Oxycodone,325
Oxycodone and Acetaminophen,65162-207-10,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040778,Amneal Pharmaceuticals LLC,65162-207,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/01/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (65162-207-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162020710,Oxycodone,325
Oxycodone and Acetaminophen,60760-276-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,St. Mary's Medical Park Pharmacy,60760-276,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/15/2017,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (60760-276-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60760027630,Oxycodone,325
oxycodone and acetaminophen,43598-547-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,Dr. Reddys Laboratories Inc.,43598-547,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/09/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (43598-547-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43598054701,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,55700-983-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040545,"Quality Care Products, LLC",55700-983,oxycodone hydrochloride and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/08/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (55700-983-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700098390,Oxycodone,325
Oxycodone and Acetaminophen,53746-204-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040778,Amneal Pharmaceuticals of New York LLC,53746-204,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/27/2007,N/A,ANDA,500 TABLET in 1 BOTTLE (53746-204-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,53746020405,Oxycodone,325
Oxycodone and Acetaminophen,60760-276-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,St. Mary's Medical Park Pharmacy,60760-276,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/15/2017,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (60760-276-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60760027660,Oxycodone,325
Oxycodone and Acetaminophen,63629-1908-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-1908,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (63629-1908-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629190801,Oxycodone,325
Oxycodone and Acetaminophen,63629-1909-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-1909,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,02/29/2024,ANDA,100 TABLET in 1 BOTTLE (63629-1909-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,63629190901,Oxycodone,325
Oxycodone and Acetaminophen,63629-1911-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-1911,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-1911-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629191101,Oxycodone,325
Oxycodone and Acetaminophen,63629-1912-1,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-1912,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2019,N/A,ANDA,500 TABLET in 1 BOTTLE (63629-1912-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629191201,Oxycodone,325
Oxycodone and Acetaminophen,55700-496-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-496,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2017,N/A,ANDA,120 TABLET in 1 BOTTLE (55700-496-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049601,Oxycodone,325
Oxycodone and Acetaminophen,55700-496-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-496,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (55700-496-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049630,Oxycodone,325
Oxycodone and Acetaminophen,55700-496-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-496,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2017,N/A,ANDA,60 TABLET in 1 BOTTLE (55700-496-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049660,Oxycodone,325
Oxycodone and Acetaminophen,55700-496-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-496,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2017,N/A,ANDA,90 TABLET in 1 BOTTLE (55700-496-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049690,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,72189-255-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,DIRECT RX,72189-255,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/10/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-255-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189025530,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,72189-256-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,DIRECT RX,72189-256,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/10/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-256-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189025630,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,67296-0355-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,"RedPharm Drug, Inc.",67296-0355,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/08/2011,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-0355-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296035506,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,67296-0355-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,"RedPharm Drug, Inc.",67296-0355,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/08/2011,N/A,ANDA,60 TABLET in 1 BOTTLE (67296-0355-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296035507,Oxycodone,325
Oxycodone and Acetaminophen,55700-967-60,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,"Quality Care Products, LLC",55700-967,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/04/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (55700-967-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700096760,Oxycodone,325
Oxycodone and Acetaminophen,63187-984-12,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Proficient Rx LP,63187-984,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/01/2018,N/A,ANDA,12 TABLET in 1 BOTTLE (63187-984-12),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187098412,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,70518-3492-0,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040545,REMEDYREPACK INC.,70518-3492,oxycodone hydrochloride and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/22/2022,N/A,ANDA,100 POUCH in 1 BOX (70518-3492-0)  / 1 TABLET in 1 POUCH (70518-3492-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,70518349200,Oxycodone,325
Oxycodone and Acetaminophen,55700-498-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-498,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/20/2019,N/A,ANDA,5 TABLET in 1 BOTTLE (55700-498-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049805,Oxycodone,325
Oxycodone and Acetaminophen,55700-498-10,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-498,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/14/2019,N/A,ANDA,10 TABLET in 1 BOTTLE (55700-498-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049810,Oxycodone,325
Oxycodone and Acetaminophen,55700-498-24,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-498,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/17/2020,N/A,ANDA,24 TABLET in 1 BOTTLE (55700-498-24),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049824,Oxycodone,325
Oxycodone and Acetaminophen,55700-498-28,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-498,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/08/2019,N/A,ANDA,21 TABLET in 1 BOTTLE (55700-498-28),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049828,Oxycodone,325
Oxycodone and Acetaminophen,55700-970-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,"Quality Care Products, LLC",55700-970,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/17/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (55700-970-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700097001,Oxycodone,325
Oxycodone and Acetaminophen,55700-970-21,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,"Quality Care Products, LLC",55700-970,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/17/2022,N/A,ANDA,21 TABLET in 1 BOTTLE (55700-970-21),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700097021,Oxycodone,325
Oxycodone and Acetaminophen,55700-970-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,"Quality Care Products, LLC",55700-970,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/17/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (55700-970-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700097030,Oxycodone,325
Oxycodone and Acetaminophen,55700-970-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,"Quality Care Products, LLC",55700-970,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/17/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (55700-970-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700097060,Oxycodone,325
Oxycodone and Acetaminophen,55700-970-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,"Quality Care Products, LLC",55700-970,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/17/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (55700-970-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700097090,Oxycodone,325
Oxycodone and Acetaminophen,55700-498-56,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-498,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/10/2018,N/A,ANDA,56 TABLET in 1 BOTTLE (55700-498-56),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049856,Oxycodone,325
Oxycodone and Acetaminophen,63187-363-12,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202677,Proficient Rx LP,63187-363,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,11/01/2016,N/A,ANDA,12 TABLET in 1 BOTTLE (63187-363-12),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187036312,Oxycodone,325
Oxycodone and Acetaminophen,63187-363-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202677,Proficient Rx LP,63187-363,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/01/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (63187-363-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187036330,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,72189-255-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,DIRECT RX,72189-255,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/10/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-255-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189025560,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,72189-256-60,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,DIRECT RX,72189-256,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/10/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-256-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189025660,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,72189-257-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,DirectRx,72189-257,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/24/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-257-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189025760,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,72189-257-90,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,DirectRx,72189-257,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/24/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (72189-257-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189025790,Oxycodone,325
Oxycodone and Acetaminophen,63187-823-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Proficient Rx LP,63187-823,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (63187-823-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187082330,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,67296-1855-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,"Redpharm Drug, Inc",67296-1855,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-1855-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,67296185501,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,67296-1855-9,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,"Redpharm Drug, Inc",67296-1855,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,12 TABLET in 1 BOTTLE (67296-1855-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,67296185509,Oxycodone,325
Oxycodone and Acetaminophen,67296-1857-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210644,"Redpharm drug, inc",67296-1857,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-1857-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,67296185701,Oxycodone,325
Oxycodone and Acetaminophen,67296-1857-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210644,"Redpharm drug, inc",67296-1857,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,20 TABLET in 1 BOTTLE (67296-1857-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,67296185702,Oxycodone,325
Oxycodone and Acetaminophen,67296-1857-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210644,"Redpharm drug, inc",67296-1857,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,4 TABLET in 1 BOTTLE (67296-1857-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,67296185704,Oxycodone,325
Oxycodone and Acetaminophen,67296-1857-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210644,"Redpharm drug, inc",67296-1857,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,15 TABLET in 1 BOTTLE (67296-1857-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,67296185707,Oxycodone,325
Oxycodone and Acetaminophen,67296-1857-8,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210644,"Redpharm drug, inc",67296-1857,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,12 TABLET in 1 BOTTLE (67296-1857-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,67296185708,Oxycodone,325
Oxycodone and Acetaminophen,68071-2932-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,"NuCare Pharmaceuticals,Inc.",68071-2932,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2023,N/A,ANDA,"4 TABLET in 1 BOTTLE, PLASTIC (68071-2932-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,68071293204,Oxycodone,325
Oxycodone and Acetaminophen,53746-203-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040777,Amneal Pharmaceuticals of New York LLC,53746-203,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/27/2007,N/A,ANDA,100 TABLET in 1 BOTTLE (53746-203-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,53746020301,Oxycodone,325
Oxycodone and Acetaminophen,68071-5054-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"NuCare Pharmaceuticals,Inc.",68071-5054,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/12/2019,N/A,ANDA,6 TABLET in 1 BOTTLE (68071-5054-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68071505406,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,61919-612-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202677,Direct rx,61919-612,OXYCODONE AND ACETAMINOPHEN,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/01/2015,N/A,ANDA,60 TABLET in 1 BOTTLE (61919-612-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,61919061260,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,61919-612-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202677,Direct rx,61919-612,OXYCODONE AND ACETAMINOPHEN,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/01/2015,N/A,ANDA,90 TABLET in 1 BOTTLE (61919-612-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,61919061290,Oxycodone,325
Oxycodone and Acetaminophen,55700-497-28,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-497,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/31/2021,N/A,ANDA,28 TABLET in 1 BOTTLE (55700-497-28),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049728,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,67296-1855-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,"Redpharm Drug, Inc",67296-1855,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (67296-1855-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,67296185503,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,67296-1855-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,"Redpharm Drug, Inc",67296-1855,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,40 TABLET in 1 BOTTLE (67296-1855-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,67296185504,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,67296-1855-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,"Redpharm Drug, Inc",67296-1855,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-1855-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,67296185506,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,67296-1855-8,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,"Redpharm Drug, Inc",67296-1855,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,15 TABLET in 1 BOTTLE (67296-1855-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,67296185508,Oxycodone,325
Oxycodone and Acetaminophen,67296-1857-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210644,"Redpharm drug, inc",67296-1857,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (67296-1857-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,67296185703,Oxycodone,325
Oxycodone and Acetaminophen,63187-363-15,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202677,Proficient Rx LP,63187-363,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/01/2016,N/A,ANDA,15 TABLET in 1 BOTTLE (63187-363-15),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187036315,Oxycodone,325
Oxycodone and Acetaminophen,67296-1392-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,"RedPharm Drug, Inc.",67296-1392,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,10 TABLET in 1 BOTTLE (67296-1392-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296139201,Oxycodone,325
Oxycodone and Acetaminophen,67296-1531-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"RedPharm Drug, Inc.",67296-1531,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/11/2017,N/A,ANDA,15 TABLET in 1 BOTTLE (67296-1531-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296153107,Oxycodone,325
Oxycodone and Acetaminophen,63187-824-15,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Proficient Rx LP,63187-824,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/28/2014,N/A,ANDA,"15 TABLET in 1 BOTTLE, PLASTIC (63187-824-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187082415,Oxycodone,325
Oxycodone and Acetaminophen,63187-824-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Proficient Rx LP,63187-824,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/01/2017,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (63187-824-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187082430,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,61919-612-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202677,Direct rx,61919-612,OXYCODONE AND ACETAMINOPHEN,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/01/2015,N/A,ANDA,30 TABLET in 1 BOTTLE (61919-612-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,61919061230,Oxycodone,325
Oxycodone and Acetaminophen,42858-102-10,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Rhodes Pharmaceuticals L.P.,42858-102,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/28/2014,N/A,ANDA,10 BLISTER PACK in 1 CARTON (42858-102-10)  / 10 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858010210,Oxycodone,325
Oxycodone and Acetaminophen,42858-104-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Rhodes Pharmaceuticals L.P.,42858-104,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/28/2014,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-104-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858010401,Oxycodone,325
Oxycodone and Acetaminophen,42858-104-10,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Rhodes Pharmaceuticals L.P.,42858-104,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/28/2014,N/A,ANDA,10 BLISTER PACK in 1 CARTON (42858-104-10)  / 10 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858010410,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,61919-871-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Direct_Rx,61919-871,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/21/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (61919-871-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,61919087130,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,61919-871-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Direct_Rx,61919-871,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/21/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (61919-871-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,61919087160,Oxycodone,325
Oxycodone and Acetaminophen,60687-642-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,American Health Packaging,60687-642,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/04/2022,N/A,ANDA,100 BLISTER PACK in 1 CARTON (60687-642-01)  / 1 TABLET in 1 BLISTER PACK (60687-642-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60687064201,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,61919-871-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Direct_Rx,61919-871,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/21/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (61919-871-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,61919087190,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0406-0512-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,SpecGx LLC,0406-0512,oxycodone hydrochloride and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/07/1983,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-0512-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406051201,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0406-0512-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,SpecGx LLC,0406-0512,oxycodone hydrochloride and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/07/1983,N/A,ANDA,500 TABLET in 1 BOTTLE (0406-0512-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406051205,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0406-0512-23,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,SpecGx LLC,0406-0512,oxycodone hydrochloride and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/07/1983,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-0512-23),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406051223,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0406-0512-62,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,SpecGx LLC,0406-0512,oxycodone hydrochloride and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/07/1983,N/A,ANDA,100 TABLET in 1 BLISTER PACK (0406-0512-62),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406051262,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0406-0512-91,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,SpecGx LLC,0406-0512,oxycodone hydrochloride and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/07/1983,N/A,ANDA,5000 TABLET in 1 PAIL (0406-0512-91),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406051291,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0406-0522-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040545,SpecGx LLC,0406-0522,oxycodone hydrochloride and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-0522-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406052201,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0406-0522-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040545,SpecGx LLC,0406-0522,oxycodone hydrochloride and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,500 TABLET in 1 BOTTLE (0406-0522-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406052205,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0406-0522-23,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040545,SpecGx LLC,0406-0522,oxycodone hydrochloride and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-0522-23),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406052223,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0406-0522-62,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040545,SpecGx LLC,0406-0522,oxycodone hydrochloride and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,100 TABLET in 1 BLISTER PACK (0406-0522-62),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406052262,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0406-0523-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040545,SpecGx LLC,0406-0523,oxycodone hydrochloride and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-0523-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406052301,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0406-0523-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040545,SpecGx LLC,0406-0523,oxycodone hydrochloride and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,500 TABLET in 1 BOTTLE (0406-0523-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406052305,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0406-0523-23,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040545,SpecGx LLC,0406-0523,oxycodone hydrochloride and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-0523-23),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406052323,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0406-0523-62,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040545,SpecGx LLC,0406-0523,oxycodone hydrochloride and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,100 TABLET in 1 BLISTER PACK (0406-0523-62),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00406052362,Oxycodone,325
Oxycodone and Acetaminophen,63187-984-15,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Proficient Rx LP,63187-984,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/01/2018,N/A,ANDA,15 TABLET in 1 BOTTLE (63187-984-15),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187098415,Oxycodone,325
Oxycodone and Acetaminophen,63187-984-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Proficient Rx LP,63187-984,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/01/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (63187-984-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187098430,Oxycodone,325
Oxycodone and Acetaminophen,63187-984-10,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Proficient Rx LP,63187-984,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/01/2018,N/A,ANDA,10 TABLET in 1 BOTTLE (63187-984-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187098410,Oxycodone,325
Oxycodone and Acetaminophen,42806-116-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA203864,"Epic Pharma, LLC",42806-116,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/02/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-116-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42806011601,Oxycodone,325
Oxycodone and Acetaminophen,63629-8888-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-8888,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2023,N/A,ANDA,40 TABLET in 1 BOTTLE (63629-8888-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629888803,Oxycodone,325
Oxycodone and Acetaminophen,63629-8888-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-8888,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/26/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (63629-8888-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629888804,Oxycodone,325
Oxycodone and Acetaminophen,63629-8888-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-8888,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/17/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (63629-8888-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629888805,Oxycodone,325
Oxycodone and Acetaminophen,63629-8888-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-8888,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/21/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (63629-8888-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629888806,Oxycodone,325
Oxycodone and Acetaminophen,63187-824-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Proficient Rx LP,63187-824,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/01/2017,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (63187-824-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187082460,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,68071-2856-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,"NuCare Pharmaceuticals,Inc.",68071-2856,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/24/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (68071-2856-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68071285603,Oxycodone,325
Oxycodone and Acetaminophen,68084-699-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA202677,American Health Packaging,68084-699,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/06/2014,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-699-01)  / 1 TABLET in 1 BLISTER PACK (68084-699-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68084069901,Oxycodone,325
Oxycodone and Acetaminophen,42858-102-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Rhodes Pharmaceuticals L.P.,42858-102,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/28/2014,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-102-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858010201,Oxycodone,325
Oxycodone and Acetaminophen,65162-207-50,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040778,Amneal Pharmaceuticals LLC,65162-207,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/01/2013,N/A,ANDA,500 TABLET in 1 BOTTLE (65162-207-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162020750,Oxycodone,325
Oxycodone and Acetaminophen,68071-2932-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,"NuCare Pharmaceuticals,Inc.",68071-2932,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2023,N/A,ANDA,"12 TABLET in 1 BOTTLE, PLASTIC (68071-2932-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,68071293202,Oxycodone,325
Oxycodone and Acetaminophen,67296-1392-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,"RedPharm Drug, Inc.",67296-1392,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-1392-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296139206,Oxycodone,325
Oxycodone and Acetaminophen,47781-230-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202677,"Alvogen, Inc.",47781-230,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/17/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (47781-230-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781023001,Oxycodone,325
Oxycodone and Acetaminophen,50268-645-15,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040778,AvPAK,50268-645,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/09/2018,N/A,ANDA,50 BLISTER PACK in 1 BOX (50268-645-15)  / 1 TABLET in 1 BLISTER PACK (50268-645-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,50268064515,Oxycodone,325
Oxycodone and Acetaminophen,63187-824-20,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Proficient Rx LP,63187-824,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/28/2014,N/A,ANDA,"20 TABLET in 1 BOTTLE, PLASTIC (63187-824-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187082420,Oxycodone,325
Oxycodone and Acetaminophen,63629-9501-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,63629-9501,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/14/2022,N/A,ANDA,"500 TABLET in 1 BOTTLE, PLASTIC (63629-9501-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629950101,Oxycodone,325
Oxycodone and Acetaminophen,67296-1531-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"RedPharm Drug, Inc.",67296-1531,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/11/2017,N/A,ANDA,20 TABLET in 1 BOTTLE (67296-1531-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296153102,Oxycodone,325
Oxycodone and Acetaminophen,67296-1531-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"RedPharm Drug, Inc.",67296-1531,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/11/2017,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-1531-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296153106,Oxycodone,325
Oxycodone and Acetaminophen,67296-1392-0,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,"RedPharm Drug, Inc.",67296-1392,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2020,N/A,ANDA,40 TABLET in 1 BOTTLE (67296-1392-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296139200,Oxycodone,325
Oxycodone and Acetaminophen,67296-1392-9,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,"RedPharm Drug, Inc.",67296-1392,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/29/2019,N/A,ANDA,4 TABLET in 1 BOTTLE (67296-1392-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296139209,Oxycodone,325
Oxycodone and Acetaminophen,63187-406-15,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040105,Proficient Rx LP,63187-406,Oxycodone hydrochloride and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/01/2019,N/A,ANDA,"15 TABLET in 1 BOTTLE, PLASTIC (63187-406-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187040615,Oxycodone,325
Oxycodone and Acetaminophen,67296-1773-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202677,"RedPharm Drug, Inc.",67296-1773,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2020,N/A,ANDA,6 TABLET in 1 BOTTLE (67296-1773-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296177306,Oxycodone,325
Oxycodone and Acetaminophen,42806-115-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA203864,"Epic Pharma, LLC",42806-115,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/02/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-115-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42806011501,Oxycodone,325
Oxycodone and Acetaminophen,60760-274-40,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,St. Mary's Medical Park Pharmacy,60760-274,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/14/2017,N/A,ANDA,"40 TABLET in 1 BOTTLE, PLASTIC (60760-274-40)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60760027440,Oxycodone,325
Oxycodone and Acetaminophen,55700-496-14,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-496,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/14/2017,N/A,ANDA,14 TABLET in 1 BOTTLE (55700-496-14),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049614,Oxycodone,325
Oxycodone and Acetaminophen,55700-498-15,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-498,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2017,N/A,ANDA,15 TABLET in 1 BOTTLE (55700-498-15),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049815,Oxycodone,325
oxycodone and acetaminophen,43598-546-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,Dr. Reddys Laboratories Inc.,43598-546,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/09/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (43598-546-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43598054605,Oxycodone,325
Oxycodone and Acetaminophen,35356-801-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202677,"Quality Care Products, LLC",35356-801,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/10/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (35356-801-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,35356080130,Oxycodone,325
Oxycodone and Acetaminophen,35356-801-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202677,"Quality Care Products, LLC",35356-801,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/10/2013,N/A,ANDA,60 TABLET in 1 BOTTLE (35356-801-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,35356080160,Oxycodone,325
Oxycodone and Acetaminophen,35356-801-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202677,"Quality Care Products, LLC",35356-801,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/10/2013,N/A,ANDA,90 TABLET in 1 BOTTLE (35356-801-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,35356080190,Oxycodone,325
Oxycodone and Acetaminophen,60760-274-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,St. Mary's Medical Park Pharmacy,60760-274,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/14/2017,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (60760-274-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60760027430,Oxycodone,325
Oxycodone and Acetaminophen,70010-667-01,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA211708,Granules Pharmaceuticals Inc.,70010-667,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (70010-667-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,70010066701,Oxycodone,325
Oxycodone and Acetaminophen,70010-667-05,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA211708,Granules Pharmaceuticals Inc.,70010-667,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2022,N/A,ANDA,500 TABLET in 1 BOTTLE (70010-667-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,70010066705,Oxycodone,325
Oxycodone and Acetaminophen,70010-668-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211708,Granules Pharmaceuticals Inc.,70010-668,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (70010-668-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,70010066801,Oxycodone,325
Oxycodone and Acetaminophen,70010-668-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA211708,Granules Pharmaceuticals Inc.,70010-668,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2022,N/A,ANDA,500 TABLET in 1 BOTTLE (70010-668-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,70010066805,Oxycodone,325
Oxycodone and Acetaminophen,70010-669-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211708,Granules Pharmaceuticals Inc.,70010-669,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (70010-669-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,70010066901,Oxycodone,325
Oxycodone and Acetaminophen,70010-669-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA211708,Granules Pharmaceuticals Inc.,70010-669,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2022,N/A,ANDA,500 TABLET in 1 BOTTLE (70010-669-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,70010066905,Oxycodone,325
Oxycodone and Acetaminophen,70010-670-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211708,Granules Pharmaceuticals Inc.,70010-670,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (70010-670-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,70010067001,Oxycodone,325
Oxycodone and Acetaminophen,70010-670-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA211708,Granules Pharmaceuticals Inc.,70010-670,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2022,N/A,ANDA,500 TABLET in 1 BOTTLE (70010-670-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,70010067005,Oxycodone,325
Oxycodone and Acetaminophen,76420-136-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,"Asclemed USA, Inc.",76420-136,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/28/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (76420-136-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,76420013630,Oxycodone,325
Oxycodone and Acetaminophen,63187-823-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Proficient Rx LP,63187-823,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,60 TABLET in 1 BOTTLE (63187-823-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187082360,Oxycodone,325
Oxycodone and Acetaminophen,68308-480-47,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA090177,Mayne Pharma Inc.,68308-480,Oxycodone Hydrochloride and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/16/2008,N/A,ANDA,10 BLISTER PACK in 1 CARTON (68308-480-47)  / 10 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68308048047,Oxycodone,325
Oxycodone and Acetaminophen,63187-824-12,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Proficient Rx LP,63187-824,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/01/2017,N/A,ANDA,"12 TABLET in 1 BOTTLE, PLASTIC (63187-824-12)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187082412,Oxycodone,325
Oxycodone and Acetaminophen,63187-824-90,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Proficient Rx LP,63187-824,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/01/2017,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (63187-824-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63187082490,Oxycodone,325
Oxycodone and Acetaminophen,67296-1392-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,"RedPharm Drug, Inc.",67296-1392,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2016,N/A,ANDA,12 TABLET in 1 BOTTLE (67296-1392-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296139204,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0904-7093-61,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,Major Pharmaceuticals,0904-7093,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,100 BLISTER PACK in 1 CARTON (0904-7093-61)  / 1 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00904709361,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0904-7094-61,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207510,Major Pharmaceuticals,0904-7094,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,100 BLISTER PACK in 1 CARTON (0904-7094-61)  / 1 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00904709461,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,0904-7095-61,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207510,Major Pharmaceuticals,0904-7095,oxycodone and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2019,N/A,ANDA,100 BLISTER PACK in 1 CARTON (0904-7095-61)  / 1 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00904709561,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,67296-0355-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,"RedPharm Drug, Inc.",67296-0355,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/08/2011,N/A,ANDA,50 TABLET in 1 BOTTLE (67296-0355-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296035505,Oxycodone,325
Oxycodone and Acetaminophen,49999-852-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,Quality Care products LLC,49999-852,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/03/2022,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (49999-852-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,49999085230,Oxycodone,325
Oxycodone and Acetaminophen,49999-852-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,Quality Care products LLC,49999-852,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/03/2022,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (49999-852-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,49999085260,Oxycodone,325
Oxycodone and Acetaminophen,49999-852-90,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA087463,Quality Care products LLC,49999-852,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/03/2022,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (49999-852-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,49999085290,Oxycodone,325
Oxycodone and Acetaminophen,72189-368-60,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,Direct_Rx,72189-368,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/28/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-368-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189036860,Oxycodone,325
Oxycodone and Acetaminophen,68308-475-47,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA090177,Mayne Pharma Inc.,68308-475,Oxycodone Hydrochloride and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/16/2008,N/A,ANDA,10 BLISTER PACK in 1 CARTON (68308-475-47)  / 10 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68308047547,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN,72189-257-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207510,DirectRx,72189-257,OXYCODONE AND ACETAMINOPHEN,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/24/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-257-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189025730,Oxycodone,325
Oxycodone and Acetaminophen,68084-710-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA202677,American Health Packaging,68084-710,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,06/04/2014,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-710-01)  / 1 TABLET in 1 BLISTER PACK (68084-710-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68084071001,Oxycodone,325
Oxycodone and Acetaminophen,55700-497-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-497,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (55700-497-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049730,Oxycodone,325
Oxycodone and Acetaminophen,60760-274-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,St. Mary's Medical Park Pharmacy,60760-274,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/14/2017,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (60760-274-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60760027460,Oxycodone,325
Oxycodone and Acetaminophen,42858-103-10,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Rhodes Pharmaceuticals L.P.,42858-103,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,08/28/2014,N/A,ANDA,10 BLISTER PACK in 1 CARTON (42858-103-10)  / 10 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858010310,Oxycodone,325
Oxycodone and Acetaminophen,31722-191-01,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-191,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-191-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722019101,Oxycodone,325
Oxycodone and Acetaminophen,31722-191-05,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-191,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (31722-191-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722019105,Oxycodone,325
Oxycodone and Acetaminophen,31722-192-01,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-192,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-192-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722019201,Oxycodone,325
Oxycodone and Acetaminophen,31722-192-05,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-192,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (31722-192-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722019205,Oxycodone,325
Oxycodone and Acetaminophen,31722-193-01,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-193,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-193-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722019301,Oxycodone,325
Oxycodone and Acetaminophen,31722-193-05,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-193,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (31722-193-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722019305,Oxycodone,325
Oxycodone and Acetaminophen,31722-194-01,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-194,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-194-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722019401,Oxycodone,325
Oxycodone and Acetaminophen,31722-194-05,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,"Camber Pharmaceuticals, Inc.",31722-194,Oxycodone and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/11/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (31722-194-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722019405,Oxycodone,325
Oxycodone and Acetaminophen,71205-329-10,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Proficient Rx LP,71205-329,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/23/2019,N/A,ANDA,10 TABLET in 1 BOTTLE (71205-329-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71205032910,Oxycodone,325
Oxycodone and Acetaminophen,71205-329-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Proficient Rx LP,71205-329,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/01/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (71205-329-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71205032930,Oxycodone,325
Oxycodone and Acetaminophen,71205-329-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Proficient Rx LP,71205-329,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/01/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (71205-329-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71205032960,Oxycodone,325
Oxycodone and Acetaminophen,71205-329-90,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,Proficient Rx LP,71205-329,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/01/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (71205-329-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71205032990,Oxycodone,325
Oxycodone and Acetaminophen,71205-347-12,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Proficient Rx LP,71205-347,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/01/2019,N/A,ANDA,12 TABLET in 1 BOTTLE (71205-347-12),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71205034712,Oxycodone,325
Oxycodone and Acetaminophen,71205-347-15,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Proficient Rx LP,71205-347,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/01/2019,N/A,ANDA,15 TABLET in 1 BOTTLE (71205-347-15),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71205034715,Oxycodone,325
Oxycodone and Acetaminophen,71205-347-20,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Proficient Rx LP,71205-347,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/01/2019,N/A,ANDA,20 TABLET in 1 BOTTLE (71205-347-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71205034720,Oxycodone,325
Oxycodone and Acetaminophen,71205-347-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Proficient Rx LP,71205-347,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/01/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (71205-347-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71205034730,Oxycodone,325
Oxycodone and Acetaminophen,71205-347-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Proficient Rx LP,71205-347,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/01/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (71205-347-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71205034760,Oxycodone,325
Oxycodone and Acetaminophen,71205-347-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Proficient Rx LP,71205-347,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/01/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (71205-347-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71205034790,Oxycodone,325
Oxycodone and Acetaminophen,71205-486-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Proficient Rx LP,71205-486,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/14/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (71205-486-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71205048630,Oxycodone,325
Oxycodone and Acetaminophen,71205-486-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Proficient Rx LP,71205-486,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/14/2020,N/A,ANDA,60 TABLET in 1 BOTTLE (71205-486-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71205048660,Oxycodone,325
Oxycodone and Acetaminophen,71205-486-90,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Proficient Rx LP,71205-486,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/14/2020,N/A,ANDA,90 TABLET in 1 BOTTLE (71205-486-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71205048690,Oxycodone,325
Oxycodone and Acetaminophen,10702-185-10,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA210644,"KVK-Tech, Inc.",10702-185,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,1000 TABLET in 1 BOTTLE (10702-185-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702018510,Oxycodone,325
Oxycodone and Acetaminophen,10702-186-50,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA210644,"KVK-Tech, Inc.",10702-186,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE,HUMAN PRESCRIPTION DRUG,02/09/2018,N/A,ANDA,500 TABLET in 1 BOTTLE (10702-186-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702018650,Oxycodone,325
Oxycodone and Acetaminophen,71335-1036-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Bryant Ranch Prepack,71335-1036,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/07/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1036-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335103601,Oxycodone,325
Oxycodone and Acetaminophen,71335-1036-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Bryant Ranch Prepack,71335-1036,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1036-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335103602,Oxycodone,325
Oxycodone and Acetaminophen,71335-1036-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Bryant Ranch Prepack,71335-1036,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/24/2018,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1036-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335103603,Oxycodone,325
Oxycodone and Acetaminophen,71335-1036-4,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Bryant Ranch Prepack,71335-1036,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1036-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335103604,Oxycodone,325
Oxycodone and Acetaminophen,71335-1036-5,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Bryant Ranch Prepack,71335-1036,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/24/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1036-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335103605,Oxycodone,325
Oxycodone and Acetaminophen,71335-1036-6,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Bryant Ranch Prepack,71335-1036,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1036-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335103606,Oxycodone,325
Oxycodone and Acetaminophen,71335-1036-7,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Bryant Ranch Prepack,71335-1036,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,45 TABLET in 1 BOTTLE (71335-1036-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335103607,Oxycodone,325
Oxycodone and Acetaminophen,71335-1036-8,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Bryant Ranch Prepack,71335-1036,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,75 TABLET in 1 BOTTLE (71335-1036-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335103608,Oxycodone,325
Oxycodone and Acetaminophen,71335-1036-9,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Bryant Ranch Prepack,71335-1036,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1036-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335103609,Oxycodone,325
Oxycodone and Acetaminophen,63629-8834-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-8834,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (63629-8834-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629883401,Oxycodone,325
Oxycodone and Acetaminophen,63629-8834-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-8834,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/26/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (63629-8834-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629883402,Oxycodone,325
Oxycodone and Acetaminophen,63629-8834-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-8834,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/07/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (63629-8834-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629883403,Oxycodone,325
Oxycodone and Acetaminophen,63629-8834-4,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-8834,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2023,N/A,ANDA,28 TABLET in 1 BOTTLE (63629-8834-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629883404,Oxycodone,325
Oxycodone and Acetaminophen,63629-8834-5,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-8834,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (63629-8834-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629883405,Oxycodone,325
Oxycodone and Acetaminophen,63629-8834-6,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-8834,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2023,N/A,ANDA,20 TABLET in 1 BOTTLE (63629-8834-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629883406,Oxycodone,325
Oxycodone and Acetaminophen,63629-8834-7,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-8834,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2023,N/A,ANDA,45 TABLET in 1 BOTTLE (63629-8834-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629883407,Oxycodone,325
Oxycodone and Acetaminophen,63629-8834-8,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-8834,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2023,N/A,ANDA,75 TABLET in 1 BOTTLE (63629-8834-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629883408,Oxycodone,325
Oxycodone and Acetaminophen,63629-8834-9,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA207419,Bryant Ranch Prepack,63629-8834,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2023,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-8834-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629883409,Oxycodone,325
Oxycodone and Acetaminophen,71335-1420-1,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1420,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/24/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1420-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335142001,Oxycodone,325
Oxycodone and Acetaminophen,71335-1420-2,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1420,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/05/2020,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1420-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335142002,Oxycodone,325
Oxycodone and Acetaminophen,71335-1420-3,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1420,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2020,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1420-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335142003,Oxycodone,325
Oxycodone and Acetaminophen,71335-1420-4,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1420,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/07/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1420-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335142004,Oxycodone,325
Oxycodone and Acetaminophen,71335-1420-5,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1420,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/21/2020,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1420-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335142005,Oxycodone,325
Oxycodone and Acetaminophen,71335-1420-6,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1420,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/07/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1420-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335142006,Oxycodone,325
Oxycodone and Acetaminophen,71335-1420-7,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1420,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/21/2020,N/A,ANDA,45 TABLET in 1 BOTTLE (71335-1420-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335142007,Oxycodone,325
Oxycodone and Acetaminophen,71335-1420-8,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1420,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/07/2022,N/A,ANDA,75 TABLET in 1 BOTTLE (71335-1420-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335142008,Oxycodone,325
Oxycodone and Acetaminophen,71335-1420-9,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1420,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/07/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1420-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335142009,Oxycodone,325
Oxycodone and Acetaminophen,55700-496-21,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-496,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/14/2017,N/A,ANDA,21 TABLET in 1 BOTTLE (55700-496-21),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049621,Oxycodone,325
Oxycodone and Acetaminophen,55700-497-90,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201972,Quality Care Products LLC,55700-497,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2017,N/A,ANDA,90 TABLET in 1 BOTTLE (55700-497-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700049790,Oxycodone,325
Oxycodone and Acetaminophen,71335-1492-0,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1492,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,25 TABLET in 1 BOTTLE (71335-1492-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335149200,Oxycodone,325
Oxycodone and Acetaminophen,71335-1492-1,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1492,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/11/2020,N/A,ANDA,10 TABLET in 1 BOTTLE (71335-1492-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335149201,Oxycodone,325
Oxycodone and Acetaminophen,71335-1492-2,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1492,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/21/2020,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1492-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335149202,Oxycodone,325
Oxycodone and Acetaminophen,71335-1492-3,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1492,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1492-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335149203,Oxycodone,325
Oxycodone and Acetaminophen,71335-1492-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1492,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/09/2020,N/A,ANDA,12 TABLET in 1 BOTTLE (71335-1492-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335149204,Oxycodone,325
Oxycodone and Acetaminophen,71335-1492-5,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1492,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/06/2020,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-1492-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335149205,Oxycodone,325
Oxycodone and Acetaminophen,71335-1492-6,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1492,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/21/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1492-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335149206,Oxycodone,325
Oxycodone and Acetaminophen,71335-1492-7,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1492,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/11/2020,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1492-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335149207,Oxycodone,325
Oxycodone and Acetaminophen,71335-1492-8,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1492,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/22/2020,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1492-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335149208,Oxycodone,325
Oxycodone and Acetaminophen,71335-1492-9,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Bryant Ranch Prepack,71335-1492,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-1492-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335149209,Oxycodone,325
Oxycodone and Acetaminophen,67296-1531-4,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA207419,"RedPharm Drug, Inc.",67296-1531,Oxycodone and Acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/11/2017,N/A,ANDA,60 TABLET in 1 BOTTLE (67296-1531-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296153104,Oxycodone,325
OXYCODONE AND ACETAMINOPHEN (U),61919-614-60,,,,,DIRECT RX,,,,,,N/A,,,N/A,N/A,N/A,,61919061460,Oxycodone,NA
OXYCODONE AND ACETAMINOPHEN (U),61919-614-90,,,,,DIRECT RX,,,,,,N/A,,,N/A,N/A,N/A,,61919061490,Oxycodone,NA
OXYCODONE AND ACETAMINOPHEN (U),61919-614-30,,,,,DIRECT RX,,,,,,N/A,,,N/A,N/A,N/A,,61919061430,Oxycodone,NA
OXYCODONE APAP,61919-615-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040778,DIRECT RX,61919-615,OXYCODONE APAP,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/23/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (61919-615-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,61919061530,Oxycodone,325
Oxycodone HCl,69238-2294-1,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Amneal Pharmaceuticals NY LLC,69238-2294,Oxycodone HCl,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/01/2022,N/A,NDA AUTHORIZED GENERIC,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69238-2294-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,69238229401,Oxycodone,10
Oxycodone HCl,69238-2296-1,20 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Amneal Pharmaceuticals NY LLC,69238-2296,Oxycodone HCl,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/01/2022,N/A,NDA AUTHORIZED GENERIC,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69238-2296-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,69238229601,Oxycodone,20
Oxycodone HCl,69238-2298-1,40 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Amneal Pharmaceuticals NY LLC,69238-2298,Oxycodone HCl,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/01/2022,N/A,NDA AUTHORIZED GENERIC,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69238-2298-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,69238229801,Oxycodone,40
Oxycodone HCl,69238-2300-1,80 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Amneal Pharmaceuticals NY LLC,69238-2300,Oxycodone HCl,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/01/2022,N/A,NDA AUTHORIZED GENERIC,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69238-2300-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,69238230001,Oxycodone,80
Oxycodone Hydchloride,49999-899-30,5 mg/1,TABLET,ORAL,ANDA091393,Lake Erie Medical DBA Quality Care Products LLC,49999-899,Oxycodone Hydchloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/20/2011,N/A,ANDA,30 TABLET in 1 BOTTLE (49999-899-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,49999089930,Oxycodone,5
Oxycodone Hydchloride,49999-899-15,5 mg/1,TABLET,ORAL,ANDA091393,Lake Erie Medical DBA Quality Care Products LLC,49999-899,Oxycodone Hydchloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/14/2019,N/A,ANDA,15 TABLET in 1 BOTTLE (49999-899-15),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,49999089915,Oxycodone,5
Oxycodone Hydchloride,49999-899-21,5 mg/1,TABLET,ORAL,ANDA091393,Lake Erie Medical DBA Quality Care Products LLC,49999-899,Oxycodone Hydchloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/14/2019,N/A,ANDA,21 TABLET in 1 BOTTLE (49999-899-21),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,49999089921,Oxycodone,5
Oxycodone Hydchloride,35356-839-60,10 mg/1,TABLET,ORAL,ANDA091393,Lake Erie Medical DBA Quality Care Products LLC,35356-839,Oxycodone Hydchloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/30/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (35356-839-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,35356083960,Oxycodone,10
Oxycodone Hydchloride,49999-899-60,5 mg/1,TABLET,ORAL,ANDA091393,Lake Erie Medical DBA Quality Care Products LLC,49999-899,Oxycodone Hydchloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/20/2011,N/A,ANDA,60 TABLET in 1 BOTTLE (49999-899-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,49999089960,Oxycodone,5
Oxycodone Hydchloride,49999-899-40,5 mg/1,TABLET,ORAL,ANDA091393,Lake Erie Medical DBA Quality Care Products LLC,49999-899,Oxycodone Hydchloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/20/2011,N/A,ANDA,40 TABLET in 1 BOTTLE (49999-899-40),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,49999089940,Oxycodone,5
Oxycodone Hydchloride,49999-899-90,5 mg/1,TABLET,ORAL,ANDA091393,Lake Erie Medical DBA Quality Care Products LLC,49999-899,Oxycodone Hydchloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/20/2011,N/A,ANDA,90 TABLET in 1 BOTTLE (49999-899-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,49999089990,Oxycodone,5
Oxycodone Hydchloride,35356-839-30,10 mg/1,TABLET,ORAL,ANDA091393,Lake Erie Medical DBA Quality Care Products LLC,35356-839,Oxycodone Hydchloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/20/2011,N/A,ANDA,30 TABLET in 1 BOTTLE (35356-839-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,35356083930,Oxycodone,10
Oxycodone Hydchloride,35356-839-90,10 mg/1,TABLET,ORAL,ANDA091393,Lake Erie Medical DBA Quality Care Products LLC,35356-839,Oxycodone Hydchloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/20/2011,N/A,ANDA,90 TABLET in 1 BOTTLE (35356-839-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,35356083990,Oxycodone,10
Oxycodone Hydrochloride,64950-354-55,5 mg/5mL,SOLUTION,ORAL,NDA200535,Genus Lifesciences Inc.,64950-354,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/09/2013,N/A,NDA,"50 CUP, UNIT-DOSE in 1 CASE (64950-354-55)  / 5 mL in 1 CUP, UNIT-DOSE (64950-354-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64950035455,Oxycodone,5
OXYCODONE HYDROCHLORIDE,0121-0827-04,5 mg/5mL,SOLUTION,ORAL,ANDA206914,"PAI Holdings, LLC",0121-0827,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/08/2019,N/A,ANDA,118 mL in 1 BOTTLE (0121-0827-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00121082704,Oxycodone,5
OXYCODONE HYDROCHLORIDE,0121-0827-16,5 mg/5mL,SOLUTION,ORAL,ANDA206914,"PAI Holdings, LLC",0121-0827,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/08/2019,N/A,ANDA,500 mL in 1 BOTTLE (0121-0827-16),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00121082716,Oxycodone,5
OXYCODONE HYDROCHLORIDE,0121-4827-40,5 mg/5mL,SOLUTION,ORAL,ANDA206914,"PAI Holdings, LLC",0121-4827,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/10/2019,N/A,ANDA,"4 TRAY in 1 CASE (0121-4827-40)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-4827-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00121482740,Oxycodone,5
Oxycodone Hydrochloride,64950-901-10,5 mg/1,CAPSULE,ORAL,NDA200534,Genus Lifesciences Inc.,64950-901,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/20/2010,N/A,NDA,"100 CAPSULE in 1 BOTTLE, PLASTIC (64950-901-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64950090110,Oxycodone,5
oxycodone hydrochloride,67296-1040-2,5 mg/1,TABLET,ORAL,ANDA090659,"RedPharm Drug, Inc.",67296-1040,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/12/2009,N/A,ANDA,20 TABLET in 1 BOTTLE (67296-1040-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296104002,Oxycodone,5
Oxycodone Hydrochloride,62559-151-40,5 mg/5mL,SOLUTION,ORAL,ANDA204979,"ANI Pharmaceuticals, Inc.",62559-151,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/31/2023,N/A,ANDA,"40 CUP, UNIT-DOSE in 1 CASE (62559-151-40)  / 5 mL in 1 CUP, UNIT-DOSE (62559-151-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,62559015140,Oxycodone,5
Oxycodone Hydrochloride,62559-151-50,5 mg/5mL,SOLUTION,ORAL,ANDA204979,"ANI Pharmaceuticals, Inc.",62559-151,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/31/2023,N/A,ANDA,"50 CUP, UNIT-DOSE in 1 CASE (62559-151-50)  / 5 mL in 1 CUP, UNIT-DOSE (62559-151-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,62559015150,Oxycodone,5
Oxycodone Hydrochloride,72162-1336-1,15 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,72162-1336,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/30/2023,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (72162-1336-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72162133601,Oxycodone,15
Oxycodone Hydrochloride,67296-1324-2,5 mg/5mL,SOLUTION,ORAL,ANDA206456,"RedPharm Drug, Inc.",67296-1324,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/17/2015,N/A,ANDA,"200 mL in 1 BOTTLE, PLASTIC (67296-1324-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296132402,Oxycodone,5
OXYCODONE HYDROCHLORIDE,0115-1556-01,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Amneal Pharmaceuticals of New York LLC,0115-1556,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/22/2016,N/A,NDA AUTHORIZED GENERIC,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0115-1556-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115155601,Oxycodone,10
OXYCODONE HYDROCHLORIDE,0115-1557-01,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Amneal Pharmaceuticals of New York LLC,0115-1557,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/22/2016,N/A,NDA AUTHORIZED GENERIC,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0115-1557-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115155701,Oxycodone,15
OXYCODONE HYDROCHLORIDE,0115-1558-01,20 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Amneal Pharmaceuticals of New York LLC,0115-1558,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/22/2016,N/A,NDA AUTHORIZED GENERIC,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0115-1558-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115155801,Oxycodone,20
OXYCODONE HYDROCHLORIDE,0115-1559-01,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Amneal Pharmaceuticals of New York LLC,0115-1559,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/22/2016,N/A,NDA AUTHORIZED GENERIC,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0115-1559-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115155901,Oxycodone,30
OXYCODONE HYDROCHLORIDE,0115-1560-01,40 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Amneal Pharmaceuticals of New York LLC,0115-1560,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/22/2016,N/A,NDA AUTHORIZED GENERIC,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0115-1560-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115156001,Oxycodone,40
OXYCODONE HYDROCHLORIDE,0115-1561-01,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Amneal Pharmaceuticals of New York LLC,0115-1561,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/22/2016,N/A,NDA AUTHORIZED GENERIC,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0115-1561-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115156101,Oxycodone,60
OXYCODONE HYDROCHLORIDE,0115-1562-01,80 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Amneal Pharmaceuticals of New York LLC,0115-1562,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/22/2016,N/A,NDA AUTHORIZED GENERIC,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0115-1562-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115156201,Oxycodone,80
Oxycodone Hydrochloride,0121-4839-40,5 mg/5mL,SOLUTION,ORAL,ANDA206456,"Pharmaceutical Associates, Inc.",0121-4839,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/16/2016,N/A,ANDA,"4 TRAY in 1 CASE (0121-4839-40)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-4839-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00121483940,Oxycodone,5
Oxycodone Hydrochloride,71930-023-30,20 mg/mL,SOLUTION,ORAL,ANDA209897,Eywa Pharma Inc,71930-023,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2018,N/A,ANDA,1 BOTTLE in 1 CARTON (71930-023-30)  / 30 mL in 1 BOTTLE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71930002330,Oxycodone,20
OXYCODONE HYDROCHLORIDE,55700-174-01,15 mg/1,TABLET,ORAL,ANDA091393,Lake Erie Medical DBA Quality Care Products LLC,55700-174,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,120 TABLET in 1 BOTTLE (55700-174-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700017401,Oxycodone,15
Oxycodone Hydrochloride,17856-0023-1,20 mg/mL,SOLUTION,ORAL,ANDA209897,ALTANTIC BIOLOGICALS CORP,17856-0023,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/09/2023,N/A,ANDA,"60 SYRINGE in 1 BOX, UNIT-DOSE (17856-0023-1)  / .5 mL in 1 SYRINGE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,17856002301,Oxycodone,20
Oxycodone Hydrochloride,17856-0023-2,20 mg/mL,SOLUTION,ORAL,ANDA209897,ALTANTIC BIOLOGICALS CORP,17856-0023,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/09/2023,N/A,ANDA,"60 SYRINGE in 1 BOX, UNIT-DOSE (17856-0023-2)  / .125 mL in 1 SYRINGE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,17856002302,Oxycodone,20
Oxycodone Hydrochloride,17856-0023-3,20 mg/mL,SOLUTION,ORAL,ANDA209897,ALTANTIC BIOLOGICALS CORP,17856-0023,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/09/2023,N/A,ANDA,"120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0023-3)  / 1 mL in 1 SYRINGE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,17856002303,Oxycodone,20
Oxycodone Hydrochloride,17856-0023-4,20 mg/mL,SOLUTION,ORAL,ANDA209897,ALTANTIC BIOLOGICALS CORP,17856-0023,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/09/2023,N/A,ANDA,"60 SYRINGE in 1 BOX, UNIT-DOSE (17856-0023-4)  / 1 mL in 1 SYRINGE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,17856002304,Oxycodone,20
Oxycodone Hydrochloride,17856-0023-6,20 mg/mL,SOLUTION,ORAL,ANDA209897,ALTANTIC BIOLOGICALS CORP,17856-0023,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/09/2023,N/A,ANDA,"60 SYRINGE in 1 BOX, UNIT-DOSE (17856-0023-6)  / .25 mL in 1 SYRINGE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,17856002306,Oxycodone,20
OXYCODONE HYDROCHLORIDE,55700-174-30,15 mg/1,TABLET,ORAL,ANDA091393,Lake Erie Medical DBA Quality Care Products LLC,55700-174,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (55700-174-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700017430,Oxycodone,15
Oxycodone Hydrochloride,72162-1334-2,5 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,72162-1334,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/30/2023,N/A,ANDA,20 TABLET in 1 BOTTLE (72162-1334-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72162133402,Oxycodone,5
Oxycodone Hydrochloride,72162-1334-3,5 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,72162-1334,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/30/2023,N/A,ANDA,30 TABLET in 1 BOTTLE (72162-1334-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72162133403,Oxycodone,5
Oxycodone Hydrochloride,72162-1334-6,5 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,72162-1334,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/30/2023,N/A,ANDA,60 TABLET in 1 BOTTLE (72162-1334-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72162133406,Oxycodone,5
Oxycodone Hydrochloride,72162-1334-9,5 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,72162-1334,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/30/2023,N/A,ANDA,90 TABLET in 1 BOTTLE (72162-1334-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72162133409,Oxycodone,5
Oxycodone Hydrochloride,72162-1335-2,10 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,72162-1335,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/30/2023,N/A,ANDA,120 TABLET in 1 BOTTLE (72162-1335-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72162133502,Oxycodone,10
Oxycodone Hydrochloride,72162-1335-3,10 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,72162-1335,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/30/2023,N/A,ANDA,30 TABLET in 1 BOTTLE (72162-1335-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72162133503,Oxycodone,10
Oxycodone Hydrochloride,72162-1335-6,10 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,72162-1335,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/30/2023,N/A,ANDA,60 TABLET in 1 BOTTLE (72162-1335-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72162133506,Oxycodone,10
Oxycodone Hydrochloride,72162-1335-9,10 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,72162-1335,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/30/2023,N/A,ANDA,28 TABLET in 1 BOTTLE (72162-1335-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72162133509,Oxycodone,10
Oxycodone Hydrochloride,72162-1337-3,30 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,72162-1337,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/30/2023,N/A,ANDA,30 TABLET in 1 BOTTLE (72162-1337-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72162133703,Oxycodone,30
Oxycodone Hydrochloride,72162-1337-6,30 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,72162-1337,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/30/2023,N/A,ANDA,60 TABLET in 1 BOTTLE (72162-1337-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72162133706,Oxycodone,30
Oxycodone Hydrochloride,72162-1337-9,30 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,72162-1337,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/30/2023,N/A,ANDA,90 TABLET in 1 BOTTLE (72162-1337-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72162133709,Oxycodone,30
Oxycodone Hydrochloride,65162-047-50,5 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-047,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,500 TABLET in 1 BOTTLE (65162-047-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162004750,Oxycodone,5
Oxycodone Hydrochloride,65162-048-10,10 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-048,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (65162-048-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162004810,Oxycodone,10
Oxycodone Hydrochloride,65162-048-25,10 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-048,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,250 TABLET in 1 BOTTLE (65162-048-25),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162004825,Oxycodone,10
Oxycodone Hydrochloride,65162-051-03,30 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-051,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,30 TABLET in 1 BOTTLE (65162-051-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162005103,Oxycodone,30
Oxycodone Hydrochloride,65162-047-03,5 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-047,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,30 TABLET in 1 BOTTLE (65162-047-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162004703,Oxycodone,5
Oxycodone Hydrochloride,65162-050-10,20 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-050,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (65162-050-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162005010,Oxycodone,20
Oxycodone hydrochloride,47781-265-05,30 mg/1,TABLET,ORAL,ANDA202116,"Alvogen, Inc.",47781-265,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,500 TABLET in 1 BOTTLE (47781-265-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781026505,Oxycodone,30
Oxycodone hydrochloride,47781-263-01,5 mg/1,TABLET,ORAL,ANDA202116,"Alvogen, Inc.",47781-263,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,100 TABLET in 1 BOTTLE (47781-263-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781026301,Oxycodone,5
Oxycodone Hydrochloride,0904-6828-92,5 mg/5mL,SOLUTION,ORAL,ANDA207511,MAJOR PHARMACEUTICALS,0904-6828,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/23/2016,N/A,ANDA,"5 TRAY in 1 CARTON (0904-6828-92)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0904-6828-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00904682892,Oxycodone,5
Oxycodone Hydrochloride,0904-6828-94,5 mg/5mL,SOLUTION,ORAL,ANDA207511,MAJOR PHARMACEUTICALS,0904-6828,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/23/2016,N/A,ANDA,"4 TRAY in 1 CARTON (0904-6828-94)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0904-6828-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00904682894,Oxycodone,5
oxycodone hydrochloride,17856-0390-2,5 mg/5mL,SOLUTION,ORAL,ANDA204037,ATLANTIC BIOLOGICALS CORP.,17856-0390,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/30/2022,N/A,ANDA,"1 CUP, UNIT-DOSE in 1 CUP, UNIT-DOSE (17856-0390-2)  / 5 CUP, UNIT-DOSE in 1 CUP, UNIT-DOSE (17856-0390-3)  / 72 CUP, UNIT-DOSE in 1 CUP, UNIT-DOSE (17856-0390-1)  / 5 mL in 1 CUP, UNIT-DOSE","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17856039002,Oxycodone,5
Oxycodone Hydrochloride,0904-6966-61,5 mg/1,TABLET,ORAL,ANDA203638,Major Pharmaceuticals,0904-6966,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,100 BLISTER PACK in 1 CARTON (0904-6966-61)  / 1 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00904696661,Oxycodone,5
OXYCODONE HYDROCHLORIDE,68084-975-01,15 mg/1,TABLET,ORAL,ANDA091393,American Health Packaging,68084-975,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/15/2018,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-975-01)  / 1 TABLET in 1 BLISTER PACK (68084-975-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68084097501,Oxycodone,15
Oxycodone Hydrochloride,67296-1595-6,5 mg/5mL,SOLUTION,ORAL,NDA201194,"RedPharm Drug, Inc.",67296-1595,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2018,N/A,NDA,60 mL in 1 BOTTLE (67296-1595-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296159506,Oxycodone,5
Oxycodone Hydrochloride,43386-920-60,20 mg/mL,SOLUTION,ORAL,ANDA204603,"Lupin Pharmaceuticals, Inc.",43386-920,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/29/2015,N/A,ANDA,1 BOTTLE in 1 CARTON (43386-920-60)  / 30 mL in 1 BOTTLE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386092060,Oxycodone,20
Oxycodone Hydrochloride,42806-005-01,5 mg/1,TABLET,ORAL,ANDA202662,"Epic Pharma, LLC",42806-005,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/22/2015,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-005-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42806000501,Oxycodone,5
OXYCODONE HYDROCHLORIDE,71335-0115-2,5 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,71335-0115,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/23/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0115-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335011502,Oxycodone,5
OXYCODONE HYDROCHLORIDE,71335-0115-3,5 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,71335-0115,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/12/2018,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0115-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335011503,Oxycodone,5
OXYCODONE HYDROCHLORIDE,71335-0115-5,5 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,71335-0115,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-0115-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335011505,Oxycodone,5
Oxycodone Hydrochloride,13107-055-01,5 mg/1,TABLET,ORAL,ANDA202160,"Aurolife Pharma, LLC",13107-055,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/12/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-055-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107005501,Oxycodone,5
Oxycodone Hydrochloride,13107-055-30,5 mg/1,TABLET,ORAL,ANDA202160,"Aurolife Pharma, LLC",13107-055,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/12/2012,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-055-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107005530,Oxycodone,5
Oxycodone Hydrochloride,13107-055-99,5 mg/1,TABLET,ORAL,ANDA202160,"Aurolife Pharma, LLC",13107-055,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/12/2012,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-055-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107005599,Oxycodone,5
Oxycodone Hydrochloride,13107-056-01,15 mg/1,TABLET,ORAL,ANDA202160,"Aurolife Pharma, LLC",13107-056,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/12/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-056-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107005601,Oxycodone,15
Oxycodone Hydrochloride,13107-056-30,15 mg/1,TABLET,ORAL,ANDA202160,"Aurolife Pharma, LLC",13107-056,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/12/2012,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-056-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107005630,Oxycodone,15
Oxycodone Hydrochloride,13107-056-99,15 mg/1,TABLET,ORAL,ANDA202160,"Aurolife Pharma, LLC",13107-056,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/12/2012,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-056-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107005699,Oxycodone,15
Oxycodone Hydrochloride,13107-057-01,30 mg/1,TABLET,ORAL,ANDA202160,"Aurolife Pharma, LLC",13107-057,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/12/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-057-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107005701,Oxycodone,30
Oxycodone Hydrochloride,13107-057-30,30 mg/1,TABLET,ORAL,ANDA202160,"Aurolife Pharma, LLC",13107-057,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/12/2012,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-057-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107005730,Oxycodone,30
Oxycodone Hydrochloride,13107-057-99,30 mg/1,TABLET,ORAL,ANDA202160,"Aurolife Pharma, LLC",13107-057,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/12/2012,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-057-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107005799,Oxycodone,30
Oxycodone Hydrochloride,68308-145-01,5 mg/1,CAPSULE,ORAL,ANDA203107,Mayne Pharma Inc.,68308-145,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/31/2012,N/A,ANDA,"100 CAPSULE in 1 BOTTLE, PLASTIC (68308-145-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68308014501,Oxycodone,5
Oxycodone Hydrochloride,71335-0677-3,30 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0677,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/24/2018,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0677-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067703,Oxycodone,30
Oxycodone Hydrochloride,71335-0677-4,30 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0677,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/30/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0677-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067704,Oxycodone,30
oxycodone hydrochloride,0054-0390-41,5 mg/5mL,SOLUTION,ORAL,ANDA204037,Hikma Pharmceuticals USA Inc.,0054-0390,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/04/2014,N/A,ANDA,15 mL in 1 BOTTLE (0054-0390-41),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00054039041,Oxycodone,5
oxycodone hydrochloride,0054-0390-63,5 mg/5mL,SOLUTION,ORAL,ANDA204037,Hikma Pharmceuticals USA Inc.,0054-0390,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/04/2014,N/A,ANDA,500 mL in 1 BOTTLE (0054-0390-63),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00054039063,Oxycodone,5
Oxycodone Hydrochloride,68094-005-61,15 mg/1,TABLET,ORAL,ANDA203638,"Precision Dose, Inc.",68094-005,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/21/2016,N/A,ANDA,10 BLISTER PACK in 1 CARTON (68094-005-61)  / 10 TABLET in 1 BLISTER PACK (68094-005-59),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68094000561,Oxycodone,15
Oxycodone Hydrochloride,67296-1560-2,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,"RedPharm Drug, Inc.",67296-1560,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/12/2015,N/A,NDA,"20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67296-1560-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296156002,Oxycodone,10
Oxycodone Hydrochloride,71930-022-43,5 mg/5mL,SOLUTION,ORAL,ANDA207511,Eywa Pharma Inc,71930-022,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/01/2019,N/A,ANDA,1 BOTTLE in 1 CARTON (71930-022-43)  / 473 mL in 1 BOTTLE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71930002243,Oxycodone,5
Oxycodone Hydrochloride,71335-0677-6,30 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0677,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/28/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-0677-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067706,Oxycodone,30
OXYCODONE HYDROCHLORIDE,72189-094-30,10 mg/1,TABLET,ORAL,ANDA091393,DIRECT RX,72189-094,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/15/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-094-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189009430,Oxycodone,10
OXYCODONE HYDROCHLORIDE,72189-094-60,10 mg/1,TABLET,ORAL,ANDA091393,DIRECT RX,72189-094,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/15/2020,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-094-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189009460,Oxycodone,10
OXYCODONE HYDROCHLORIDE,72189-094-90,10 mg/1,TABLET,ORAL,ANDA091393,DIRECT RX,72189-094,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/15/2020,N/A,ANDA,90 TABLET in 1 BOTTLE (72189-094-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189009490,Oxycodone,10
OXYCODONE HYDROCHLORIDE,72189-095-30,5 mg/1,TABLET,ORAL,ANDA204021,DIRECT RX,72189-095,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/15/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-095-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189009530,Oxycodone,5
OXYCODONE HYDROCHLORIDE,72189-095-60,5 mg/1,TABLET,ORAL,ANDA204021,DIRECT RX,72189-095,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/15/2020,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-095-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189009560,Oxycodone,5
OXYCODONE HYDROCHLORIDE,72189-095-90,5 mg/1,TABLET,ORAL,ANDA204021,DIRECT RX,72189-095,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/15/2020,N/A,ANDA,90 TABLET in 1 BOTTLE (72189-095-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189009590,Oxycodone,5
Oxycodone Hydrochloride,0406-8557-30,100 mg/5mL,SOLUTION,ORAL,ANDA210758,SpecGx LLC,0406-8557,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/30/2018,N/A,ANDA,"1 BOTTLE, PLASTIC in 1 CARTON (0406-8557-30)  / 30 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406855730,Oxycodone,100
Oxycodone hydrochloride,47781-265-01,30 mg/1,TABLET,ORAL,ANDA202116,"Alvogen, Inc.",47781-265,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,100 TABLET in 1 BOTTLE (47781-265-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781026501,Oxycodone,30
OXYCODONE HYDROCHLORIDE,71335-0115-8,5 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,71335-0115,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-0115-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335011508,Oxycodone,5
Oxycodone Hydrochloride,62559-151-16,5 mg/5mL,SOLUTION,ORAL,ANDA204979,"ANI Pharmaceuticals, Inc.",62559-151,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/13/2015,N/A,ANDA,1 BOTTLE in 1 CARTON (62559-151-16)  / 473 mL in 1 BOTTLE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,62559015116,Oxycodone,5
OXYCODONE HYDROCHLORIDE,42858-010-15,100 mg/5mL,SOLUTION,ORAL,ANDA205853,Rhodes Pharmaceuticals L.P.,42858-010,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/14/2020,N/A,ANDA,"1 BOTTLE, PLASTIC in 1 CARTON (42858-010-15)  / 30 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858001015,Oxycodone,100
oxycodone hydrochloride,57664-224-88,30 mg/1,TABLET,ORAL,ANDA090659,"Sun Pharmaceutical Industries, Inc.",57664-224,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/12/2009,N/A,ANDA,100 TABLET in 1 BOTTLE (57664-224-88),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,57664022488,Oxycodone,30
Oxycodone Hydrochloride,0406-8556-05,5 mg/5mL,SOLUTION,ORAL,ANDA210758,SpecGx LLC,0406-8556,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/30/2018,N/A,ANDA,"1 BOTTLE, PLASTIC in 1 CARTON (0406-8556-05)  / 500 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406855605,Oxycodone,5
Oxycodone Hydrochloride,43386-430-01,15 mg/1,TABLET,ORAL,ANDA204021,"Lupin Pharmaceuticals,Inc.",43386-430,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-430-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386043001,Oxycodone,15
Oxycodone Hydrochloride,43386-430-03,15 mg/1,TABLET,ORAL,ANDA204021,"Lupin Pharmaceuticals,Inc.",43386-430,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (43386-430-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386043003,Oxycodone,15
Oxycodone Hydrochloride,43386-430-05,15 mg/1,TABLET,ORAL,ANDA204021,"Lupin Pharmaceuticals,Inc.",43386-430,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-430-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386043005,Oxycodone,15
Oxycodone Hydrochloride,43386-431-01,30 mg/1,TABLET,ORAL,ANDA204021,"Lupin Pharmaceuticals,Inc.",43386-431,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-431-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386043101,Oxycodone,30
Oxycodone Hydrochloride,43386-431-03,30 mg/1,TABLET,ORAL,ANDA204021,"Lupin Pharmaceuticals,Inc.",43386-431,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (43386-431-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386043103,Oxycodone,30
Oxycodone Hydrochloride,43386-431-05,30 mg/1,TABLET,ORAL,ANDA204021,"Lupin Pharmaceuticals,Inc.",43386-431,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-431-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386043105,Oxycodone,30
Oxycodone Hydrochloride,43386-432-01,5 mg/1,TABLET,ORAL,ANDA204021,"Lupin Pharmaceuticals,Inc.",43386-432,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-432-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386043201,Oxycodone,5
Oxycodone Hydrochloride,43386-432-03,5 mg/1,TABLET,ORAL,ANDA204021,"Lupin Pharmaceuticals,Inc.",43386-432,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (43386-432-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386043203,Oxycodone,5
Oxycodone Hydrochloride,43386-432-05,5 mg/1,TABLET,ORAL,ANDA204021,"Lupin Pharmaceuticals,Inc.",43386-432,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-432-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386043205,Oxycodone,5
Oxycodone Hydrochloride,43386-433-01,10 mg/1,TABLET,ORAL,ANDA204021,"Lupin Pharmaceuticals,Inc.",43386-433,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-433-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386043301,Oxycodone,10
Oxycodone Hydrochloride,43386-433-03,10 mg/1,TABLET,ORAL,ANDA204021,"Lupin Pharmaceuticals,Inc.",43386-433,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (43386-433-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386043303,Oxycodone,10
Oxycodone Hydrochloride,43386-433-05,10 mg/1,TABLET,ORAL,ANDA204021,"Lupin Pharmaceuticals,Inc.",43386-433,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-433-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386043305,Oxycodone,10
Oxycodone Hydrochloride,43386-434-01,20 mg/1,TABLET,ORAL,ANDA204021,"Lupin Pharmaceuticals,Inc.",43386-434,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-434-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386043401,Oxycodone,20
Oxycodone Hydrochloride,43386-434-03,20 mg/1,TABLET,ORAL,ANDA204021,"Lupin Pharmaceuticals,Inc.",43386-434,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (43386-434-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386043403,Oxycodone,20
Oxycodone Hydrochloride,43386-434-05,20 mg/1,TABLET,ORAL,ANDA204021,"Lupin Pharmaceuticals,Inc.",43386-434,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-434-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,43386043405,Oxycodone,20
oxycodone hydrochloride,57664-223-88,5 mg/1,TABLET,ORAL,ANDA090659,"Sun Pharmaceutical Industries, Inc.",57664-223,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/12/2009,N/A,ANDA,100 TABLET in 1 BOTTLE (57664-223-88),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,57664022388,Oxycodone,5
Oxycodone Hydrochloride,71335-0677-7,30 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0677,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/28/2022,N/A,ANDA,18 TABLET in 1 BOTTLE (71335-0677-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067707,Oxycodone,30
Oxycodone Hydrochloride,0904-7180-61,15 mg/1,TABLET,ORAL,ANDA203638,Major Pharmaceuticals,0904-7180,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,100 BLISTER PACK in 1 CARTON (0904-7180-61)  / 1 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00904718061,Oxycodone,15
OXYCODONE HYDROCHLORIDE,63629-3775-1,10 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-3775,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (63629-3775-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629377501,Oxycodone,10
OXYCODONE HYDROCHLORIDE,63629-3775-2,10 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-3775,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (63629-3775-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629377502,Oxycodone,10
OXYCODONE HYDROCHLORIDE,63629-3775-3,10 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-3775,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (63629-3775-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629377503,Oxycodone,10
OXYCODONE HYDROCHLORIDE,63629-3775-4,10 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-3775,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,10 TABLET in 1 BOTTLE (63629-3775-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629377504,Oxycodone,10
OXYCODONE HYDROCHLORIDE,63629-3775-5,10 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-3775,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (63629-3775-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629377505,Oxycodone,10
OXYCODONE HYDROCHLORIDE,67296-1376-2,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,"RedPharm Drug, Inc.",67296-1376,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/22/2016,N/A,NDA AUTHORIZED GENERIC,"20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67296-1376-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296137602,Oxycodone,10
OXYCODONE HYDROCHLORIDE,63629-7399-1,20 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-7399,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (63629-7399-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629739901,Oxycodone,20
OXYCODONE HYDROCHLORIDE,63629-7399-2,20 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-7399,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (63629-7399-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629739902,Oxycodone,20
OXYCODONE HYDROCHLORIDE,63629-7399-3,20 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-7399,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (63629-7399-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629739903,Oxycodone,20
OXYCODONE HYDROCHLORIDE,63629-7399-4,20 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-7399,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (63629-7399-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629739904,Oxycodone,20
OXYCODONE HYDROCHLORIDE,63629-7399-5,20 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-7399,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,8 TABLET in 1 BOTTLE (63629-7399-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629739905,Oxycodone,20
OXYCODONE HYDROCHLORIDE,63629-7399-6,20 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-7399,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,6 TABLET in 1 BOTTLE (63629-7399-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629739906,Oxycodone,20
Oxycodone Hydrochloride,64950-354-45,5 mg/5mL,SOLUTION,ORAL,NDA200535,Genus Lifesciences Inc.,64950-354,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/09/2013,N/A,NDA,"40 CUP, UNIT-DOSE in 1 CASE (64950-354-45)  / 5 mL in 1 CUP, UNIT-DOSE (64950-354-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64950035445,Oxycodone,5
Oxycodone Hydrochloride,65162-050-25,20 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-050,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,250 TABLET in 1 BOTTLE (65162-050-25),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162005025,Oxycodone,20
Oxycodone Hydrochloride,65162-051-50,30 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-051,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,500 TABLET in 1 BOTTLE (65162-051-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162005150,Oxycodone,30
OXYCODONE HYDROCHLORIDE,71335-0115-7,5 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,71335-0115,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,50 TABLET in 1 BOTTLE (71335-0115-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335011507,Oxycodone,5
OXYCODONE HYDROCHLORIDE,71335-0115-9,5 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,71335-0115,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/21/2018,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-0115-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335011509,Oxycodone,5
Oxycodone Hydrochloride,63629-2104-1,5 mg/5mL,SOLUTION,ORAL,ANDA204979,Bryant Ranch Prepack,63629-2104,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/13/2015,N/A,ANDA,473 mL in 1 BOTTLE (63629-2104-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629210401,Oxycodone,5
Oxycodone Hydrochloride,0904-6678-40,5 mg/5mL,SOLUTION,ORAL,ANDA207511,MAJOR PHARMACEUTICALS,0904-6678,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/23/2016,N/A,ANDA,"1 BOTTLE, PLASTIC in 1 CARTON (0904-6678-40)  / 500 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00904667840,Oxycodone,5
oxycodone hydrochloride,57664-371-88,20 mg/1,TABLET,ORAL,ANDA090659,"Sun Pharmaceutical Industries, Inc.",57664-371,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/19/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (57664-371-88),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,57664037188,Oxycodone,20
Oxycodone hydrochloride,47781-264-01,15 mg/1,TABLET,ORAL,ANDA202116,"Alvogen, Inc.",47781-264,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,100 TABLET in 1 BOTTLE (47781-264-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781026401,Oxycodone,15
Oxycodone Hydrochloride,71335-1414-1,30 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1414,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1414-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141401,Oxycodone,30
Oxycodone Hydrochloride,71335-1414-2,30 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1414,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1414-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141402,Oxycodone,30
Oxycodone Hydrochloride,71335-1414-3,30 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1414,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1414-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141403,Oxycodone,30
Oxycodone Hydrochloride,71335-1414-4,30 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1414,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1414-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141404,Oxycodone,30
Oxycodone Hydrochloride,71335-1414-5,30 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1414,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1414-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141405,Oxycodone,30
Oxycodone Hydrochloride,71335-1414-6,30 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1414,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-1414-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141406,Oxycodone,30
Oxycodone Hydrochloride,71335-1414-7,30 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1414,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,18 TABLET in 1 BOTTLE (71335-1414-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141407,Oxycodone,30
Oxycodone Hydrochloride,71335-1414-8,30 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1414,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1414-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141408,Oxycodone,30
Oxycodone Hydrochloride,71335-1421-1,5 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1421,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1421-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335142101,Oxycodone,5
Oxycodone Hydrochloride,71335-1421-2,5 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1421,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1421-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335142102,Oxycodone,5
Oxycodone Hydrochloride,71335-1421-3,5 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1421,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1421-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335142103,Oxycodone,5
Oxycodone Hydrochloride,71335-1421-4,5 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1421,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-1421-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335142104,Oxycodone,5
Oxycodone Hydrochloride,71335-1421-5,5 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1421,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1421-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335142105,Oxycodone,5
Oxycodone Hydrochloride,71335-1421-6,5 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1421,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1421-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335142106,Oxycodone,5
Oxycodone Hydrochloride,71335-1421-7,5 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1421,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,50 TABLET in 1 BOTTLE (71335-1421-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335142107,Oxycodone,5
Oxycodone Hydrochloride,71335-1421-8,5 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1421,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-1421-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335142108,Oxycodone,5
Oxycodone Hydrochloride,71335-1421-9,5 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1421,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1421-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335142109,Oxycodone,5
Oxycodone Hydrochloride,71335-1422-1,10 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1422,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1422-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335142201,Oxycodone,10
Oxycodone Hydrochloride,71335-1422-2,10 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1422,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1422-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335142202,Oxycodone,10
Oxycodone Hydrochloride,71335-1422-3,10 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1422,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1422-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335142203,Oxycodone,10
Oxycodone Hydrochloride,71335-1422-4,10 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1422,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1422-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335142204,Oxycodone,10
Oxycodone Hydrochloride,71335-1422-5,10 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1422,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-1422-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335142205,Oxycodone,10
Oxycodone Hydrochloride,71335-1422-6,10 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1422,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1422-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335142206,Oxycodone,10
OXYCODONE HYDROCHLORIDE,68084-968-01,10 mg/1,TABLET,ORAL,ANDA091393,American Health Packaging,68084-968,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/31/2019,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-968-01)  / 1 TABLET in 1 BLISTER PACK (68084-968-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68084096801,Oxycodone,10
Oxycodone Hydrochloride,65162-049-10,15 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-049,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (65162-049-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162004910,Oxycodone,15
OXYCODONE HYDROCHLORIDE,70752-136-10,5 mg/5mL,SOLUTION,ORAL,ANDA213761,QUAGEN PHARMACEUTICALS LLC,70752-136,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/02/2021,N/A,ANDA,"1 BOTTLE, PLASTIC in 1 CARTON (70752-136-10)  / 100 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,70752013610,Oxycodone,5
OXYCODONE HYDROCHLORIDE,70752-136-14,5 mg/5mL,SOLUTION,ORAL,ANDA213761,QUAGEN PHARMACEUTICALS LLC,70752-136,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/02/2021,N/A,ANDA,"1 BOTTLE, PLASTIC in 1 CARTON (70752-136-14)  / 500 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,70752013614,Oxycodone,5
OXYCODONE HYDROCHLORIDE,70752-137-03,100 mg/5mL,SOLUTION,ORAL,ANDA213761,QUAGEN PHARMACEUTICALS LLC,70752-137,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/02/2021,N/A,ANDA,1 BOTTLE in 1 CARTON (70752-137-03)  / 30 mL in 1 BOTTLE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,70752013703,Oxycodone,100
Oxycodone Hydrochloride,0527-1774-01,5 mg/1,CAPSULE,ORAL,ANDA203823,"Lannett Company, Inc.",0527-1774,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/01/2014,N/A,ANDA,"100 CAPSULE in 1 BOTTLE, PLASTIC (0527-1774-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00527177401,Oxycodone,5
Oxycodone Hydrochloride,68462-347-37,100 mg/5mL,SOLUTION,ORAL,NDA200535,"Glenmark Pharmaceuticals, Inc",68462-347,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/20/2010,N/A,NDA AUTHORIZED GENERIC,"1 BOTTLE, PLASTIC in 1 CARTON (68462-347-37)  / 30 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68462034737,Oxycodone,100
Oxycodone Hydrochloride,72865-128-01,15 mg/1,TABLET,ORAL,ANDA207418,"XLCare Pharmaceuticals, Inc",72865-128,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/25/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-128-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865012801,Oxycodone,15
Oxycodone Hydrochloride,72865-128-05,15 mg/1,TABLET,ORAL,ANDA207418,"XLCare Pharmaceuticals, Inc",72865-128,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/25/2020,N/A,ANDA,500 TABLET in 1 BOTTLE (72865-128-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865012805,Oxycodone,15
Oxycodone Hydrochloride,72865-129-01,30 mg/1,TABLET,ORAL,ANDA207418,"XLCare Pharmaceuticals, Inc",72865-129,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/25/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-129-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865012901,Oxycodone,30
Oxycodone Hydrochloride,72865-129-05,30 mg/1,TABLET,ORAL,ANDA207418,"XLCare Pharmaceuticals, Inc",72865-129,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/25/2020,N/A,ANDA,500 TABLET in 1 BOTTLE (72865-129-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865012905,Oxycodone,30
Oxycodone Hydrochloride,66689-403-16,5 mg/5mL,SOLUTION,ORAL,NDA201194,"VistaPharm, Inc.",66689-403,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2012,N/A,NDA,500 mL in 1 BOTTLE (66689-403-16),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,66689040316,Oxycodone,5
Oxycodone Hydrochloride,65162-049-03,15 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-049,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,30 TABLET in 1 BOTTLE (65162-049-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162004903,Oxycodone,15
Oxycodone Hydrochloride,65162-049-25,15 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-049,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,250 TABLET in 1 BOTTLE (65162-049-25),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162004925,Oxycodone,15
Oxycodone Hydrochloride,65162-050-03,20 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-050,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,30 TABLET in 1 BOTTLE (65162-050-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162005003,Oxycodone,20
Oxycodone Hydrochloride,65162-051-10,30 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-051,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (65162-051-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162005110,Oxycodone,30
Oxycodone Hydrochloride,71335-1023-1,20 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-1023,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1023-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335102301,Oxycodone,20
Oxycodone Hydrochloride,71335-1023-2,20 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-1023,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1023-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335102302,Oxycodone,20
Oxycodone Hydrochloride,71335-1023-3,20 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-1023,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1023-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335102303,Oxycodone,20
Oxycodone Hydrochloride,71335-1023-4,20 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-1023,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1023-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335102304,Oxycodone,20
Oxycodone Hydrochloride,71335-1023-5,20 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-1023,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2022,N/A,ANDA,8 TABLET in 1 BOTTLE (71335-1023-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335102305,Oxycodone,20
Oxycodone Hydrochloride,71335-1023-6,20 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-1023,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2022,N/A,ANDA,6 TABLET in 1 BOTTLE (71335-1023-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335102306,Oxycodone,20
Oxycodone Hydrochloride,71335-1080-1,15 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-1080,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1080-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335108001,Oxycodone,15
Oxycodone Hydrochloride,71335-1080-2,15 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-1080,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1080-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335108002,Oxycodone,15
Oxycodone Hydrochloride,71335-1080-3,15 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-1080,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1080-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335108003,Oxycodone,15
Oxycodone Hydrochloride,71335-1080-4,15 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-1080,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1080-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335108004,Oxycodone,15
Oxycodone Hydrochloride,71335-1080-5,15 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-1080,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1080-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335108005,Oxycodone,15
Oxycodone Hydrochloride,71335-1080-6,15 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-1080,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-1080-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335108006,Oxycodone,15
Oxycodone Hydrochloride,71335-1080-7,15 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-1080,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-1080-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335108007,Oxycodone,15
Oxycodone Hydrochloride,71335-1080-8,15 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-1080,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,45 TABLET in 1 BOTTLE (71335-1080-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335108008,Oxycodone,15
Oxycodone Hydrochloride,71335-1080-9,15 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-1080,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2022,N/A,ANDA,18 TABLET in 1 BOTTLE (71335-1080-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335108009,Oxycodone,15
Oxycodone hydrochloride,68071-2536-6,5 mg/1,TABLET,ORAL,ANDA202116,"NuCare Pharmaceuticals,Inc,",68071-2536,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2021,N/A,ANDA,6 TABLET in 1 BOTTLE (68071-2536-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,68071253606,Oxycodone,5
OXYCODONE HYDROCHLORIDE,68084-354-01,5 mg/1,TABLET,ORAL,ANDA091393,American Health Packaging,68084-354,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/24/2009,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-354-01)  / 1 TABLET in 1 BLISTER PACK (68084-354-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68084035401,Oxycodone,5
Oxycodone Hydrochloride,42858-001-01,5 mg/1,TABLET,ORAL,ANDA091490,Rhodes Pharmaceuticals L.P.,42858-001,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/08/2014,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-001-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858000101,Oxycodone,5
Oxycodone Hydrochloride,42858-001-10,5 mg/1,TABLET,ORAL,ANDA091490,Rhodes Pharmaceuticals L.P.,42858-001,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/08/2014,N/A,ANDA,10 BLISTER PACK in 1 CARTON (42858-001-10)  / 10 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858000110,Oxycodone,5
Oxycodone Hydrochloride,42858-002-01,10 mg/1,TABLET,ORAL,ANDA091490,Rhodes Pharmaceuticals L.P.,42858-002,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/08/2014,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-002-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858000201,Oxycodone,10
Oxycodone Hydrochloride,42858-002-10,10 mg/1,TABLET,ORAL,ANDA091490,Rhodes Pharmaceuticals L.P.,42858-002,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/08/2014,N/A,ANDA,10 BLISTER PACK in 1 CARTON (42858-002-10)  / 10 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858000210,Oxycodone,10
Oxycodone Hydrochloride,42858-003-01,15 mg/1,TABLET,ORAL,ANDA091490,Rhodes Pharmaceuticals L.P.,42858-003,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/08/2014,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-003-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858000301,Oxycodone,15
Oxycodone Hydrochloride,42858-004-01,20 mg/1,TABLET,ORAL,ANDA091490,Rhodes Pharmaceuticals L.P.,42858-004,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/08/2014,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-004-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858000401,Oxycodone,20
Oxycodone Hydrochloride,42858-005-01,30 mg/1,TABLET,ORAL,ANDA091490,Rhodes Pharmaceuticals L.P.,42858-005,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/08/2014,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (42858-005-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42858000501,Oxycodone,30
Oxycodone Hydrochloride,63629-1927-1,15 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,63629-1927,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-1927-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629192701,Oxycodone,15
Oxycodone Hydrochloride,63629-1928-1,15 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,63629-1928,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (63629-1928-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629192801,Oxycodone,15
Oxycodone Hydrochloride,63629-1929-1,30 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,63629-1929,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-1929-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629192901,Oxycodone,30
Oxycodone Hydrochloride,63629-1930-1,30 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,63629-1930,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (63629-1930-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629193001,Oxycodone,30
Oxycodone Hydrochloride,67296-1324-6,5 mg/5mL,SOLUTION,ORAL,ANDA206456,"RedPharm Drug, Inc.",67296-1324,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/17/2015,N/A,ANDA,"60 mL in 1 BOTTLE, PLASTIC (67296-1324-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296132406,Oxycodone,5
Oxycodone Hydrochloride,71335-0981-1,5 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0981,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/23/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0981-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335098101,Oxycodone,5
Oxycodone Hydrochloride,71335-0981-2,5 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0981,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/23/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0981-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335098102,Oxycodone,5
Oxycodone Hydrochloride,71335-0981-3,5 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0981,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/23/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0981-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335098103,Oxycodone,5
Oxycodone Hydrochloride,71335-0981-4,5 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0981,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/23/2022,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-0981-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335098104,Oxycodone,5
Oxycodone Hydrochloride,71335-0981-5,5 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0981,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/23/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-0981-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335098105,Oxycodone,5
Oxycodone Hydrochloride,71335-0981-6,5 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0981,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/23/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0981-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335098106,Oxycodone,5
Oxycodone Hydrochloride,71335-0981-7,5 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0981,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/23/2022,N/A,ANDA,50 TABLET in 1 BOTTLE (71335-0981-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335098107,Oxycodone,5
Oxycodone Hydrochloride,71335-0981-8,5 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0981,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/23/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-0981-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335098108,Oxycodone,5
Oxycodone Hydrochloride,71335-0981-9,5 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0981,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/23/2022,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-0981-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335098109,Oxycodone,5
Oxycodone Hydrochloride,68462-204-01,5 mg/1,CAPSULE,ORAL,NDA200534,"Glenmark Pharmaceuticals, Inc",68462-204,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/15/2010,N/A,NDA AUTHORIZED GENERIC,100 CAPSULE in 1 BOTTLE (68462-204-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68462020401,Oxycodone,5
Oxycodone Hydrochloride,67296-1434-7,5 mg/1,TABLET,ORAL,ANDA091490,"Redpharm Drug, Inc",67296-1434,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/08/2014,N/A,ANDA,"12 TABLET in 1 BOTTLE, PLASTIC (67296-1434-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,67296143407,Oxycodone,5
Oxycodone Hydrochloride,50383-964-30,100 mg/5mL,SOLUTION,ORAL,ANDA208795,Akorn,50383-964,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2017,N/A,ANDA,1 BOTTLE in 1 CARTON (50383-964-30)  / 30 mL in 1 BOTTLE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,50383096430,Oxycodone,100
OXYCODONE HYDROCHLORIDE,55700-174-90,15 mg/1,TABLET,ORAL,ANDA091393,Lake Erie Medical DBA Quality Care Products LLC,55700-174,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,90 TABLET in 1 BOTTLE (55700-174-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700017490,Oxycodone,15
Oxycodone Hydrochloride,65162-049-50,15 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-049,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,500 TABLET in 1 BOTTLE (65162-049-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162004950,Oxycodone,15
Oxycodone Hydrochloride,65162-051-25,30 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-051,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,250 TABLET in 1 BOTTLE (65162-051-25),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162005125,Oxycodone,30
Oxycodone Hydrochloride,60687-406-67,5 mg/5mL,SOLUTION,ORAL,ANDA204037,American Health Packaging,60687-406,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/22/2019,N/A,ANDA,"5 TRAY in 1 CASE (60687-406-67)  / 10 CUP, UNIT-DOSE in 1 TRAY (60687-406-46)  / 5 mL in 1 CUP, UNIT-DOSE (60687-406-40)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,60687040667,Oxycodone,5
Oxycodone Hydrochloride,60687-406-77,5 mg/5mL,SOLUTION,ORAL,ANDA204037,American Health Packaging,60687-406,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/22/2019,N/A,ANDA,"4 TRAY in 1 CASE (60687-406-77)  / 10 CUP, UNIT-DOSE in 1 TRAY (60687-406-46)  / 5 mL in 1 CUP, UNIT-DOSE (60687-406-40)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,60687040677,Oxycodone,5
Oxycodone Hydrochloride,68071-2899-6,5 mg/1,TABLET,ORAL,ANDA091490,"NuCare Pharmaceuticals,Inc.",68071-2899,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/08/2022,N/A,ANDA,"6 TABLET in 1 BOTTLE, PLASTIC (68071-2899-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68071289906,Oxycodone,5
OXYCODONE HYDROCHLORIDE,10702-008-01,15 mg/1,TABLET,ORAL,ANDA091393,"KVK-TECH,INC",10702-008,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-008-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702000801,Oxycodone,15
OXYCODONE HYDROCHLORIDE,10702-008-50,15 mg/1,TABLET,ORAL,ANDA091393,"KVK-TECH,INC",10702-008,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,500 TABLET in 1 BOTTLE (10702-008-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702000850,Oxycodone,15
OXYCODONE HYDROCHLORIDE,10702-009-01,30 mg/1,TABLET,ORAL,ANDA091393,"KVK-TECH,INC",10702-009,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-009-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702000901,Oxycodone,30
OXYCODONE HYDROCHLORIDE,10702-009-50,30 mg/1,TABLET,ORAL,ANDA091393,"KVK-TECH,INC",10702-009,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,500 TABLET in 1 BOTTLE (10702-009-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702000950,Oxycodone,30
OXYCODONE HYDROCHLORIDE,0406-0552-01,5 mg/1,TABLET,ORAL,ANDA076758,SpecGx LLC,0406-0552,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-0552-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406055201,Oxycodone,5
OXYCODONE HYDROCHLORIDE,0406-0552-23,5 mg/1,TABLET,ORAL,ANDA076758,SpecGx LLC,0406-0552,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-0552-23),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406055223,Oxycodone,5
OXYCODONE HYDROCHLORIDE,0406-0552-62,5 mg/1,TABLET,ORAL,ANDA076758,SpecGx LLC,0406-0552,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,100 TABLET in 1 BLISTER PACK (0406-0552-62),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406055262,Oxycodone,5
OXYCODONE HYDROCHLORIDE,0406-8515-01,15 mg/1,TABLET,ORAL,ANDA076758,SpecGx LLC,0406-8515,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-8515-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406851501,Oxycodone,15
OXYCODONE HYDROCHLORIDE,0406-8515-23,15 mg/1,TABLET,ORAL,ANDA076758,SpecGx LLC,0406-8515,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-8515-23),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406851523,Oxycodone,15
OXYCODONE HYDROCHLORIDE,0406-8515-62,15 mg/1,TABLET,ORAL,ANDA076758,SpecGx LLC,0406-8515,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,100 TABLET in 1 BLISTER PACK (0406-8515-62),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406851562,Oxycodone,15
OXYCODONE HYDROCHLORIDE,0406-8530-01,30 mg/1,TABLET,ORAL,ANDA076758,SpecGx LLC,0406-8530,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-8530-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406853001,Oxycodone,30
OXYCODONE HYDROCHLORIDE,0406-8530-23,30 mg/1,TABLET,ORAL,ANDA076758,SpecGx LLC,0406-8530,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-8530-23),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406853023,Oxycodone,30
OXYCODONE HYDROCHLORIDE,0406-8530-62,30 mg/1,TABLET,ORAL,ANDA076758,SpecGx LLC,0406-8530,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/30/2004,N/A,ANDA,100 TABLET in 1 BLISTER PACK (0406-8530-62),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406853062,Oxycodone,30
Oxycodone Hydrochloride,63629-8889-1,15 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,63629-8889,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/21/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (63629-8889-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629888901,Oxycodone,15
Oxycodone Hydrochloride,42806-009-01,20 mg/1,TABLET,ORAL,ANDA202662,"Epic Pharma, LLC",42806-009,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/16/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-009-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42806000901,Oxycodone,20
Oxycodone Hydrochloride,71335-0677-5,30 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0677,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/28/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-0677-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067705,Oxycodone,30
Oxycodone Hydrochloride,71335-2126-1,30 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,71335-2126,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/18/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-2126-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335212601,Oxycodone,30
Oxycodone Hydrochloride,42806-007-01,15 mg/1,TABLET,ORAL,ANDA202662,"Epic Pharma, LLC",42806-007,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/22/2015,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-007-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42806000701,Oxycodone,15
Oxycodone Hydrochloride,71335-2126-2,30 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,71335-2126,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/18/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-2126-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335212602,Oxycodone,30
Oxycodone Hydrochloride,71335-2126-3,30 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,71335-2126,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/18/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-2126-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335212603,Oxycodone,30
Oxycodone Hydrochloride,71335-2126-4,30 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,71335-2126,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/18/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-2126-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335212604,Oxycodone,30
Oxycodone Hydrochloride,71335-2126-5,30 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,71335-2126,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/18/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-2126-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335212605,Oxycodone,30
Oxycodone Hydrochloride,71335-2126-6,30 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,71335-2126,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/18/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-2126-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335212606,Oxycodone,30
Oxycodone Hydrochloride,71335-2126-7,30 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,71335-2126,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/18/2022,N/A,ANDA,18 TABLET in 1 BOTTLE (71335-2126-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335212607,Oxycodone,30
Oxycodone Hydrochloride,71335-2126-8,30 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,71335-2126,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/18/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-2126-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335212608,Oxycodone,30
OXYCODONE HYDROCHLORIDE,63629-3775-6,10 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-3775,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,20 TABLET in 1 BOTTLE (63629-3775-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629377506,Oxycodone,10
Oxycodone Hydrochloride,63629-1174-1,5 mg/5mL,SOLUTION,ORAL,ANDA207511,Bryant Ranch Prepack,63629-1174,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/01/2019,N/A,ANDA,1 BOTTLE in 1 CARTON (63629-1174-1)  / 473 mL in 1 BOTTLE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629117401,Oxycodone,5
OXYCODONE HYDROCHLORIDE,10702-018-01,5 mg/1,TABLET,ORAL,ANDA091393,"KVK-TECH,INC",10702-018,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-018-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702001801,Oxycodone,5
OXYCODONE HYDROCHLORIDE,10702-018-50,5 mg/1,TABLET,ORAL,ANDA091393,"KVK-TECH,INC",10702-018,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,500 TABLET in 1 BOTTLE (10702-018-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702001850,Oxycodone,5
Oxycodone Hydrochloride,10702-023-01,5 mg/1,CAPSULE,ORAL,ANDA202773,"KVK-TECH, INC.",10702-023,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/20/2015,N/A,ANDA,100 CAPSULE in 1 BOTTLE (10702-023-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702002301,Oxycodone,5
Oxycodone Hydrochloride,10702-023-06,5 mg/1,CAPSULE,ORAL,ANDA202773,"KVK-TECH, INC.",10702-023,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/20/2015,N/A,ANDA,60 CAPSULE in 1 BOTTLE (10702-023-06),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702002306,Oxycodone,5
OXYCODONE HYDROCHLORIDE,0406-8510-01,10 mg/1,TABLET,ORAL,ANDA076758,SpecGx LLC,0406-8510,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/12/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-8510-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406851001,Oxycodone,10
OXYCODONE HYDROCHLORIDE,10702-056-01,10 mg/1,TABLET,ORAL,ANDA091393,"KVK-TECH,INC",10702-056,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-056-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702005601,Oxycodone,10
OXYCODONE HYDROCHLORIDE,10702-056-50,10 mg/1,TABLET,ORAL,ANDA091393,"KVK-TECH,INC",10702-056,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,500 TABLET in 1 BOTTLE (10702-056-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702005650,Oxycodone,10
OXYCODONE HYDROCHLORIDE,10702-057-01,20 mg/1,TABLET,ORAL,ANDA091393,"KVK-TECH,INC",10702-057,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-057-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702005701,Oxycodone,20
OXYCODONE HYDROCHLORIDE,10702-057-50,20 mg/1,TABLET,ORAL,ANDA091393,"KVK-TECH,INC",10702-057,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,500 TABLET in 1 BOTTLE (10702-057-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702005750,Oxycodone,20
OXYCODONE HYDROCHLORIDE,10702-171-03,100 mg/5mL,SOLUTION,ORAL,ANDA208593,"KVK-Tech, Inc.",10702-171,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/21/2017,N/A,ANDA,"1 BOTTLE, PLASTIC in 1 CARTON (10702-171-03)  / 30 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702017103,Oxycodone,100
Oxycodone Hydrochloride,10702-183-50,5 mg/5mL,SOLUTION,ORAL,ANDA208593,"KVK-Tech, Inc.",10702-183,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/21/2017,N/A,ANDA,"1 BOTTLE, PLASTIC in 1 CARTON (10702-183-50)  / 500 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702018350,Oxycodone,5
Oxycodone Hydrochloride,63629-8889-2,15 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,63629-8889,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/21/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (63629-8889-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629888902,Oxycodone,15
Oxycodone Hydrochloride,63629-8889-3,15 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,63629-8889,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/21/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (63629-8889-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629888903,Oxycodone,15
Oxycodone Hydrochloride,63629-8889-4,15 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,63629-8889,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/21/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (63629-8889-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629888904,Oxycodone,15
Oxycodone Hydrochloride,63629-8890-1,30 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,63629-8890,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/11/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (63629-8890-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629889001,Oxycodone,30
Oxycodone Hydrochloride,63629-8890-2,30 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,63629-8890,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/11/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (63629-8890-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629889002,Oxycodone,30
Oxycodone Hydrochloride,63629-8890-3,30 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,63629-8890,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/11/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (63629-8890-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629889003,Oxycodone,30
Oxycodone Hydrochloride,63629-8890-4,30 mg/1,TABLET,ORAL,ANDA207418,Bryant Ranch Prepack,63629-8890,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/11/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (63629-8890-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629889004,Oxycodone,30
Oxycodone Hydrochloride,71335-0677-1,30 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0677,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/09/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0677-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067701,Oxycodone,30
Oxycodone Hydrochloride,71335-0677-2,30 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0677,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/27/2018,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0677-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067702,Oxycodone,30
Oxycodone Hydrochloride,65162-047-10,5 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-047,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (65162-047-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162004710,Oxycodone,5
Oxycodone Hydrochloride,65162-047-25,5 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-047,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,250 TABLET in 1 BOTTLE (65162-047-25),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162004725,Oxycodone,5
Oxycodone Hydrochloride,62559-167-01,5 mg/1,CAPSULE,ORAL,ANDA205177,"ANI Pharmaceuticals, Inc.",62559-167,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/10/2016,N/A,ANDA,100 CAPSULE in 1 BOTTLE (62559-167-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,62559016701,Oxycodone,5
OXYCODONE HYDROCHLORIDE,71335-0115-4,5 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,71335-0115,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-0115-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335011504,Oxycodone,5
OXYCODONE HYDROCHLORIDE,71335-0115-6,5 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,71335-0115,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/27/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0115-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335011506,Oxycodone,5
Oxycodone Hydrochloride,60432-706-05,5 mg/5mL,SOLUTION,ORAL,ANDA206456,"Morton Grove Pharmaceuticals, Inc.",60432-706,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/17/2015,N/A,ANDA,"500 mL in 1 BOTTLE, PLASTIC (60432-706-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,60432070605,Oxycodone,5
OXYCODONE HYDROCHLORIDE,63629-4606-1,10 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-4606,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/25/2013,N/A,ANDA,120 TABLET in 1 BOTTLE (63629-4606-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629460601,Oxycodone,10
OXYCODONE HYDROCHLORIDE,63629-4606-2,10 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-4606,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (63629-4606-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629460602,Oxycodone,10
OXYCODONE HYDROCHLORIDE,63629-4606-3,10 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-4606,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/05/2013,N/A,ANDA,60 TABLET in 1 BOTTLE (63629-4606-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629460603,Oxycodone,10
OXYCODONE HYDROCHLORIDE,63629-4606-4,10 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-4606,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2013,N/A,ANDA,90 TABLET in 1 BOTTLE (63629-4606-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629460604,Oxycodone,10
OXYCODONE HYDROCHLORIDE,63629-4606-5,10 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-4606,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,40 TABLET in 1 BOTTLE (63629-4606-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629460605,Oxycodone,10
OXYCODONE HYDROCHLORIDE,63629-4606-6,10 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,63629-4606,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/22/2021,N/A,ANDA,28 TABLET in 1 BOTTLE (63629-4606-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629460606,Oxycodone,10
oxycodone hydrochloride,57664-370-88,10 mg/1,TABLET,ORAL,ANDA090659,"Sun Pharmaceutical Industries, Inc.",57664-370,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/19/2012,N/A,ANDA,100 TABLET in 1 BOTTLE (57664-370-88),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,57664037088,Oxycodone,10
Oxycodone Hydrochloride,71335-9606-1,15 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-9606,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/20/2022,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (71335-9606-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335960601,Oxycodone,15
Oxycodone Hydrochloride,71335-9606-2,15 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-9606,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/20/2022,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (71335-9606-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335960602,Oxycodone,15
Oxycodone Hydrochloride,71335-9606-3,15 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-9606,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/20/2022,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (71335-9606-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335960603,Oxycodone,15
Oxycodone Hydrochloride,71335-9606-4,15 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-9606,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/20/2022,N/A,ANDA,"120 TABLET in 1 BOTTLE, PLASTIC (71335-9606-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335960604,Oxycodone,15
OXYCODONE HYDROCHLORIDE,55700-174-60,15 mg/1,TABLET,ORAL,ANDA091393,Lake Erie Medical DBA Quality Care Products LLC,55700-174,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,60 TABLET in 1 BOTTLE (55700-174-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700017460,Oxycodone,15
Oxycodone hydrochloride,47781-263-05,5 mg/1,TABLET,ORAL,ANDA202116,"Alvogen, Inc.",47781-263,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,500 TABLET in 1 BOTTLE (47781-263-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781026305,Oxycodone,5
Oxycodone hydrochloride,47781-264-05,15 mg/1,TABLET,ORAL,ANDA202116,"Alvogen, Inc.",47781-264,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,500 TABLET in 1 BOTTLE (47781-264-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,47781026405,Oxycodone,15
oxycodone hydrochloride,57664-187-88,15 mg/1,TABLET,ORAL,ANDA090659,"Sun Pharmaceutical Industries, Inc.",57664-187,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/12/2009,N/A,ANDA,100 TABLET in 1 BOTTLE (57664-187-88),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,57664018788,Oxycodone,15
Oxycodone Hydrochloride,42806-006-01,10 mg/1,TABLET,ORAL,ANDA202662,"Epic Pharma, LLC",42806-006,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/22/2015,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-006-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42806000601,Oxycodone,10
Oxycodone Hydrochloride,31722-917-01,15 mg/1,TABLET,ORAL,ANDA207418,Camber Pharmaceuticals Inc,31722-917,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-917-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722091701,Oxycodone,15
Oxycodone Hydrochloride,31722-917-05,15 mg/1,TABLET,ORAL,ANDA207418,Camber Pharmaceuticals Inc,31722-917,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (31722-917-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722091705,Oxycodone,15
Oxycodone Hydrochloride,31722-918-01,30 mg/1,TABLET,ORAL,ANDA207418,Camber Pharmaceuticals Inc,31722-918,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2017,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-918-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722091801,Oxycodone,30
Oxycodone Hydrochloride,31722-918-05,30 mg/1,TABLET,ORAL,ANDA207418,Camber Pharmaceuticals Inc,31722-918,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2017,N/A,ANDA,500 TABLET in 1 BOTTLE (31722-918-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722091805,Oxycodone,30
Oxycodone Hydrochloride,66689-025-30,100 mg/5mL,SOLUTION,ORAL,ANDA202537,"VistaPharm, Inc.",66689-025,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/15/2012,N/A,ANDA,30 mL in 1 BOTTLE (66689-025-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,66689002530,Oxycodone,100
Oxycodone Hydrochloride,68094-801-58,100 mg/5mL,SOLUTION,ORAL,ANDA204092,"Precision Dose, Inc.",68094-801,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/01/2016,11/30/2023,ANDA,50 BAG in 1 CASE (68094-801-58)  / 1 SYRINGE in 1 BAG / .5 mL in 1 SYRINGE (68094-801-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,68094080158,Oxycodone,100
OXYCODONE HYDROCHLORIDE,68084-983-01,30 mg/1,TABLET,ORAL,ANDA091393,American Health Packaging,68084-983,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/15/2018,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-983-01)  / 1 TABLET in 1 BLISTER PACK (68084-983-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68084098301,Oxycodone,30
oxycodone hydrochloride,67296-1040-4,5 mg/1,TABLET,ORAL,ANDA090659,"RedPharm Drug, Inc.",67296-1040,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/12/2009,N/A,ANDA,40 TABLET in 1 BOTTLE (67296-1040-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67296104004,Oxycodone,5
OXYCODONE HYDROCHLORIDE,0121-0826-01,100 mg/5mL,SOLUTION,ORAL,ANDA206822,"Pharmaceutical Associates, Inc.",0121-0826,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/04/2018,N/A,ANDA,1 BOTTLE in 1 CARTON (0121-0826-01)  / 30 mL in 1 BOTTLE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00121082601,Oxycodone,100
Oxycodone Hydrochloride,64950-353-03,100 mg/5mL,SOLUTION,ORAL,NDA200535,Genus Lifesciences Inc.,64950-353,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/20/2010,N/A,NDA,"1 BOTTLE, PLASTIC in 1 CARTON (64950-353-03)  / 30 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64950035303,Oxycodone,100
Oxycodone Hydrochloride,64950-354-50,5 mg/5mL,SOLUTION,ORAL,NDA200535,Genus Lifesciences Inc.,64950-354,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/09/2013,N/A,NDA,"1 BOTTLE, PLASTIC in 1 CARTON (64950-354-50)  / 500 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64950035450,Oxycodone,5
Oxycodone Hydrochloride,63629-8526-1,15 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,63629-8526,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/19/2021,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (63629-8526-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,63629852601,Oxycodone,15
Oxycodone Hydrochloride,64950-353-51,100 mg/5mL,SOLUTION,ORAL,NDA200535,Genus Lifesciences Inc.,64950-353,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2020,N/A,NDA,"50 POUCH in 1 CASE (64950-353-51)  / 5 SYRINGE, PLASTIC in 1 POUCH (64950-353-91)  / .5 mL in 1 SYRINGE, PLASTIC (64950-353-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64950035351,Oxycodone,100
Oxycodone Hydrochloride,64950-353-52,100 mg/5mL,SOLUTION,ORAL,NDA200535,Genus Lifesciences Inc.,64950-353,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2020,N/A,NDA,"50 POUCH in 1 CASE (64950-353-52)  / 5 SYRINGE, PLASTIC in 1 POUCH (64950-353-92)  / 1 mL in 1 SYRINGE, PLASTIC (64950-353-02)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64950035352,Oxycodone,100
Oxycodone Hydrochloride,64950-354-10,5 mg/5mL,SOLUTION,ORAL,NDA200535,Genus Lifesciences Inc.,64950-354,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/09/2013,N/A,NDA,"1 BOTTLE, PLASTIC in 1 CARTON (64950-354-10)  / 100 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64950035410,Oxycodone,5
Oxycodone Hydrochloride,71335-0677-8,30 mg/1,TABLET,ORAL,ANDA203638,Bryant Ranch Prepack,71335-0677,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/28/2022,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-0677-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335067708,Oxycodone,30
OXYCODONE HYDROCHLORIDE,55700-509-30,20 mg/1,TABLET,ORAL,ANDA091393,"Quality Care Products, LLC",55700-509,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/31/2017,N/A,ANDA,30 TABLET in 1 BOTTLE (55700-509-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700050930,Oxycodone,20
OXYCODONE HYDROCHLORIDE,0121-4827-50,5 mg/5mL,SOLUTION,ORAL,ANDA206914,"PAI Holdings, LLC",0121-4827,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/10/2020,N/A,ANDA,"5 TRAY in 1 CASE (0121-4827-50)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-4827-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00121482750,Oxycodone,5
OXYCODONE HYDROCHLORIDE,71335-0115-1,5 mg/1,TABLET,ORAL,ANDA077290,Bryant Ranch Prepack,71335-0115,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/08/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0115-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335011501,Oxycodone,5
Oxycodone Hydrochloride,50383-961-34,5 mg/5mL,SOLUTION,ORAL,ANDA208817,Akorn,50383-961,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/10/2017,N/A,ANDA,1 BOTTLE in 1 CARTON (50383-961-34)  / 500 mL in 1 BOTTLE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,50383096134,Oxycodone,5
Oxycodone Hydrochloride,42806-008-01,30 mg/1,TABLET,ORAL,ANDA202662,"Epic Pharma, LLC",42806-008,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/22/2015,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-008-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42806000801,Oxycodone,30
Oxycodone Hydrochloride,66689-401-50,5 mg/5mL,SOLUTION,ORAL,NDA201194,"VistaPharm, Inc.",66689-401,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/15/2012,N/A,NDA,"5 TRAY in 1 CASE (66689-401-50)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (66689-401-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,66689040150,Oxycodone,5
Oxycodone Hydrochloride,65162-048-03,10 mg/1,TABLET,ORAL,ANDA203638,Amneal Pharmaceuticals LLC,65162-048,Oxycodone,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/30/2012,N/A,ANDA,30 TABLET in 1 BOTTLE (65162-048-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,65162004803,Oxycodone,10
Oxycodone Hydrochloride,68308-020-03,100 mg/5mL,SOLUTION,ORAL,ANDA204092,Mayne Pharma Inc.,68308-020,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2014,N/A,ANDA,"1 BOTTLE, PLASTIC in 1 CARTON (68308-020-03)  / 30 mL in 1 BOTTLE, PLASTIC","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,68308002003,Oxycodone,100
Oxycodone Hydrochloride,0093-5731-01,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,"Teva Pharmaceuticals USA, Inc.",0093-5731,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/12/2015,12/31/2024,NDA AUTHORIZED GENERIC,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-5731-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,00093573101,Oxycodone,10
Oxycodone Hydrochloride,0093-5732-01,20 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,"Teva Pharmaceuticals USA, Inc.",0093-5732,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/12/2015,12/31/2024,NDA AUTHORIZED GENERIC,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-5732-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,00093573201,Oxycodone,20
Oxycodone Hydrochloride,0093-5733-01,40 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,"Teva Pharmaceuticals USA, Inc.",0093-5733,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/14/2015,01/31/2025,NDA AUTHORIZED GENERIC,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-5733-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,00093573301,Oxycodone,40
Oxycodone Hydrochloride,0093-5734-01,80 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,"Teva Pharmaceuticals USA, Inc.",0093-5734,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/14/2015,01/31/2025,NDA AUTHORIZED GENERIC,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-5734-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,N/A,00093573401,Oxycodone,80
OXYCODONE HYDROCHLORIDE,71335-1245-1,30 mg/1,TABLET,ORAL,ANDA091393,Bryant Ranch Prepack,71335-1245,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1245-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335124501,Oxycodone,30
OXYCODONE HYDROCHLORIDE,71335-1245-2,30 mg/1,TABLET,ORAL,ANDA091393,Bryant Ranch Prepack,71335-1245,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1245-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335124502,Oxycodone,30
OXYCODONE HYDROCHLORIDE,71335-1245-3,30 mg/1,TABLET,ORAL,ANDA091393,Bryant Ranch Prepack,71335-1245,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1245-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335124503,Oxycodone,30
OXYCODONE HYDROCHLORIDE,71335-1245-4,30 mg/1,TABLET,ORAL,ANDA091393,Bryant Ranch Prepack,71335-1245,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1245-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335124504,Oxycodone,30
OXYCODONE HYDROCHLORIDE,71335-1245-5,30 mg/1,TABLET,ORAL,ANDA091393,Bryant Ranch Prepack,71335-1245,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1245-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335124505,Oxycodone,30
OXYCODONE HYDROCHLORIDE,71335-1245-6,30 mg/1,TABLET,ORAL,ANDA091393,Bryant Ranch Prepack,71335-1245,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-1245-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335124506,Oxycodone,30
OXYCODONE HYDROCHLORIDE,71335-1245-7,30 mg/1,TABLET,ORAL,ANDA091393,Bryant Ranch Prepack,71335-1245,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,18 TABLET in 1 BOTTLE (71335-1245-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335124507,Oxycodone,30
OXYCODONE HYDROCHLORIDE,71335-1245-8,30 mg/1,TABLET,ORAL,ANDA091393,Bryant Ranch Prepack,71335-1245,OXYCODONE HYDROCHLORIDE,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2013,N/A,ANDA,28 TABLET in 1 BOTTLE (71335-1245-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335124508,Oxycodone,30
Oxycodone Hydrochloride,71335-1361-1,5 mg/1,TABLET,ORAL,ANDA202160,Bryant Ranch Prepack,71335-1361,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/19/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1361-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136101,Oxycodone,5
Oxycodone Hydrochloride,71335-1361-2,5 mg/1,TABLET,ORAL,ANDA202160,Bryant Ranch Prepack,71335-1361,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/01/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1361-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136102,Oxycodone,5
Oxycodone Hydrochloride,71335-1361-3,5 mg/1,TABLET,ORAL,ANDA202160,Bryant Ranch Prepack,71335-1361,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/01/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1361-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136103,Oxycodone,5
Oxycodone Hydrochloride,71335-1361-4,5 mg/1,TABLET,ORAL,ANDA202160,Bryant Ranch Prepack,71335-1361,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-1361-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136104,Oxycodone,5
Oxycodone Hydrochloride,71335-1361-5,5 mg/1,TABLET,ORAL,ANDA202160,Bryant Ranch Prepack,71335-1361,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1361-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136105,Oxycodone,5
Oxycodone Hydrochloride,71335-1361-6,5 mg/1,TABLET,ORAL,ANDA202160,Bryant Ranch Prepack,71335-1361,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1361-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136106,Oxycodone,5
Oxycodone Hydrochloride,71335-1361-7,5 mg/1,TABLET,ORAL,ANDA202160,Bryant Ranch Prepack,71335-1361,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,50 TABLET in 1 BOTTLE (71335-1361-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136107,Oxycodone,5
Oxycodone Hydrochloride,71335-1361-8,5 mg/1,TABLET,ORAL,ANDA202160,Bryant Ranch Prepack,71335-1361,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-1361-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136108,Oxycodone,5
Oxycodone Hydrochloride,71335-1361-9,5 mg/1,TABLET,ORAL,ANDA202160,Bryant Ranch Prepack,71335-1361,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2019,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-1361-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,71335136109,Oxycodone,5
Oxycodone Hydrochloride,71335-1413-1,15 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1413,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/03/2020,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-1413-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141301,Oxycodone,15
Oxycodone Hydrochloride,71335-1413-2,15 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1413,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/06/2020,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-1413-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141302,Oxycodone,15
Oxycodone Hydrochloride,71335-1413-3,15 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1413,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/23/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-1413-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141303,Oxycodone,15
Oxycodone Hydrochloride,71335-1413-4,15 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1413,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/31/2019,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-1413-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141304,Oxycodone,15
Oxycodone Hydrochloride,71335-1413-5,15 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1413,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-1413-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141305,Oxycodone,15
Oxycodone Hydrochloride,71335-1413-6,15 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1413,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-1413-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141306,Oxycodone,15
Oxycodone Hydrochloride,71335-1413-7,15 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1413,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-1413-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141307,Oxycodone,15
Oxycodone Hydrochloride,71335-1413-8,15 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1413,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,45 TABLET in 1 BOTTLE (71335-1413-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141308,Oxycodone,15
Oxycodone Hydrochloride,71335-1413-9,15 mg/1,TABLET,ORAL,ANDA091490,Bryant Ranch Prepack,71335-1413,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,18 TABLET in 1 BOTTLE (71335-1413-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,71335141309,Oxycodone,15
OXYCODONE HYDROCHLORIDE,0406-8510-23,10 mg/1,TABLET,ORAL,ANDA076758,SpecGx LLC,0406-8510,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/12/2021,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-8510-23),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406851023,Oxycodone,10
OXYCODONE HYDROCHLORIDE,0406-8510-62,10 mg/1,TABLET,ORAL,ANDA076758,SpecGx LLC,0406-8510,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/12/2021,N/A,ANDA,100 TABLET in 1 BLISTER PACK (0406-8510-62),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406851062,Oxycodone,10
OXYCODONE HYDROCHLORIDE,0406-8520-01,20 mg/1,TABLET,ORAL,ANDA076758,SpecGx LLC,0406-8520,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/12/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (0406-8520-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406852001,Oxycodone,20
OXYCODONE HYDROCHLORIDE,0406-8520-23,20 mg/1,TABLET,ORAL,ANDA076758,SpecGx LLC,0406-8520,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/12/2021,N/A,ANDA,1 TABLET in 1 BLISTER PACK (0406-8520-23),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406852023,Oxycodone,20
OXYCODONE HYDROCHLORIDE,0406-8520-62,20 mg/1,TABLET,ORAL,ANDA076758,SpecGx LLC,0406-8520,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/12/2021,N/A,ANDA,100 TABLET in 1 BLISTER PACK (0406-8520-62),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,00406852062,Oxycodone,20
Oxycodone Hydrochloride and Acetaminophen,29033-405-35,"325 mg/5mL,                         5  mg/5mL",SOLUTION,ORAL,ANDA201448,"Nostrum Laboratories, Inc.",29033-405,Oxycodone Hydrochloride and Acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/01/2021,N/A,ANDA,500 mL in 1 BOTTLE (29033-405-35),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,29033040535,Oxycodone,325
oxycodone hydrochloride and acetaminophen,72887-648-12,"300 mg/5mL,                         10  mg/5mL",SOLUTION,ORAL,ANDA202142,FH2 Pharma LLC,72887-648,oxycodone hydrochloride and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/01/2020,N/A,ANDA,"120 mL in 1 BOTTLE, PLASTIC (72887-648-12)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72887064812,Oxycodone,300
Oxycodone/APAP,72189-426-60,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040545,Direct_Rx,72189-426,Oxycodone/APAP,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2023,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-426-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72189042660,Oxycodone,325
Oxycodone/APAP,72189-375-60,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Direct_Rx,72189-375,Oxycodone/APAP,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/09/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-375-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189037560,Oxycodone,325
OXYCODONE/APAP,61919-432-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202677,DIRECT RX,61919-432,OXYCODONE/APAP,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/15/2016,N/A,ANDA,90 TABLET in 1 BOTTLE (61919-432-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,61919043260,Oxycodone,325
OXYCODONE/APAP,61919-432-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202677,DIRECT RX,61919-432,OXYCODONE/APAP,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/15/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (61919-432-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,61919043230,Oxycodone,325
OXYCODONE/APAP,61919-432-90,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA202677,DIRECT RX,61919-432,OXYCODONE/APAP,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/15/2016,N/A,ANDA,90 TABLET in 1 BOTTLE (61919-432-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,61919043290,Oxycodone,325
OXYCODONE/APAP,61919-524-90,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201972,DirectRX,61919-524,OXYCODONE/APAP,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,04/19/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (61919-524-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,61919052490,Oxycodone,325
Oxycodone/APAP,72189-375-30,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA201278,Direct_Rx,72189-375,Oxycodone/APAP,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/09/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-375-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189037530,Oxycodone,325
Oxycodone/APAP,72189-398-30,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Direct_Rx,72189-398,Oxycodone/APAP,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/22/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-398-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72189039830,Oxycodone,325
Oxycodone/APAP,72189-426-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040545,Direct_Rx,72189-426,Oxycodone/APAP,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2023,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-426-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72189042630,Oxycodone,325
Oxycodone/APAP,72189-398-60,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA201278,Direct_Rx,72189-398,Oxycodone/APAP,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/22/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (72189-398-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,72189039860,Oxycodone,325
OxyContin,59011-415-20,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Purdue Pharma LP,59011-415,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2010,N/A,NDA,"2 BLISTER PACK in 1 CARTON (59011-415-20)  / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,59011041520,Oxycodone,15
OxyContin,59011-415-10,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Purdue Pharma LP,59011-415,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2010,N/A,NDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59011-415-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,59011041510,Oxycodone,15
OxyContin,59011-480-10,80 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Purdue Pharma LP,59011-480,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2010,N/A,NDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59011-480-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,59011048010,Oxycodone,80
OxyContin,59011-460-10,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Purdue Pharma LP,59011-460,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2010,N/A,NDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59011-460-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,59011046010,Oxycodone,60
OxyContin,59011-420-20,20 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Purdue Pharma LP,59011-420,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2010,N/A,NDA,"2 BLISTER PACK in 1 CARTON (59011-420-20)  / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,59011042020,Oxycodone,20
OxyContin,59011-440-20,40 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Purdue Pharma LP,59011-440,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2010,N/A,NDA,"2 BLISTER PACK in 1 CARTON (59011-440-20)  / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,59011044020,Oxycodone,40
OxyContin,59011-420-10,20 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Purdue Pharma LP,59011-420,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2010,N/A,NDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59011-420-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,59011042010,Oxycodone,20
OxyContin,59011-460-20,60 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Purdue Pharma LP,59011-460,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2010,N/A,NDA,"2 BLISTER PACK in 1 CARTON (59011-460-20)  / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,59011046020,Oxycodone,60
OxyContin,59011-480-20,80 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Purdue Pharma LP,59011-480,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2010,N/A,NDA,"2 BLISTER PACK in 1 CARTON (59011-480-20)  / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,59011048020,Oxycodone,80
OxyContin,59011-410-10,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Purdue Pharma LP,59011-410,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2010,N/A,NDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59011-410-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,59011041010,Oxycodone,10
OxyContin,59011-410-20,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Purdue Pharma LP,59011-410,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2010,N/A,NDA,"2 BLISTER PACK in 1 CARTON (59011-410-20)  / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,59011041020,Oxycodone,10
OxyContin,59011-430-10,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Purdue Pharma LP,59011-430,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2010,N/A,NDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59011-430-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,59011043010,Oxycodone,30
OxyContin,59011-430-20,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Purdue Pharma LP,59011-430,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2010,N/A,NDA,"2 BLISTER PACK in 1 CARTON (59011-430-20)  / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,59011043020,Oxycodone,30
OxyContin,59011-440-10,40 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA022272,Purdue Pharma LP,59011-440,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/08/2010,N/A,NDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59011-440-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,59011044010,Oxycodone,40
PERCOCET,63481-628-70,"325 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040330,Endo Pharmaceuticals Inc.,63481-628,oxycodone hydrochloride and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/30/2001,N/A,ANDA,100 TABLET in 1 BOTTLE (63481-628-70),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63481062870,Oxycodone,325
PERCOCET,63481-623-70,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040330,Endo Pharmaceuticals Inc.,63481-623,oxycodone hydrochloride and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/30/1999,N/A,ANDA,100 TABLET in 1 BOTTLE (63481-623-70),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63481062370,Oxycodone,325
PERCOCET,63481-627-70,"325 mg/1,                         2.5  mg/1",TABLET,ORAL,ANDA040330,Endo Pharmaceuticals Inc.,63481-627,oxycodone hydrochloride and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/30/1999,N/A,ANDA,100 TABLET in 1 BOTTLE (63481-627-70),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63481062770,Oxycodone,325
PERCOCET,63481-629-70,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040330,Endo Pharmaceuticals Inc.,63481-629,oxycodone hydrochloride and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/30/2001,N/A,ANDA,100 TABLET in 1 BOTTLE (63481-629-70),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63481062970,Oxycodone,325
PERCOCET,63481-623-85,"325 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040330,Endo Pharmaceuticals Inc.,63481-623,oxycodone hydrochloride and acetaminophen,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/30/1999,N/A,ANDA,500 TABLET in 1 BOTTLE (63481-623-85),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63481062385,Oxycodone,325
Percocet,72189-397-30,"325 mg/1,                         10  mg/1",TABLET,ORAL,ANDA201278,Direct_Rx,72189-397,Oxycodone/APAP,ACETAMINOPHEN;  OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/22/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (72189-397-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72189039730,Oxycodone,325
Prolate,72245-648-12,"300 mg/5mL,                         10  mg/5mL",SOLUTION,ORAL,ANDA202142,Forte Bio-Pharma LLC,72245-648,oxycodone hydrochloride and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/01/2020,N/A,ANDA,"120 mL in 1 BOTTLE, PLASTIC (72245-648-12)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72245064812,Oxycodone,300
Prolate,72245-648-50,"300 mg/5mL,                         10  mg/5mL",SOLUTION,ORAL,ANDA202142,Forte Bio-Pharma LLC,72245-648,oxycodone hydrochloride and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/01/2020,N/A,ANDA,"500 mL in 1 BOTTLE, PLASTIC (72245-648-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72245064850,Oxycodone,300
Prolate,72245-681-03,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040608,Forte Bio-Pharma LLC,72245-681,oxycodone and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (72245-681-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72245068103,Oxycodone,300
Prolate,72245-681-10,"300 mg/1,                         5  mg/1",TABLET,ORAL,ANDA040608,Forte Bio-Pharma LLC,72245-681,oxycodone and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (72245-681-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72245068110,Oxycodone,300
Prolate,72245-682-03,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040608,Forte Bio-Pharma LLC,72245-682,oxycodone and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (72245-682-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72245068203,Oxycodone,300
Prolate,72245-682-10,"300 mg/1,                         7.5  mg/1",TABLET,ORAL,ANDA040608,Forte Bio-Pharma LLC,72245-682,oxycodone and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (72245-682-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72245068210,Oxycodone,300
Prolate,72245-683-03,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040608,Forte Bio-Pharma LLC,72245-683,oxycodone and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (72245-683-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72245068303,Oxycodone,300
Prolate,72245-683-10,"300 mg/1,                         10  mg/1",TABLET,ORAL,ANDA040608,Forte Bio-Pharma LLC,72245-683,oxycodone and acetaminophen,OXYCODONE HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,02/17/2020,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (72245-683-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72245068310,Oxycodone,300
Roxicodone,23635-581-10,15 mg/1,TABLET,ORAL,NDA021011,SpecGx LLC,23635-581,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/31/2000,N/A,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (23635-581-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,23635058110,Oxycodone,15
Roxicodone,23635-582-10,30 mg/1,TABLET,ORAL,NDA021011,SpecGx LLC,23635-582,oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/31/2000,N/A,NDA,"100 TABLET in 1 BOTTLE, PLASTIC (23635-582-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2024,23635058210,Oxycodone,30
RoxyBond,81140-101-10,5 mg/1,"TABLET, COATED",ORAL,NDA209777,Protega Pharmaceuticals LLC,81140-101,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/31/2022,N/A,NDA,"100 TABLET, COATED in 1 BOTTLE (81140-101-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,81140010110,Oxycodone,5
RoxyBond,81140-102-10,15 mg/1,"TABLET, COATED",ORAL,NDA209777,Protega Pharmaceuticals LLC,81140-102,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/31/2022,N/A,NDA,"100 TABLET, COATED in 1 BOTTLE (81140-102-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,81140010210,Oxycodone,15
RoxyBond,81140-103-10,30 mg/1,"TABLET, COATED",ORAL,NDA209777,Protega Pharmaceuticals LLC,81140-103,Oxycodone hydrochloride,OXYCODONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/31/2022,N/A,NDA,"100 TABLET, COATED in 1 BOTTLE (81140-103-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,81140010310,Oxycodone,30
XTAMPZA,24510-110-10,9 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA208090,"Collegium Pharmaceutical, Inc.",24510-110,OXYCODONE,OXYCODONE,HUMAN PRESCRIPTION DRUG,05/10/2016,N/A,NDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24510-110-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,24510011010,Oxycodone,9
XTAMPZA,24510-110-20,9 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA208090,"Collegium Pharmaceutical, Inc.",24510-110,OXYCODONE,OXYCODONE,HUMAN PRESCRIPTION DRUG,05/10/2016,N/A,NDA,"20 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (24510-110-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,24510011020,Oxycodone,9
XTAMPZA,24510-115-10,13.5 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA208090,"Collegium Pharmaceutical, Inc.",24510-115,OXYCODONE,OXYCODONE,HUMAN PRESCRIPTION DRUG,05/10/2016,N/A,NDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24510-115-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,24510011510,Oxycodone,13.5
XTAMPZA,24510-115-20,13.5 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA208090,"Collegium Pharmaceutical, Inc.",24510-115,OXYCODONE,OXYCODONE,HUMAN PRESCRIPTION DRUG,05/10/2016,N/A,NDA,"20 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (24510-115-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,24510011520,Oxycodone,13.5
XTAMPZA,24510-120-10,18 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA208090,"Collegium Pharmaceutical, Inc.",24510-120,OXYCODONE,OXYCODONE,HUMAN PRESCRIPTION DRUG,05/10/2016,N/A,NDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24510-120-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,24510012010,Oxycodone,18
XTAMPZA,24510-120-20,18 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA208090,"Collegium Pharmaceutical, Inc.",24510-120,OXYCODONE,OXYCODONE,HUMAN PRESCRIPTION DRUG,05/10/2016,N/A,NDA,"20 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (24510-120-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,24510012020,Oxycodone,18
XTAMPZA,24510-130-10,27 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA208090,"Collegium Pharmaceutical, Inc.",24510-130,OXYCODONE,OXYCODONE,HUMAN PRESCRIPTION DRUG,05/10/2016,N/A,NDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24510-130-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,24510013010,Oxycodone,27
XTAMPZA,24510-130-20,27 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA208090,"Collegium Pharmaceutical, Inc.",24510-130,OXYCODONE,OXYCODONE,HUMAN PRESCRIPTION DRUG,05/10/2016,N/A,NDA,"20 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (24510-130-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,24510013020,Oxycodone,27
XTAMPZA,24510-140-10,36 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA208090,"Collegium Pharmaceutical, Inc.",24510-140,OXYCODONE,OXYCODONE,HUMAN PRESCRIPTION DRUG,05/10/2016,N/A,NDA,"100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24510-140-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,24510014010,Oxycodone,36
XTAMPZA,24510-140-20,36 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA208090,"Collegium Pharmaceutical, Inc.",24510-140,OXYCODONE,OXYCODONE,HUMAN PRESCRIPTION DRUG,05/10/2016,N/A,NDA,"20 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (24510-140-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,24510014020,Oxycodone,36
Oxymorphone Hydrochloride,42806-330-01,5 mg/1,TABLET,ORAL,ANDA201187,"Epic Pharma, LLC",42806-330,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/15/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-330-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42806033001,Oxymorphone,5
Oxymorphone Hydrochloride,42806-331-01,10 mg/1,TABLET,ORAL,ANDA201187,"Epic Pharma, LLC",42806-331,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/15/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (42806-331-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,42806033101,Oxymorphone,10
Oxymorphone Hydrochloride,35356-967-30,5 mg/1,TABLET,ORAL,ANDA203601,Lake Erie Medical DBA Quality Care Products LLC,35356-967,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (35356-967-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,35356096730,Oxymorphone,5
Oxymorphone Hydrochloride,35356-968-01,10 mg/1,TABLET,ORAL,ANDA203601,Lake Erie Medical DBA Quality Care Products LLC,35356-968,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2013,N/A,ANDA,120 TABLET in 1 BOTTLE (35356-968-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,35356096801,Oxymorphone,10
Oxymorphone Hydrochloride,35356-968-30,10 mg/1,TABLET,ORAL,ANDA203601,Lake Erie Medical DBA Quality Care Products LLC,35356-968,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (35356-968-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,35356096830,Oxymorphone,10
Oxymorphone Hydrochloride,35356-968-60,10 mg/1,TABLET,ORAL,ANDA203601,Lake Erie Medical DBA Quality Care Products LLC,35356-968,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2013,N/A,ANDA,60 TABLET in 1 BOTTLE (35356-968-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,35356096860,Oxymorphone,10
Oxymorphone Hydrochloride,10702-070-06,5 mg/1,TABLET,ORAL,ANDA203601,"KVK-Tech, Inc.",10702-070,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/25/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (10702-070-06),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702007006,Oxymorphone,5
Oxymorphone Hydrochloride,10702-071-06,10 mg/1,TABLET,ORAL,ANDA203601,"KVK-Tech, Inc.",10702-071,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/25/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (10702-071-06),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702007106,Oxymorphone,10
Oxymorphone Hydrochloride,13107-103-01,5 mg/1,TABLET,ORAL,ANDA204459,"Aurolife Pharma, LLC",13107-103,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/26/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-103-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010301,Oxymorphone,5
Oxymorphone Hydrochloride,13107-103-30,5 mg/1,TABLET,ORAL,ANDA204459,"Aurolife Pharma, LLC",13107-103,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/26/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-103-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010330,Oxymorphone,5
Oxymorphone Hydrochloride,13107-103-99,5 mg/1,TABLET,ORAL,ANDA204459,"Aurolife Pharma, LLC",13107-103,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/26/2016,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-103-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010399,Oxymorphone,5
Oxymorphone Hydrochloride,13107-104-01,10 mg/1,TABLET,ORAL,ANDA204459,"Aurolife Pharma, LLC",13107-104,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/26/2016,N/A,ANDA,100 TABLET in 1 BOTTLE (13107-104-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010401,Oxymorphone,10
Oxymorphone Hydrochloride,13107-104-30,10 mg/1,TABLET,ORAL,ANDA204459,"Aurolife Pharma, LLC",13107-104,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/26/2016,N/A,ANDA,30 TABLET in 1 BOTTLE (13107-104-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010430,Oxymorphone,10
Oxymorphone Hydrochloride,13107-104-99,10 mg/1,TABLET,ORAL,ANDA204459,"Aurolife Pharma, LLC",13107-104,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/26/2016,N/A,ANDA,1000 TABLET in 1 BOTTLE (13107-104-99),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,13107010499,Oxymorphone,10
Oxymorphone Hydrochloride,0054-0283-25,5 mg/1,TABLET,ORAL,ANDA090964,West-Ward Pharmaceuticals Corp.,0054-0283,oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/27/2010,N/A,ANDA,100 TABLET in 1 BOTTLE (0054-0283-25),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054028325,Oxymorphone,5
Oxymorphone Hydrochloride,0054-0284-25,10 mg/1,TABLET,ORAL,ANDA090964,West-Ward Pharmaceuticals Corp.,0054-0284,oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/27/2010,N/A,ANDA,100 TABLET in 1 BOTTLE (0054-0284-25),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00054028425,Oxymorphone,10
Oxymorphone hydrochloride,55700-788-60,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,"Quality Care Products, LLC",55700-788,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2021,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55700-788-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,55700078860,Oxymorphone,10
OXYMORPHONE HYDROCHLORIDE,72865-130-01,5 mg/1,TABLET,ORAL,ANDA210175,"XLCare Pharmaceuticals, Inc.",72865-130,OXYMORPHONE HYDROCHLORIDE,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/06/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-130-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865013001,Oxymorphone,5
OXYMORPHONE HYDROCHLORIDE,72865-131-01,10 mg/1,TABLET,ORAL,ANDA210175,"XLCare Pharmaceuticals, Inc.",72865-131,OXYMORPHONE HYDROCHLORIDE,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/06/2020,N/A,ANDA,100 TABLET in 1 BOTTLE (72865-131-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,72865013101,Oxymorphone,10
OXYMORPHONE HYDROCHLORIDE,63629-1925-1,10 mg/1,TABLET,ORAL,ANDA210175,Bryant Ranch Prepack,63629-1925,OXYMORPHONE HYDROCHLORIDE,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/14/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-1925-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629192501,Oxymorphone,10
OXYMORPHONE HYDROCHLORIDE,63629-1926-1,5 mg/1,TABLET,ORAL,ANDA210175,Bryant Ranch Prepack,63629-1926,OXYMORPHONE HYDROCHLORIDE,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/14/2021,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-1926-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63629192601,Oxymorphone,5
Oxymorphone Hydrochloride,10702-070-01,5 mg/1,TABLET,ORAL,ANDA203601,"KVK-Tech, Inc.",10702-070,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-070-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702007001,Oxymorphone,5
Oxymorphone Hydrochloride,10702-071-01,10 mg/1,TABLET,ORAL,ANDA203601,"KVK-Tech, Inc.",10702-071,Oxymorphone Hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2013,N/A,ANDA,100 TABLET in 1 BOTTLE (10702-071-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,10702007101,Oxymorphone,10
Oxymorphone hydrochloride,64896-695-01,5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-695,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-695-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069501,Oxymorphone,5
Oxymorphone hydrochloride,64896-695-03,5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-695,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-695-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069503,Oxymorphone,5
Oxymorphone hydrochloride,64896-695-08,5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-695,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-695-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069508,Oxymorphone,5
Oxymorphone hydrochloride,64896-695-13,5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-695,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-695-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069513,Oxymorphone,5
Oxymorphone hydrochloride,64896-696-01,7.5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-696,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-696-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069601,Oxymorphone,7.5
Oxymorphone hydrochloride,64896-696-03,7.5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-696,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-696-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069603,Oxymorphone,7.5
Oxymorphone hydrochloride,64896-696-08,7.5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-696,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-696-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069608,Oxymorphone,7.5
Oxymorphone hydrochloride,64896-696-13,7.5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-696,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-696-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069613,Oxymorphone,7.5
Oxymorphone hydrochloride,64896-697-01,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-697,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-697-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069701,Oxymorphone,10
Oxymorphone hydrochloride,64896-697-03,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-697,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-697-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069703,Oxymorphone,10
Oxymorphone hydrochloride,64896-697-08,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-697,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-697-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069708,Oxymorphone,10
Oxymorphone hydrochloride,64896-697-13,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-697,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-697-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069713,Oxymorphone,10
Oxymorphone hydrochloride,64896-698-01,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-698,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-698-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069801,Oxymorphone,15
Oxymorphone hydrochloride,64896-698-03,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-698,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-698-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069803,Oxymorphone,15
Oxymorphone hydrochloride,64896-698-08,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-698,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-698-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069808,Oxymorphone,15
Oxymorphone hydrochloride,64896-698-13,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-698,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-698-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069813,Oxymorphone,15
Oxymorphone hydrochloride,64896-699-01,20 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-699,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-699-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069901,Oxymorphone,20
Oxymorphone hydrochloride,64896-699-03,20 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-699,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-699-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069903,Oxymorphone,20
Oxymorphone hydrochloride,64896-699-08,20 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-699,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-699-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069908,Oxymorphone,20
Oxymorphone hydrochloride,64896-699-13,20 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-699,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-699-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896069913,Oxymorphone,20
Oxymorphone hydrochloride,64896-700-01,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-700,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-700-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896070001,Oxymorphone,30
Oxymorphone hydrochloride,64896-700-03,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-700,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-700-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896070003,Oxymorphone,30
Oxymorphone hydrochloride,64896-700-08,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-700,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-700-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896070008,Oxymorphone,30
Oxymorphone hydrochloride,64896-700-13,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-700,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-700-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896070013,Oxymorphone,30
Oxymorphone hydrochloride,64896-701-01,40 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-701,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-701-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896070101,Oxymorphone,40
Oxymorphone hydrochloride,64896-701-03,40 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-701,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-701-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896070103,Oxymorphone,40
Oxymorphone hydrochloride,64896-701-08,40 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-701,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-701-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896070108,Oxymorphone,40
Oxymorphone hydrochloride,64896-701-13,40 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals LLC,64896-701,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-701-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,64896070113,Oxymorphone,40
OXYMORPHONE HYDROCHLORIDE,31722-929-01,5 mg/1,TABLET,ORAL,ANDA210175,"Camber Pharmaceuticals, Inc",31722-929,OXYMORPHONE HYDROCHLORIDE,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/01/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-929-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722092901,Oxymorphone,5
Oxymorphone hydrochloride,0115-1231-01,5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1231,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1231-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123101,Oxymorphone,5
Oxymorphone hydrochloride,0115-1231-03,5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1231,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1231-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123103,Oxymorphone,5
Oxymorphone hydrochloride,0115-1231-08,5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1231,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1231-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123108,Oxymorphone,5
Oxymorphone hydrochloride,0115-1231-13,5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1231,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1231-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123113,Oxymorphone,5
Oxymorphone hydrochloride,0115-1232-01,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1232,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1232-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123201,Oxymorphone,10
OXYMORPHONE HYDROCHLORIDE,31722-930-01,10 mg/1,TABLET,ORAL,ANDA210175,"Camber Pharmaceuticals, Inc",31722-930,OXYMORPHONE HYDROCHLORIDE,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/01/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (31722-930-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,31722093001,Oxymorphone,10
Oxymorphone hydrochloride,0115-1232-03,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1232,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1232-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123203,Oxymorphone,10
Oxymorphone hydrochloride,0115-1232-08,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1232,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1232-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123208,Oxymorphone,10
Oxymorphone hydrochloride,0115-1232-13,10 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1232,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1232-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123213,Oxymorphone,10
Oxymorphone hydrochloride,0115-1233-01,20 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1233,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1233-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123301,Oxymorphone,20
Oxymorphone hydrochloride,0115-1233-03,20 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1233,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1233-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123303,Oxymorphone,20
Oxymorphone hydrochloride,0115-1233-08,20 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1233,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1233-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123308,Oxymorphone,20
Oxymorphone hydrochloride,0115-1233-13,20 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1233,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1233-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123313,Oxymorphone,20
Oxymorphone hydrochloride,0115-1234-01,40 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1234,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1234-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123401,Oxymorphone,40
Oxymorphone hydrochloride,0115-1234-03,40 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1234,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1234-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123403,Oxymorphone,40
Oxymorphone hydrochloride,0115-1234-08,40 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1234,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1234-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123408,Oxymorphone,40
Oxymorphone hydrochloride,0115-1234-13,40 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1234,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1234-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115123413,Oxymorphone,40
Oxymorphone hydrochloride,0115-1315-01,7.5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1315,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115131501,Oxymorphone,7.5
Oxymorphone hydrochloride,0115-1315-03,7.5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1315,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115131503,Oxymorphone,7.5
Oxymorphone hydrochloride,0115-1315-08,7.5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1315,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115131508,Oxymorphone,7.5
Oxymorphone hydrochloride,0115-1315-13,7.5 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1315,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115131513,Oxymorphone,7.5
Oxymorphone hydrochloride,0115-1316-01,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1316,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1316-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115131601,Oxymorphone,15
Oxymorphone hydrochloride,0115-1316-03,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1316,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1316-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115131603,Oxymorphone,15
Oxymorphone hydrochloride,0115-1316-08,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1316,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1316-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115131608,Oxymorphone,15
Oxymorphone hydrochloride,0115-1316-13,15 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1316,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1316-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115131613,Oxymorphone,15
Oxymorphone hydrochloride,0115-1317-01,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1317,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1317-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115131701,Oxymorphone,30
Oxymorphone hydrochloride,0115-1317-03,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1317,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1317-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115131703,Oxymorphone,30
Oxymorphone hydrochloride,0115-1317-08,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1317,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1317-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115131708,Oxymorphone,30
Oxymorphone hydrochloride,0115-1317-13,30 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,ANDA079087,Amneal Pharmaceuticals of New York LLC,0115-1317,Oxymorphone hydrochloride,OXYMORPHONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/02/2013,N/A,ANDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1317-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00115131713,Oxymorphone,30
Pentazocine and naloxone,0591-0395-01,".5 mg/1,                         50  mg/1",TABLET,ORAL,ANDA074736,"Actavis Pharma, Inc.",0591-0395,Pentazocine hydrochloride and naloxone hydrochloride,PENTAZOCINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/21/1997,N/A,ANDA,"100 TABLET in 1 BOTTLE, PLASTIC (0591-0395-01)","Competitive Opioid Antagonists [MoA],  Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",CIV,No,12/31/2023,00591039501,Pentazocine,0.5
pentazocine and naloxone,63304-506-01,".5 mg/1,                         50  mg/1",TABLET,ORAL,ANDA075523,"Sun Pharmaceutical Industries, Inc.",63304-506,pentazocine and naloxone,PENTAZOCINE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/31/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (63304-506-01),"Competitive Opioid Antagonists [MoA],  Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",CIV,No,12/31/2023,63304050601,Pentazocine,0.5
PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE,43386-680-01,".5 mg/1,                         50  mg/1",TABLET,ORAL,ANDA075735,"Lupin Pharmaceuticals,Inc.",43386-680,pentazocine hydrochloride and naloxone hydrochloride,PENTAZOCINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/11/2011,N/A,ANDA,100 TABLET in 1 BOTTLE (43386-680-01),"Competitive Opioid Antagonists [MoA],  Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",CIV,No,12/31/2023,43386068001,Pentazocine,0.5
PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE,43386-680-05,".5 mg/1,                         50  mg/1",TABLET,ORAL,ANDA075735,"Lupin Pharmaceuticals,Inc.",43386-680,pentazocine hydrochloride and naloxone hydrochloride,PENTAZOCINE HYDROCHLORIDE;  NALOXONE HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/11/2011,N/A,ANDA,500 TABLET in 1 BOTTLE (43386-680-05),"Competitive Opioid Antagonists [MoA],  Opioid Antagonist [EPC],  Opioid Antagonists [MoA],  Partial Opioid Agonist/Antagonist [EPC],  Partial Opioid Agonists [MoA]",CIV,No,12/31/2023,43386068005,Pentazocine,0.5
PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (U),61919-556-30,,,,,DIRECT RX,,,,,,N/A,,,N/A,N/A,N/A,,61919055630,Pentazocine,NA
Remifentanil Hydrochloride,63323-724-05,1 mg/mL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,ANDA206223,"Fresenius Kabi USA, LLC",63323-724,Remifentanil Hydrochloride,REMIFENTANIL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/19/2018,N/A,ANDA,"10 VIAL, SINGLE-DOSE in 1 CARTON (63323-724-05)  / 5 mL in 1 VIAL, SINGLE-DOSE (63323-724-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323072405,Remifentanil,1
Remifentanil Hydrochloride,63323-723-06,1 mg/mL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,ANDA206223,"Fresenius Kabi USA, LLC",63323-723,Remifentanil Hydrochloride,REMIFENTANIL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/19/2018,N/A,ANDA,"10 VIAL, SINGLE-DOSE in 1 CARTON (63323-723-06)  / 3 mL in 1 VIAL, SINGLE-DOSE (63323-723-04)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323072306,Remifentanil,1
REMIFENTANIL HYDROCHLORIDE,0143-9391-10,1 mg/mL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,ANDA210594,Hikma Pharmaceuticals USA Inc.,0143-9391,REMIFENTANIL HYDROCHLORIDE,REMIFENTANIL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/15/2021,N/A,ANDA,10 VIAL in 1 CARTON (0143-9391-10)  / 3 mL in 1 VIAL (0143-9391-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00143939110,Remifentanil,1
REMIFENTANIL HYDROCHLORIDE,0143-9392-10,2 mg/2mL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,ANDA210594,Hikma Pharmaceuticals USA Inc.,0143-9392,REMIFENTANIL HYDROCHLORIDE,REMIFENTANIL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/15/2021,N/A,ANDA,10 VIAL in 1 CARTON (0143-9392-10)  / 5 mL in 1 VIAL (0143-9392-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00143939210,Remifentanil,2
REMIFENTANIL HYDROCHLORIDE,0143-9393-10,5 mg/5mL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,ANDA210594,Hikma Pharmaceuticals USA Inc.,0143-9393,REMIFENTANIL HYDROCHLORIDE,REMIFENTANIL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/15/2021,N/A,ANDA,10 VIAL in 1 CARTON (0143-9393-10)  / 10 mL in 1 VIAL (0143-9393-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00143939310,Remifentanil,5
Remifentanil Hydrochloride,63323-723-03,1 mg/mL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,ANDA206223,"Fresenius Kabi USA, LLC",63323-723,Remifentanil Hydrochloride,REMIFENTANIL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/19/2018,N/A,ANDA,"10 VIAL, SINGLE-DOSE in 1 CARTON (63323-723-03)  / 3 mL in 1 VIAL, SINGLE-DOSE (63323-723-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323072303,Remifentanil,1
Remifentanil Hydrochloride,63323-725-10,1 mg/mL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,ANDA206223,"Fresenius Kabi USA, LLC",63323-725,Remifentanil Hydrochloride,REMIFENTANIL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/19/2018,N/A,ANDA,"10 VIAL, SINGLE-DOSE in 1 CARTON (63323-725-10)  / 10 mL in 1 VIAL, SINGLE-DOSE (63323-725-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,63323072510,Remifentanil,1
Ultiva,67457-198-03,1 mg/mL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA020630,Mylan Institutional LLC,67457-198,Remifentanil Hydrochloride,REMIFENTANIL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/06/1996,N/A,NDA,"10 VIAL, GLASS in 1 CARTON (67457-198-03)  / 3 mL in 1 VIAL, GLASS (67457-198-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67457019803,Remifentanil,1
Ultiva,67457-198-05,1 mg/mL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA020630,Mylan Institutional LLC,67457-198,Remifentanil Hydrochloride,REMIFENTANIL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/06/1996,N/A,NDA,"10 VIAL, GLASS in 1 CARTON (67457-198-05)  / 5 mL in 1 VIAL, GLASS (67457-198-99)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67457019805,Remifentanil,1
Ultiva,67457-912-01,1 mg/mL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA020630,Mylan Institutional LLC,67457-912,Remifentanil Hydrochloride,REMIFENTANIL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/15/2020,N/A,NDA,"10 VIAL, GLASS in 1 CARTON (67457-912-01)  / 3 mL in 1 VIAL, GLASS (67457-912-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67457091201,Remifentanil,1
Ultiva,67457-913-02,1 mg/mL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA020630,Mylan Institutional LLC,67457-913,Remifentanil Hydrochloride,REMIFENTANIL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/15/2020,N/A,NDA,"10 VIAL, GLASS in 1 CARTON (67457-913-02)  / 5 mL in 1 VIAL, GLASS (67457-913-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67457091302,Remifentanil,1
Ultiva,67457-914-05,1 mg/mL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA020630,Mylan Institutional LLC,67457-914,Remifentanil Hydrochloride,REMIFENTANIL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/15/2020,N/A,NDA,"10 VIAL, GLASS in 1 CARTON (67457-914-05)  / 10 mL in 1 VIAL, GLASS (67457-914-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67457091405,Remifentanil,1
Ultiva,67457-198-10,1 mg/mL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA020630,Mylan Institutional LLC,67457-198,Remifentanil Hydrochloride,REMIFENTANIL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/06/1996,N/A,NDA,"10 VIAL, GLASS in 1 CARTON (67457-198-10)  / 10 mL in 1 VIAL, GLASS (67457-198-98)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,67457019810,Remifentanil,1
Dsuvia,61621-430-11,30 ug/1,TABLET,SUBLINGUAL,NDA209128,"AcelRx Pharmaceuticals, Inc",61621-430,Sufentanil,SUFENTANIL,HUMAN PRESCRIPTION DRUG,11/02/2018,N/A,NDA,10 TABLET in 1 CARTON (61621-430-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,61621043011,Sufentanil,30
Dsuvia,61621-430-01,30 ug/1,TABLET,SUBLINGUAL,NDA209128,"AcelRx Pharmaceuticals, Inc",61621-430,Sufentanil,SUFENTANIL,HUMAN PRESCRIPTION DRUG,11/02/2018,N/A,NDA,1 TABLET in 1 POUCH (61621-430-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,61621043001,Sufentanil,30
Sufentanil Citrate,0641-6110-10,.05 mg/mL,INJECTION,EPIDURAL; INTRAVENOUS,ANDA074413,West-Ward Pharmaceuticals Corp.,0641-6110,Sufentanil Citrate,SUFENTANIL CITRATE,HUMAN PRESCRIPTION DRUG,12/15/1995,N/A,ANDA,10 AMPULE in 1 CARTON (0641-6110-10)  / 1 mL in 1 AMPULE (0641-6110-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641611010,Sufentanil,0.05
Sufentanil Citrate,0641-6111-10,.05 mg/mL,INJECTION,EPIDURAL; INTRAVENOUS,ANDA074413,West-Ward Pharmaceuticals Corp.,0641-6111,Sufentanil Citrate,SUFENTANIL CITRATE,HUMAN PRESCRIPTION DRUG,12/15/1995,N/A,ANDA,10 AMPULE in 1 CARTON (0641-6111-10)  / 2 mL in 1 AMPULE (0641-6111-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641611110,Sufentanil,0.05
Sufentanil Citrate,0641-6112-10,.05 mg/mL,INJECTION,EPIDURAL; INTRAVENOUS,ANDA074413,West-Ward Pharmaceuticals Corp.,0641-6112,Sufentanil Citrate,SUFENTANIL CITRATE,HUMAN PRESCRIPTION DRUG,12/15/1995,N/A,ANDA,10 AMPULE in 1 CARTON (0641-6112-10)  / 5 mL in 1 AMPULE (0641-6112-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00641611210,Sufentanil,0.05
Sufentanil Citrate,0409-3382-21,50 ug/mL,"INJECTION, SOLUTION",EPIDURAL; INTRAVENOUS,ANDA074534,"Hospira, Inc.",0409-3382,SUFENTANIL CITRATE,SUFENTANIL CITRATE,HUMAN PRESCRIPTION DRUG,07/26/2005,N/A,ANDA,"10 VIAL, SINGLE-DOSE in 1 CARTON (0409-3382-21)  / 1 mL in 1 VIAL, SINGLE-DOSE (0409-3382-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,00409338221,Sufentanil,50
Sufentanil Citrate,17478-050-01,50 ug/mL,INJECTION,EPIDURAL; INTRAVENOUS,NDA019050,Akorn,17478-050,Sufentanil Citrate,SUFENTANIL CITRATE,HUMAN PRESCRIPTION DRUG,12/01/2010,N/A,NDA,10 AMPULE in 1 CARTON (17478-050-01)  / 1 mL in 1 AMPULE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17478005001,Sufentanil,50
Sufentanil Citrate,17478-050-02,50 ug/mL,INJECTION,EPIDURAL; INTRAVENOUS,NDA019050,Akorn,17478-050,Sufentanil Citrate,SUFENTANIL CITRATE,HUMAN PRESCRIPTION DRUG,12/01/2010,N/A,NDA,10 AMPULE in 1 CARTON (17478-050-02)  / 2 mL in 1 AMPULE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17478005002,Sufentanil,50
Sufentanil Citrate,17478-050-05,50 ug/mL,INJECTION,EPIDURAL; INTRAVENOUS,NDA019050,Akorn,17478-050,Sufentanil Citrate,SUFENTANIL CITRATE,HUMAN PRESCRIPTION DRUG,12/01/2010,N/A,NDA,10 AMPULE in 1 CARTON (17478-050-05)  / 5 mL in 1 AMPULE,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CII,No,12/31/2023,17478005005,Sufentanil,50
Nucynta,24510-050-01,50 mg/1,"TABLET, FILM COATED",ORAL,NDA022304,"Collegium Pharmaceutical, Inc.",24510-050,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/01/2019,N/A,NDA,"10 BLISTER PACK in 1 CARTON (24510-050-01)  / 10 TABLET, FILM COATED in 1 BLISTER PACK","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510005001,Tapentadol,50
Nucynta,24510-050-10,50 mg/1,"TABLET, FILM COATED",ORAL,NDA022304,"Collegium Pharmaceutical, Inc.",24510-050,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/01/2019,N/A,NDA,"100 TABLET, FILM COATED in 1 BOTTLE (24510-050-10)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510005010,Tapentadol,50
Nucynta,24510-058-01,50 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA200533,"Collegium Pharmaceutical, Inc.",24510-058,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/19/2019,N/A,NDA,"10 BLISTER PACK in 1 CARTON (24510-058-01)  / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510005801,Tapentadol,50
Nucynta,24510-058-60,50 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA200533,"Collegium Pharmaceutical, Inc.",24510-058,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/19/2019,N/A,NDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24510-058-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510005860,Tapentadol,50
Nucynta,24510-075-01,75 mg/1,"TABLET, FILM COATED",ORAL,NDA022304,"Collegium Pharmaceutical, Inc.",24510-075,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/01/2019,N/A,NDA,"10 BLISTER PACK in 1 CARTON (24510-075-01)  / 10 TABLET, FILM COATED in 1 BLISTER PACK","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510007501,Tapentadol,75
Nucynta,24510-075-10,75 mg/1,"TABLET, FILM COATED",ORAL,NDA022304,"Collegium Pharmaceutical, Inc.",24510-075,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/01/2019,N/A,NDA,"100 TABLET, FILM COATED in 1 BOTTLE (24510-075-10)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510007510,Tapentadol,75
Nucynta,24510-100-01,100 mg/1,"TABLET, FILM COATED",ORAL,NDA022304,"Collegium Pharmaceutical, Inc.",24510-100,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/01/2019,N/A,NDA,"10 BLISTER PACK in 1 CARTON (24510-100-01)  / 10 TABLET, FILM COATED in 1 BLISTER PACK","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510010001,Tapentadol,100
Nucynta,24510-100-10,100 mg/1,"TABLET, FILM COATED",ORAL,NDA022304,"Collegium Pharmaceutical, Inc.",24510-100,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/01/2019,N/A,NDA,"100 TABLET, FILM COATED in 1 BOTTLE (24510-100-10)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510010010,Tapentadol,100
Nucynta,24510-116-01,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA200533,"Collegium Pharmaceutical, Inc.",24510-116,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/19/2019,N/A,NDA,"10 BLISTER PACK in 1 CARTON (24510-116-01)  / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510011601,Tapentadol,100
Nucynta,24510-116-60,100 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA200533,"Collegium Pharmaceutical, Inc.",24510-116,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/19/2019,N/A,NDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24510-116-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510011660,Tapentadol,100
Nucynta,24510-174-01,150 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA200533,"Collegium Pharmaceutical, Inc.",24510-174,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/19/2019,N/A,NDA,"10 BLISTER PACK in 1 CARTON (24510-174-01)  / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510017401,Tapentadol,150
Nucynta,24510-174-60,150 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA200533,"Collegium Pharmaceutical, Inc.",24510-174,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/19/2019,N/A,NDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24510-174-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510017460,Tapentadol,150
Nucynta,24510-232-01,200 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA200533,"Collegium Pharmaceutical, Inc.",24510-232,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/19/2019,N/A,NDA,"10 BLISTER PACK in 1 CARTON (24510-232-01)  / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510023201,Tapentadol,200
Nucynta,24510-232-60,200 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA200533,"Collegium Pharmaceutical, Inc.",24510-232,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/19/2019,N/A,NDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24510-232-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510023260,Tapentadol,200
Nucynta,24510-291-01,250 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA200533,"Collegium Pharmaceutical, Inc.",24510-291,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/19/2019,N/A,NDA,"10 BLISTER PACK in 1 CARTON (24510-291-01)  / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510029101,Tapentadol,250
Nucynta,24510-291-60,250 mg/1,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA200533,"Collegium Pharmaceutical, Inc.",24510-291,tapentadol hydrochloride,TAPENTADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/19/2019,N/A,NDA,"60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24510-291-60)","Opioid Agonist [EPC],  Opioid Agonists [MoA]",CII,No,12/31/2023,24510029160,Tapentadol,250
ConZip,68025-071-30,100 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA022370,"Vertical Pharmaceuticals, LLC",68025-071,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/20/2011,N/A,NDA,"30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68025-071-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68025007130,Tramadol,100
ConZip,68025-072-30,200 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA022370,"Vertical Pharmaceuticals, LLC",68025-072,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/20/2011,N/A,NDA,"30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68025-072-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68025007230,Tramadol,200
ConZip,68025-073-30,300 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA022370,"Vertical Pharmaceuticals, LLC",68025-073,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/20/2011,N/A,NDA,"30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68025-073-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68025007330,Tramadol,300
QDOLO,71511-301-16,5 mg/mL,SOLUTION,ORAL,NDA214044,"Athena Bioscience, LLC",71511-301,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/11/2020,N/A,NDA,473 mL in 1 BOTTLE (71511-301-16),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71511030116,Tramadol,5
SEGLENTIS,66869-564-90,"56 mg/1,                         44  mg/1",TABLET,ORAL,NDA213426,"Kowa Pharmaceuticals America, Inc.",66869-564,celecoxib and tramadol hydrochloride,CELECOXIB;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2022,N/A,NDA,"1 BOTTLE, PLASTIC in 1 CARTON (66869-564-90)  / 90 TABLET in 1 BOTTLE, PLASTIC","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Full Opioid Agonists [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC]",CIV,No,12/31/2023,66869056490,Tramadol,56
SEGLENTIS,66869-564-30,"56 mg/1,                         44  mg/1",TABLET,ORAL,NDA213426,"Kowa Pharmaceuticals America, Inc.",66869-564,celecoxib and tramadol hydrochloride,CELECOXIB;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2022,N/A,NDA,"1 BOTTLE, PLASTIC in 1 CARTON (66869-564-30)  / 30 TABLET in 1 BOTTLE, PLASTIC","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Full Opioid Agonists [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC]",CIV,No,12/31/2023,66869056430,Tramadol,56
SEGLENTIS,66869-564-35,"56 mg/1,                         44  mg/1",TABLET,ORAL,NDA213426,"Kowa Pharmaceuticals America, Inc.",66869-564,celecoxib and tramadol hydrochloride,CELECOXIB;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2022,N/A,NDA,"35 TABLET in 1 BOTTLE, PLASTIC (66869-564-35)","Anti-Inflammatory Agents,  Non-Steroidal [CS],  Cyclooxygenase Inhibitors [MoA],  Full Opioid Agonists [MoA],  Nonsteroidal Anti-inflammatory Drug [EPC],  Opioid Agonist [EPC]",CIV,No,12/31/2023,66869056435,Tramadol,56
Tramadol Acetaminophen (U),61919-335-60,,,,,Direct Rx,,,,,,N/A,,,N/A,N/A,N/A,,61919033560,Tramadol,NA
Tramadol Acetaminophen (U),61919-335-30,,,,,Direct Rx,,,,,,N/A,,,N/A,N/A,N/A,,61919033530,Tramadol,NA
Tramadol Acetaminophen (U),61919-335-72,,,,,Direct Rx,,,,,,N/A,,,N/A,N/A,N/A,,61919033572,Tramadol,NA
Tramadol HCL,80425-0312-1,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0312,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/07/2023,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0312-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425031201,Tramadol,300
Tramadol HCL,80425-0312-2,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0312,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/07/2023,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0312-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425031202,Tramadol,300
Tramadol HCL,80425-0312-3,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0312,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/07/2023,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0312-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425031203,Tramadol,300
Tramadol HCL,80425-0108-1,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0108,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/19/2014,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0108-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425010801,Tramadol,100
Tramadol HCL,80425-0058-1,50 mg/1,TABLET,ORAL,ANDA075964,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0058,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2002,N/A,ANDA,30 TABLET in 1 BOTTLE (80425-0058-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425005801,Tramadol,50
Tramadol HCL,80425-0141-2,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0141,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0141-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425014102,Tramadol,100
Tramadol HCL,80425-0141-1,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0141,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0141-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425014101,Tramadol,100
Tramadol HCL,80425-0108-2,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0108,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/19/2014,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0108-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425010802,Tramadol,100
Tramadol HCL,80425-0127-1,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA091607,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0127,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0127-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425012701,Tramadol,200
Tramadol HCL,80425-0159-2,50 mg/1,TABLET,ORAL,ANDA075964,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0159,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2002,N/A,ANDA,30 TABLET in 1 BOTTLE (80425-0159-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425015902,Tramadol,50
Tramadol HCL,80425-0159-3,50 mg/1,TABLET,ORAL,ANDA075964,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0159,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2002,N/A,ANDA,60 TABLET in 1 BOTTLE (80425-0159-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425015903,Tramadol,50
Tramadol HCL,80425-0159-4,50 mg/1,TABLET,ORAL,ANDA075964,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0159,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2002,N/A,ANDA,90 TABLET in 1 BOTTLE (80425-0159-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425015904,Tramadol,50
Tramadol HCL,80425-0159-5,50 mg/1,TABLET,ORAL,ANDA075964,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0159,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2002,N/A,ANDA,120 TABLET in 1 BOTTLE (80425-0159-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425015905,Tramadol,50
Tramadol HCL,80425-0057-1,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0057,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/15/2010,N/A,ANDA,"30 TABLET, COATED in 1 BOTTLE (80425-0057-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425005701,Tramadol,50
Tramadol HCL,80425-0057-2,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0057,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/15/2010,N/A,ANDA,"60 TABLET, COATED in 1 BOTTLE (80425-0057-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425005702,Tramadol,50
Tramadol HCL,80425-0057-3,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0057,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/15/2010,N/A,ANDA,"90 TABLET, COATED in 1 BOTTLE (80425-0057-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425005703,Tramadol,50
Tramadol HCL,80425-0057-4,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0057,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/15/2010,N/A,ANDA,"15 TABLET, COATED in 1 BOTTLE (80425-0057-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425005704,Tramadol,50
Tramadol HCL,80425-0159-1,50 mg/1,TABLET,ORAL,ANDA075964,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0159,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2002,N/A,ANDA,15 TABLET in 1 BOTTLE (80425-0159-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425015901,Tramadol,50
Tramadol HCL,80425-0127-2,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA091607,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0127,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0127-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425012702,Tramadol,200
TRAMADOL HCL,61919-818-30,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,DIRECT RX,61919-818,TRAMADOL HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/03/2019,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-818-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,61919081830,Tramadol,100
TRAMADOL HCL,61919-818-60,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,DIRECT RX,61919-818,TRAMADOL HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/03/2019,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-818-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,61919081860,Tramadol,100
Tramadol HCL,80425-0159-6,50 mg/1,TABLET,ORAL,ANDA075964,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0159,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2002,N/A,ANDA,40 TABLET in 1 BOTTLE (80425-0159-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425015906,Tramadol,50
Tramadol HCL,80425-0136-2,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0136,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/19/2014,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0136-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425013602,Tramadol,200
Tramadol HCL,80425-0058-2,50 mg/1,TABLET,ORAL,ANDA075964,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0058,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2002,N/A,ANDA,60 TABLET in 1 BOTTLE (80425-0058-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425005802,Tramadol,50
Tramadol HCL,80425-0057-5,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0057,Tramadol HCL,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/15/2010,N/A,ANDA,"120 TABLET, COATED in 1 BOTTLE (80425-0057-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,80425005705,Tramadol,50
tramadol hydrochloride,71093-119-05,50 mg/1,TABLET,ORAL,ANDA202075,"ACI Healthcare USA, Inc.",71093-119,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/04/2022,N/A,ANDA,500 TABLET in 1 PACKAGE (71093-119-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71093011905,Tramadol,50
TRAMADOL HYDROCHLORIDE,47335-531-18,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA091607,"Sun Pharmaceutical Industries, Inc.",47335-531,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,"1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-531-18)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335053118,Tramadol,100
TRAMADOL HYDROCHLORIDE,47335-533-18,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA091607,"Sun Pharmaceutical Industries, Inc.",47335-533,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,"1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-533-18)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335053318,Tramadol,200
TRAMADOL HYDROCHLORIDE,47335-537-18,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA091607,"Sun Pharmaceutical Industries, Inc.",47335-537,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,"1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-537-18)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335053718,Tramadol,300
TRAMADOL HYDROCHLORIDE,61919-893-60,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,DIRECT RX,61919-893,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-893-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,61919089360,Tramadol,200
Tramadol Hydrochloride,72888-080-00,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Advagen Pharma Limited,72888-080,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/22/2021,N/A,ANDA,"1000 TABLET, COATED in 1 BOTTLE (72888-080-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,72888008000,Tramadol,50
Tramadol Hydrochloride,72888-080-01,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Advagen Pharma Limited,72888-080,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/22/2021,N/A,ANDA,"100 TABLET, COATED in 1 BOTTLE (72888-080-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,72888008001,Tramadol,50
Tramadol Hydrochloride,72888-080-05,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Advagen Pharma Limited,72888-080,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/22/2021,N/A,ANDA,"500 TABLET, COATED in 1 BOTTLE (72888-080-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,72888008005,Tramadol,50
TRAMADOL HYDROCHLORIDE,83008-009-30,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Quality Care Products, LLC",83008-009,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/03/2023,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (83008-009-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,83008000930,Tramadol,200
TRAMADOL HYDROCHLORIDE,71335-1675-1,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Bryant Ranch Prepack,71335-1675,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/23/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1675-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335167501,Tramadol,100
TRAMADOL HYDROCHLORIDE,71335-1675-2,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Bryant Ranch Prepack,71335-1675,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/22/2020,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1675-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335167502,Tramadol,100
TRAMADOL HYDROCHLORIDE,71335-1675-3,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Bryant Ranch Prepack,71335-1675,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/10/2020,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1675-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335167503,Tramadol,100
TRAMADOL HYDROCHLORIDE,71335-1675-4,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Bryant Ranch Prepack,71335-1675,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/15/2022,N/A,ANDA,"120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1675-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335167504,Tramadol,100
TRAMADOL HYDROCHLORIDE,71335-1676-1,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Bryant Ranch Prepack,71335-1676,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/10/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1676-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335167601,Tramadol,200
TRAMADOL HYDROCHLORIDE,71335-1676-2,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Bryant Ranch Prepack,71335-1676,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/08/2020,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1676-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335167602,Tramadol,200
TRAMADOL HYDROCHLORIDE,71335-1676-3,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Bryant Ranch Prepack,71335-1676,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/13/2020,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1676-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335167603,Tramadol,200
TRAMADOL HYDROCHLORIDE,71335-1676-4,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Bryant Ranch Prepack,71335-1676,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/14/2022,N/A,ANDA,"120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1676-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335167604,Tramadol,200
TRAMADOL HYDROCHLORIDE,71335-9670-1,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Bryant Ranch Prepack,71335-9670,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9670-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335967001,Tramadol,300
TRAMADOL HYDROCHLORIDE,71335-9670-2,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Bryant Ranch Prepack,71335-9670,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9670-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335967002,Tramadol,300
TRAMADOL HYDROCHLORIDE,71335-9670-3,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Bryant Ranch Prepack,71335-9670,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9670-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335967003,Tramadol,300
TRAMADOL HYDROCHLORIDE,71335-9670-4,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Bryant Ranch Prepack,71335-9670,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/27/2023,N/A,ANDA,"120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9670-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335967004,Tramadol,300
TRAMADOL HYDROCHLORIDE,70518-3397-0,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,REMEDYREPACK INC.,70518-3397,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/28/2022,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-3397-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518339700,Tramadol,100
TRAMADOL HYDROCHLORIDE,68071-2648-3,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"NuCare Pharmaceuticals,Inc.",68071-2648,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/25/2022,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-2648-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071264803,Tramadol,100
TRAMADOL HYDROCHLORIDE,68180-697-02,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Lupin Pharmaceuticals, Inc.",68180-697,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/19/2014,N/A,ANDA,"500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-697-02)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68180069702,Tramadol,100
TRAMADOL HYDROCHLORIDE,68180-698-06,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Lupin Pharmaceuticals, Inc.",68180-698,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/19/2014,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-698-06)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68180069806,Tramadol,200
TRAMADOL HYDROCHLORIDE,68180-699-01,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Lupin Pharmaceuticals, Inc.",68180-699,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/19/2014,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-699-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68180069901,Tramadol,300
TRAMADOL HYDROCHLORIDE,47335-859-18,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Sun Pharmaceutical Industries, Inc.",47335-859,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-859-18)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335085918,Tramadol,100
TRAMADOL HYDROCHLORIDE,47335-860-88,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Sun Pharmaceutical Industries, Inc.",47335-860,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-860-88)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335086088,Tramadol,200
TRAMADOL HYDROCHLORIDE,47335-537-88,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA091607,"Sun Pharmaceutical Industries, Inc.",47335-537,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-537-88)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335053788,Tramadol,300
TRAMADOL HYDROCHLORIDE,47335-859-08,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Sun Pharmaceutical Industries, Inc.",47335-859,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-859-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335085908,Tramadol,100
TRAMADOL HYDROCHLORIDE,47335-861-83,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Sun Pharmaceutical Industries, Inc.",47335-861,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-861-83)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335086183,Tramadol,300
Tramadol Hydrochloride,80425-0276-7,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0276,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/31/2023,N/A,ANDA,"180 TABLET, COATED in 1 BOTTLE (80425-0276-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425027607,Tramadol,50
Tramadol Hydrochloride,80425-0276-8,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0276,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/31/2023,N/A,ANDA,"240 TABLET, COATED in 1 BOTTLE (80425-0276-8)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425027608,Tramadol,50
TRAMADOL HYDROCHLORIDE,68071-2923-3,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"NuCare Pharmaceuticals,Inc.",68071-2923,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/26/2023,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-2923-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68071292303,Tramadol,200
Tramadol Hydrochloride,70518-0118-1,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,REMEDYREPACK INC.,70518-0118,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/12/2017,N/A,ANDA,"30 TABLET, COATED in 1 BLISTER PACK (70518-0118-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518011801,Tramadol,50
tramadol hydrochloride,53002-4322-1,50 mg/1,TABLET,ORAL,ANDA075964,"RPK Pharmaceuticals, Inc.",53002-4322,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2021,N/A,ANDA,10 TABLET in 1 BOTTLE (53002-4322-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,53002432201,Tramadol,50
tramadol hydrochloride,53002-4322-2,50 mg/1,TABLET,ORAL,ANDA075964,"RPK Pharmaceuticals, Inc.",53002-4322,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2021,N/A,ANDA,20 TABLET in 1 BOTTLE (53002-4322-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,53002432202,Tramadol,50
tramadol hydrochloride,53002-4322-3,50 mg/1,TABLET,ORAL,ANDA075964,"RPK Pharmaceuticals, Inc.",53002-4322,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (53002-4322-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,53002432203,Tramadol,50
TRAMADOL HYDROCHLORIDE,65841-754-30,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Zydus Lifesciences Limited,65841-754,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/31/2011,N/A,ANDA,"10 BLISTER PACK in 1 CARTON (65841-754-30)  / 10 TABLET, FILM COATED in 1 BLISTER PACK","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,65841075430,Tramadol,50
TRAMADOL HYDROCHLORIDE,63187-597-30,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Proficient Rx LP,63187-597,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2018,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-597-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187059730,Tramadol,100
TRAMADOL HYDROCHLORIDE,68180-698-01,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Lupin Pharmaceuticals, Inc.",68180-698,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/19/2014,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-698-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68180069801,Tramadol,200
Tramadol Hydrochloride,0615-8005-39,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,"NCS HealthCare of KY, LLC dba Vangard Labs",0615-8005,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/09/2016,02/28/2024,ANDA,"30 TABLET, COATED in 1 BLISTER PACK (0615-8005-39)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,N/A,00615800539,Tramadol,50
Tramadol Hydrochloride,33342-201-11,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA205702,Macleods Pharmaceuticals Limited,33342-201,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/07/2015,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (33342-201-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,33342020111,Tramadol,50
Tramadol Hydrochloride,33342-201-15,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA205702,Macleods Pharmaceuticals Limited,33342-201,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/07/2015,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (33342-201-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,33342020115,Tramadol,50
Tramadol Hydrochloride,33342-201-44,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA205702,Macleods Pharmaceuticals Limited,33342-201,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/07/2015,N/A,ANDA,"1000 TABLET, FILM COATED in 1 BOTTLE (33342-201-44)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,33342020144,Tramadol,50
TRAMADOL HYDROCHLORIDE,47335-533-08,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA091607,"Sun Pharmaceutical Industries, Inc.",47335-533,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-533-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335053308,Tramadol,200
tramadol hydrochloride,50090-0806-0,50 mg/1,TABLET,ORAL,ANDA075964,A-S Medication Solutions,50090-0806,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/28/2014,N/A,ANDA,30 TABLET in 1 BOTTLE (50090-0806-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,50090080600,Tramadol,50
tramadol hydrochloride,50090-0806-1,50 mg/1,TABLET,ORAL,ANDA075964,A-S Medication Solutions,50090-0806,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/28/2014,N/A,ANDA,20 TABLET in 1 BOTTLE (50090-0806-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,50090080601,Tramadol,50
tramadol hydrochloride,50090-0806-2,50 mg/1,TABLET,ORAL,ANDA075964,A-S Medication Solutions,50090-0806,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/28/2014,N/A,ANDA,50 TABLET in 1 BOTTLE (50090-0806-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,50090080602,Tramadol,50
tramadol hydrochloride,50090-0806-3,50 mg/1,TABLET,ORAL,ANDA075964,A-S Medication Solutions,50090-0806,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/28/2014,N/A,ANDA,100 TABLET in 1 BOTTLE (50090-0806-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,50090080603,Tramadol,50
tramadol hydrochloride,50090-0806-4,50 mg/1,TABLET,ORAL,ANDA075964,A-S Medication Solutions,50090-0806,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/28/2014,N/A,ANDA,15 TABLET in 1 BOTTLE (50090-0806-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,50090080604,Tramadol,50
tramadol hydrochloride,50090-0806-5,50 mg/1,TABLET,ORAL,ANDA075964,A-S Medication Solutions,50090-0806,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/28/2014,N/A,ANDA,60 TABLET in 1 BOTTLE (50090-0806-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,50090080605,Tramadol,50
tramadol hydrochloride,50090-0806-7,50 mg/1,TABLET,ORAL,ANDA075964,A-S Medication Solutions,50090-0806,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/15/2014,N/A,ANDA,45 TABLET in 1 BOTTLE (50090-0806-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,50090080607,Tramadol,50
tramadol hydrochloride,50090-0806-9,50 mg/1,TABLET,ORAL,ANDA075964,A-S Medication Solutions,50090-0806,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/28/2014,N/A,ANDA,120 TABLET in 1 BOTTLE (50090-0806-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,50090080609,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-15,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"15 TABLET, FILM COATED in 1 BOTTLE (71610-398-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039815,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-20,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"20 TABLET, FILM COATED in 1 BOTTLE (71610-398-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039820,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-24,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"224 TABLET, FILM COATED in 1 BOTTLE (71610-398-24)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039824,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-28,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"28 TABLET, FILM COATED in 1 BOTTLE (71610-398-28)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039828,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-30,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (71610-398-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039830,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-40,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"40 TABLET, FILM COATED in 1 BOTTLE (71610-398-40)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039840,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-45,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"45 TABLET, FILM COATED in 1 BOTTLE (71610-398-45)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039845,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-46,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"56 TABLET, FILM COATED in 1 BOTTLE (71610-398-46)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039846,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-50,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"50 TABLET, FILM COATED in 1 BOTTLE (71610-398-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039850,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-53,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"60 TABLET, FILM COATED in 1 BOTTLE (71610-398-53)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039853,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-54,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"84 TABLET, FILM COATED in 1 BOTTLE (71610-398-54)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039854,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-57,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"80 TABLET, FILM COATED in 1 BOTTLE (71610-398-57)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039857,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-60,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"90 TABLET, FILM COATED in 1 BOTTLE (71610-398-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039860,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-65,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (71610-398-65)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039865,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-67,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"168 TABLET, FILM COATED in 1 BOTTLE (71610-398-67)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039867,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-70,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"120 TABLET, FILM COATED in 1 BOTTLE (71610-398-70)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039870,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-72,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"112 TABLET, FILM COATED in 1 BOTTLE (71610-398-72)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039872,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-73,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"135 TABLET, FILM COATED in 1 BOTTLE (71610-398-73)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039873,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-75,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"150 TABLET, FILM COATED in 1 BOTTLE (71610-398-75)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039875,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-80,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"180 TABLET, FILM COATED in 1 BOTTLE (71610-398-80)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039880,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-85,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"200 TABLET, FILM COATED in 1 BOTTLE (71610-398-85)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039885,Tramadol,50
TRAMADOL HYDROCHLORIDE,71610-398-90,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Aphena Pharma Solutions - Tennessee, LLC",71610-398,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2020,N/A,ANDA,"240 TABLET, FILM COATED in 1 BOTTLE (71610-398-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610039890,Tramadol,50
TRAMADOL HYDROCHLORIDE,50090-2215-0,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,A-S Medication Solutions,50090-2215,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/02/2015,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-2215-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,50090221500,Tramadol,100
TRAMADOL HYDROCHLORIDE,68382-319-77,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Zydus Pharmaceuticals USA Inc.,68382-319,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/31/2011,N/A,ANDA,"100 BLISTER PACK in 1 CARTON (68382-319-77)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (68382-319-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68382031977,Tramadol,50
Tramadol Hydrochloride,63187-063-30,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Proficient Rx LP,63187-063,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/01/2014,N/A,ANDA,"30 TABLET, COATED in 1 BOTTLE (63187-063-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187006330,Tramadol,50
Tramadol Hydrochloride,63187-063-72,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Proficient Rx LP,63187-063,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/01/2014,N/A,ANDA,"120 TABLET, COATED in 1 BOTTLE (63187-063-72)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187006372,Tramadol,50
TRAMADOL HYDROCHLORIDE,47335-859-83,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Sun Pharmaceutical Industries, Inc.",47335-859,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-859-83)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335085983,Tramadol,100
TRAMADOL HYDROCHLORIDE,47335-861-18,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Sun Pharmaceutical Industries, Inc.",47335-861,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-861-18)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335086118,Tramadol,300
TRAMADOL HYDROCHLORIDE,70518-3386-0,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,REMEDYREPACK INC.,70518-3386,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/11/2022,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-3386-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,70518338600,Tramadol,200
tramadol hydrochloride,70518-0258-0,50 mg/1,TABLET,ORAL,ANDA075964,REMEDYREPACK INC.,70518-0258,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/23/2017,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-0258-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518025800,Tramadol,50
tramadol hydrochloride,70518-0258-2,50 mg/1,TABLET,ORAL,ANDA075964,REMEDYREPACK INC.,70518-0258,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/02/2018,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (70518-0258-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518025802,Tramadol,50
tramadol hydrochloride,71335-0521-8,50 mg/1,TABLET,ORAL,ANDA075964,Bryant Ranch Prepack,71335-0521,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/29/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-0521-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335052108,Tramadol,50
tramadol hydrochloride,68071-5204-8,50 mg/1,TABLET,ORAL,ANDA075964,"NuCare Pharmaceuticals,Inc.",68071-5204,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2020,N/A,ANDA,180 TABLET in 1 BOTTLE (68071-5204-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071520408,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-656-30,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Proficient Rx LP,71205-656,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/27/2022,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-656-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205065630,Tramadol,300
TRAMADOL HYDROCHLORIDE,63187-597-90,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Proficient Rx LP,63187-597,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2018,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-597-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187059790,Tramadol,100
TRAMADOL HYDROCHLORIDE,71205-656-60,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Proficient Rx LP,71205-656,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/27/2022,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-656-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205065660,Tramadol,300
TRAMADOL HYDROCHLORIDE,71205-656-90,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Proficient Rx LP,71205-656,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/27/2022,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-656-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205065690,Tramadol,300
TRAMADOL HYDROCHLORIDE,70518-0886-3,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,REMEDYREPACK INC.,70518-0886,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/19/2021,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-0886-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518088603,Tramadol,200
Tramadol Hydrochloride,68071-2952-3,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,"NuCare Pharmaceuticals,Inc.",68071-2952,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/28/2023,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (68071-2952-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68071295203,Tramadol,50
Tramadol Hydrochloride,52817-615-16,5 mg/mL,SOLUTION,ORAL,NDA214044,"TruPharma, LLC",52817-615,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/25/2023,N/A,NDA AUTHORIZED GENERIC,473 mL in 1 BOTTLE (52817-615-16),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,52817061516,Tramadol,5
TRAMADOL HYDROCHLORIDE,63187-597-60,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Proficient Rx LP,63187-597,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2018,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-597-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187059760,Tramadol,100
tramadol hydrochloride,68134-402-40,5 mg/mL,SOLUTION,ORAL,NDA214044,"Palmetto Pharmaceuticals, Inc.",68134-402,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/16/2021,N/A,NDA AUTHORIZED GENERIC,"4 TRAY in 1 CASE (68134-402-40)  / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (68134-402-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68134040240,Tramadol,5
tramadol hydrochloride,68071-5204-9,50 mg/1,TABLET,ORAL,ANDA075964,"NuCare Pharmaceuticals,Inc.",68071-5204,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2020,N/A,ANDA,90 TABLET in 1 BOTTLE (68071-5204-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071520409,Tramadol,50
tramadol hydrochloride,76420-205-10,50 mg/1,TABLET,ORAL,ANDA075964,"Asclemed USA, Inc.",76420-205,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/18/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (76420-205-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,76420020510,Tramadol,50
tramadol hydrochloride,71335-0521-6,50 mg/1,TABLET,ORAL,ANDA075964,Bryant Ranch Prepack,71335-0521,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/27/2018,N/A,ANDA,180 TABLET in 1 BOTTLE (71335-0521-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335052106,Tramadol,50
tramadol hydrochloride,60760-377-20,50 mg/1,TABLET,ORAL,ANDA075964,St. Mary's Medical Park Pharmacy,60760-377,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"20 TABLET in 1 BOTTLE, PLASTIC (60760-377-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,60760037720,Tramadol,50
tramadol hydrochloride,68071-5204-5,50 mg/1,TABLET,ORAL,ANDA075964,"NuCare Pharmaceuticals,Inc.",68071-5204,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2020,N/A,ANDA,15 TABLET in 1 BOTTLE (68071-5204-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071520405,Tramadol,50
tramadol hydrochloride,70518-1254-4,50 mg/1,TABLET,ORAL,ANDA075964,REMEDYREPACK INC.,70518-1254,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/07/2023,N/A,ANDA,"180 TABLET in 1 BOTTLE, PLASTIC (70518-1254-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518125404,Tramadol,50
Tramadol Hydrochloride,29300-355-01,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA211825,"Unichem Pharmaceuticals (USA), Inc.",29300-355,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/04/2019,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-355-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,29300035501,Tramadol,50
Tramadol Hydrochloride,29300-355-05,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA211825,"Unichem Pharmaceuticals (USA), Inc.",29300-355,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/04/2019,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-355-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,29300035505,Tramadol,50
Tramadol Hydrochloride,29300-355-10,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA211825,"Unichem Pharmaceuticals (USA), Inc.",29300-355,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/04/2019,N/A,ANDA,"1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-355-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,29300035510,Tramadol,50
Tramadol Hydrochloride,68071-2945-6,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,"NuCare Pharmaceuticals,Inc.",68071-2945,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/28/2023,N/A,ANDA,"6 TABLET, FILM COATED in 1 BOTTLE (68071-2945-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68071294506,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-066-40,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Proficient Rx LP,71205-066,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/02/2018,N/A,ANDA,"40 TABLET, FILM COATED in 1 BOTTLE (71205-066-40)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205006640,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-066-60,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Proficient Rx LP,71205-066,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/02/2018,N/A,ANDA,"60 TABLET, FILM COATED in 1 BOTTLE (71205-066-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205006660,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-066-90,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Proficient Rx LP,71205-066,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/02/2018,N/A,ANDA,"90 TABLET, FILM COATED in 1 BOTTLE (71205-066-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205006690,Tramadol,50
TRAMADOL HYDROCHLORIDE,72189-311-12,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,DirectRx,72189-311,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/12/2022,N/A,ANDA,"12 TABLET, COATED in 1 BOTTLE (72189-311-12)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,72189031112,Tramadol,50
TRAMADOL HYDROCHLORIDE,72189-311-20,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,DirectRx,72189-311,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/12/2022,N/A,ANDA,"20 TABLET, COATED in 1 BOTTLE (72189-311-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,72189031120,Tramadol,50
TRAMADOL HYDROCHLORIDE,72189-311-30,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,DirectRx,72189-311,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/12/2022,N/A,ANDA,"30 TABLET, COATED in 1 BOTTLE (72189-311-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,72189031130,Tramadol,50
tramadol hydrochloride,71093-119-04,50 mg/1,TABLET,ORAL,ANDA202075,"ACI Healthcare USA, Inc.",71093-119,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/01/2018,N/A,ANDA,100 TABLET in 1 BOTTLE (71093-119-04),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71093011904,Tramadol,50
tramadol hydrochloride,71093-119-06,50 mg/1,TABLET,ORAL,ANDA202075,"ACI Healthcare USA, Inc.",71093-119,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/01/2018,N/A,ANDA,1000 TABLET in 1 BOTTLE (71093-119-06),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71093011906,Tramadol,50
tramadol hydrochloride,71335-0521-9,50 mg/1,TABLET,ORAL,ANDA075964,Bryant Ranch Prepack,71335-0521,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/11/2019,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-0521-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335052109,Tramadol,50
TRAMADOL HYDROCHLORIDE,72189-311-40,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,DirectRx,72189-311,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/12/2022,N/A,ANDA,"40 TABLET, COATED in 1 BOTTLE (72189-311-40)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,72189031140,Tramadol,50
TRAMADOL HYDROCHLORIDE,72189-311-82,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,DirectRx,72189-311,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/12/2022,N/A,ANDA,"180 TABLET, COATED in 1 BOTTLE (72189-311-82)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,72189031182,Tramadol,50
TRAMADOL HYDROCHLORIDE,72189-154-30,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,DIRECT RX,72189-154,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/10/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-154-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,72189015430,Tramadol,200
TRAMADOL HYDROCHLORIDE,68382-319-01,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Zydus Pharmaceuticals USA Inc.,68382-319,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/31/2011,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (68382-319-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68382031901,Tramadol,50
TRAMADOL HYDROCHLORIDE,65841-754-01,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Zydus Lifesciences Limited,65841-754,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/31/2011,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (65841-754-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,65841075401,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-229-30,50 mg/1,TABLET,ORAL,ANDA075964,Direct Rx,61919-229,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,30 TABLET in 1 BOTTLE (61919-229-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919022930,Tramadol,50
TRAMADOL HYDROCHLORIDE,70518-0886-0,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,REMEDYREPACK INC.,70518-0886,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/04/2017,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-0886-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518088600,Tramadol,200
TRAMADOL HYDROCHLORIDE,70518-0942-0,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,REMEDYREPACK INC.,70518-0942,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/09/2018,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-0942-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518094200,Tramadol,100
tramadol hydrochloride,68071-5204-4,50 mg/1,TABLET,ORAL,ANDA075964,"NuCare Pharmaceuticals,Inc.",68071-5204,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2020,N/A,ANDA,40 TABLET in 1 BOTTLE (68071-5204-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071520404,Tramadol,50
TRAMADOL HYDROCHLORIDE,70518-2795-0,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,REMEDYREPACK INC.,70518-2795,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/24/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2795-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,70518279500,Tramadol,300
tramadol hydrochloride,70518-1254-3,50 mg/1,TABLET,ORAL,ANDA075964,REMEDYREPACK INC.,70518-1254,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/05/2022,N/A,ANDA,30 TABLET in 1 BLISTER PACK (70518-1254-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518125403,Tramadol,50
Tramadol Hydrochloride,69238-2348-1,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Amneal Pharmaceuticals NY LLC,69238-2348,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/15/2010,N/A,ANDA,"100 TABLET, COATED in 1 BOTTLE (69238-2348-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,69238234801,Tramadol,50
Tramadol Hydrochloride,69238-2348-4,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Amneal Pharmaceuticals NY LLC,69238-2348,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/15/2010,N/A,ANDA,"10 TABLET, COATED in 1 BOTTLE (69238-2348-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,69238234804,Tramadol,50
Tramadol Hydrochloride,69238-2348-5,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Amneal Pharmaceuticals NY LLC,69238-2348,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/15/2010,N/A,ANDA,"500 TABLET, COATED in 1 BOTTLE (69238-2348-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,69238234805,Tramadol,50
Tramadol Hydrochloride,69238-2348-7,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Amneal Pharmaceuticals NY LLC,69238-2348,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/15/2010,N/A,ANDA,"1000 TABLET, COATED in 1 BOTTLE (69238-2348-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,69238234807,Tramadol,50
tramadol hydrochloride,68071-5204-3,50 mg/1,TABLET,ORAL,ANDA075964,"NuCare Pharmaceuticals,Inc.",68071-5204,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (68071-5204-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071520403,Tramadol,50
TRAMADOL HYDROCHLORIDE,68071-5261-3,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"NuCare Pharmaceuticals,Inc.",68071-5261,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/22/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-5261-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071526103,Tramadol,200
Tramadol Hydrochloride,63187-063-64,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Proficient Rx LP,63187-063,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/01/2014,N/A,ANDA,"240 TABLET, COATED in 1 BOTTLE (63187-063-64)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187006364,Tramadol,50
Tramadol Hydrochloride,63187-063-78,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Proficient Rx LP,63187-063,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/01/2014,N/A,ANDA,"180 TABLET, COATED in 1 BOTTLE (63187-063-78)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187006378,Tramadol,50
Tramadol Hydrochloride,50090-5790-2,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA211825,A-S Medication Solutions,50090-5790,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2021,N/A,ANDA,"10 TABLET, FILM COATED in 1 BOTTLE (50090-5790-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,50090579002,Tramadol,50
Tramadol Hydrochloride,71610-006-20,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"20 TABLET, FILM COATED in 1 BOTTLE (71610-006-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000620,Tramadol,50
Tramadol Hydrochloride,71610-006-30,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (71610-006-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000630,Tramadol,50
Tramadol Hydrochloride,71610-006-45,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"45 TABLET, FILM COATED in 1 BOTTLE (71610-006-45)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000645,Tramadol,50
TRAMADOL HYDROCHLORIDE,68382-319-05,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Zydus Pharmaceuticals USA Inc.,68382-319,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/31/2011,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (68382-319-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68382031905,Tramadol,50
tramadol hydrochloride,45865-120-30,50 mg/1,TABLET,ORAL,ANDA075964,Medsource Pharmaceuticals,45865-120,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (45865-120-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,45865012030,Tramadol,50
tramadol hydrochloride,45865-120-60,50 mg/1,TABLET,ORAL,ANDA075964,Medsource Pharmaceuticals,45865-120,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2020,N/A,ANDA,60 TABLET in 1 BOTTLE (45865-120-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,45865012060,Tramadol,50
tramadol hydrochloride,70518-0258-1,50 mg/1,TABLET,ORAL,ANDA075964,REMEDYREPACK INC.,70518-0258,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/06/2018,N/A,ANDA,"120 TABLET in 1 BOTTLE, PLASTIC (70518-0258-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518025801,Tramadol,50
TRAMADOL HYDROCHLORIDE,45865-876-30,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,medsource pharmaceuticals,45865-876,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2018,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (45865-876-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,45865087630,Tramadol,100
TRAMADOL HYDROCHLORIDE,45865-900-30,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,medsource pharmaceuticals,45865-900,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2018,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (45865-900-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,45865090030,Tramadol,200
TRAMADOL HYDROCHLORIDE,45865-969-30,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,medsource pharmaceuticals,45865-969,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/11/2019,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (45865-969-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,45865096930,Tramadol,100
TRAMADOL HYDROCHLORIDE,45865-969-60,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,medsource pharmaceuticals,45865-969,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/11/2019,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (45865-969-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,45865096960,Tramadol,100
TRAMADOL HYDROCHLORIDE,45865-976-30,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,medsource pharmaceuticals,45865-976,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/11/2019,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (45865-976-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,45865097630,Tramadol,200
Tramadol Hydrochloride,70518-3586-0,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,REMEDYREPACK INC.,70518-3586,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/05/2022,N/A,ANDA,"90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-3586-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,70518358600,Tramadol,50
Tramadol Hydrochloride,71610-006-67,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"168 TABLET, FILM COATED in 1 BOTTLE (71610-006-67)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000667,Tramadol,50
TRAMADOL HYDROCHLORIDE,65841-754-10,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Zydus Lifesciences Limited,65841-754,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/31/2011,N/A,ANDA,"1000 TABLET, FILM COATED in 1 BOTTLE (65841-754-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,65841075410,Tramadol,50
tramadol hydrochloride,71335-0521-3,50 mg/1,TABLET,ORAL,ANDA075964,Bryant Ranch Prepack,71335-0521,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2018,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0521-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335052103,Tramadol,50
tramadol hydrochloride,71335-0521-5,50 mg/1,TABLET,ORAL,ANDA075964,Bryant Ranch Prepack,71335-0521,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/03/2018,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0521-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335052105,Tramadol,50
tramadol hydrochloride,57664-377-13,50 mg/1,TABLET,ORAL,ANDA075964,"Sun Pharmaceutical Industries, Inc.",57664-377,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2002,N/A,ANDA,500 TABLET in 1 BOTTLE (57664-377-13),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,57664037713,Tramadol,50
Tramadol Hydrochloride,63187-063-15,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Proficient Rx LP,63187-063,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/01/2017,N/A,ANDA,"15 TABLET, COATED in 1 BOTTLE (63187-063-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187006315,Tramadol,50
Tramadol Hydrochloride,63187-063-40,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Proficient Rx LP,63187-063,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/01/2014,N/A,ANDA,"40 TABLET, COATED in 1 BOTTLE (63187-063-40)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187006340,Tramadol,50
Tramadol Hydrochloride,63187-063-90,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Proficient Rx LP,63187-063,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/01/2014,N/A,ANDA,"90 TABLET, COATED in 1 BOTTLE (63187-063-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187006390,Tramadol,50
tramadol hydrochloride,76420-205-01,50 mg/1,TABLET,ORAL,ANDA075964,"Asclemed USA, Inc.",76420-205,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/27/2023,N/A,ANDA,1000 TABLET in 1 BOTTLE (76420-205-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,76420020501,Tramadol,50
Tramadol Hydrochloride,65162-627-01,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Amneal Pharmaceuticals LLC,65162-627,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/15/2010,N/A,ANDA,"10 TABLET, COATED in 1 BOTTLE (65162-627-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,65162062701,Tramadol,50
Tramadol Hydrochloride,65162-627-10,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Amneal Pharmaceuticals LLC,65162-627,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/15/2010,N/A,ANDA,"100 TABLET, COATED in 1 BOTTLE (65162-627-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,65162062710,Tramadol,50
Tramadol Hydrochloride,65162-627-11,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Amneal Pharmaceuticals LLC,65162-627,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/15/2010,N/A,ANDA,"1000 TABLET, COATED in 1 BOTTLE (65162-627-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,65162062711,Tramadol,50
Tramadol Hydrochloride,65162-627-50,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Amneal Pharmaceuticals LLC,65162-627,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/15/2010,N/A,ANDA,"500 TABLET, COATED in 1 BOTTLE (65162-627-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,65162062750,Tramadol,50
Tramadol Hydrochloride,60219-2348-1,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Amneal Pharmaceuticals NY LLC,60219-2348,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/13/2023,N/A,ANDA,"100 TABLET, COATED in 1 BOTTLE (60219-2348-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,60219234801,Tramadol,50
Tramadol Hydrochloride,60219-2348-4,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Amneal Pharmaceuticals NY LLC,60219-2348,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/13/2023,N/A,ANDA,"10 TABLET, COATED in 1 BOTTLE (60219-2348-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,60219234804,Tramadol,50
Tramadol Hydrochloride,60219-2348-5,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Amneal Pharmaceuticals NY LLC,60219-2348,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/13/2023,N/A,ANDA,"500 TABLET, COATED in 1 BOTTLE (60219-2348-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,60219234805,Tramadol,50
Tramadol Hydrochloride,60219-2348-7,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Amneal Pharmaceuticals NY LLC,60219-2348,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/13/2023,N/A,ANDA,"1000 TABLET, COATED in 1 BOTTLE (60219-2348-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,60219234807,Tramadol,50
Tramadol Hydrochloride,60760-772-20,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,ST. MARY'S MEDICAL PARK PHARMACY,60760-772,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/02/2023,N/A,ANDA,"20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-772-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,60760077220,Tramadol,50
Tramadol Hydrochloride,60760-772-50,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,ST. MARY'S MEDICAL PARK PHARMACY,60760-772,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/02/2023,N/A,ANDA,"50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-772-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,60760077250,Tramadol,50
Tramadol Hydrochloride,60760-772-60,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,ST. MARY'S MEDICAL PARK PHARMACY,60760-772,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/02/2023,N/A,ANDA,"60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-772-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,60760077260,Tramadol,50
Tramadol Hydrochloride,60760-772-90,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,ST. MARY'S MEDICAL PARK PHARMACY,60760-772,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/02/2023,N/A,ANDA,"90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-772-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,60760077290,Tramadol,50
Tramadol Hydrochloride,63187-063-20,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Proficient Rx LP,63187-063,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/01/2016,N/A,ANDA,"20 TABLET, COATED in 1 BOTTLE (63187-063-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187006320,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-066-78,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Proficient Rx LP,71205-066,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/02/2018,N/A,ANDA,"180 TABLET, FILM COATED in 1 BOTTLE (71205-066-78)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205006678,Tramadol,50
Tramadol Hydrochloride,71610-006-48,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"480 TABLET, FILM COATED in 1 BOTTLE (71610-006-48)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000648,Tramadol,50
Tramadol Hydrochloride,71610-006-73,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"135 TABLET, FILM COATED in 1 BOTTLE (71610-006-73)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000673,Tramadol,50
Tramadol Hydrochloride,72888-008-00,100 mg/1,"TABLET, COATED",ORAL,ANDA208708,Advagen Pharma Limited,72888-008,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/24/2020,N/A,ANDA,"1000 TABLET, COATED in 1 BOTTLE (72888-008-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,72888000800,Tramadol,100
Tramadol Hydrochloride,72888-008-01,100 mg/1,"TABLET, COATED",ORAL,ANDA208708,Advagen Pharma Limited,72888-008,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/24/2020,N/A,ANDA,"100 TABLET, COATED in 1 BOTTLE (72888-008-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,72888000801,Tramadol,100
Tramadol Hydrochloride,72888-008-05,100 mg/1,"TABLET, COATED",ORAL,ANDA208708,Advagen Pharma Limited,72888-008,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/24/2020,N/A,ANDA,"500 TABLET, COATED in 1 BOTTLE (72888-008-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,72888000805,Tramadol,100
TRAMADOL HYDROCHLORIDE,63629-8323-1,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Bryant Ranch Prepack,63629-8323,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/01/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8323-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,63629832301,Tramadol,100
TRAMADOL HYDROCHLORIDE,63629-8323-2,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Bryant Ranch Prepack,63629-8323,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/01/2020,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8323-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,63629832302,Tramadol,100
TRAMADOL HYDROCHLORIDE,63629-8323-3,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Bryant Ranch Prepack,63629-8323,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/16/2021,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8323-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,63629832303,Tramadol,100
TRAMADOL HYDROCHLORIDE,63629-8323-4,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Bryant Ranch Prepack,63629-8323,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/10/2023,N/A,ANDA,"120 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8323-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,63629832304,Tramadol,100
Tramadol Hydrochloride,71610-006-60,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"90 TABLET, FILM COATED in 1 BOTTLE (71610-006-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000660,Tramadol,50
Tramadol Hydrochloride,71610-006-72,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"112 TABLET, FILM COATED in 1 BOTTLE (71610-006-72)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000672,Tramadol,50
Tramadol Hydrochloride,50090-5790-1,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA211825,A-S Medication Solutions,50090-5790,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/08/2022,N/A,ANDA,"90 TABLET, FILM COATED in 1 BOTTLE (50090-5790-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,50090579001,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-893-30,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,DIRECT RX,61919-893,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/26/2015,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-893-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,61919089330,Tramadol,200
tramadol hydrochloride,60760-377-60,50 mg/1,TABLET,ORAL,ANDA075964,St. Mary's Medical Park Pharmacy,60760-377,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (60760-377-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,60760037760,Tramadol,50
tramadol hydrochloride,60760-377-90,50 mg/1,TABLET,ORAL,ANDA075964,St. Mary's Medical Park Pharmacy,60760-377,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (60760-377-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,60760037790,Tramadol,50
Tramadol Hydrochloride,70518-0118-2,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,REMEDYREPACK INC.,70518-0118,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/02/2017,N/A,ANDA,"120 TABLET, COATED in 1 BOTTLE, PLASTIC (70518-0118-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518011802,Tramadol,50
tramadol hydrochloride,57664-377-18,50 mg/1,TABLET,ORAL,ANDA075964,"Sun Pharmaceutical Industries, Inc.",57664-377,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2002,N/A,ANDA,1000 TABLET in 1 BOTTLE (57664-377-18),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,57664037718,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-229-12,50 mg/1,TABLET,ORAL,ANDA075964,Direct_Rx,61919-229,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/20/2019,N/A,ANDA,12 TABLET in 1 BOTTLE (61919-229-12),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919022912,Tramadol,50
Tramadol Hydrochloride,52817-195-00,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,TRUPHARMA LLC,52817-195,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/01/2020,N/A,ANDA,"1000 TABLET, COATED in 1 BOTTLE (52817-195-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,52817019500,Tramadol,50
Tramadol Hydrochloride,52817-195-10,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,TRUPHARMA LLC,52817-195,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/01/2020,N/A,ANDA,"100 TABLET, COATED in 1 BOTTLE (52817-195-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,52817019510,Tramadol,50
Tramadol Hydrochloride,52817-195-50,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,TRUPHARMA LLC,52817-195,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/01/2020,N/A,ANDA,"500 TABLET, COATED in 1 BOTTLE (52817-195-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,52817019550,Tramadol,50
Tramadol Hydrochloride,52817-196-00,100 mg/1,"TABLET, COATED",ORAL,ANDA208708,TRUPHARMA LLC,52817-196,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/24/2020,N/A,ANDA,"1000 TABLET, COATED in 1 BOTTLE (52817-196-00)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,52817019600,Tramadol,100
Tramadol Hydrochloride,52817-196-10,100 mg/1,"TABLET, COATED",ORAL,ANDA208708,TRUPHARMA LLC,52817-196,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/24/2020,N/A,ANDA,"100 TABLET, COATED in 1 BOTTLE (52817-196-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,52817019610,Tramadol,100
Tramadol Hydrochloride,52817-196-50,100 mg/1,"TABLET, COATED",ORAL,ANDA208708,TRUPHARMA LLC,52817-196,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/24/2020,N/A,ANDA,"500 TABLET, COATED in 1 BOTTLE (52817-196-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,52817019650,Tramadol,100
tramadol hydrochloride,60760-377-09,50 mg/1,TABLET,ORAL,ANDA075964,St. Mary's Medical Park Pharmacy,60760-377,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"9 TABLET in 1 BOTTLE, PLASTIC (60760-377-09)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,60760037709,Tramadol,50
Tramadol Hydrochloride,50090-5789-0,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA211825,A-S Medication Solutions,50090-5789,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2021,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (50090-5789-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,50090578900,Tramadol,50
Tramadol Hydrochloride,50090-5789-1,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA211825,A-S Medication Solutions,50090-5789,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2021,N/A,ANDA,"20 TABLET, FILM COATED in 1 BOTTLE (50090-5789-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,50090578901,Tramadol,50
Tramadol Hydrochloride,50090-5789-2,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA211825,A-S Medication Solutions,50090-5789,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2021,N/A,ANDA,"50 TABLET, FILM COATED in 1 BOTTLE (50090-5789-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,50090578902,Tramadol,50
Tramadol Hydrochloride,50090-5789-3,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA211825,A-S Medication Solutions,50090-5789,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2021,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (50090-5789-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,50090578903,Tramadol,50
Tramadol Hydrochloride,50090-5789-4,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA211825,A-S Medication Solutions,50090-5789,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2021,N/A,ANDA,"15 TABLET, FILM COATED in 1 BOTTLE (50090-5789-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,50090578904,Tramadol,50
Tramadol Hydrochloride,50090-5789-5,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA211825,A-S Medication Solutions,50090-5789,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2021,N/A,ANDA,"60 TABLET, FILM COATED in 1 BOTTLE (50090-5789-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,50090578905,Tramadol,50
Tramadol Hydrochloride,50090-5789-9,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA211825,A-S Medication Solutions,50090-5789,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2021,N/A,ANDA,"120 TABLET, FILM COATED in 1 BOTTLE (50090-5789-9)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,50090578909,Tramadol,50
Tramadol Hydrochloride,63187-063-60,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Proficient Rx LP,63187-063,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/01/2014,N/A,ANDA,"60 TABLET, COATED in 1 BOTTLE (63187-063-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187006360,Tramadol,50
Tramadol Hydrochloride,71610-006-80,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"180 TABLET, FILM COATED in 1 BOTTLE (71610-006-80)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000680,Tramadol,50
Tramadol Hydrochloride,71610-006-94,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"360 TABLET, FILM COATED in 1 BOTTLE (71610-006-94)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000694,Tramadol,50
Tramadol Hydrochloride,60429-588-01,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Golden State Medical Supply, Inc.",60429-588,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/08/2017,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (60429-588-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,60429058801,Tramadol,50
Tramadol Hydrochloride,63187-615-72,150 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA022370,Proficient Rx LP,63187-615,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2018,N/A,NDA,"120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63187-615-72)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187061572,Tramadol,150
tramadol hydrochloride,70934-461-20,50 mg/1,TABLET,ORAL,ANDA075964,"Denton Pharma, Inc. dba Northwind Pharmaceuticals",70934-461,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/31/2019,01/31/2024,ANDA,"20 TABLET in 1 BOTTLE, PLASTIC (70934-461-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,N/A,70934046120,Tramadol,50
tramadol hydrochloride,70934-461-30,50 mg/1,TABLET,ORAL,ANDA075964,"Denton Pharma, Inc. dba Northwind Pharmaceuticals",70934-461,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/19/2021,01/31/2024,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (70934-461-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,N/A,70934046130,Tramadol,50
tramadol hydrochloride,70934-461-60,50 mg/1,TABLET,ORAL,ANDA075964,"Denton Pharma, Inc. dba Northwind Pharmaceuticals",70934-461,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/19/2021,01/31/2024,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (70934-461-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,N/A,70934046160,Tramadol,50
tramadol hydrochloride,70934-461-90,50 mg/1,TABLET,ORAL,ANDA075964,"Denton Pharma, Inc. dba Northwind Pharmaceuticals",70934-461,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/07/2020,01/31/2024,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (70934-461-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,N/A,70934046190,Tramadol,50
TRAMADOL HYDROCHLORIDE,55700-016-30,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Lake Erie Medical DBA Quality Care Products LLC,55700-016,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55700-016-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,55700001630,Tramadol,200
tramadol hydrochloride,55700-864-01,50 mg/1,TABLET,ORAL,ANDA075964,"Quality Care Products, LLC",55700-864,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/25/2020,N/A,ANDA,120 TABLET in 1 BOTTLE (55700-864-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,55700086401,Tramadol,50
tramadol hydrochloride,55700-864-15,50 mg/1,TABLET,ORAL,ANDA075964,"Quality Care Products, LLC",55700-864,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/25/2020,N/A,ANDA,15 TABLET in 1 BOTTLE (55700-864-15),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,55700086415,Tramadol,50
tramadol hydrochloride,55700-864-18,50 mg/1,TABLET,ORAL,ANDA075964,"Quality Care Products, LLC",55700-864,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/25/2020,N/A,ANDA,180 TABLET in 1 BOTTLE (55700-864-18),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,55700086418,Tramadol,50
tramadol hydrochloride,55700-864-90,50 mg/1,TABLET,ORAL,ANDA075964,"Quality Care Products, LLC",55700-864,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/25/2020,N/A,ANDA,90 TABLET in 1 BOTTLE (55700-864-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,55700086490,Tramadol,50
tramadol hydrochloride,57664-377-08,50 mg/1,TABLET,ORAL,ANDA075964,"Sun Pharmaceutical Industries, Inc.",57664-377,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2002,N/A,ANDA,100 TABLET in 1 BOTTLE (57664-377-08),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,57664037708,Tramadol,50
Tramadol Hydrochloride,80425-0274-1,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0274,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2023,N/A,ANDA,"15 TABLET, COATED in 1 BOTTLE (80425-0274-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425027401,Tramadol,50
Tramadol Hydrochloride,80425-0274-2,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0274,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2023,N/A,ANDA,"30 TABLET, COATED in 1 BOTTLE (80425-0274-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425027402,Tramadol,50
Tramadol Hydrochloride,80425-0274-3,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0274,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2023,N/A,ANDA,"60 TABLET, COATED in 1 BOTTLE (80425-0274-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425027403,Tramadol,50
Tramadol Hydrochloride,80425-0274-4,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0274,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2023,N/A,ANDA,"90 TABLET, COATED in 1 BOTTLE (80425-0274-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425027404,Tramadol,50
Tramadol Hydrochloride,80425-0274-5,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0274,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2023,N/A,ANDA,"120 TABLET, COATED in 1 BOTTLE (80425-0274-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425027405,Tramadol,50
Tramadol Hydrochloride,80425-0274-6,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0274,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/09/2023,N/A,ANDA,"40 TABLET, COATED in 1 BOTTLE (80425-0274-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425027406,Tramadol,50
TRAMADOL HYDROCHLORIDE,68071-2732-3,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"NuCare Pharmaceuticals,Inc.",68071-2732,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/25/2022,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-2732-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071273203,Tramadol,300
tramadol hydrochloride,68071-5142-2,50 mg/1,TABLET,ORAL,ANDA075964,"NuCare Pharmaceuticals,Inc.",68071-5142,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/08/2020,N/A,ANDA,12 TABLET in 1 BOTTLE (68071-5142-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071514202,Tramadol,50
tramadol hydrochloride,58118-0377-8,50 mg/1,TABLET,ORAL,ANDA075964,"Clinical Solutions Wholesale, LLC",58118-0377,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/26/2020,N/A,ANDA,30 TABLET in 1 BLISTER PACK (58118-0377-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,58118037708,Tramadol,50
Tramadol Hydrochloride,63187-615-20,150 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA022370,Proficient Rx LP,63187-615,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2018,N/A,NDA,"20 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63187-615-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187061520,Tramadol,150
Tramadol Hydrochloride,63187-615-30,150 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA022370,Proficient Rx LP,63187-615,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2018,N/A,NDA,"30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63187-615-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187061530,Tramadol,150
Tramadol Hydrochloride,63187-615-78,150 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA022370,Proficient Rx LP,63187-615,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2018,N/A,NDA,"180 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63187-615-78)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187061578,Tramadol,150
TRAMADOL HYDROCHLORIDE,68180-698-02,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Lupin Pharmaceuticals, Inc.",68180-698,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/19/2014,N/A,ANDA,"500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-698-02)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68180069802,Tramadol,200
TRAMADOL HYDROCHLORIDE,47335-531-08,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA091607,"Sun Pharmaceutical Industries, Inc.",47335-531,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-531-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335053108,Tramadol,100
Tramadol Hydrochloride,59651-441-01,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,Aurobindo Pharma Limited,59651-441,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2020,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (59651-441-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,59651044101,Tramadol,50
Tramadol Hydrochloride,59651-441-05,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,Aurobindo Pharma Limited,59651-441,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2020,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (59651-441-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,59651044105,Tramadol,50
Tramadol Hydrochloride,59651-441-99,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,Aurobindo Pharma Limited,59651-441,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2020,N/A,ANDA,"1000 TABLET, FILM COATED in 1 BOTTLE (59651-441-99)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,59651044199,Tramadol,50
Tramadol Hydrochloride,67296-1834-1,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,RedPharm Drug Inc,67296-1834,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/22/2021,N/A,ANDA,"10 TABLET, COATED in 1 BOTTLE (67296-1834-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,67296183401,Tramadol,50
Tramadol Hydrochloride,67296-1834-2,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,RedPharm Drug Inc,67296-1834,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/22/2021,N/A,ANDA,"20 TABLET, COATED in 1 BOTTLE (67296-1834-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,67296183402,Tramadol,50
Tramadol Hydrochloride,67296-1834-3,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,RedPharm Drug Inc,67296-1834,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/22/2021,N/A,ANDA,"30 TABLET, COATED in 1 BOTTLE (67296-1834-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,67296183403,Tramadol,50
Tramadol Hydrochloride,67296-1834-4,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,RedPharm Drug Inc,67296-1834,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/22/2021,N/A,ANDA,"40 TABLET, COATED in 1 BOTTLE (67296-1834-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,67296183404,Tramadol,50
Tramadol Hydrochloride,67296-1834-6,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,RedPharm Drug Inc,67296-1834,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/22/2021,N/A,ANDA,"6 TABLET, COATED in 1 BOTTLE (67296-1834-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,67296183406,Tramadol,50
Tramadol Hydrochloride,67296-1834-7,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,RedPharm Drug Inc,67296-1834,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/22/2021,N/A,ANDA,"15 TABLET, COATED in 1 BOTTLE (67296-1834-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,67296183407,Tramadol,50
tramadol hydrochloride,70518-1254-1,50 mg/1,TABLET,ORAL,ANDA075964,REMEDYREPACK INC.,70518-1254,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/12/2020,N/A,ANDA,"60 TABLET in 1 BOTTLE, PLASTIC (70518-1254-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518125401,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-708-30,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Proficient Rx LP,71205-708,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/31/2022,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-708-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205070830,Tramadol,200
TRAMADOL HYDROCHLORIDE,71205-708-60,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Proficient Rx LP,71205-708,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/31/2022,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-708-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205070860,Tramadol,200
tramadol hydrochloride,60760-377-50,50 mg/1,TABLET,ORAL,ANDA075964,St. Mary's Medical Park Pharmacy,60760-377,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/18/2019,N/A,ANDA,"50 TABLET in 1 BOTTLE, PLASTIC (60760-377-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,60760037750,Tramadol,50
tramadol hydrochloride,60760-377-98,50 mg/1,TABLET,ORAL,ANDA075964,St. Mary's Medical Park Pharmacy,60760-377,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/14/2019,N/A,ANDA,"180 TABLET in 1 BOTTLE, PLASTIC (60760-377-98)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,60760037798,Tramadol,50
TRAMADOL HYDROCHLORIDE,76420-536-30,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Asclemed USA, Inc.",76420-536,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/16/2023,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-536-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,76420053630,Tramadol,100
TRAMADOL HYDROCHLORIDE,76420-536-60,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Asclemed USA, Inc.",76420-536,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/16/2023,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-536-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,76420053660,Tramadol,100
TRAMADOL HYDROCHLORIDE,76420-536-90,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Asclemed USA, Inc.",76420-536,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/16/2023,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-536-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,76420053690,Tramadol,100
TRAMADOL HYDROCHLORIDE,76420-537-30,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Asclemed USA, Inc.",76420-537,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/16/2023,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-537-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,76420053730,Tramadol,200
TRAMADOL HYDROCHLORIDE,76420-537-60,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Asclemed USA, Inc.",76420-537,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/16/2023,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-537-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,76420053760,Tramadol,200
TRAMADOL HYDROCHLORIDE,76420-537-90,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Asclemed USA, Inc.",76420-537,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/16/2023,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-537-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,76420053790,Tramadol,200
TRAMADOL HYDROCHLORIDE,76420-538-30,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Asclemed USA, Inc.",76420-538,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/16/2023,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-538-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,76420053830,Tramadol,300
TRAMADOL HYDROCHLORIDE,76420-538-60,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Asclemed USA, Inc.",76420-538,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/16/2023,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-538-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,76420053860,Tramadol,300
TRAMADOL HYDROCHLORIDE,76420-538-90,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Asclemed USA, Inc.",76420-538,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/16/2023,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-538-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,76420053890,Tramadol,300
Tramadol Hydrochloride,50090-5790-3,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA211825,A-S Medication Solutions,50090-5790,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/29/2022,N/A,ANDA,"180 TABLET, FILM COATED in 1 BOTTLE (50090-5790-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,50090579003,Tramadol,50
tramadol hydrochloride,71205-303-15,50 mg/1,TABLET,ORAL,ANDA075964,Proficient Rx LP,71205-303,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/09/2021,N/A,ANDA,15 TABLET in 1 BOTTLE (71205-303-15),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205030315,Tramadol,50
Tramadol Hydrochloride,80425-0276-1,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0276,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2023,N/A,ANDA,"15 TABLET, COATED in 1 BOTTLE (80425-0276-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425027601,Tramadol,50
Tramadol Hydrochloride,80425-0276-2,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0276,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2023,N/A,ANDA,"30 TABLET, COATED in 1 BOTTLE (80425-0276-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425027602,Tramadol,50
Tramadol Hydrochloride,80425-0276-3,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0276,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2023,N/A,ANDA,"60 TABLET, COATED in 1 BOTTLE (80425-0276-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425027603,Tramadol,50
Tramadol Hydrochloride,80425-0276-4,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0276,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2023,N/A,ANDA,"90 TABLET, COATED in 1 BOTTLE (80425-0276-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425027604,Tramadol,50
Tramadol Hydrochloride,80425-0276-5,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0276,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2023,N/A,ANDA,"120 TABLET, COATED in 1 BOTTLE (80425-0276-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425027605,Tramadol,50
Tramadol Hydrochloride,80425-0276-6,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Advanced Rx Pharmacy of Tennessee, LLC",80425-0276,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/17/2023,N/A,ANDA,"40 TABLET, COATED in 1 BOTTLE (80425-0276-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,80425027606,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-073-21,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,DIRECT RX,61919-073,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/15/2018,N/A,ANDA,"21 TABLET, COATED in 1 BOTTLE (61919-073-21)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,61919007321,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-229-84,50 mg/1,TABLET,ORAL,ANDA075964,Direct_Rx,61919-229,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/20/2019,N/A,ANDA,240 TABLET in 1 BOTTLE (61919-229-84),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919022984,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-597-20,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,DirectRX,61919-597,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/23/2020,N/A,ANDA,"20 TABLET, FILM COATED in 1 BOTTLE (61919-597-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919059720,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-597-30,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,DirectRX,61919-597,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/23/2020,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (61919-597-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919059730,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-597-40,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,DirectRX,61919-597,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/23/2020,N/A,ANDA,"40 TABLET, FILM COATED in 1 BOTTLE (61919-597-40)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919059740,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-597-60,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,DirectRX,61919-597,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/23/2020,N/A,ANDA,"60 TABLET, FILM COATED in 1 BOTTLE (61919-597-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919059760,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-597-72,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,DirectRX,61919-597,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/23/2020,N/A,ANDA,"120 TABLET, FILM COATED in 1 BOTTLE (61919-597-72)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919059772,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-597-82,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,DirectRX,61919-597,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/23/2020,N/A,ANDA,"180 TABLET, FILM COATED in 1 BOTTLE (61919-597-82)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919059782,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-597-84,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,DirectRX,61919-597,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/23/2020,N/A,ANDA,"240 TABLET, FILM COATED in 1 BOTTLE (61919-597-84)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919059784,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-597-90,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,DirectRX,61919-597,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/23/2020,N/A,ANDA,"90 TABLET, FILM COATED in 1 BOTTLE (61919-597-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919059790,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-892-60,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,DirectRX,61919-892,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/27/2022,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-892-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919089260,Tramadol,100
TRAMADOL HYDROCHLORIDE,61919-229-20,50 mg/1,TABLET,ORAL,ANDA075964,Direct Rx,61919-229,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,20 TABLET in 1 BOTTLE (61919-229-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919022920,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-229-71,50 mg/1,TABLET,ORAL,ANDA075964,Direct Rx,61919-229,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,100 TABLET in 1 BOTTLE (61919-229-71),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919022971,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-229-82,50 mg/1,TABLET,ORAL,ANDA075964,Direct Rx,61919-229,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,180 TABLET in 1 BOTTLE (61919-229-82),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919022982,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-229-90,50 mg/1,TABLET,ORAL,ANDA075964,Direct Rx,61919-229,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,90 BOTTLE in 1 BOTTLE (61919-229-90)  / 120 BOTTLE in 1 BOTTLE (61919-229-72)  / 60 BOTTLE in 1 BOTTLE (61919-229-60)  / 50 BOTTLE in 1 BOTTLE (61919-229-50)  / 30 TABLET in 1 BOTTLE (61919-229-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919022990,Tramadol,50
TRAMADOL HYDROCHLORIDE,72189-154-60,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,DIRECT RX,72189-154,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/10/2020,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-154-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,72189015460,Tramadol,200
TRAMADOL HYDROCHLORIDE,61919-229-40,50 mg/1,TABLET,ORAL,ANDA075964,Direct Rx,61919-229,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,40 TABLET in 1 BOTTLE (61919-229-40),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919022940,Tramadol,50
tramadol hydrochloride,60760-377-30,50 mg/1,TABLET,ORAL,ANDA075964,St. Mary's Medical Park Pharmacy,60760-377,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2014,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (60760-377-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,60760037730,Tramadol,50
TRAMADOL HYDROCHLORIDE,68180-697-01,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Lupin Pharmaceuticals, Inc.",68180-697,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/19/2014,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-697-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68180069701,Tramadol,100
TRAMADOL HYDROCHLORIDE,68180-697-06,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Lupin Pharmaceuticals, Inc.",68180-697,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/19/2014,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-697-06)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68180069706,Tramadol,100
TRAMADOL HYDROCHLORIDE,50090-6033-0,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,A-S Medication Solutions,50090-6033,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/12/2022,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6033-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,50090603300,Tramadol,200
tramadol hydrochloride,45865-115-21,50 mg/1,TABLET,ORAL,ANDA075964,Medsource Pharmaceuticals,45865-115,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/01/2020,N/A,ANDA,21 TABLET in 1 BOTTLE (45865-115-21),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,45865011521,Tramadol,50
tramadol hydrochloride,45865-115-30,50 mg/1,TABLET,ORAL,ANDA075964,Medsource Pharmaceuticals,45865-115,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/01/2020,N/A,ANDA,30 TABLET in 1 BOTTLE (45865-115-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,45865011530,Tramadol,50
tramadol hydrochloride,45865-115-60,50 mg/1,TABLET,ORAL,ANDA075964,Medsource Pharmaceuticals,45865-115,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/01/2020,N/A,ANDA,60 TABLET in 1 BOTTLE (45865-115-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,45865011560,Tramadol,50
TRAMADOL HYDROCHLORIDE,76420-244-30,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Asclemed USA, Inc.",76420-244,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/25/2022,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-244-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420024430,Tramadol,100
TRAMADOL HYDROCHLORIDE,76420-244-60,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Asclemed USA, Inc.",76420-244,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/25/2022,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-244-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420024460,Tramadol,100
TRAMADOL HYDROCHLORIDE,76420-244-90,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Asclemed USA, Inc.",76420-244,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/25/2022,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-244-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420024490,Tramadol,100
TRAMADOL HYDROCHLORIDE,76420-245-30,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Asclemed USA, Inc.",76420-245,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/25/2022,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-245-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420024530,Tramadol,200
TRAMADOL HYDROCHLORIDE,76420-245-60,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Asclemed USA, Inc.",76420-245,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/25/2022,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-245-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420024560,Tramadol,200
TRAMADOL HYDROCHLORIDE,76420-245-90,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Asclemed USA, Inc.",76420-245,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/25/2022,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-245-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420024590,Tramadol,200
TRAMADOL HYDROCHLORIDE,76420-246-30,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Asclemed USA, Inc.",76420-246,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/25/2022,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-246-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420024630,Tramadol,300
TRAMADOL HYDROCHLORIDE,68788-8367-2,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Preferred Pharmaceuticals, Inc.",68788-8367,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/01/2023,N/A,ANDA,"20 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8367-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68788836702,Tramadol,100
TRAMADOL HYDROCHLORIDE,68788-8367-3,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Preferred Pharmaceuticals, Inc.",68788-8367,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/01/2023,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8367-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68788836703,Tramadol,100
TRAMADOL HYDROCHLORIDE,68788-8367-6,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Preferred Pharmaceuticals, Inc.",68788-8367,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/01/2023,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8367-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68788836706,Tramadol,100
TRAMADOL HYDROCHLORIDE,68788-8367-9,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Preferred Pharmaceuticals, Inc.",68788-8367,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/01/2023,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8367-9)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68788836709,Tramadol,100
tramadol hydrochloride,70518-1254-2,50 mg/1,TABLET,ORAL,ANDA075964,REMEDYREPACK INC.,70518-1254,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/20/2022,N/A,ANDA,"90 TABLET in 1 BOTTLE, PLASTIC (70518-1254-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518125402,Tramadol,50
Tramadol Hydrochloride,70518-0118-4,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,REMEDYREPACK INC.,70518-0118,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/05/2017,N/A,ANDA,"90 TABLET, COATED in 1 BOTTLE, PLASTIC (70518-0118-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518011804,Tramadol,50
tramadol hydrochloride,71335-0521-7,50 mg/1,TABLET,ORAL,ANDA075964,Bryant Ranch Prepack,71335-0521,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/31/2019,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-0521-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335052107,Tramadol,50
TRAMADOL HYDROCHLORIDE,72189-311-60,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,DirectRx,72189-311,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/12/2022,N/A,ANDA,"60 TABLET, COATED in 1 BOTTLE (72189-311-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,72189031160,Tramadol,50
TRAMADOL HYDROCHLORIDE,63629-8319-1,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Bryant Ranch Prepack,63629-8319,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/04/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8319-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,63629831901,Tramadol,200
TRAMADOL HYDROCHLORIDE,63629-8319-2,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Bryant Ranch Prepack,63629-8319,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/14/2020,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8319-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,63629831902,Tramadol,200
TRAMADOL HYDROCHLORIDE,63629-8319-3,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Bryant Ranch Prepack,63629-8319,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/03/2020,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8319-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,63629831903,Tramadol,200
TRAMADOL HYDROCHLORIDE,63629-8319-4,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Bryant Ranch Prepack,63629-8319,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/10/2023,N/A,ANDA,"120 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8319-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,63629831904,Tramadol,200
TRAMADOL HYDROCHLORIDE,63629-8324-1,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Bryant Ranch Prepack,63629-8324,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8324-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629832401,Tramadol,300
TRAMADOL HYDROCHLORIDE,63629-8324-2,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Bryant Ranch Prepack,63629-8324,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/04/2021,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8324-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629832402,Tramadol,300
TRAMADOL HYDROCHLORIDE,63629-8324-3,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Bryant Ranch Prepack,63629-8324,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/19/2022,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8324-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629832403,Tramadol,300
TRAMADOL HYDROCHLORIDE,63629-8324-4,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Bryant Ranch Prepack,63629-8324,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/19/2022,N/A,ANDA,"120 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8324-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629832404,Tramadol,300
TRAMADOL HYDROCHLORIDE,55700-996-30,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Quality Care Products, LLC",55700-996,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/24/2023,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55700-996-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,55700099630,Tramadol,100
Tramadol Hydrochloride,55700-997-01,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Quality Care Products, LLC",55700-997,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/07/2023,N/A,ANDA,"120 TABLET, COATED in 1 BOTTLE (55700-997-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,55700099701,Tramadol,50
Tramadol Hydrochloride,55700-997-15,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Quality Care Products, LLC",55700-997,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/07/2023,N/A,ANDA,"15 TABLET, COATED in 1 BOTTLE (55700-997-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,55700099715,Tramadol,50
Tramadol Hydrochloride,55700-997-18,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Quality Care Products, LLC",55700-997,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/07/2023,N/A,ANDA,"180 TABLET, COATED in 1 BOTTLE (55700-997-18)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,55700099718,Tramadol,50
Tramadol Hydrochloride,55700-997-24,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Quality Care Products, LLC",55700-997,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/07/2023,N/A,ANDA,"240 TABLET, COATED in 1 BOTTLE (55700-997-24)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,55700099724,Tramadol,50
Tramadol Hydrochloride,55700-997-30,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Quality Care Products, LLC",55700-997,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/07/2023,N/A,ANDA,"30 TABLET, COATED in 1 BOTTLE (55700-997-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,55700099730,Tramadol,50
Tramadol Hydrochloride,55700-997-60,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Quality Care Products, LLC",55700-997,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/07/2023,N/A,ANDA,"60 TABLET, COATED in 1 BOTTLE (55700-997-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,55700099760,Tramadol,50
Tramadol Hydrochloride,55700-997-90,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,"Quality Care Products, LLC",55700-997,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/07/2023,N/A,ANDA,"90 TABLET, COATED in 1 BOTTLE (55700-997-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,55700099790,Tramadol,50
Tramadol Hydrochloride,71335-9658-0,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Bryant Ranch Prepack,71335-9658,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/27/2023,N/A,ANDA,"50 TABLET, COATED in 1 BOTTLE (71335-9658-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335965800,Tramadol,50
Tramadol Hydrochloride,71335-9658-1,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Bryant Ranch Prepack,71335-9658,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/27/2023,N/A,ANDA,"30 TABLET, COATED in 1 BOTTLE (71335-9658-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335965801,Tramadol,50
Tramadol Hydrochloride,71335-9658-2,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Bryant Ranch Prepack,71335-9658,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/27/2023,N/A,ANDA,"20 TABLET, COATED in 1 BOTTLE (71335-9658-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335965802,Tramadol,50
Tramadol Hydrochloride,71335-9658-3,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Bryant Ranch Prepack,71335-9658,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/27/2023,N/A,ANDA,"90 TABLET, COATED in 1 BOTTLE (71335-9658-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335965803,Tramadol,50
Tramadol Hydrochloride,71335-9658-4,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Bryant Ranch Prepack,71335-9658,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/27/2023,N/A,ANDA,"60 TABLET, COATED in 1 BOTTLE (71335-9658-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335965804,Tramadol,50
Tramadol Hydrochloride,71335-9658-5,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Bryant Ranch Prepack,71335-9658,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/27/2023,N/A,ANDA,"120 TABLET, COATED in 1 BOTTLE (71335-9658-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335965805,Tramadol,50
Tramadol Hydrochloride,71335-9658-6,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Bryant Ranch Prepack,71335-9658,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/27/2023,N/A,ANDA,"180 TABLET, COATED in 1 BOTTLE (71335-9658-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335965806,Tramadol,50
Tramadol Hydrochloride,71335-9658-7,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Bryant Ranch Prepack,71335-9658,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/27/2023,N/A,ANDA,"40 TABLET, COATED in 1 BOTTLE (71335-9658-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335965807,Tramadol,50
Tramadol Hydrochloride,71335-9658-8,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Bryant Ranch Prepack,71335-9658,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/27/2023,N/A,ANDA,"100 TABLET, COATED in 1 BOTTLE (71335-9658-8)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335965808,Tramadol,50
Tramadol Hydrochloride,71335-9658-9,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Bryant Ranch Prepack,71335-9658,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/27/2023,N/A,ANDA,"15 TABLET, COATED in 1 BOTTLE (71335-9658-9)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335965809,Tramadol,50
tramadol hydrochloride,76420-205-30,50 mg/1,TABLET,ORAL,ANDA075964,"Asclemed USA, Inc.",76420-205,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/27/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (76420-205-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,76420020530,Tramadol,50
tramadol hydrochloride,76420-205-60,50 mg/1,TABLET,ORAL,ANDA075964,"Asclemed USA, Inc.",76420-205,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/27/2022,N/A,ANDA,60 TABLET in 1 BOTTLE (76420-205-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,76420020560,Tramadol,50
tramadol hydrochloride,76420-205-90,50 mg/1,TABLET,ORAL,ANDA075964,"Asclemed USA, Inc.",76420-205,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/27/2022,N/A,ANDA,90 TABLET in 1 BOTTLE (76420-205-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,76420020590,Tramadol,50
Tramadol Hydrochloride,68071-2945-2,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,"NuCare Pharmaceuticals,Inc.",68071-2945,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/28/2023,N/A,ANDA,"12 TABLET, FILM COATED in 1 BOTTLE (68071-2945-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68071294502,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-708-90,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Proficient Rx LP,71205-708,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/31/2022,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-708-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205070890,Tramadol,200
TRAMADOL HYDROCHLORIDE,76420-127-30,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Asclemed USA, Inc.",76420-127,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/27/2020,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (76420-127-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420012730,Tramadol,50
TRAMADOL HYDROCHLORIDE,76420-127-60,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,"Asclemed USA, Inc.",76420-127,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/27/2020,N/A,ANDA,"60 TABLET, FILM COATED in 1 BOTTLE (76420-127-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420012760,Tramadol,50
TRAMADOL HYDROCHLORIDE,70518-3418-0,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,REMEDYREPACK INC.,70518-3418,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/12/2022,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-3418-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,70518341800,Tramadol,300
Tramadol Hydrochloride,60429-588-05,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Golden State Medical Supply, Inc.",60429-588,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/08/2017,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (60429-588-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,60429058805,Tramadol,50
TRAMADOL HYDROCHLORIDE,65841-754-05,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Zydus Lifesciences Limited,65841-754,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/31/2011,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (65841-754-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,65841075405,Tramadol,50
Tramadol Hydrochloride,63187-615-15,150 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA022370,Proficient Rx LP,63187-615,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2018,N/A,NDA,"15 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63187-615-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187061515,Tramadol,150
Tramadol Hydrochloride,63187-615-90,150 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA022370,Proficient Rx LP,63187-615,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2018,N/A,NDA,"90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63187-615-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187061590,Tramadol,150
Tramadol Hydrochloride,63629-4899-0,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Bryant Ranch Prepack,63629-4899,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/30/2013,N/A,ANDA,"50 TABLET, COATED in 1 BOTTLE (63629-4899-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629489900,Tramadol,50
Tramadol Hydrochloride,63629-4899-1,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Bryant Ranch Prepack,63629-4899,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/13/2013,N/A,ANDA,"30 TABLET, COATED in 1 BOTTLE (63629-4899-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629489901,Tramadol,50
Tramadol Hydrochloride,63629-4899-2,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Bryant Ranch Prepack,63629-4899,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/01/2013,N/A,ANDA,"20 TABLET, COATED in 1 BOTTLE (63629-4899-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629489902,Tramadol,50
Tramadol Hydrochloride,63629-4899-3,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Bryant Ranch Prepack,63629-4899,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/06/2013,N/A,ANDA,"90 TABLET, COATED in 1 BOTTLE (63629-4899-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629489903,Tramadol,50
Tramadol Hydrochloride,63629-4899-4,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Bryant Ranch Prepack,63629-4899,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/07/2013,N/A,ANDA,"60 TABLET, COATED in 1 BOTTLE (63629-4899-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629489904,Tramadol,50
Tramadol Hydrochloride,63629-4899-5,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Bryant Ranch Prepack,63629-4899,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/21/2013,N/A,ANDA,"120 TABLET, COATED in 1 BOTTLE (63629-4899-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629489905,Tramadol,50
Tramadol Hydrochloride,63629-4899-6,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Bryant Ranch Prepack,63629-4899,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2013,N/A,ANDA,"180 TABLET, COATED in 1 BOTTLE (63629-4899-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629489906,Tramadol,50
Tramadol Hydrochloride,63629-4899-7,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Bryant Ranch Prepack,63629-4899,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/15/2013,N/A,ANDA,"40 TABLET, COATED in 1 BOTTLE (63629-4899-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629489907,Tramadol,50
Tramadol Hydrochloride,63629-4899-8,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Bryant Ranch Prepack,63629-4899,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/13/2014,N/A,ANDA,"100 TABLET, COATED in 1 BOTTLE (63629-4899-8)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629489908,Tramadol,50
Tramadol Hydrochloride,63629-4899-9,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,Bryant Ranch Prepack,63629-4899,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/04/2013,N/A,ANDA,"15 TABLET, COATED in 1 BOTTLE (63629-4899-9)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629489909,Tramadol,50
Tramadol Hydrochloride,71610-006-15,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"15 TABLET, FILM COATED in 1 BOTTLE (71610-006-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000615,Tramadol,50
Tramadol Hydrochloride,71610-006-28,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"28 TABLET, FILM COATED in 1 BOTTLE (71610-006-28)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000628,Tramadol,50
Tramadol Hydrochloride,71610-006-57,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/24/2017,N/A,ANDA,"80 TABLET, FILM COATED in 1 BOTTLE (71610-006-57)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000657,Tramadol,50
Tramadol Hydrochloride,71610-006-65,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (71610-006-65)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000665,Tramadol,50
Tramadol Hydrochloride,45865-709-30,150 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA022370,Medsource Pharmaceuticals,45865-709,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/27/2015,N/A,NDA,"30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (45865-709-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,45865070930,Tramadol,150
TRAMADOL HYDROCHLORIDE,69543-136-11,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,Virtus Pharmaceuticals LLC,69543-136,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/22/2015,06/21/2023,ANDA,"1000 TABLET, FILM COATED in 1 BOTTLE (69543-136-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,N/A,69543013611,Tramadol,50
TRAMADOL HYDROCHLORIDE,47335-859-88,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Sun Pharmaceutical Industries, Inc.",47335-859,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-859-88)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335085988,Tramadol,100
TRAMADOL HYDROCHLORIDE,47335-860-08,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Sun Pharmaceutical Industries, Inc.",47335-860,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-860-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335086008,Tramadol,200
TRAMADOL HYDROCHLORIDE,55700-029-30,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Quality Care Products LLC,55700-029,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/27/2013,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55700-029-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,55700002930,Tramadol,100
tramadol hydrochloride,68071-5142-6,50 mg/1,TABLET,ORAL,ANDA075964,"NuCare Pharmaceuticals,Inc.",68071-5142,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/08/2020,N/A,ANDA,6 TABLET in 1 BOTTLE (68071-5142-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071514206,Tramadol,50
Tramadol Hydrochloride,71610-006-24,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"224 TABLET, FILM COATED in 1 BOTTLE (71610-006-24)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000624,Tramadol,50
Tramadol Hydrochloride,71610-006-40,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"40 TABLET, FILM COATED in 1 BOTTLE (71610-006-40)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000640,Tramadol,50
Tramadol Hydrochloride,71610-006-53,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"60 TABLET, FILM COATED in 1 BOTTLE (71610-006-53)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000653,Tramadol,50
Tramadol Hydrochloride,71610-006-54,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"84 TABLET, FILM COATED in 1 BOTTLE (71610-006-54)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000654,Tramadol,50
Tramadol Hydrochloride,71610-006-89,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"720 TABLET, FILM COATED in 1 BOTTLE (71610-006-89)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000689,Tramadol,50
Tramadol Hydrochloride,71610-006-92,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"270 TABLET, FILM COATED in 1 BOTTLE (71610-006-92)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000692,Tramadol,50
Tramadol Hydrochloride,60760-772-09,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,ST. MARY'S MEDICAL PARK PHARMACY,60760-772,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2022,N/A,ANDA,"9 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-772-09)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,60760077209,Tramadol,50
Tramadol Hydrochloride,60760-772-30,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,ST. MARY'S MEDICAL PARK PHARMACY,60760-772,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2022,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-772-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,60760077230,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-389-15,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,Proficient Rx LP,71205-389,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/16/2020,N/A,ANDA,"15 TABLET, FILM COATED in 1 BOTTLE (71205-389-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205038915,Tramadol,50
tramadol hydrochloride,68788-7321-1,50 mg/1,TABLET,ORAL,ANDA075964,Preferred Pharmaceuticals Inc.,68788-7321,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2019,N/A,ANDA,100 TABLET in 1 BOTTLE (68788-7321-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788732101,Tramadol,50
tramadol hydrochloride,68788-7321-2,50 mg/1,TABLET,ORAL,ANDA075964,Preferred Pharmaceuticals Inc.,68788-7321,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2019,N/A,ANDA,20 TABLET in 1 BOTTLE (68788-7321-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788732102,Tramadol,50
tramadol hydrochloride,68788-7321-3,50 mg/1,TABLET,ORAL,ANDA075964,Preferred Pharmaceuticals Inc.,68788-7321,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (68788-7321-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788732103,Tramadol,50
tramadol hydrochloride,68788-7321-4,50 mg/1,TABLET,ORAL,ANDA075964,Preferred Pharmaceuticals Inc.,68788-7321,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2019,N/A,ANDA,40 TABLET in 1 BOTTLE (68788-7321-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788732104,Tramadol,50
tramadol hydrochloride,68788-7321-5,50 mg/1,TABLET,ORAL,ANDA075964,Preferred Pharmaceuticals Inc.,68788-7321,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2019,N/A,ANDA,15 TABLET in 1 BOTTLE (68788-7321-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788732105,Tramadol,50
tramadol hydrochloride,68788-7321-6,50 mg/1,TABLET,ORAL,ANDA075964,Preferred Pharmaceuticals Inc.,68788-7321,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (68788-7321-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788732106,Tramadol,50
tramadol hydrochloride,68788-7321-7,50 mg/1,TABLET,ORAL,ANDA075964,Preferred Pharmaceuticals Inc.,68788-7321,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2019,N/A,ANDA,50 TABLET in 1 BOTTLE (68788-7321-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788732107,Tramadol,50
tramadol hydrochloride,68788-7321-8,50 mg/1,TABLET,ORAL,ANDA075964,Preferred Pharmaceuticals Inc.,68788-7321,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2019,N/A,ANDA,120 TABLET in 1 BOTTLE (68788-7321-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788732108,Tramadol,50
tramadol hydrochloride,68788-7321-9,50 mg/1,TABLET,ORAL,ANDA075964,Preferred Pharmaceuticals Inc.,68788-7321,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/12/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (68788-7321-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788732109,Tramadol,50
Tramadol Hydrochloride,68071-4119-1,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,"NuCare Pharmaceuticals,Inc.",68071-4119,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/16/2017,N/A,ANDA,"120 TABLET, COATED in 1 BOTTLE (68071-4119-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071411901,Tramadol,50
Tramadol Hydrochloride,68071-4119-3,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,"NuCare Pharmaceuticals,Inc.",68071-4119,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/16/2017,N/A,ANDA,"30 TABLET, COATED in 1 BOTTLE (68071-4119-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071411903,Tramadol,50
Tramadol Hydrochloride,68071-4119-4,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,"NuCare Pharmaceuticals,Inc.",68071-4119,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/16/2017,N/A,ANDA,"40 TABLET, COATED in 1 BOTTLE (68071-4119-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071411904,Tramadol,50
Tramadol Hydrochloride,68071-4119-5,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,"NuCare Pharmaceuticals,Inc.",68071-4119,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/16/2017,N/A,ANDA,"15 TABLET, COATED in 1 BOTTLE (68071-4119-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071411905,Tramadol,50
Tramadol Hydrochloride,68071-4119-6,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,"NuCare Pharmaceuticals,Inc.",68071-4119,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/16/2017,N/A,ANDA,"60 TABLET, COATED in 1 BOTTLE (68071-4119-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071411906,Tramadol,50
Tramadol Hydrochloride,68071-4119-7,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,"NuCare Pharmaceuticals,Inc.",68071-4119,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/16/2017,N/A,ANDA,"84 TABLET, COATED in 1 BOTTLE (68071-4119-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071411907,Tramadol,50
Tramadol Hydrochloride,68071-4119-8,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,"NuCare Pharmaceuticals,Inc.",68071-4119,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/16/2017,N/A,ANDA,"180 TABLET, COATED in 1 BOTTLE (68071-4119-8)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071411908,Tramadol,50
Tramadol Hydrochloride,68071-4119-9,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,"NuCare Pharmaceuticals,Inc.",68071-4119,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/16/2017,N/A,ANDA,"90 TABLET, COATED in 1 BOTTLE (68071-4119-9)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071411909,Tramadol,50
Tramadol Hydrochloride,70518-3598-0,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,REMEDYREPACK INC.,70518-3598,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/23/2022,N/A,ANDA,"90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-3598-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,70518359800,Tramadol,50
Tramadol Hydrochloride,70518-3598-1,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,REMEDYREPACK INC.,70518-3598,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2022,N/A,ANDA,"120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-3598-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,70518359801,Tramadol,50
TRAMADOL HYDROCHLORIDE,68788-7601-2,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Preferred Pharmaceuticals, Inc.",68788-7601,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/06/2020,N/A,ANDA,"20 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7601-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788760102,Tramadol,200
TRAMADOL HYDROCHLORIDE,68788-7601-3,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Preferred Pharmaceuticals, Inc.",68788-7601,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/06/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7601-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788760103,Tramadol,200
TRAMADOL HYDROCHLORIDE,68788-7601-6,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Preferred Pharmaceuticals, Inc.",68788-7601,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/06/2020,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7601-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788760106,Tramadol,200
TRAMADOL HYDROCHLORIDE,68788-7601-9,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Preferred Pharmaceuticals, Inc.",68788-7601,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/06/2020,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7601-9)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788760109,Tramadol,200
TRAMADOL HYDROCHLORIDE,68788-7762-2,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Preferred Pharmaceuticals, Inc.",68788-7762,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/22/2020,N/A,ANDA,"20 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7762-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788776202,Tramadol,200
TRAMADOL HYDROCHLORIDE,68788-7762-3,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Preferred Pharmaceuticals, Inc.",68788-7762,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/22/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7762-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788776203,Tramadol,200
TRAMADOL HYDROCHLORIDE,68788-7762-6,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Preferred Pharmaceuticals, Inc.",68788-7762,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/22/2020,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7762-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788776206,Tramadol,200
TRAMADOL HYDROCHLORIDE,68788-7762-9,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Preferred Pharmaceuticals, Inc.",68788-7762,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/22/2020,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7762-9)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788776209,Tramadol,200
TRAMADOL HYDROCHLORIDE,68788-7763-2,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Preferred Pharmaceuticals, Inc.",68788-7763,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/22/2020,N/A,ANDA,"20 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7763-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788776302,Tramadol,100
TRAMADOL HYDROCHLORIDE,68788-7763-3,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Preferred Pharmaceuticals, Inc.",68788-7763,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/22/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7763-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788776303,Tramadol,100
TRAMADOL HYDROCHLORIDE,68788-7763-6,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Preferred Pharmaceuticals, Inc.",68788-7763,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/22/2020,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7763-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788776306,Tramadol,100
TRAMADOL HYDROCHLORIDE,68788-7763-9,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Preferred Pharmaceuticals, Inc.",68788-7763,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/22/2020,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7763-9)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788776309,Tramadol,100
TRAMADOL HYDROCHLORIDE,71205-066-72,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Proficient Rx LP,71205-066,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/02/2018,N/A,ANDA,"120 TABLET, FILM COATED in 1 BOTTLE (71205-066-72)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205006672,Tramadol,50
Tramadol Hydrochloride,63187-615-60,150 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA022370,Proficient Rx LP,63187-615,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2018,N/A,NDA,"60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63187-615-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187061560,Tramadol,150
TRAMADOL HYDROCHLORIDE,68382-319-10,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Zydus Pharmaceuticals USA Inc.,68382-319,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/31/2011,N/A,ANDA,"1000 TABLET, FILM COATED in 1 BOTTLE (68382-319-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68382031910,Tramadol,50
TRAMADOL HYDROCHLORIDE,47335-531-83,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA091607,"Sun Pharmaceutical Industries, Inc.",47335-531,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-531-83)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335053183,Tramadol,100
TRAMADOL HYDROCHLORIDE,47335-531-88,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA091607,"Sun Pharmaceutical Industries, Inc.",47335-531,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-531-88)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335053188,Tramadol,100
Tramadol Hydrochloride,13811-689-30,100 mg/1,CAPSULE,ORAL,NDA022370,"Trigen Laboratories, LLC",13811-689,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2015,N/A,NDA AUTHORIZED GENERIC,"30 CAPSULE in 1 BOTTLE, PLASTIC (13811-689-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,13811068930,Tramadol,100
Tramadol Hydrochloride,13811-690-30,200 mg/1,CAPSULE,ORAL,NDA022370,"Trigen Laboratories, LLC",13811-690,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2015,N/A,NDA AUTHORIZED GENERIC,"30 CAPSULE in 1 BOTTLE, PLASTIC (13811-690-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,13811069030,Tramadol,200
Tramadol Hydrochloride,13811-691-30,300 mg/1,CAPSULE,ORAL,NDA022370,"Trigen Laboratories, LLC",13811-691,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2015,N/A,NDA AUTHORIZED GENERIC,"30 CAPSULE in 1 BOTTLE, PLASTIC (13811-691-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,13811069130,Tramadol,300
TRAMADOL HYDROCHLORIDE,70518-0942-1,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,REMEDYREPACK INC.,70518-0942,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/02/2023,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-0942-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518094201,Tramadol,100
Tramadol Hydrochloride,16571-716-01,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,"Rising Pharma Holdings, Inc.",16571-716,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2020,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (16571-716-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,16571071601,Tramadol,50
Tramadol Hydrochloride,16571-716-10,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,"Rising Pharma Holdings, Inc.",16571-716,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2020,N/A,ANDA,"1000 TABLET, FILM COATED in 1 BOTTLE (16571-716-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,16571071610,Tramadol,50
Tramadol Hydrochloride,16571-716-50,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA203494,"Rising Pharma Holdings, Inc.",16571-716,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/23/2020,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (16571-716-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,16571071650,Tramadol,50
tramadol hydrochloride,71335-0521-0,50 mg/1,TABLET,ORAL,ANDA075964,Bryant Ranch Prepack,71335-0521,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/12/2019,N/A,ANDA,50 TABLET in 1 BOTTLE (71335-0521-0),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335052100,Tramadol,50
tramadol hydrochloride,71335-0521-2,50 mg/1,TABLET,ORAL,ANDA075964,Bryant Ranch Prepack,71335-0521,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/11/2019,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-0521-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335052102,Tramadol,50
Tramadol Hydrochloride,0093-0058-01,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Teva Pharmaceuticals USA, Inc.",0093-0058,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/20/2002,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (0093-0058-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,00093005801,Tramadol,50
Tramadol Hydrochloride,0093-0058-05,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Teva Pharmaceuticals USA, Inc.",0093-0058,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/03/2002,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (0093-0058-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,00093005805,Tramadol,50
Tramadol Hydrochloride,71610-006-46,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"56 TABLET, FILM COATED in 1 BOTTLE (71610-006-46)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000646,Tramadol,50
Tramadol Hydrochloride,71610-006-50,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"50 TABLET, FILM COATED in 1 BOTTLE (71610-006-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000650,Tramadol,50
Tramadol Hydrochloride,71610-006-75,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"150 TABLET, FILM COATED in 1 BOTTLE (71610-006-75)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000675,Tramadol,50
Tramadol Hydrochloride,71610-006-85,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"200 TABLET, FILM COATED in 1 BOTTLE (71610-006-85)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000685,Tramadol,50
Tramadol Hydrochloride,71610-006-98,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"540 TABLET, FILM COATED in 1 BOTTLE (71610-006-98)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000698,Tramadol,50
Tramadol Hydrochloride,68788-8121-1,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Preferred Pharmaceuticals Inc.,68788-8121,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/05/2022,N/A,ANDA,"100 TABLET, COATED in 1 BOTTLE (68788-8121-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788812101,Tramadol,50
Tramadol Hydrochloride,68788-8121-2,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Preferred Pharmaceuticals Inc.,68788-8121,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/05/2022,N/A,ANDA,"20 TABLET, COATED in 1 BOTTLE (68788-8121-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788812102,Tramadol,50
Tramadol Hydrochloride,68788-8121-3,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Preferred Pharmaceuticals Inc.,68788-8121,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/05/2022,N/A,ANDA,"30 TABLET, COATED in 1 BOTTLE (68788-8121-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788812103,Tramadol,50
Tramadol Hydrochloride,68788-8121-4,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Preferred Pharmaceuticals Inc.,68788-8121,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/05/2022,N/A,ANDA,"40 TABLET, COATED in 1 BOTTLE (68788-8121-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788812104,Tramadol,50
Tramadol Hydrochloride,68788-8121-5,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Preferred Pharmaceuticals Inc.,68788-8121,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/05/2022,N/A,ANDA,"15 TABLET, COATED in 1 BOTTLE (68788-8121-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788812105,Tramadol,50
Tramadol Hydrochloride,68788-8121-6,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Preferred Pharmaceuticals Inc.,68788-8121,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/05/2022,N/A,ANDA,"60 TABLET, COATED in 1 BOTTLE (68788-8121-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788812106,Tramadol,50
Tramadol Hydrochloride,68788-8121-7,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Preferred Pharmaceuticals Inc.,68788-8121,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/05/2022,N/A,ANDA,"50 TABLET, COATED in 1 BOTTLE (68788-8121-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788812107,Tramadol,50
Tramadol Hydrochloride,68788-8121-8,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Preferred Pharmaceuticals Inc.,68788-8121,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/05/2022,N/A,ANDA,"120 TABLET, COATED in 1 BOTTLE (68788-8121-8)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788812108,Tramadol,50
Tramadol Hydrochloride,68788-8121-9,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,Preferred Pharmaceuticals Inc.,68788-8121,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/05/2022,N/A,ANDA,"90 TABLET, COATED in 1 BOTTLE (68788-8121-9)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788812109,Tramadol,50
tramadol hydrochloride,70518-0258-3,50 mg/1,TABLET,ORAL,ANDA075964,REMEDYREPACK INC.,70518-0258,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/04/2019,N/A,ANDA,"30 TABLET in 1 BOTTLE, PLASTIC (70518-0258-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518025803,Tramadol,50
TRAMADOL HYDROCHLORIDE,61919-892-30,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,DirectRX,61919-892,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/01/2014,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-892-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,61919089230,Tramadol,100
TRAMADOL HYDROCHLORIDE,71205-066-15,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Proficient Rx LP,71205-066,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/02/2018,N/A,ANDA,"15 TABLET, FILM COATED in 1 BOTTLE (71205-066-15)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205006615,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-389-78,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,Proficient Rx LP,71205-389,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/11/2020,N/A,ANDA,"180 TABLET, FILM COATED in 1 BOTTLE (71205-389-78)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205038978,Tramadol,50
tramadol hydrochloride,0904-7179-61,50 mg/1,TABLET,ORAL,ANDA075964,Major Pharmaceuticals,0904-7179,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/22/2002,N/A,ANDA,100 BLISTER PACK in 1 CARTON (0904-7179-61)  / 1 TABLET in 1 BLISTER PACK,"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,00904717961,Tramadol,50
TRAMADOL HYDROCHLORIDE,70518-3397-1,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,REMEDYREPACK INC.,70518-3397,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/13/2022,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-3397-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,70518339701,Tramadol,100
TRAMADOL HYDROCHLORIDE,71205-569-30,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Proficient Rx LP,71205-569,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/26/2021,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-569-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205056930,Tramadol,300
TRAMADOL HYDROCHLORIDE,71205-569-60,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Proficient Rx LP,71205-569,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/26/2021,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-569-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205056960,Tramadol,300
TRAMADOL HYDROCHLORIDE,71205-569-90,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Proficient Rx LP,71205-569,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/26/2021,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-569-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205056990,Tramadol,300
TRAMADOL HYDROCHLORIDE,47335-860-83,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Sun Pharmaceutical Industries, Inc.",47335-860,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-860-83)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335086083,Tramadol,200
TRAMADOL HYDROCHLORIDE,47335-861-08,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Sun Pharmaceutical Industries, Inc.",47335-861,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-861-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335086108,Tramadol,300
TRAMADOL HYDROCHLORIDE,47335-861-88,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Sun Pharmaceutical Industries, Inc.",47335-861,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-861-88)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335086188,Tramadol,300
Tramadol Hydrochloride,68084-808-01,50 mg/1,"TABLET, COATED",ORAL,ANDA076003,American Health Packaging,68084-808,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/05/2014,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-808-01)  / 1 TABLET, COATED in 1 BLISTER PACK (68084-808-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68084080801,Tramadol,50
TRAMADOL HYDROCHLORIDE,68180-699-06,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,"Lupin Pharmaceuticals, Inc.",68180-699,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/19/2014,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-699-06)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,68180069906,Tramadol,300
TRAMADOL HYDROCHLORIDE,69543-136-50,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,Virtus Pharmaceuticals LLC,69543-136,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,05/22/2015,04/30/2023,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (69543-136-50)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,N/A,69543013650,Tramadol,50
tramadol hydrochloride,71205-303-20,50 mg/1,TABLET,ORAL,ANDA075964,Proficient Rx LP,71205-303,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/01/2019,N/A,ANDA,20 TABLET in 1 BOTTLE (71205-303-20),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205030320,Tramadol,50
tramadol hydrochloride,71205-303-30,50 mg/1,TABLET,ORAL,ANDA075964,Proficient Rx LP,71205-303,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/01/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (71205-303-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205030330,Tramadol,50
tramadol hydrochloride,71205-303-40,50 mg/1,TABLET,ORAL,ANDA075964,Proficient Rx LP,71205-303,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/01/2019,N/A,ANDA,40 TABLET in 1 BOTTLE (71205-303-40),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205030340,Tramadol,50
tramadol hydrochloride,71205-303-60,50 mg/1,TABLET,ORAL,ANDA075964,Proficient Rx LP,71205-303,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/01/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (71205-303-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205030360,Tramadol,50
tramadol hydrochloride,71205-303-72,50 mg/1,TABLET,ORAL,ANDA075964,Proficient Rx LP,71205-303,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/01/2019,N/A,ANDA,120 TABLET in 1 BOTTLE (71205-303-72),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205030372,Tramadol,50
tramadol hydrochloride,71205-303-78,50 mg/1,TABLET,ORAL,ANDA075964,Proficient Rx LP,71205-303,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/01/2019,N/A,ANDA,180 TABLET in 1 BOTTLE (71205-303-78),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205030378,Tramadol,50
tramadol hydrochloride,71205-303-90,50 mg/1,TABLET,ORAL,ANDA075964,Proficient Rx LP,71205-303,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/01/2019,N/A,ANDA,90 TABLET in 1 BOTTLE (71205-303-90),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205030390,Tramadol,50
tramadol hydrochloride,71335-0521-4,50 mg/1,TABLET,ORAL,ANDA075964,Bryant Ranch Prepack,71335-0521,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2018,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0521-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335052104,Tramadol,50
tramadol hydrochloride,71335-0521-1,50 mg/1,TABLET,ORAL,ANDA075964,Bryant Ranch Prepack,71335-0521,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/14/2018,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0521-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335052101,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-389-20,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,Proficient Rx LP,71205-389,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/17/2020,N/A,ANDA,"20 TABLET, FILM COATED in 1 BOTTLE (71205-389-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205038920,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-389-30,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,Proficient Rx LP,71205-389,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/17/2020,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (71205-389-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205038930,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-389-60,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,Proficient Rx LP,71205-389,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/17/2020,N/A,ANDA,"60 TABLET, FILM COATED in 1 BOTTLE (71205-389-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205038960,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-389-72,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,Proficient Rx LP,71205-389,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/21/2020,N/A,ANDA,"120 TABLET, FILM COATED in 1 BOTTLE (71205-389-72)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205038972,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-389-90,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA091498,Proficient Rx LP,71205-389,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/17/2020,N/A,ANDA,"90 TABLET, FILM COATED in 1 BOTTLE (71205-389-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205038990,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-463-30,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Proficient Rx LP,71205-463,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/21/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-463-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205046330,Tramadol,100
TRAMADOL HYDROCHLORIDE,71205-463-60,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Proficient Rx LP,71205-463,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/21/2020,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-463-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205046360,Tramadol,100
TRAMADOL HYDROCHLORIDE,71205-463-90,100 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Proficient Rx LP,71205-463,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/21/2020,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-463-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205046390,Tramadol,100
TRAMADOL HYDROCHLORIDE,71205-468-30,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Proficient Rx LP,71205-468,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/13/2020,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-468-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205046830,Tramadol,200
TRAMADOL HYDROCHLORIDE,71205-468-60,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Proficient Rx LP,71205-468,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/13/2020,N/A,ANDA,"60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-468-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205046860,Tramadol,200
TRAMADOL HYDROCHLORIDE,71205-468-90,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA200503,Proficient Rx LP,71205-468,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/13/2020,N/A,ANDA,"90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-468-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205046890,Tramadol,200
TRAMADOL HYDROCHLORIDE,72189-311-72,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,DirectRx,72189-311,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/12/2022,N/A,ANDA,"120 TABLET, COATED in 1 BOTTLE (72189-311-72)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,72189031172,Tramadol,50
TRAMADOL HYDROCHLORIDE,72189-311-90,50 mg/1,"TABLET, COATED",ORAL,ANDA208708,DirectRx,72189-311,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/12/2022,N/A,ANDA,"90 TABLET, COATED in 1 BOTTLE (72189-311-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,72189031190,Tramadol,50
Tramadol Hydrochloride,71610-006-70,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"120 TABLET, FILM COATED in 1 BOTTLE (71610-006-70)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000670,Tramadol,50
Tramadol Hydrochloride,71610-006-90,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA075977,"Aphena Pharma Solutions - Tennessee, LLC",71610-006,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/06/2017,N/A,ANDA,"240 TABLET, FILM COATED in 1 BOTTLE (71610-006-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71610000690,Tramadol,50
TRAMADOL HYDROCHLORIDE,47335-533-83,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA091607,"Sun Pharmaceutical Industries, Inc.",47335-533,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-533-83)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335053383,Tramadol,200
TRAMADOL HYDROCHLORIDE,47335-533-88,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA091607,"Sun Pharmaceutical Industries, Inc.",47335-533,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-533-88)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335053388,Tramadol,200
TRAMADOL HYDROCHLORIDE,47335-537-08,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA091607,"Sun Pharmaceutical Industries, Inc.",47335-537,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,"100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-537-08)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335053708,Tramadol,300
Tramadol Hydrochloride,45865-709-60,150 mg/1,"CAPSULE, EXTENDED RELEASE",ORAL,NDA022370,Medsource Pharmaceuticals,45865-709,Tramadol Hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/27/2015,N/A,NDA,"60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (45865-709-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,45865070960,Tramadol,150
tramadol hydrochloride,71335-1319-1,50 mg/1,TABLET,ORAL,ANDA075964,Bryant Ranch Prepack,71335-1319,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/10/2020,N/A,ANDA,8 TABLET in 1 BOTTLE (71335-1319-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335131901,Tramadol,50
tramadol hydrochloride,71335-1319-2,50 mg/1,TABLET,ORAL,ANDA075964,Bryant Ranch Prepack,71335-1319,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2021,N/A,ANDA,84 TABLET in 1 BOTTLE (71335-1319-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335131902,Tramadol,50
tramadol hydrochloride,71335-1319-3,50 mg/1,TABLET,ORAL,ANDA075964,Bryant Ranch Prepack,71335-1319,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/28/2019,N/A,ANDA,56 TABLET in 1 BOTTLE (71335-1319-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335131903,Tramadol,50
tramadol hydrochloride,71335-1319-4,50 mg/1,TABLET,ORAL,ANDA075964,Bryant Ranch Prepack,71335-1319,tramadol hydrochloride,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/19/2020,N/A,ANDA,10 TABLET in 1 BOTTLE (71335-1319-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,71335131904,Tramadol,50
TRAMADOL HYDROCHLORIDE,35356-790-30,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,Lake Erie Medical DBA Quality Care Products LLC,35356-790,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (35356-790-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,35356079030,Tramadol,300
TRAMADOL HYDROCHLORIDE,71205-066-20,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Proficient Rx LP,71205-066,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/02/2018,N/A,ANDA,"20 TABLET, FILM COATED in 1 BOTTLE (71205-066-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205006620,Tramadol,50
TRAMADOL HYDROCHLORIDE,71205-066-30,50 mg/1,"TABLET, FILM COATED",ORAL,ANDA090404,Proficient Rx LP,71205-066,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/02/2018,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (71205-066-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205006630,Tramadol,50
TRAMADOL HYDROCHLORIDE,47335-537-83,300 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA091607,"Sun Pharmaceutical Industries, Inc.",47335-537,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/30/2011,N/A,ANDA,"30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-537-83)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335053783,Tramadol,300
TRAMADOL HYDROCHLORIDE,47335-860-18,200 mg/1,"TABLET, EXTENDED RELEASE",ORAL,ANDA201384,"Sun Pharmaceutical Industries, Inc.",47335-860,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/12/2011,N/A,ANDA,"1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-860-18)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,47335086018,Tramadol,200
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,71335-0151-6,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA077184,Bryant Ranch Prepack,71335-0151,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/20/2022,N/A,ANDA,"40 TABLET, FILM COATED in 1 BOTTLE (71335-0151-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335015106,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,68382-334-05,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA090460,Zydus Pharmaceuticals USA Inc.,68382-334,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/15/2012,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (68382-334-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68382033405,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,65841-758-05,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA090460,Zydus Lifesciences Limited,65841-758,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/15/2012,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (65841-758-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,65841075805,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,63187-585-90,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA090460,Proficient Rx LP,63187-585,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2018,N/A,ANDA,"90 TABLET, FILM COATED in 1 BOTTLE (63187-585-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187058590,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,71335-0151-3,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA077184,Bryant Ranch Prepack,71335-0151,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/04/2020,N/A,ANDA,"90 TABLET, FILM COATED in 1 BOTTLE (71335-0151-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335015103,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,71335-0151-5,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA077184,Bryant Ranch Prepack,71335-0151,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/08/2019,N/A,ANDA,"20 TABLET, FILM COATED in 1 BOTTLE (71335-0151-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335015105,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,65162-617-50,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Amneal Pharmaceuticals LLC,65162-617,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/17/2009,N/A,ANDA,500 TABLET in 1 BOTTLE (65162-617-50),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,65162061750,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,68788-7855-2,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Preferred Pharmaceuticals Inc.,68788-7855,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/29/2021,N/A,ANDA,20 TABLET in 1 BOTTLE (68788-7855-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788785502,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,68788-7855-3,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Preferred Pharmaceuticals Inc.,68788-7855,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/29/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (68788-7855-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788785503,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,68788-7855-9,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Preferred Pharmaceuticals Inc.,68788-7855,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/29/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (68788-7855-9),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68788785509,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,65862-922-78,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Aurobindo Pharma Limited,65862-922,Tramadol Hydrochloride and Acetaminophen,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/22/2017,N/A,ANDA,"10 BLISTER PACK in 1 CARTON (65862-922-78)  / 10 TABLET, FILM COATED in 1 BLISTER PACK (65862-922-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,65862092278,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,50268-774-15,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,AvPAK,50268-774,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/14/2015,N/A,ANDA,50 BLISTER PACK in 1 BOX (50268-774-15)  / 1 TABLET in 1 BLISTER PACK (50268-774-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,50268077415,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,71335-0151-4,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA077184,Bryant Ranch Prepack,71335-0151,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/21/2020,N/A,ANDA,"120 TABLET, FILM COATED in 1 BOTTLE (71335-0151-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335015104,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,71335-0151-7,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA077184,Bryant Ranch Prepack,71335-0151,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/20/2022,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (71335-0151-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335015107,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,53746-617-01,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Amneal Pharmaceuticals of New York LLC,53746-617,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/17/2009,N/A,ANDA,100 TABLET in 1 BOTTLE (53746-617-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,53746061701,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,53746-617-05,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Amneal Pharmaceuticals of New York LLC,53746-617,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/17/2009,N/A,ANDA,500 TABLET in 1 BOTTLE (53746-617-05),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,53746061705,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,53746-617-10,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Amneal Pharmaceuticals of New York LLC,53746-617,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/17/2009,N/A,ANDA,1000 TABLET in 1 BOTTLE (53746-617-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,53746061710,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,53746-617-30,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Amneal Pharmaceuticals of New York LLC,53746-617,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/17/2009,N/A,ANDA,30 TABLET in 1 BOTTLE (53746-617-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,53746061730,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-0111-8,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,71335-0111,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/26/2022,N/A,ANDA,15 TABLET in 1 BOTTLE (71335-0111-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335011108,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,42571-119-01,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA201952,Micro Labs Limited,42571-119,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/15/2012,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (42571-119-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,42571011901,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,70518-2784-0,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA201952,REMEDYREPACK INC.,70518-2784,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/12/2020,N/A,ANDA,"30 TABLET, FILM COATED in 1 BLISTER PACK (70518-2784-0)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,70518278400,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-0111-1,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,71335-0111,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/17/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (71335-0111-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335011101,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,42571-119-90,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA201952,Micro Labs Limited,42571-119,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/15/2012,N/A,ANDA,"90 TABLET, FILM COATED in 1 BOTTLE (42571-119-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,42571011990,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,65862-922-05,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Aurobindo Pharma Limited,65862-922,Tramadol Hydrochloride and Acetaminophen,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/22/2017,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (65862-922-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,65862092205,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,57664-537-18,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA077184,"Sun Pharmaceutical Industries, Inc.",57664-537,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/16/2005,N/A,ANDA,"1000 TABLET, FILM COATED in 1 BOTTLE (57664-537-18)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,57664053718,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-0111-4,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,71335-0111,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/26/2022,N/A,ANDA,120 TABLET in 1 BOTTLE (71335-0111-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335011104,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,71335-0151-8,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA077184,Bryant Ranch Prepack,71335-0151,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,07/07/2021,N/A,ANDA,"15 TABLET, FILM COATED in 1 BOTTLE (71335-0151-8)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335015108,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-1742-8,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Bryant Ranch Prepack,71335-1742,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/29/2021,N/A,ANDA,"15 TABLET, FILM COATED in 1 BOTTLE (71335-1742-8)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335174208,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,65162-617-11,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Amneal Pharmaceuticals LLC,65162-617,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/17/2009,N/A,ANDA,1000 TABLET in 1 BOTTLE (65162-617-11),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,65162061711,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,63187-084-60,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Proficient Rx LP,63187-084,Tramadol Hydrochloride and Acetaminophen,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/01/2019,N/A,ANDA,60 TABLET in 1 BOTTLE (63187-084-60),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187008460,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,63629-4901-1,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,63629-4901,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/25/2013,N/A,ANDA,30 TABLET in 1 BOTTLE (63629-4901-1),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629490101,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,63629-4901-2,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,63629-4901,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/21/2013,N/A,ANDA,60 TABLET in 1 BOTTLE (63629-4901-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629490102,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,63629-4901-3,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,63629-4901,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,06/09/2014,N/A,ANDA,90 TABLET in 1 BOTTLE (63629-4901-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629490103,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,63629-4901-4,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,63629-4901,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,11/15/2013,N/A,ANDA,120 TABLET in 1 BOTTLE (63629-4901-4),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629490104,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,63629-4901-5,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,63629-4901,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/28/2014,N/A,ANDA,20 TABLET in 1 BOTTLE (63629-4901-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629490105,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,63629-4901-6,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,63629-4901,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/02/2014,N/A,ANDA,40 TABLET in 1 BOTTLE (63629-4901-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629490106,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,63629-4901-7,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,63629-4901,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/15/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (63629-4901-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629490107,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,63629-4901-8,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,63629-4901,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/15/2022,N/A,ANDA,15 TABLET in 1 BOTTLE (63629-4901-8),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63629490108,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,72189-382-60,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Direct_Rx,72189-382,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/14/2022,N/A,ANDA,"60 TABLET, FILM COATED in 1 BOTTLE (72189-382-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,72189038260,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,68071-2831-2,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA077184,"NuCare Pharmaceuticals,Inc.",68071-2831,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/14/2022,N/A,ANDA,"20 TABLET, FILM COATED in 1 BOTTLE (68071-2831-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071283102,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,68071-2351-1,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,"NuCare Pharmaceuticals,Inc.",68071-2351,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,02/18/2021,N/A,ANDA,"16 TABLET, FILM COATED in 1 BOTTLE (68071-2351-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68071235101,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71205-625-30,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Proficient Rx LP,71205-625,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/15/2021,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (71205-625-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205062530,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,57664-537-13,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA077184,"Sun Pharmaceutical Industries, Inc.",57664-537,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/16/2005,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (57664-537-13)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,57664053713,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,57664-537-88,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA077184,"Sun Pharmaceutical Industries, Inc.",57664-537,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,12/16/2005,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (57664-537-88)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,57664053788,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-0111-5,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,71335-0111,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/14/2021,N/A,ANDA,20 TABLET in 1 BOTTLE (71335-0111-5),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335011105,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,42571-119-23,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA201952,Micro Labs Limited,42571-119,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/15/2012,N/A,ANDA,"8 BLISTER PACK in 1 CARTON (42571-119-23)  / 10 TABLET, FILM COATED in 1 BLISTER PACK (42571-119-32)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,42571011923,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,65862-922-01,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Aurobindo Pharma Limited,65862-922,Tramadol Hydrochloride and Acetaminophen,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/22/2017,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (65862-922-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,65862092201,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,65862-922-30,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Aurobindo Pharma Limited,65862-922,Tramadol Hydrochloride and Acetaminophen,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/22/2017,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (65862-922-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,65862092230,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-0111-2,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,71335-0111,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,04/14/2021,N/A,ANDA,60 TABLET in 1 BOTTLE (71335-0111-2),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335011102,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-0111-7,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,71335-0111,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/26/2022,N/A,ANDA,100 TABLET in 1 BOTTLE (71335-0111-7),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335011107,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,71335-0151-1,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA077184,Bryant Ranch Prepack,71335-0151,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/18/2019,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (71335-0151-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335015101,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,76420-983-01,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,"Asclemed USA, Inc.",76420-983,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/14/2022,N/A,ANDA,1 TABLET in 1 BOTTLE (76420-983-01),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420098301,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,76420-983-03,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,"Asclemed USA, Inc.",76420-983,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/14/2022,N/A,ANDA,3 TABLET in 1 BOTTLE (76420-983-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420098303,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,76420-983-10,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,"Asclemed USA, Inc.",76420-983,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/14/2022,N/A,ANDA,10 TABLET in 1 BOTTLE (76420-983-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420098310,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,76420-983-30,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,"Asclemed USA, Inc.",76420-983,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/14/2022,N/A,ANDA,30 TABLET in 1 BOTTLE (76420-983-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420098330,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,76420-105-01,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA201952,"Asclemed USA, Inc.",76420-105,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/30/2020,N/A,ANDA,"1 TABLET, FILM COATED in 1 BOTTLE (76420-105-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420010501,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,76420-105-02,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA201952,"Asclemed USA, Inc.",76420-105,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/30/2020,N/A,ANDA,"2 TABLET, FILM COATED in 1 BOTTLE (76420-105-02)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420010502,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,76420-105-03,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA201952,"Asclemed USA, Inc.",76420-105,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/30/2020,N/A,ANDA,"3 TABLET, FILM COATED in 1 BOTTLE (76420-105-03)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420010503,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,76420-105-10,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA201952,"Asclemed USA, Inc.",76420-105,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/30/2020,N/A,ANDA,"10 TABLET, FILM COATED in 1 BOTTLE (76420-105-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420010510,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,76420-105-30,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA201952,"Asclemed USA, Inc.",76420-105,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,10/30/2020,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (76420-105-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420010530,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71205-625-60,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Proficient Rx LP,71205-625,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/15/2021,N/A,ANDA,"60 TABLET, FILM COATED in 1 BOTTLE (71205-625-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205062560,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71205-625-90,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Proficient Rx LP,71205-625,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/15/2021,N/A,ANDA,"90 TABLET, FILM COATED in 1 BOTTLE (71205-625-90)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71205062590,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,65162-617-03,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Amneal Pharmaceuticals LLC,65162-617,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/17/2009,N/A,ANDA,30 TABLET in 1 BOTTLE (65162-617-03),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,65162061703,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,65162-617-10,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Amneal Pharmaceuticals LLC,65162-617,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/17/2009,N/A,ANDA,100 TABLET in 1 BOTTLE (65162-617-10),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2024,65162061710,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,63187-585-30,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA090460,Proficient Rx LP,63187-585,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2018,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (63187-585-30)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187058530,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,63187-585-60,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA090460,Proficient Rx LP,63187-585,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/01/2018,N/A,ANDA,"60 TABLET, FILM COATED in 1 BOTTLE (63187-585-60)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187058560,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,42571-119-05,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA201952,Micro Labs Limited,42571-119,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/15/2012,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (42571-119-05)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,42571011905,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,60760-922-20,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,St. Mary's Medical Park Pharmacy,60760-922,Tramadol Hydrochloride and Acetaminophen,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,09/02/2021,N/A,ANDA,"20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-922-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,60760092220,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,65862-922-99,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Aurobindo Pharma Limited,65862-922,Tramadol Hydrochloride and Acetaminophen,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,03/22/2017,N/A,ANDA,"1000 TABLET, FILM COATED in 1 BOTTLE (65862-922-99)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,65862092299,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,65841-758-01,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA090460,Zydus Lifesciences Limited,65841-758,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/15/2012,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (65841-758-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,65841075801,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,68382-334-10,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA090460,Zydus Pharmaceuticals USA Inc.,68382-334,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/15/2012,N/A,ANDA,"1000 TABLET, FILM COATED in 1 BOTTLE (68382-334-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68382033410,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,68084-825-01,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA077184,American Health Packaging,68084-825,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/05/2014,N/A,ANDA,"100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-825-01)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (68084-825-11)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68084082501,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-0111-3,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,71335-0111,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,08/20/2021,N/A,ANDA,90 TABLET in 1 BOTTLE (71335-0111-3),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335011103,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-0111-6,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Bryant Ranch Prepack,71335-0111,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,09/26/2022,N/A,ANDA,40 TABLET in 1 BOTTLE (71335-0111-6),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335011106,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-1742-1,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Bryant Ranch Prepack,71335-1742,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/28/2020,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (71335-1742-1)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335174201,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-1742-2,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Bryant Ranch Prepack,71335-1742,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/26/2021,N/A,ANDA,"60 TABLET, FILM COATED in 1 BOTTLE (71335-1742-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335174202,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-1742-3,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Bryant Ranch Prepack,71335-1742,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,03/05/2021,N/A,ANDA,"90 TABLET, FILM COATED in 1 BOTTLE (71335-1742-3)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335174203,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-1742-4,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Bryant Ranch Prepack,71335-1742,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/29/2021,N/A,ANDA,"120 TABLET, FILM COATED in 1 BOTTLE (71335-1742-4)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335174204,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-1742-5,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Bryant Ranch Prepack,71335-1742,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/29/2021,N/A,ANDA,"20 TABLET, FILM COATED in 1 BOTTLE (71335-1742-5)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335174205,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-1742-6,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Bryant Ranch Prepack,71335-1742,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/29/2021,N/A,ANDA,"40 TABLET, FILM COATED in 1 BOTTLE (71335-1742-6)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335174206,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,71335-1742-7,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA207152,Bryant Ranch Prepack,71335-1742,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/29/2021,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (71335-1742-7)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335174207,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,68382-334-01,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA090460,Zydus Pharmaceuticals USA Inc.,68382-334,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/15/2012,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (68382-334-01)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,68382033401,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,63187-084-30,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,Proficient Rx LP,63187-084,Tramadol Hydrochloride and Acetaminophen,TRAMADOL HYDROCHLORIDE;  ACETAMINOPHEN,HUMAN PRESCRIPTION DRUG,01/01/2019,N/A,ANDA,30 TABLET in 1 BOTTLE (63187-084-30),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,63187008430,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,60760-335-20,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA090460,St. Mary's Medical Park Pharmacy,60760-335,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/15/2017,N/A,ANDA,"20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-335-20)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,60760033520,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,65841-758-10,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA090460,Zydus Lifesciences Limited,65841-758,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,10/15/2012,N/A,ANDA,"1000 TABLET, FILM COATED in 1 BOTTLE (65841-758-10)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,65841075810,Tramadol,325
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,71335-0151-2,"325 mg/1,                         37.5  mg/1","TABLET, FILM COATED",ORAL,ANDA077184,Bryant Ranch Prepack,71335-0151,TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,12/17/2019,N/A,ANDA,"60 TABLET, FILM COATED in 1 BOTTLE (71335-0151-2)","Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,71335015102,Tramadol,325
Tramadol Hydrochloride and Acetaminophen,76420-983-02,"325 mg/1,                         37.5  mg/1",TABLET,ORAL,ANDA090485,"Asclemed USA, Inc.",76420-983,Tramadol Hydrochloride and Acetaminophen,ACETAMINOPHEN;  TRAMADOL HYDROCHLORIDE,HUMAN PRESCRIPTION DRUG,01/14/2022,N/A,ANDA,2 TABLET in 1 BOTTLE (76420-983-02),"Full Opioid Agonists [MoA],  Opioid Agonist [EPC]",CIV,No,12/31/2023,76420098302,Tramadol,325
